<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>BRPI0619092A2 - 
  isolated nucleic acid molecule, isolated polypeptide, vector, host cell, transgenic plant, seed, method for producing polypeptide with herbicide resistance activity, method for conferring herbicide resistance to plant, method for measuring enzyme phosphate release
 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/BRPI0619092A2/en">
    <meta name="description" content="
   
    ISOLATED NUCLEIC ACID MOLECULA, ISOLATED POLYPEPTIDE, VECTOR, HOST CELL, TRANSGENIC PLANT, SEED, METHOD FOR PRODUCING HERBICID RESISTANCE ACTIVITY FOR MEBRAID MEASURES FOR PLANTAN MEASURES Compositions and methods for imparting herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include polynucleotides encoding herbicide resistance or tolerance polypeptides, vectors comprising those polynucleotides, and host cells comprising the vectors. The nucleotide sequences of the invention may be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also comprise transformed bacteria, plants, plants, plant cells, tissues and seeds. In particular, isolated polynucleotides encoding glyphosate resistance or tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides isolated polynucleotides comprising nucleotide sequences encoding the amino acid sequence set forth in SEQ ID NO: 2, 4, or 6, or the nucleotide sequence set forth in SEQ ID NO: 1, 3, or 5. A The present invention further provides a method for measuring enzyme kinetic activity using fluorogenic substrates.
   
 
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="
  isolated nucleic acid molecule, isolated polypeptide, vector, host cell, transgenic plant, seed, method for producing polypeptide with herbicide resistance activity, method for conferring herbicide resistance to plant, method for measuring enzyme phosphate release
 
     ">
    <meta name="DC.date" content="2006-12-01" scheme="dateSubmitted">
    <meta name="DC.description" content="
   
    ISOLATED NUCLEIC ACID MOLECULA, ISOLATED POLYPEPTIDE, VECTOR, HOST CELL, TRANSGENIC PLANT, SEED, METHOD FOR PRODUCING HERBICID RESISTANCE ACTIVITY FOR MEBRAID MEASURES FOR PLANTAN MEASURES Compositions and methods for imparting herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include polynucleotides encoding herbicide resistance or tolerance polypeptides, vectors comprising those polynucleotides, and host cells comprising the vectors. The nucleotide sequences of the invention may be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also comprise transformed bacteria, plants, plants, plant cells, tissues and seeds. In particular, isolated polynucleotides encoding glyphosate resistance or tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides isolated polynucleotides comprising nucleotide sequences encoding the amino acid sequence set forth in SEQ ID NO: 2, 4, or 6, or the nucleotide sequence set forth in SEQ ID NO: 1, 3, or 5. A The present invention further provides a method for measuring enzyme kinetic activity using fluorogenic substrates.
   
 
   ">
    <meta name="citation_patent_application_number" content="BR:PI0619092-8A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/c0/77/f1/dd4e233d94823a/BRPI0619092A2.pdf">
    <meta name="citation_patent_publication_number" content="BR:PI0619092:A2">
    <meta name="DC.date" content="2011-09-13">
    <meta name="DC.contributor" content="Cheryl L Peters" scheme="inventor">
    <meta name="DC.contributor" content="Jill Hinson" scheme="inventor">
    <meta name="DC.contributor" content="Philip E Hammer" scheme="inventor">
    <meta name="DC.contributor" content="Brian Vande Berg" scheme="inventor">
    <meta name="DC.contributor" content="Laura Cooper Schouten" scheme="inventor">
    <meta name="DC.contributor" content="Brian Carr" scheme="inventor">
    <meta name="DC.contributor" content="Athenix Corp" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            
  isolated nucleic acid molecule, isolated polypeptide, vector, host cell, transgenic plant, seed, method for producing polypeptide with herbicide resistance activity, method for conferring herbicide resistance to plant, method for measuring enzyme phosphate release
 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result">translated from Portuguese</div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA90205482" lang="EN" source="national office" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MOLCULA DE CIDO NUCLICO ISOLADA, POLIPEPTDEO ISOLADO, VETOR, CLULA HOSPEDEIRA, PLANTA TRANSGNICA, SEMENTE, MTODO PARA PRODUZIR POLIPEPTIDEO COM ATIVIDADE DE RESISTNCIA A HERBICIDAS, METODO PARA CONFERIR RESISTNCIA A HERBICIDA PARA PLANTA, MTODO PARA MEDIR A LIBERAO DE FOSFATO POR ENZIMA. Composies e mtodos para conferir resistncia ou tolerncia a herbicidas para bactrias, plantas, clulas vegetais, tecidos e sementes so providos. Composies incluem polinucleotdeos codificando polipeptdeos de resistncia ou tolerncia a herbicidas, vetores compreendendo aqueles polinucleotdeos, e clulas hospedeiras compreendendo os vetores. As seqncias de nucleotdeos da inveno podem ser usadas em constructos de DNA ou cassetes de expresso para transformao e expresso em organismos, incluindo microorganismos e plantas. Composies tambm compreendem bactrias, plantas, plantas, clulas vegetais, tecidos e sementes transformadas. Em particular, so providos polinucleotdeos isolados codificando polipeptdeos de resistncia ou tolerncia a glifosato. Adicionalmente, seqncias de aminocidos correspondentes aos polinucleotideos so englobadas. Em particular, a presente inveno prov polinucleotdeos isolados compreendendo seqncias de nucleotdeos codificando a seqUncia de aminocidos apresentada em SEQ ID NO: 2, 4, ou 6, ou a seqUncia de nucleotdeos apresentada em SEQ ID NO: 1, 3, ou 5. A presente inveno prov, adicionalmente, um mtodo para medir atividade cintica de enzima usando substratos fluorognicos.</span>ISOLATED NUCLEIC ACID MOLECULA, ISOLATED POLYPEPTIDE, VECTOR, HOST CELL, TRANSGENIC PLANT, SEED, METHOD FOR PRODUCING HERBICID RESISTANCE ACTIVITY FOR MEBRAID MEASURES FOR PLANTAN MEASURES Compositions and methods for imparting herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include polynucleotides encoding herbicide resistance or tolerance polypeptides, vectors comprising those polynucleotides, and host cells comprising the vectors. The nucleotide sequences of the invention may be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also comprise transformed bacteria, plants, plants, plant cells, tissues and seeds. In particular, isolated polynucleotides encoding glyphosate resistance or tolerance polypeptides are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides isolated polynucleotides comprising nucleotide sequences encoding the amino acid sequence set forth in SEQ ID NO: 2, 4, or 6, or the nucleotide sequence set forth in SEQ ID NO: 1, 3, or 5. A The present invention further provides a method for measuring enzyme kinetic activity using fluorogenic substrates.</span>
  </p>
</abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/63"><a id="link" href="#" class="style-scope state-modifier">C12N15/63</a></state-modifier>
                  <span class="description style-scope classification-tree">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/79"><a id="link" href="#" class="style-scope state-modifier">C12N15/79</a></state-modifier>
                  <span class="description style-scope classification-tree">Vectors or expression systems specially adapted for eukaryotic hosts</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/82"><a id="link" href="#" class="style-scope state-modifier">C12N15/82</a></state-modifier>
                  <span class="description style-scope classification-tree">Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8241"><a id="link" href="#" class="style-scope state-modifier">C12N15/8241</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8261"><a id="link" href="#" class="style-scope state-modifier">C12N15/8261</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8271"><a id="link" href="#" class="style-scope state-modifier">C12N15/8271</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8274"><a id="link" href="#" class="style-scope state-modifier">C12N15/8274</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C12N15/8275"><a id="link" href="#" class="style-scope state-modifier">C12N15/8275</a></state-modifier>
                  <span class="description style-scope classification-tree">Glyphosate</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/195"><a id="link" href="#" class="style-scope state-modifier">C07K14/195</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/00"><a id="link" href="#" class="style-scope state-modifier">C07K14/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K14/415"><a id="link" href="#" class="style-scope state-modifier">C07K14/415</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N"><a id="link" href="#" class="style-scope state-modifier">C12N</a></state-modifier>
                  <span class="description style-scope classification-tree">MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/00"><a id="link" href="#" class="style-scope state-modifier">C12N15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/09"><a id="link" href="#" class="style-scope state-modifier">C12N15/09</a></state-modifier>
                  <span class="description style-scope classification-tree">Recombinant DNA-technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/63"><a id="link" href="#" class="style-scope state-modifier">C12N15/63</a></state-modifier>
                  <span class="description style-scope classification-tree">Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/79"><a id="link" href="#" class="style-scope state-modifier">C12N15/79</a></state-modifier>
                  <span class="description style-scope classification-tree">Vectors or expression systems specially adapted for eukaryotic hosts</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/82"><a id="link" href="#" class="style-scope state-modifier">C12N15/82</a></state-modifier>
                  <span class="description style-scope classification-tree">Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8241"><a id="link" href="#" class="style-scope state-modifier">C12N15/8241</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8261"><a id="link" href="#" class="style-scope state-modifier">C12N15/8261</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8271"><a id="link" href="#" class="style-scope state-modifier">C12N15/8271</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12N15/8274"><a id="link" href="#" class="style-scope state-modifier">C12N15/8274</a></state-modifier>
                  <span class="description style-scope classification-tree">Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q"><a id="link" href="#" class="style-scope state-modifier">C12Q</a></state-modifier>
                  <span class="description style-scope classification-tree">MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/00"><a id="link" href="#" class="style-scope state-modifier">C12Q1/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/34"><a id="link" href="#" class="style-scope state-modifier">C12Q1/34</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12Q1/42"><a id="link" href="#" class="style-scope state-modifier">C12Q1/42</a></state-modifier>
                  <span class="description style-scope classification-tree">Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 4 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">BRPI0619092A2</h2>
                  <p class="tagline style-scope patent-result">Brazil</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Application for a patent of invention published without search report</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/c0/77/f1/dd4e233d94823a/BRPI0619092A2.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;gly&quot;,&quot;wing&quot;,&quot;leu&quot;,&quot;arg&quot;,&quot;thr&quot;]" data-before="20051201"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/BRPI0619092A2"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0619092A2/pt"><a id="link" href="#" class="style-scope state-modifier">Portuguese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Cheryl L Peters"><a id="link" href="#" class="style-scope state-modifier">Cheryl L Peters</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jill Hinson"><a id="link" href="#" class="style-scope state-modifier">Jill Hinson</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Philip E Hammer"><a id="link" href="#" class="style-scope state-modifier">Philip E Hammer</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Brian Vande Berg"><a id="link" href="#" class="style-scope state-modifier">Brian Vande Berg</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Laura Cooper Schouten"><a id="link" href="#" class="style-scope state-modifier">Laura Cooper Schouten</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Brian Carr"><a id="link" href="#" class="style-scope state-modifier">Brian Carr</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2006</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US7674958B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US11/605,824</div>
                <div class="style-scope application-timeline">Filing date: 2006-11-29</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AR057205A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ARP060105284A</div>
                <div class="style-scope application-timeline">Filing date: 2006-11-29</div>
                <div class="style-scope application-timeline">Legal status: IP Right Grant</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ569433A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ569433A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2393225C2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">RU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RU2008126711/13A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK1963510T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK06844685T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE440954T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT06844685T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PT1963510E/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PT06844685T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP2078754B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP09004550.1A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Not-in-force</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2332380T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES06844685T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BRPI0619092A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BRPI0619092-8A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SI1963510T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">SI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SI200630475T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE602006008827D1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE602006008827T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RS51134B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">RS</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RSP-2009/0511A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PL1963510T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">PL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PL06844685T</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP1963510B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP06844685A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2007064828A2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/US2006/045908</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Application Filing</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU2006320516C1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU2006320516A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2631406C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA2631406A</div>
                <div class="style-scope application-timeline">Filing date: 2006-12-01</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2009</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US8309332B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US12/468,205</div>
                <div class="style-scope application-timeline">Filing date: 2009-05-19</div>
                <div class="style-scope application-timeline">Legal status: Active</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HRP20090610T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">HR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HR20090610T</div>
                <div class="style-scope application-timeline">Filing date: 2009-11-13</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application BRPI0619092-8A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2006-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Athenix Corp"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Athenix Corp</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2011-09-13</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BRPI0619092A2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of BRPI0619092A2</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (15)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (27)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=BR&amp;NR=PI0619092A2&amp;KC=A2&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/BR/PI0619092/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/BRPI0619092A2">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Portuguese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES96645858" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MOLCULA DE ACIDO NUCLEICO ISOLADA, POLIPEPTIDEO ISOLADO, VETOR, CLULA HOSPEDEIRA, PLANTA TRANS GNICA, SEMENTE, MTODO PARA PRODUZIR POLIPEPTIDEO COM ATIVIDADE DE RESISTNCIA A HERBICIDAS, MTODO PARA CONFERIR RESISTNCIA A HERBICIDA PARA PLANTA, MTODO PARA MEDIR A LIBERAO DE FOSFATO POR ENZIMA</span>ISOLATED NUCLEIC ACID MOLECULA, ISOLATED POLYPEPTIDE, VECTOR, HOST CELL, TRANS GENERIC PLANT, SEED, METHOD FOR PRODUCING HERBICIDE RESISTANCE ACTIVITY, METHOD FOR HERPIC RESERTATION FOR PERMANIZATION FOR PERMANIZATION</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CAMPO DA INVENO</span>FIELD OF INVENTION</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Esta inveno prov novos genes codificando resistncia a herbicidas, os quais so teis em biologia vegetal, melhoramento de cultivares, e cultura de clulas vegetais.</span>This invention provides novel genes encoding herbicide resistance, which are useful in plant biology, cultivar improvement, and plant cell culture.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FUNDAMENTOS DA INVENO</span>BACKGROUND OF THE INVENTION</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">N-fosfonometilglicina, comumente referida como glifosato,  um importante qumico agrcola. Glifosato inibe a enzima que converte cido fosfoenolpirvico (PEP) e cido 3-fosfochiqumico (S3P) a cido 5-enolpiruvil-3- fosfochiqumico. A inibio dessa enzima (5- enolpiruvilchiquimato-3-fosfato sintase; aqui referida como "EPSPS") mata clulas vegetais desligando a via de chiquimato, inibindo, dessa forma a biossntese de cido aromtico.</span>N-phosphonomethylglycine, commonly referred to as glyphosate, is an important agricultural chemist. Glyphosate inhibits the enzyme that converts phosphoenolpyruvic acid (PEP) and 3-phosphochiquimic acid (S3P) to 5-enolpyruvyl-3-phosphochiquimic acid. Inhibition of this enzyme (5-enolpyruvylchiquimate-3-phosphate synthase; herein referred to as "EPSPS") kills plant cells by shutting down the shikimate pathway, thereby inhibiting aromatic acid biosynthesis.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Como herbicidas da classe do glifosato inibem a biossntese de cido aromtico, ele no matam apenas clulas vegetais, mas so tambm txicos a clulas  bacterianas. Glifosato inibe vrias sintases EPSP     bacterianas, e, assim,  txico a essas bactrias. Contudo, certas sintases EPSP bacterianas possuem uma alta tolerncia a glifosato.</span>Because glyphosate-class herbicides inhibit aromatic acid biosynthesis, they not only kill plant cells but are also toxic to bacterial cells. Glyphosate inhibits various bacterial EPSP synthases, and thus is toxic to these bacteria. However, certain bacterial EPSP synthases have a high tolerance to glyphosate.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clulas vegetais resistentes a toxicidade de glifosato podem ser produzidas transformando clulas vegetais para expressar sintases EPSP bacterianas resistentes a glifosato. Notavelmente, o gene bacteriano de Agrobacterium tumefaciens linhagem CP4 foi usado para conferir resistncia a herbicidas em clulas vegetais aps a expresso em plantas. Uma sintase EPSP mutada de Salmonella typhimurium linhagem CT7 confere resistncia a glifosato em clulas bacterianas, e confere resistncia a glifosato em clulas vegetais (U.S. Patent Nos. 4.535.060; 4.769.061; e 5.094.945). Contudo, h uma necessidade por outros genes de resistncia a herbicidas.</span>Glyphosate toxicity resistant plant cells can be produced by transforming plant cells to express glyphosate resistant bacterial EPSP synthases. Notably, the bacterial gene from Agrobacterium tumefaciens strain CP4 was used to confer herbicide resistance on plant cells after expression on plants. A mutated EPSP synthase from the Salmonella typhimurium CT7 strain confers glyphosate resistance in bacterial cells, and confers glyphosate resistance in plant cells (U.S. Patent Nos. 4,535,060; 4,769,061; and 5,094,945). However, there is a need for other herbicide resistance genes.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A atividade cintica de EPSPS pode ser testada medindo a liberao de fosfato. A liberao de fosfato  detectada usando um teste combinado para a deteco fluorescente de fosfato baseado na gerao de N-acetil-3,7- dihidroxifenoxacina (Amplex Red), como  conhecido na arte (Vazquez et al. (2003) Analytical Biochemistry 320: 292- 298) . As condies de teste publicadas podem levar  saturao do teste em experimentos onde o fosfato  liberado muito rapidamente. Mtodos adicionais so necessrios para a medio de atividade cintica de EPSPS.</span>The kinetic activity of EPSPS can be tested by measuring phosphate release. Phosphate release is detected using a combined fluorescent phosphate detection test based on the generation of N-acetyl-3,7-dihydroxyphenoxacin (Amplex Red), as is known in the art (Vazquez et al. (2003) Analytical Biochemistry 320: 292-298). Published test conditions may lead to test saturation in experiments where phosphate is released very quickly. Additional methods are required for measuring EPSPS kinetic activity.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">SUMRIO DA INVENO     Composies e mtodos para conferir resistncia a herbicidas ou tolerncia a bactrias, plantas, clulas vegetais, tecidos e sementes so providas. Composies incluem molculas de cidos nuclicos codificando polipeptideos de resistncia ou tolerncia a herbicidas, vetores compreendendo aquelas molculas de cidos nuclicos, e clulas hospedeiras compreendendo os vetores. Composies tambm incluem anticorpos para os polipeptideos de resistncia ou tolerncia a herbicidas. Como observado, as seqncias de nucleotideos da inveno podem ser usadas em constructos de DNA ou cassetes de expresso para transformao e expresso em organismos, incluindo microorganismos e plantas. Composies tambm compreendem bactrias, plantas, clulas vegetais, tecidos, e sementes transformadas. Alm disso, so providos mtodos para produzir os polipeptideos codificados pelos nucleotideos sintticos da inveno.</span>SUMMARY OF THE INVENTION Compositions and methods for imparting herbicide resistance or tolerance to bacteria, plants, plant cells, tissues and seeds are provided. Compositions include nucleic acid molecules encoding herbicide resistance or tolerance polypeptides, vectors comprising those nucleic acid molecules, and host cells comprising the vectors. Compositions also include antibodies to herbicide resistance or tolerance polypeptides. As noted, the nucleotide sequences of the invention may be used in DNA constructs or expression cassettes for transformation and expression in organisms, including microorganisms and plants. Compositions also comprise transformed bacteria, plants, plant cells, tissues, and seeds. In addition, methods are provided for producing the polypeptides encoded by the synthetic nucleotides of the invention.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Molculas de cidos nuclicos isoladas e variantes dessas codificando polipeptideos de resistncia ou tolerncia a herbicidas so providas. Adicionalmente, seqncias de aminocidos e variantes dessas codificadas pelos polinucleotideos que conferem resistncia ou tolerncia a herbicidas so englobadas. A presente inveno prov molculas de cidos nuclicos isoladas compreendendo uma seqncia de nucleotideos apresentada em SEQ ID NO: 1, 3, ou 5, uma seqncia de nucleotideos codificando a seqncia de aminocidos apresentada em SEQ ID N0:2, 4, ou     6, a seqncia de nucleotideos de resistncia a herbicidas depositada em um hospedeiro bacteriano com Nos.de Acesso NRRL B-30888 ou NRRL B-30949, assim como variantes e fragmentos dessas. Seqncias de nucleotideos que so complementares a uma seqncia de nucleotideos da inveno, ou que hibridizam a uma seqncia da inveno so tambm englobadas.</span>Isolated nucleic acid molecules and variants thereof encoding herbicide resistance or tolerance polypeptides are provided. Additionally, amino acid sequences and variants thereof encoded by polynucleotides conferring herbicide resistance or tolerance are encompassed. The present invention provides isolated nucleic acid molecules comprising a nucleotide sequence shown in SEQ ID NO: 1, 3, or 5, a nucleotide sequence encoding the amino acid sequence shown in SEQ ID NO: 2, 4, or 6; herbicide resistance nucleotide sequence deposited on a bacterial host with Accession Nos. NRRL B-30888 or NRRL B-30949, as well as variants and fragments thereof. Nucleotide sequences that are complementary to a nucleotide sequence of the invention or that hybridize to a sequence of the invention are also encompassed.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mtodos para medir a atividade cintica enzimtica usando substratos fluorognicos so tambm providos.</span>Methods for measuring enzymatic kinetic activity using fluorogenic substrates are also provided.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">DESCRIO DAS FIGURAS</span>DESCRIPTION OF THE FIGURES</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A Figura 1 apresenta um alinhamento da seqncia de aminocidos ORFl GRG23 (SEQ ID 30 NO: 2) e GRG51 (SEQ ID NO: 6) com Bacillus clausii (SEQ ID NO:7), Rubrobacer xylanophilus (SEQ ID N0:8), Escherichia coli (SEQ ID NO: 11), Agrobacterium sp. linhagem CP4 (SEQ IDNOilO) e Zea mays (SEQ ID NO:9).</span>Figure 1 shows an alignment of the amino acid sequence ORFl GRG23 (SEQ ID 30 NO: 2) and GRG51 (SEQ ID NO: 6) with Bacillus clausii (SEQ ID NO: 7), Rubrobacer xylanophilus (SEQ ID NO: 8), Escherichia coli (SEQ ID NO: 11), Agrobacterium sp. strain CP4 (SEQ ID NO 1 O) and Zea mays (SEQ ID NO: 9).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A Figura 2 apresenta um grfico de distribuio de atividade de enzima GRG23 (eixo y) em funo da concentrao de PEP (eixo x) em concentraes de glifosato de 0, 3, 5 e 10 mM.</span>Figure 2 presents a graph of distribution of GRG23 enzyme activity (y axis) as a function of PEP concentration (x axis) at glyphosate concentrations of 0, 3, 5 and 10 mM.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A Figura 3 apresenta um grfico de distribuio de Km (app) (eixo y) em funo da concentrao de glifosato (eixo ) . A interceptao do eixo X representa a Kj para glifosato.     DESCRIO DETALHADA DA INVENO</span>Figure 3 presents a graph of distribution of Km (app) (y axis) as a function of glyphosate concentration ( axis). The X axis intercept represents the Kj for glyphosate. DETAILED DESCRIPTION OF THE INVENTION</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">As presentes invenes sero, agora, descritas mais completamente daqui em diante com referncia s figuras que as acompanham, nas quais alguns, mas no todos os avanos das invenes so apresentados. De fato, essas invenes podem ser incorporadas de vrias formas diferentes e no deveriam ser construdas limitadas aos avanos aqui relatados; ao invs, esses avanos so providos de forma que esta descrio satisfaa requisitos legais aplicveis. Nmeros relativos referem-se a elementos relativos.</span>The present inventions will now be more fully described hereinafter with reference to the accompanying figures, in which some, but not all, advances of the inventions are presented. Indeed, these inventions can be incorporated in many different ways and should not be construed limited to the advances reported here; rather, these advances are provided so that this description satisfies applicable legal requirements. Relative numbers refer to relative elements.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Vrias modificaes e outros avanos das invenes aqui relatados viro  mente de algum especialista na arte a qual estas invenes pertencem, tendo o benefcio dos ensinamentos apresentados nas descries precedentes e desenhos associados. Portanto, deve ser entendido que as invenes no so limitadas aos avanos especficos descritos e que se pretende que modificaes e outros avanos sejam includos no escopo das reivindicaes em anexo. Apesar de termos especficos serem aqui empregados, eles so usados em um senso genrico e descritivo e no para propsitos de limitao.</span>Various modifications and other advances of the inventions reported herein will come to the mind of one skilled in the art to which these inventions belong, having the benefit of the teachings set forth in the preceding descriptions and associated drawings. Therefore, it should be understood that the inventions are not limited to the specific advances described and that modifications and other advances are intended to be included within the scope of the appended claims. Although specific terms are used herein, they are used in a generic and descriptive sense and not for purposes of limitation.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A presente inveno  desenhada para composies e mtodos para regular resistncia a herbicidas em organismos, particularmente em plantas ou clulas vegetais. Os mtodos envolvem transformar organismos com seqncias     de nucleotideos codificando o gene de resistncia a glifosato da inveno. As seqncias de nucleotideos da inveno so teis para preparar plantas que apresentam tolerncia aumentada ao herbicida glifosato. Assim, so providas bactrias, plantas, clulas vegetais, tecidos vegetais e sementes transformadas. Composies incluem cidos nuclicos e protenas relacionadas a tolerncia a herbicidas em microorganismos e plantas, assim como bactrias, plantas, tecidos vegetais e sementes transformadas. Seqncias de nucleotideos do gene de resistncia a glifosato (grg23 e grg51) e as seqncias de aminocidos das protenas dessa forma codificadas so descritas. As seqncias so teis na construo de vetores de expresso para subseqente transformao em plantas de interesse, como sondas para o isolamento de outros genes de resistncia a glifosato, como marcadores de seleo, e similares. Assim, por "gene de resistncia a glifosato da inveno" pretende-se a seqncia de nucleotideos apresentada em SEQ ID NO:l ou 3, e variantes e fragmentos dessas (SEQ ID NO:5, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, e 32), que codificam um polipeptdeo de resistncia ou tolerncia a glifosato. Igualmente, um "polipeptdeo de resistncia a glifosato da inveno"  um polipeptdeo tendo a seqncia de aminocidos apresentada em SEQ ID NO: 2 ou 4, e variantes e fragmentos dessas (SEQ ID NO:6, 15, 17, 19, 21, 23, 25, 27, 29, 31, e 33), que conferem resistncia ou tolerncia a glifosato para uma clula hospedeira.     Plasmdios contendo as seqncias de nucleotideos de resistncia a herbicidas da inveno foram depositadas na coleo de culturas permanente da autoridade depositria internacional Agricultural Research Service Culture Collection, Northern Regional Research Laboratory (NRRL) em 18 de novembro de 2005, e designados com o No. de Acesso NRRL B-30888 (grg23), e em 26 de junho de 2006 e designados com o No. de Acesso NRRL B-30949 (grg51) . Esse depsito ser mantido sob os termos do Tratado de Budapeste sobre o Tratado Internacional de Reconhecimento do Depsito de Microorganismos para Propsitos de Procedimentos de Patente (Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure) . Esse depsito foi feito meramente como uma convenincia para aqueles especialistas na arte e no  uma admisso de que um depsito  necessrio sob o 35 U.S.C. 112.</span>The present invention is designed for compositions and methods for regulating herbicide resistance in organisms, particularly in plants or plant cells. The methods involve transforming nucleotide sequence organisms encoding the glyphosate resistance gene of the invention. The nucleotide sequences of the invention are useful for preparing plants that have increased tolerance to the glyphosate herbicide. Thus, bacteria, plants, plant cells, plant tissues and transformed seeds are provided. Compositions include nucleic acids and proteins related to herbicide tolerance in microorganisms and plants, as well as bacteria, plants, plant tissues and transformed seeds. Nucleotide sequences of the glyphosate resistance gene (grg23 and grg51) and the amino acid sequences of the proteins encoded in this way are described. The sequences are useful in constructing expression vectors for subsequent transformation into plants of interest, as probes for isolation of other glyphosate resistance genes, as selection markers, and the like. Thus, by "glyphosate resistance gene of the invention" is meant the nucleotide sequence set forth in SEQ ID NO: 1 or 3, and variants and fragments thereof (SEQ ID NO: 5, 12, 14, 16, 18, 20 , 22, 24, 26, 28, 30, and 32), which encode a glyphosate resistance or tolerance polypeptide. Also, a "glyphosate resistance polypeptide of the invention" is a polypeptide having the amino acid sequence set forth in SEQ ID NO: 2 or 4, and variants and fragments thereof (SEQ ID NO: 6, 15, 17, 19, 21, 23, 25, 27, 29, 31, and 33), which confer glyphosate resistance or tolerance to a host cell. Plasmids containing the herbicide-resistant nucleotide sequences of the invention were deposited in the permanent culture collection of the International Depository Authority Agricultural Research Service Collection, Northern Regional Research Laboratory (NRRL) on November 18, 2005, and designated as No. Access NRRL B-30888 (grg23), and on June 26, 2006 and designated with Access No. NRRL B-30949 (grg51). Such deposit shall be maintained under the terms of the Budapest Treaty on the International Treaty for the Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedures (Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure). This deposit was made merely as a convenience to those skilled in the art and is not an admission that a deposit is required under U.S.C. 112.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por "glifosato" pretende-se qualquer forma herbicida da N-fosfonometilglicina (incluindo qualquer sal dessa) e outras formas que resultam na produo do nion de glifosato em planta. Uma "protena de resistncia a herbicidas" ou uma protena resultando da expresso de uma "molcula de cido nuclico codificando resistncia a herbicidas" inclui protenas que conferem a uma clula a habilidade de tolerar uma concentrao mais alta de um herbicida do que clulas que no expressa a protena, ou tolerar uma certa concentrao de um herbicida por um tempo maior do que clulas que no expressam a protena. Uma "protena de resistncia a glifosato" inclui uma protena     que confere a uma clula a habilidade de tolerar uma maior concentrao de glifosato do que clulas que no expressam a protena, ou tolerar certas concentraes de glifosato por um perodo de tempo maior do que clulas que no expressam a protena. Por "tolerar" ou "tolerncia" pretende-se tanto sobreviver, ou conduzir funes celulares essenciais, tais como sntese de protenas e respirao, de maneira que no seja prontamente discernvel a partir de clulas no tratadas.</span>By "glyphosate" is meant any herbicidal form of N-phosphonomethylglycine (including any salt thereof) and other forms that result in the production of the glyphosate anion in plant. A "herbicide resistance protein" or a protein resulting from the expression of a "herbicide resistance encoding nucleic acid molecule" includes proteins that give a cell the ability to tolerate a higher concentration of a herbicide than cells that do not express the protein, or tolerate a certain concentration of a herbicide for a longer time than cells that do not express the protein. A "glyphosate resistance protein" includes a protein that gives a cell the ability to tolerate a higher glyphosate concentration than non-protein expressing cells, or to tolerate certain glyphosate concentrations for a longer period of time than cells that do not express it. do not express protein. By "tolerating" or "tolerating" is meant either to survive, or to conduct essential cellular functions, such as protein synthesis and respiration, so that it is not readily discernible from untreated cells.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Molculas de cidos nuclicos isoladas, e Variantes e Fragmentos Dessas</span>Isolated Nucleic Acid Molecules, and Variants and Fragments of These</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Um aspecto da inveno pertence a molculas de cidos nuclicos isoladas compreendendo seqncias de nucleotdeos codificando protenas de resistncia a herbicidas e polipeptdeos ou pores biologicamente ativas desses, assim como molculas de cidos nuclicos suficientes para uso como sondas de hibridizao para identificar cidos nuclicos codificando resistncia a herbicidas. Como aqui usado, o termo "molcula de cido nuclico" deve incluir molculas de DNA (e.g., DNAc ou DNA genmico) e molculas de RNA (e.g., RNAm) e anlogos do DNA ou RNA gerado usando anlogos de nucleotdeos. A molcula de cido nuclico pode ser de fita simples ou dupla-fita.</span>One aspect of the invention pertains to isolated nucleic acid molecules comprising nucleotide sequences encoding herbicide resistance proteins and polypeptides or biologically active portions thereof, as well as sufficient nucleic acid molecules for use as hybridization probes to identify nucleic acids encoding herbicide resistance. . As used herein, the term "nucleic acid molecule" shall include DNA molecules (e.g., cDNA or genomic DNA) and RNA molecules (e.g., mRNA) and analogs of DNA or RNA generated using nucleotide analogs. The nucleic acid molecule may be single stranded or double stranded.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Seqncias de nucleotdeos codificando as protenas da presente inveno incluem as seqncias apresentadas em SEQ ID NO: 1, 3, e 5 a seqncia de nucleotdeos de resistncia     a herbicidas depositada em um hospedeiro bacteriano com com os Nos. de Acesso NRRL B-30888 e B-30949, e variantes, fragmentos, e complementos dessas. Por "complemento" pretende-se uma seqncia de nucleotideos que suficientemente complementar a uma dada seqncia de nucleotideos, de forma que esta possa hibridizar  dada seqncia de nucleotideos para, dessa forma, formar um duplex estvel. A seqncia de aminocidos correspondente para a protena de resistncia a herbicidas codificada por essas seqncias de nucleotideos  apresentada em SEQ ID NO:2, 4, ou 6. A inveno tambm engloba molculas de cidos nuclicos compreendendo seqncias de nucleotideos codificando protenas de resistncia a herbicidas de comprimento parcial, e complementos dessas.</span>Nucleotide sequences encoding the proteins of the present invention include the sequences set forth in SEQ ID NO: 1, 3, and 5 the herbicide resistance nucleotide sequence deposited in a bacterial host with Nos. Access NRRL B-30888 and B-30949, and variants, fragments, and additions thereof. By "complement" is meant a nucleotide sequence which is sufficiently complementary to a given nucleotide sequence so that it can hybridize to the given nucleotide sequence to thereby form a stable duplex. The corresponding amino acid sequence for the herbicide resistance protein encoded by such nucleotide sequences is set forth in SEQ ID NO: 2, 4, or 6. The invention also encompasses nucleic acid molecules comprising nucleotide sequences encoding herbicide resistance proteins. of partial length, and complements thereof.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Uma molcula de cido nuclico ou protena "isolada" ou "purificada", ou poro biologicamente ativa dessa,  substancialmente livre de outro material celular, ou meio de cultura quando produzida por tcnicas recombinantes, ou substancialmente livre de precursores qumicos ou outros qumicos	quando	quimicamente	sintetizada.</span>An "isolated" or "purified" nucleic acid or protein molecule, or biologically active portion thereof, is substantially free of other cellular material, or culture medium when produced by recombinant techniques, or substantially free of chemical or other chemical precursors when chemically Synthesized.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Preferencialmente, um cido nuclico "isolado"  livre de seqncias (preferencialmente seqncias codificando protenas) que naturalmente flanqueiam o cido nuclico (i.e., seqncias localizadas nas extremidades 5' e 3' do cido nuclico) no DNA genmico do organismo do qual o cido nuclico  derivado. Para propsitos da inveno, "isolado" quando usado para referir-se a molculas de cidos nuclicos exclui cromossomos isolados. Por exemplo,     em vrios avanos, a molcula de cido nuclico isolada codificando resistncia a glifosato pode conter menos do que cerca de 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0,5 kb, ou 0,1 kb da seqncia de nucleotideos que naturalmente flanqueia a molcula de cido nuclico no DNA genmico da clula da qual o cido nuclico  derivado. Uma protena de resistncia a herbicidas, que  substancialmente livre de material celular, inclui preparaes de protena tendo menos do que cerca de 30%, 20%, 10%, ou 5% (por peso seco) de protenas que no de resistncia a herbicidas (tambm referida como "protena contaminante").</span>Preferably, an "isolated" nucleic acid is free of sequences (preferably protein coding sequences) that naturally flank nucleic acid (ie, sequences located at the 5 'and 3' ends of nucleic acid) in the genomic DNA of the organism from which the nucleic acid is present. It is derived from. For purposes of the invention, "isolated" when used to refer to nucleic acid molecules excludes isolated chromosomes. For example, in various advances, the isolated nucleic acid molecule encoding glyphosate resistance may contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide sequence that naturally flanks the nucleic acid molecule in the genomic DNA of the cell from which the nucleic acid is derived. A herbicide resistance protein, which is substantially free of cellular material, includes protein preparations having less than about 30%, 20%, 10%, or 5% (by dry weight) non-herbicide resistance proteins. (also referred to as a "contaminating protein").</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Molculas de cidos nuclicos que so fragmentos dessas seqncias de nucleotideos codificadoras de resistncia a herbicidas so tambm englobadas pela presente inveno. Por "fragmento" pretende-se uma poro da seqncia de nucleotideos codificando uma protena de resistncia a herbicidas. Um fragmento de uma seqncia de nucleotideos pode codificar uma poro biologicamente ativa de uma protena de resistncia a herbicidas, ou pode ser um fragmento que pode ser usado como uma sonda de hibridizao ou primer de PCR usando mtodos descritos abaixo. Molculas de cidos nuclicos que so fragmentos de uma seqncia de nucleotideos de resistncia a herbicidas compreendem pelo menos cerca de 15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, 1500, 1550, 1600, 1650, 1700, 1750, 1800, 1850, 1900, 1950 nucleotideos contguos, ou at o nmero de nucleotideos     presentes em uma seqncia de nucleotideos codificadora de resistncia a herbicidas de comprimento total aqui descrita (por exemplo, 1892 nucleotideos para SEQ ID NO: 1, 1259 nucleotideos para SEQ ID NO:3, e 1242 nucleotideos para SEQ ID NO:5). Por nucleotideos "contguos" pretende-se resduos de nucleotideos que esto imediatamente adjacentes um ao outro.</span>Nucleic acid molecules that are fragments of such herbicide resistance coding nucleotide sequences are also encompassed by the present invention. By "fragment" is meant a portion of the nucleotide sequence encoding a herbicide resistance protein. A fragment of a nucleotide sequence may encode a biologically active portion of a herbicide resistance protein, or may be a fragment that may be used as a hybridization probe or PCR primer using methods described below. Nucleic acid molecules that are fragments of a herbicide resistance nucleotide sequence comprise at least about 15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450, 1500, 1550, 1600, 1650, 1700, 1750, 1800, 1850, 1900, 1950 contiguous nucleotides, or up to the number of nucleotides present in a full-length herbicide resistance coding nucleotide sequence described herein (for example, 1892 nucleotides for SEQ ID NO: 1, 1259 nucleotides for SEQ ID NO: 3, and 1242 nucleotides for SEQ ID NO: 5). By "contiguous" nucleotides are meant nucleotide residues that are immediately adjacent to each other.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Fragmentos das seqncias de nucleotideos da presente inveno geralmente codificaro fragmentos de protena que retm a atividade biolgica da protena de resistncia a glifosato de comprimento total; i.e., atividade de resistncia a herbicidas. Por "retm a atividade de resistncia a herbicidas" pretende-se que o fragmento tenha pelo menos cerca de 30%, pelo menos cerca de 50%, pelo menos cerca de 70%, ou pelo menos cerca de 80% da atividade de resistncia a herbicidas das protenas de resistncia a glifosato de comprimento total aqui descritas como SEQ ID NO: 2, 4, ou 6. Mtodos para medir a atividade de resistncia a herbicidas so bem conhecidos na arte. Ver, por exemplo, U.S. Patent Nos. 4.535.060, e 5.188.642, cada qual so aqui incorporados por referncia em sua integridade.</span>Fragments of the nucleotide sequences of the present invention will generally encode protein fragments that retain the biological activity of the full length glyphosate resistance protein; i.e. herbicide resistance activity. By "retains herbicide resistance activity" is meant that the fragment has at least about 30%, at least about 50%, at least about 70%, or at least about 80% of resistance to activity. herbicides of the full length glyphosate resistance proteins described herein as SEQ ID NO: 2, 4, or 6. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which are incorporated herein by reference in their entirety.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Um fragmento de uma seqncia de nucleotideos codificadora de resistncia a herbicidas que codifica uma poro biologicamente ativa de uma protena da inveno codificar pelo menos cerca de 15, 25, 30, 50, 75, 100, 125. 150, 175, 200, 250, 300, 350, 400 aminocidos     contguos, ou at o nmero total de aminocidos presente em uma protena de resistncia a herbi.cidas da inveno de comprimento total (por exemplo, 436 aminocidos para SEQ ID N0:2, 413 aminocidos para SEQ ID N0:4, e 413 aminocidos para SEQ ID NO:6).</span>A fragment of a herbicide resistance coding nucleotide sequence encoding a biologically active portion of a protein of the invention will encode at least about 15, 25, 30, 50, 75, 100, 125. 150, 175, 200, 250, 300, 350, 400 contiguous amino acids, or up to the total number of amino acids present in a full-length herbicide resistance protein of the invention (e.g., 436 amino acids for SEQ ID NO: 2, 413 amino acids for SEQ ID NO: 4, and 413 amino acids for SEQ ID NO: 6).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Protenas de resistncia a herbicidas da presente inveno so codificadas por uma seqncia de nucleotdeos suficientemente idntica  seqncia de nucleotdeos de SEQ ID NO:l, 3, ou 5. Para o termo "suficientemente idntica" pretende-se um aminocido ou seqncia de nucleotdeos que possui pelo menos cerca de 60% ou 65% de identidade de seqncia, cerca de 70% ou 75% de identidade de seqncia, cerca de 80% ou 85% de identidade de seqncia, cerca de 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% ou 99% de identidade de seqncia comparado a uma seqncia referncia usando um dos programas de alinhamento aqui descritos usando parmetros padro. Algum especialista na arte reconhecer que esses valores podem ser apropriadamente ajustados para determinar identidade correspondente de protenas codificadas por duas seqncias de nucleotdeos levando-se em conta a degenerao de cdons, similaridade de aminocidos, posicionamento de quadro de leitura, e similares.</span>Herbicide resistance proteins of the present invention are encoded by a nucleotide sequence sufficiently identical to the nucleotide sequence of SEQ ID NO: 1, 3, or 5. For the term "sufficiently identical" is meant an amino acid or nucleotide sequence that is has at least about 60% or 65% sequence identity, about 70% or 75% sequence identity, about 80% or 85% sequence identity, about 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% of sequence identity compared to a reference sequence using one of the alignment programs described here using standard parameters. One skilled in the art will recognize that these values may be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences taking into account codon degeneration, amino acid similarity, reading frame positioning, and the like.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para determinar a identidade percentual de duas seqncias de aminocidos ou de dois cidos nuclicos, as seqncias so alinhadas para propsitos de comparao tima. A identidade percentual entre as duas seqncias      uma funo do nmero de posies idnticas compartilhadas pelas seqncias (i.e., identidade percentual = nmero de posies idnticas/ nmero total de posies (e.g., posies de sobreposio)  100) . Em um avano, as duas seqncias so do mesmo comprimento. A identidade percentual entre duas seqncias pode ser determinada usando tcnicas similares quelas descritas abaixo, com ou sem espaos permitidos. Para calcular a identidade percentual, so contados, tipicamente, correspondncias exatas.</span>To determine the percent identity of two amino acid sequences or two nucleic acids, the sequences are aligned for optimal comparison purposes. Percent identity between the two sequences is a function of the number of identical positions shared by the sequences (i.e., percent identity = number of identical positions / total number of positions (e.g., overlapping positions)  100). In one advance, the two sequences are of the same length. The percent identity between two sequences can be determined using techniques similar to those described below, with or without allowed spaces. To calculate percent identity, typical matches are typically counted.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A determinao da identidade percentual entre duas seqncias pode ser conseguida usando um algoritmo matemtico. Um exemplo no limitante de um algoritmo matemtico utilizado para a comparao de duas seqncias  o algoritmo de Karlin and Altschul (1990) Proc. Natl Acad. Set USA 87:2264-2268, modificado como em Karlin and Altschul (1993) Proc. Natl. Acad. Sei. USA 90:5873-5877. Tal algoritmo  incorporado nos programas BLASTN e BLASTX de Altschul et al. (1990) J Mol. Biol. 215:403-410. Buscas BLAST de nucleotideos podem ser efetuadas com o programa BLASTN, pontuao = 100, comprimento de palavra = 12, para obter seqncias de nucleotideos homlogas a molculas de cidos nuclicos tipo GDC da inveno. Buscas BLAST de protenas podem ser efetuadas com o programa BLASTX, pontuao = 50, comprimento de palavra = 3, para obter seqncias de aminocidos homlogas a molculas de protena de resistncia a herbicidas da inveno. Para obter alinhamentos espaados para propsitos de comparao,     Gapped BLAST pode ser utilizado como descrito em Altschul et al. (1997) Nucleic Acids Res. 25:338 9-34 02. Alternativamente, PSI-Blast pode ser usado para efetuar uma busca iterada que detecte relaes distantes entre molculas. Ver Altschul et al. (1997) supra. Quando utilizando os programas BLAST, Gapped BLAST, e PSI-Blast, os parmetros padro dos respectivos programas (e.g., BLASTX	e	BLASTN)	podem ser usados.	Ver www.ncbi.nlm.nih.gov. Outro exemplo no limitante de um algoritmo matemtico utilizado para a comparao de seqncias  o algoritmo do ClustalW (Higgins et al. 1994) Nucleic Acids Res. 22:4673-4680). ClustalW compara seqncias e alinha a totalidade da seqncia de aminocidos ou DNA, e, assim, pode prover dados sobre a conservao de seqncia de toda a seqncia de aminocidos. 0 algoritmo de ClustalW  usado em diversos comercialmente pacotes de software disponveis para anlise de DNA/aminocidos, tais como o mdulo ALIGNX da suite Vector NTI Program Suite (Invitrogen Corporation, Carlsbad, CA) . Aps o alinhamento de seqncias de aminocidos com ClustalW, a identidade percentual de aminocidos pode ser avaliada. Um exemplo no limitante de um programa computacional til para anlise de alinhamentos ClustalW  GeneDoc. GeneDoc (Karl Nicholas) permite a avaliao de similaridade e identidade de aminocidos (ou DNA) entre mltiplas protenas. Outro exemplo no limitante de um algoritmo matemtico utilizado para a comparao de seqncias  o algoritmo de Myers and Miller (1988) CABIOS 4:11-17. Tal algoritmo  incorporado no programa ALIGN     (verso 2.0), que  parte do pacote de software de alinhamento de seqncias GCG (disponibilizado pela Accelrys, Inc., San Diego, CA). Quando utilizando o programa ALIGN para comparar seqncias de aminocidos, uma tabela de peso de resduos PAM 120, uma penalidade por extenso de espao de 12, e uma penalidade de espao de 4 podem ser usadas.</span>Determination of percent identity between two sequences can be achieved using a mathematical algorithm. A non-limiting example of a mathematical algorithm used for comparing two sequences is the Karlin and Altschul (1990) Proc algorithm. Natl Acad. Set USA 87: 2264-2268, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Know. USA 90: 5873-5877. Such an algorithm is incorporated into the BLASTN and BLASTX programs of Altschul et al. (1990) J Mol. Biol. 215: 403-410. BLAST nucleotide searches can be performed with the BLASTN program, score = 100, word length = 12, to obtain nucleotide sequences homologous to GDC-type nucleic acid molecules of the invention. BLAST protein searches can be performed with the BLASTX program, score = 50, word length = 3, to obtain amino acid sequences homologous to herbicide resistance protein molecules of the invention. To obtain spaced alignments for comparison purposes, Gapped BLAST can be used as described in Altschul et al. (1997) Nucleic Acids Res. 25: 338 9-34 02. Alternatively, PSI-Blast can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al. (1997) supra. When using the BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the respective programs (e.g., BLASTX and BLASTN) may be used. See www.ncbi.nlm.nih.gov. Another non-limiting example of a mathematical algorithm used for sequence comparison is the ClustalW algorithm (Higgins et al. 1994) Nucleic Acids Res. 22: 4673-4680). ClustalW compares sequences and aligns the entire amino acid or DNA sequence, and thus can provide sequence conservation data for the entire amino acid sequence. The ClustalW algorithm is used in a number of commercially available DNA / amino acid analysis software packages, such as the ALIGNX module of the Vector NTI Program Suite (Invitrogen Corporation, Carlsbad, CA). Following alignment of amino acid sequences with ClustalW, percent amino acid identity can be assessed. A non-limiting example of a useful computational program for ClustalW alignment analysis is GeneDoc . GeneDoc  (Karl Nicholas) allows assessment of amino acid (or DNA) similarity and identity between multiple proteins. Another non-limiting example of a mathematical algorithm used for sequence comparison is the Myers and Miller (1988) algorithm CABIOS 4: 11-17. Such an algorithm is incorporated into the ALIGN (version 2.0) program, which is part of the GCG sequence alignment software package (available from Accelrys, Inc., San Diego, CA). When using the ALIGN program to compare amino acid sequences, a PAM 120 residue weight table, a space extension penalty of 12, and a space penalty of 4 may be used.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A menos que declarado ao contrrio, GAP Version 10, que usa o algoritmo de Needleman and Wunsch (1970) J. MoI Biol. 48(3) : 443-453, ser usado para determinar a identidade de seqncia ou similaridade usando os seguintes parmetros: % identidade % similaridade para uma seqncia de nucleotdeos usando GAP Weight de 50 e Length Weight de 3, e a matriz de pontuao nwsgapdna.cmp; % identidade ou % similaridade para uma seqncia de aminocidos usando GAP weight de 8 e length weight of 2, e o programa de pontuao BLOSUM62. Programas equivalentes podem ser tambm usados. Por "programa equivalente" pretende-se qualquer programa de comparao de seqncias que, para quaisquer duas seqncias em questo, gere um alinhamento tendo correspondncias de resduos de nucleotdeos idnticas e uma identidade percentual de seqncia idntica quando comparado ao alinhamento correspondente gerado por GAP Version 10.</span>Unless otherwise stated, GAP Version 10, which uses the algorithm of Needleman and Wunsch (1970) J. MoI Biol. 48 (3): 443-453, will be used to determine sequence identity or similarity using the following parameters:% identity% similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3, and the nwsgapdna scoring matrix. .cmp; % identity or% similarity for an amino acid sequence using GAP weight of 8 and length weight of 2, and the BLOSUM62 scoring program. Equivalent programs may also be used. By "equivalent program" is meant any sequence comparison program which, for any two sequences in question, generates an alignment having identical nucleotide residue matches and an identical percent sequence identity as compared to the corresponding alignment generated by GAP Version 10. .</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A inveno tambm engloba molculas de cidos nuclicos variantes. "Variantes" das seqncias de nucleotdeos codificadoras de resistncia a herbicidas     incluem aquelas seqncias que codificam a protena de resistncia a herbicidas aqui descrita, mas que diferem de forma conservadora por causa da degenerao do cdigo gentico, assim como aquelas que so suficientemente idnticas, como discutido acima (por exemplo, SEQ ID NO: 5, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, e 32 so variantes de SEQ ID NO:l). Variantes allicos naturalmente ocorrentes podem ser identificados com o uso de tcnicas conhecidas de biologia molecular, tais como reao de cadeia de polimerase (PCR) e tcnicas de hibridizao, como destacado abaixo. Seqncias de nucleotdeos variantes tambm incluem seqncias de nucleotdeos derivadas sinteticamente que foram geradas, por exemplo, usando mutagnese stio- direcionada, mas que ainda codificam as protenas de resistncia a herbicidas descritas na presente inveno, como discutido abaixo. Protenas variantes englobadas pela presente inveno so biologicamente ativas, isto , elas retm a atividade biolgica desejada da protena nativa, ou seja, atividade de resistncia a herbicidas. Por "retm atividade de resistncia a herbicidas" pretende-se que o variante tenha pelo menos cerca de 30%, pelo menos cerca de 50%, pelo menos cerca de 70%, ou pelo menos cerca de 80% da atividade de resistncia a herbicidas da protena nativa. Mtodos para medir a atividade de resistncia a herbicidas so bem conhecidos na arte. Ver, por exemplo, U.S. Patent Nos. 4.535.060, e 5.188.642, cada qual  aqui incorporada por referncia em sua integridade.     O especialista ir avaliar, ainda, que mudanas podem ser introduzidas por mutao nas seqncias de nucleotideos da inveno, levando, dessa forma, a mudanas na seqncia de aminocidos das protenas de resistncia a herbicidas codificadas, sem alterar a atividade biolgica das protenas. Assim, molculas de cidos nuclicos isoladas variantes podem ser criadas introduzindo-se um ou mais substituies, adies, ou delees de nucleotideos na seqncia de nucleotideos correspondente aqui descrita, de forma que uma ou mais substituies, adies, ou delees de aminocidos sejam introduzidas na protena codificada. Mutaes podem ser introduzidas por tcnicas padro, tais como mutagnese stio-direcionada e mutagnese mediada por PCR. Tais seqncias de nucleotideos variantes so tambm englobadas pela presente inveno.</span>The invention also encompasses variant nucleic acid molecules. "Variants" of the herbicide resistance coding nucleotide sequences include those sequences that code for the herbicide resistance protein described herein, but which conservatively differ because of the degeneration of the genetic code, as well as those that are sufficiently identical, as discussed. above (for example, SEQ ID NO: 5, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, and 32 are variants of SEQ ID NO: 1). Naturally occurring allelic variants can be identified using known molecular biology techniques, such as polymerase chain reaction (PCR) and hybridization techniques, as outlined below. Variant nucleotide sequences also include synthetically derived nucleotide sequences that have been generated, for example, using site-directed mutagenesis, but which still encode the herbicide resistance proteins described in the present invention, as discussed below. Variant proteins encompassed by the present invention are biologically active, that is, they retain the desired biological activity of the native protein, i.e. herbicide resistance activity. By "retains herbicide resistance activity" is meant that the variant has at least about 30%, at least about 50%, at least about 70%, or at least about 80% of herbicide resistance activity. of native protein. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which is incorporated herein by reference in its entirety. The skilled artisan will further appreciate that changes can be introduced by mutation in the nucleotide sequences of the invention, thereby leading to changes in the amino acid sequence of encoded herbicide resistance proteins without altering the biological activity of the proteins. Thus, variant isolated nucleic acid molecules may be created by introducing one or more nucleotide substitutions, additions, or deletions into the corresponding nucleotide sequence described herein, such that one or more amino acid substitutions, additions, or deletions are introduced into the nucleotide substitution. encoded protein. Mutations can be introduced by standard techniques such as site-directed mutagenesis and PCR-mediated mutagenesis. Such variant nucleotide sequences are also encompassed by the present invention.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por exemplo,	substituies de aminocidos conservativas podem ser feitas em um ou mais resduos de aminocidos previstos, no essenciais. Um resduo de aminocido "no essencial"  um resduo que pode ser alterado a partir da seqncia de tipo selvagem de uma protena de resistncia a herbicidas sem alterar a atividade biolgica, enquanto que um resduo de aminocido "essencial"  necessrio para a atividade biolgica. Uma "substituio de aminocido conservativa"  uma na qual o resduo de aminocido  substitudo com um resduo de aminocido tendo uma cadeia lateral similar. Famlias de resduos de aminocidos tendo cadeias laterais similares foram definidas na arte. Essas famlias incluem aminocidos     com cadeias laterais bsicas (e.g., lisina, arginina, histidina), cadeias laterais cidas (e.g., cido asprtico, cido glutmico), cadeias laterais polares sem carga (e.g., glicina, asparagina, glutamina, serina, treonina, tirosina, cisteina), cadeias laterais apolares (e.g., alanina, valina, leucina, isoleucina, prolina, fenilalanina, metionina, triptofano), cadeias laterais beta-ramifiadas (e.g., treonina, valina, isoleucina) e cadeias laterais aromticas (e.g., tirosina, fenilalanina, triptofano, histidina). Substituies de aminocidos podem ser feitas em regies no conservadas que retm funo. Em geral, tais substituies no seriam feitas para resduos de aminocidos conservados, ou para resduos de aminocidos residindo em um motivo conservado, onde tais resduos so essenciais para atividade de protena. Contudo, algum especialista na arte entenderia que variantes funcionais podem ter pequenas alteraes conservadas ou no conservadas nos resduos conservados.</span>For example, conservative amino acid substitutions may be made at one or more predicted non-essential amino acid residues. A "nonessential" amino acid residue is a residue that can be altered from the wild-type sequence of a herbicide resistance protein without altering biological activity, while an "essential" amino acid residue is required for biological activity. . A "conservative amino acid substitution" is one in which the amino acid residue is replaced with an amino acid residue having a similar side chain. Families of amino acid residues having similar side chains have been defined in the art. These families include amino acids with basic side chains (eg, lysine, arginine, histidine), acidic side chains (eg, aspartic acid, glutamic acid), uncharged polar side chains (eg, glycine, asparagine, glutamine, serine, threonine, tyrosine , cysteine), nonpolar side chains (eg, alanine, valine, leucine, isoleucine, proline, phenylalanine, methionine, tryptophan), beta-branched side chains (eg, threonine, valine, isoleucine) and aromatic side chains (eg, tyrosine, phenylalanine, tryptophan, histidine). Amino acid substitutions can be made in non-conserved regions that retain function. In general, such substitutions would not be made for conserved amino acid residues, or for amino acid residues residing in a conserved motif, where such residues are essential for protein activity. However, one skilled in the art would understand that functional variants may have small conserved or non-conserved changes in conserved residues.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Lis-22, Arg-124, Asp-313, Arg-344, Arg-386, e Lis-411, so resduos conservados da EPSP sintase de E. coli (Schonbrunn et al. (2001) Proc. Natl. Acad. Sei. USA 98:1376-1380). Resduos conservados importantes para atividade de EPSP sintase tambm incluem Arg-100, Asp-242, e Asp-384 (Selvapandiyan et al. (1995) FEBS Letters 374:253-256). Arg-27 se liga a S3P (Shuttleworth et al. (1999) Biochemistry 38:296- 302).     Alternativamente, seqncias de nucleotideos variantes podem ser feitas introduzindo mutaes aleatoriamente junto de toda ou parte da seqncia codificadora, tal como pode mutagnese de saturao, e os mutantes resultantes podem ser rastreados para a habilidade de conferir atividade de resistncia a herbicidas para identificar mutantes que retm atividade. Aps a mutagnese, a protena codificada pode ser expressada de forma recombinante, e a atividade da protena pode ser determinada usando tcnicas de teste padro.</span>Lys-22, Arg-124, Asp-313, Arg-344, Arg-386, and Lys-411, are conserved residues of E. coli EPSP synthase (Schonbrunn et al. (2001) Proc. Natl. Acad. Sci USA 98: 1376-1380). Important conserved residues for EPSP synthase activity also include Arg-100, Asp-242, and Asp-384 (Selvapandiyan et al. (1995) FEBS Letters 374: 253-256). Arg-27 binds to S3P (Shuttleworth et al. (1999) Biochemistry 38: 296-302). Alternatively, variant nucleotide sequences may be made by introducing mutations randomly to all or part of the coding sequence, as may saturation mutagenesis, and the resulting mutants may be screened for the ability to confer herbicide resistance activity to identify mutants that retain activity. Following mutagenesis, the encoded protein can be recombinantly expressed, and protein activity can be determined using standard testing techniques.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Usando mtodos tais como PCR, hibridizao, e similares, seqncias de resistncia a herbicidas correspondentes podem ser identificadas, tais seqncias tendo identidade substancial s seqncias da inveno. Ver, por exemplo, Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) e Innis, et al. (1990) PCR Protocols: A Guide to Methods and Applications (Academic Press, St. Louis, MO).</span>Using methods such as PCR, hybridization, and the like, corresponding herbicide resistance sequences can be identified, such sequences having substantial identity to the sequences of the invention. See, for example, Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY) and Innis, et al. (1990) PCR Protocols: A Guide to Methods and Applications (Academic Press, St. Louis, MO).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Em um mtodo de hibridizao, toda ou parte da seqncia de nucleotideos de resistncia a herbicidas pode ser usada para rastrear DNAc ou bibliotecas genmicas.</span>In a hybridization method, all or part of the herbicide resistance nucleotide sequence may be used to screen for cDNA or genomic libraries.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mtodos para construo de tais bibliotecas de DNAc e genmicas so geralmente conhecidos na arte e so descritos em Sambrook and Russell (2001) supra. As chamadas sondas de hibridizao podem ser fragmentos de DNA genmico, fragmentos de DNAc, fragmentos de RNA, ou outros     oligonucleotideos, e podem ser rotuladas com um grupo detectvel, tal como 32P3 ou qualquer outro marcador detectvel, tal como outros radioistopos, um composto fluorescente, uma enzima, ou um co-fator enzimtico. Sondas para hibridizao podem ser feitas rotulando oligonucleotideos sintticos baseado na(s) seqncia(s) de nucleotideos codificadora de resistncia a herbicidas conhecida(s) aqui descrita(s). Primers de degenerao projetados com base em nucleotideos ou resduos de aminocidos conservados na seqncia de nucleotideos ou seqncia de aminocidos codificada podem, adicionalmente, ser usados. A sonda tipicamente compreende uma regio de seqncia de nucleotideos que hibridiza sob condies rigorosas a pelo menos cerca de 12, pelo menos cerca de 25, pelo menos cerca de 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400, 500, 600, 700, 800, 900, 1000, 1200, 1400, 1600, ou 1800 nucleotideos consecutivos da(s) seqncia(s) de nucleotideos codificadora(s) de resistncia a herbicidas da inveno ou um fragmento ou variante dessas. Mtodos para a preparao de sondas para hibridizao so geralmente conhecidos na arte e so descritos em Sambrook and Russell (2001) supra, e Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), ambos so aqui incorporados por referncia. Por exemplo, toda uma seqncia resistncia a herbicidas aqui descrita, ou uma ou mais pores desta, pode ser usada como uma sonda capaz de hibridizar especificamente a seqncias de resistncia a herbicidas correspondentes e RNAs mensageiros. Para     alcanar hibridizao especifica sob uma variedade de condies, tais sondas incluem seqncias que so nicas e so pelo menos cerca de 10 nucleotideos em comprimento, e pelo menos cerca de 20 nucleotideos em comprimento. Tais sondas podem ser usadas para amplificar seqncias de resistncia a herbicidas correspondentes a partir de um organismo escolhido por PCR. Essa tcnica pode ser usada para isolar seqncias codificadoras adicionais, a partir de um organismo desejado, ou como um teste diagnstico para determinar a presena de seqncias codificadoras em um organismo. Tcnicas de hibridizao incluem rastreamento de hibridizao de bibliotecas de DNA em placas (tanto placas como colnias; ver, por exemplo, Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).</span>Methods for building such cDNA and genomic libraries are generally known in the art and are described in Sambrook and Russell (2001) supra. So-called hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group, such as 32P3 or any other detectable marker, such as other radioisotopes, a fluorescent compound , an enzyme, or an enzymatic cofactor. Probes for hybridization may be made by labeling synthetic oligonucleotides based on the known herbicide resistance coding nucleotide sequence (s) described herein. Degeneration primers designed based on nucleotides or amino acid residues conserved in the nucleotide sequence or encoded amino acid sequence may additionally be used. The probe typically comprises a nucleotide sequence region that hybridizes under stringent conditions to at least about 12, at least about 25, at least about 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400, 500, 600, 700, 800, 900, 1000, 1200, 1400, 1600, or 1800 consecutive nucleotides of the herbicide resistance coding nucleotide sequence (s) of the invention or a fragment or variant of these. Methods for preparing probes for hybridization are generally known in the art and are described in Sambrook and Russell (2001) supra, and Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), both are incorporated herein by reference. For example, an entire herbicide resistance sequence described herein, or one or more portions thereof, may be used as a probe capable of specifically hybridizing to corresponding herbicide resistance sequences and messenger RNAs. To achieve specific hybridization under a variety of conditions, such probes include sequences that are unique and are at least about 10 nucleotides in length, and at least about 20 nucleotides in length. Such probes can be used to amplify corresponding herbicide resistance sequences from an organism chosen by PCR. This technique can be used to isolate additional coding sequences from a desired organism or as a diagnostic test to determine the presence of coding sequences in an organism. Hybridization techniques include DNA library hybridization screening on plaques (both plaques and colonies; see, for example, Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Press, Cold Spring Harbor, NY).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A hibridizao de tais seqncias pode ser conduzida sob condies rigorosas. Por "condies rigorosas" ou "condies de hibridizao rigorosas" pretende-se condies sob as quais uma sonda ira hibridizar a sua seqncia alvo a um grau detectavelmente maior do que a outras seqncias (e.g., pelo menos 2 vezes em relao  base). Condies rigorosas so dependentes de seqncia e sero diferentes em diferentes circunstncias. Controlando-se o rigor das condies de hibridizao e/ou lavagem, seqncias alvo que so 100% complementares  sonda podem ser identificadas (sondagem homloga). Alternativamente, condies de rigor podem ser ajustadas para permitir alguma falta de correspondncia em seqncias, de forma que menores graus     de similaridade sejam detectados (sondagem heterloga). Geralmente, uma sonda  menor do que cerca de 1000 nucleotideos em comprimento, ou menor do que cerca de 500 nucleotideos em comprimento.</span>Hybridization of such sequences may be conducted under stringent conditions. By "stringent conditions" or "stringent hybridization conditions" is meant conditions under which a probe will hybridize its target sequence to a detectably greater degree than to other sequences (e.g., at least 2-fold relative to the base). Strict conditions are sequence dependent and will differ under different circumstances. By controlling the stringency of hybridization and / or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions may be adjusted to allow some sequence mismatch so that lower degrees of similarity are detected (heterologous sounding). Generally, a probe is less than about 1000 nucleotides in length, or less than about 500 nucleotides in length.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tipicamente, condies rigorosas sero aquelas nas quais a concentrao de sais  menor do que cerca de 1,5 M de ion Na, tipicamente cerca de 0,01 a 1,0 M de concentrao de ion Na (ou outros sais) em pH 7,0 a 8,3 e a temperatura  de pelo menos cerca de 30C para sondas curtas (e.g.,10 a 50 nucleotideos) e pelo menos cerca de 60C para sondas longas (e.g., maiores do que 50 nucleotideos). Condies rigorosas podem ser tambm alcanadas com a adio de agentes desestabilizantes, tais como formamida. Condies exemplares de baixo rigor incluem hibridizao com uma soluo tampo de 30 a 35% formamida, NaCl a 1 M, 1% de SDS (sdio dodecil sulfato) a 37C, e uma lavagem em IX a 2X SSC (20X SSC = 3,0 M NaCl/0,3 M trissdio citrato) a 50 a 55C. Condies exemplares de rigor moderado incluem hibridizao em 40 a 45% formamida, 1,0 M NaCl, 1% SDS a 37C, e uma lavagem em 0,5X a IX SSC a 55 a 60C. Condies exemplares de alto rigor incluem hibridizao em 50% formamida, NaCl a 1 M, 1% SDS a 37C, e uma lavagem em 0,1X SSC a 60 a 65C. Opcionalmente, tampes de lavagem podem compreender cerca de 0,1% a cerca de 1% de SDS. A durao de hibridizao  geralmente menor do que cerca de 24 horas, usualmente cerca de 4 a cerca de 12 horas.     A especificidade  tipicamente a funo de lavagens ps-hibridizao, os fatores crticos sendo a fora inica e a temperatura da soluo de lavagem final. Para hbridos DNA-DNA, a Tm pode ser aproximada a partir da equao de Meinkoth and Wahl (1984) Anal. Biochem. 138:267-284: Tm = 81,50C + 16,6 (log M) + 0,41 (%GC) - 0,61 (% form) - 500/L; onde M  a molaridade de ctions monovalentes, %GC  a porcentagem de nucleotdeos de guanosina e citosina no DNA, % form  a porcentagem de formamida na soluo de hibridizao, e L  o comprimento do hbrido em pares de base. Tm  a temperatura (sob fora inica e pH definidos) na qual 50% de uma seqncia alvo complementar hibridiza a uma sonda perfeitamente correspondente. A Tm  reduzida em cerca de 1C para cada 1% de falta de correspondncia; assim, Tm, condies de hibridizao, e/ou lavagem podem ser ajustadas para hibridizar a seqncias da identidade desejada. Por exemplo, se seqncias com &gt;90% de identidade so procuradas, a Tm, pode ser diminuda em 10C. Geralmente, condies rigorosas so selecionadas para serem cerca de 5C menores do que o ponto trmico de derretimento (Tm) para a seqncia especfica e seu complemento em uma definida fora inica e pH. Contudo, condies severamente rigorosas podem utilizar uma hibridizao e/ou lavagem a 1, 2, 3, ou 4 C menor do que o ponto trmico de derretimento (Tm); condies moderadamente rigorosas podem utilizar uma hibridizao e/ou lavagem a 6, 7, 8, 9, ou 10C menor do que o ponto trmico de derretimento (Tm) ; condies de baixo rigor podem utilizar uma hibridizao e/ou lavagem a 11 , 12, 13, 14, 15, ou 20C menor do que o ponto trmico     de derretimento (Tm) . Usando a equao, composies de hibridizao e lavagem, e Tm desejada, aqueles de conhecimento ordinrio entendero que variaes no rigor de solues de hibridizao e/ou lavagem so inerentemente descritas. Se o grau desejado de falta de correspondncia resulta em uma Tm de menos de 45C (soluo aquosa) ou 32C (soluo de formamida),  prefervel aumentar a concentrao de SSC de forma que uma maior temperatura possa ser usada. Um guia extenso para a hibridizao de cidos nuclicos  encontrado em Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology Hybridization with Nucleic Acid Probes, Part I, Chapter 2 (Elsevier, New York); e Ausubel et al, eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). Ver Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).</span>Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M ion Na, typically about 0.01 to 1.0 M ion Na (or other salts) concentration at pH 7. 0 to 8.3 and the temperature is at least about 30  C for short probes (eg, 10 to 50 nucleotides) and at least about 60  C for long probes (eg, greater than 50 nucleotides). Strict conditions can also be achieved with the addition of destabilizing agents such as formamide. Exemplary low stringency conditions include hybridization with a 30 to 35% formamide buffer solution, 1 M NaCl, 1% SDS (sodium dodecyl sulfate) at 37  C, and a 2X SSC wash (20X SSC = 3 0.0 M NaCl / 0.3 M trisodium citrate) at 50 to 55  C. Exemplary conditions of moderate stringency include hybridization in 40 to 45% formamide, 1.0 M NaCl, 1% SDS at 37  C, and a 0.5X wash at IX SSC at 55 to 60  C. Exemplary high stringency conditions include 50% formamide hybridization, 1 M NaCl, 1% SDS at 37  C, and a 0.1X SSC wash at 60 to 65  C. Optionally, wash buffers may comprise from about 0.1% to about 1% SDS. The hybridization duration is generally less than about 24 hours, usually about 4 to about 12 hours. Specificity is typically the function of posthybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. For DNA-DNA hybrids, Tm can be approximated from the Meinkoth and Wahl (1984) Anal equation. Biochem. 138: 267-284: Tm = 81.50 C + 16.6 (log M) + 0.41 (% GC) - 0.61 (% form) - 500 / L; where M is the monovalent cation molarity,% GC is the percentage of guanosine and cytosine nucleotides in DNA,% form is the percentage of formamide in the hybridization solution, and L is the hybrid length in base pairs. Tm is the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. Tm is reduced by about 1  C for every 1% mismatch; thus Tm, hybridization, and / or wash conditions may be adjusted to hybridize to sequences of desired identity. For example, if sequences with&gt; 90% identity are sought, Tm may be decreased by 10  C. Generally, stringent conditions are selected to be about 5  C lower than the melting thermal point (Tm) for the specific sequence and its complement at a defined ionic strength and pH. However, severely stringent conditions may use hybridization and / or washing at 1, 2, 3, or 4  C below the melting point (Tm); Moderately stringent conditions may use hybridization and / or wash at 6, 7, 8, 9, or 10  C below the melting point (Tm); Low stringency conditions may use hybridization and / or wash at 11, 12, 13, 14, 15, or 20  C below the melting point (Tm). Using the equation, hybridization and wash compositions, and desired Tm, those of ordinary skill will understand that variations in the stringency of hybridization and / or wash solutions are inherently described. If the desired degree of mismatch results in a Tm of less than 45  C (aqueous solution) or 32  C (formamide solution), it is preferable to increase the SSC concentration so that a higher temperature can be used. An extensive guide to nucleic acid hybridization is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology Hybridization with Nucleic Acid Probes, Part I, Chapter 2 (Elsevier, New York); and Ausubel et al, eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). See Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Protenas isoladas e Variantes e Fragmentos Dessas</span>Isolated Proteins and Variants and Fragments of These</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Protenas de resistncia a herbicidas so tambm englobadas na presente inveno. Por "protena de resistncia a herbicidas" ou " protena de tolerncia a herbicidas" pretende-se uma protena tendo a seqncia de aminocidos apresentada em SEQ ID NO: 2, 4, ou 6. Fragmentos, pores biologicamente ativas, e variantes dessas so tambm providos, e podem ser usados para praticar os mtodos da presente inveno.     "Fragmentos" ou "pores biologicamente ativas" incluem fragmentos de polipeptideos compreendendo uma poro de uma seqncia de aminocidos codificando uma proteina de resistncia a herbicidas como apresentado em SEQ ID NO: 2, 4, ou 6 e que retm atividade de resistncia a herbicidas. Uma poro biologicamente ativa de uma proteina de resistncia a herbicidas pode ser um polipeptideo que , por exemplo, de 10, 25, 50, 100 ou mais aminocidos em comprimento. Tais pores biologicamente ativas podem ser preparadas por tcnicas recombinantes e avaliadas para atividade de resistncia a herbicidas. Mtodos para medir a atividade de resistncia a herbicidas so bem conhecidos na arte. Ver, por exemplo, U.S. Patent Nos. 4.535.060, e 5.188.642, cada qual  aqui incorporada por referncia em sua integridade. Como usado aqui, um fragmento compreende pelo menos 8 aminocidos contguos de SEQ ID NO: 2, 4, ou 6. A inveno engloba outros fragmentos, contudo, tais como qualquer fragmento na protena maior do que cerca de 10, 20, 30, 50, 100, 150, 200, 250, 300, 350, ou 400 aminocidos.</span>Herbicide resistance proteins are also encompassed by the present invention. By "herbicide resistance protein" or "herbicide tolerance protein" is meant a protein having the amino acid sequence set forth in SEQ ID NO: 2, 4, or 6. Fragments, biologically active portions, and variants thereof are also provided, and may be used to practice the methods of the present invention. "Fragments" or "biologically active portions" include polypeptide fragments comprising a portion of an amino acid sequence encoding a herbicide resistance protein as set forth in SEQ ID NO: 2, 4, or 6 and retaining herbicide resistance activity. A biologically active portion of a herbicide resistance protein may be a polypeptide that is, for example, 10, 25, 50, 100 or more amino acids in length. Such biologically active portions may be prepared by recombinant techniques and evaluated for herbicide resistance activity. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which is incorporated herein by reference in its entirety. As used herein, a fragment comprises at least 8 contiguous amino acids of SEQ ID NO: 2, 4, or 6. The invention encompasses other fragments, however, such as any protein fragment larger than about 10, 20, 30, 50. , 100, 150, 200, 250, 300, 350, or 400 amino acids.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Por "variantes" pretende-se protenas ou polipeptideos tendo uma seqncia de aminocidos que  pelo menos cerca de 60%, 65%, pelo menos cerca de 70%, 75%, pelo menos cerca de 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% ou 99% idntica  seqncia de aminocidos de SEQ ID NO: 2, 4, ou 6 (por exemplo, SEQ ID NO:6, 15, 17, 19, 21, 23, 25, 27, 29, 31, e 33 so variantes de SEQ ID NO:2). Variantes     tambm incluem polipeptdeos codificados por uma molcula de cido nuclico que hibridiza  molcula de cido nuclico de SEQ ID N0:1, 3, ou 5, ou um complemento dessas, sob condies rigorosas. Variantes incluem polipeptdeos que diferem em seqncia de aminocidos devido  mutagnese. Protenas variantes englobadas pela presente inveno so biologicamente ativas, ou seja, elas continuam a possuir a atividade biolgica desejada da protena nativa, isto , retendo a atividade de resistncia a herbicidas. Mtodos para medir a atividade de resistncia a herbicidas so bem conhecidos na arte. Ver, por exemplo, U.S. Patent Nos. 4.535.060, e 5.188.642, cada qual  aqui incorporada por referncia em sua integridade.</span>By "variants" is meant proteins or polypeptides having an amino acid sequence that is at least about 60%, 65%, at least about 70%, 75%, at least about 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identical to the amino acid sequence of SEQ ID NO: 2, 4, or 6 (e.g. SEQ ID NO: 6, 15, 17, 19, 21, 23, 25, 27, 29, 31, and 33 are variants of SEQ ID NO: 2). Variants also include polypeptides encoded by a nucleic acid molecule that hybridizes to the nucleic acid molecule of SEQ ID NO: 1, 3, or 5, or a complement thereof, under stringent conditions. Variants include polypeptides that differ in amino acid sequence due to mutagenesis. Variant proteins encompassed by the present invention are biologically active, that is, they still possess the desired biological activity of the native protein, i.e. retaining herbicide resistance activity. Methods for measuring herbicide resistance activity are well known in the art. See, for example, U.S. Patent Nos. 4,535,060, and 5,188,642, each of which is incorporated herein by reference in its entirety.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Genes bacterianos, tais como os genes grg23 ou grg51 desta inveno, muito freqentemente possuem mltiplos cdons de iniciao de metionina na proximidade do incio do quadro de abertura de leitura. Freqentemente, a iniciao da traduo em um ou mais desses cdons de incio levar  gerao de uma protena funcional. Esses cdons de incio podem incluir cdons ATG. Contudo, bactrias, tais como Bacillus sp. tambm reconhecem o cdon GTG como um cdon de incio, e protenas que iniciam a traduo nos cdons GTG contm uma metionina no primeiro aminocido. Adicionalmente, no  freqentemente determinado a priori quais desses cdons so usados naturalmente na bactria. Assim,  entendido que o uso de um dos cdons alternados de metionina pode levar  gerao de variantes de grg23 ou grg51 que conferem resistncia a herbicidas. Essas     protenas de resistncia a herbicidas so englobadas na presente inveno e podem ser usadas nos mtodos da presente inveno.</span>Bacterial genes, such as the grg23 or grg51 genes of this invention, most often have multiple methionine initiation codons in the vicinity of the start of the reading aperture frame. Frequently, initiation of translation into one or more of these start codons will lead to the generation of a functional protein. These start codons may include ATG codons. However, bacteria such as Bacillus sp. also recognize the GTG codon as a start codon, and proteins that initiate translation into the GTG codons contain a methionine in the first amino acid. Additionally, it is often not a priori determined which of these codons are naturally used in the bacteria. Thus, it is understood that the use of one of the alternating methionine codons may lead to the generation of grg23 or grg51 variants that confer herbicide resistance. Such herbicide resistance proteins are encompassed by the present invention and may be used in the methods of the present invention.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Anticorpos para os polipeptdeos da presente inveno, ou para variantes ou fragmentos desses, so tambm englobados. Mtodos para produzir anticorpos so bem conhecidos na arte (ver, por exemplo, Harlow and Lane (1988) Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY); U.S. Patent No. 4 .196.265) .</span>Antibodies to the polypeptides of the present invention, or to variants or fragments thereof, are also encompassed. Methods for producing antibodies are well known in the art (see, for example, Harlow and Lane (1988) Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY); U.S. Patent No. 4 .196,265).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Variantes Alterados ou Melhorados</span>Changed or Improved Variants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> reconhecido que a seqncia de DNA de grg23 ou grg51 pode ser alterada por vrios mtodos, e que essas alteraes podem resultar em seqncias de DNA codificando protenas com seqncias de aminocidos diferentes daquelas codificadas por grg23 ou grg51. Esta protena pode ser alterada de vrios jeitos, incluindo substituies de aminocidos, delees, truncaes, e inseres. Mtodos para tais manipulaes so geralmente conhecidos na arte. Por exemplo, variantes da seqncia de aminocidos da protena GRG23 ou GRG51 podem ser preparados por mutaes no DNA. Isso pode ser tambm conseguido por um de diversas formas de mutagnese e/ou por evoluo direcionada. Em alguns aspectos, as mudanas codificadas na seqncia de aminocidos no afetaro substancialmente a funo da protena. Tais variantes possuiro a desejada atividade de     resistncia a herbicidas. Contudo,  entendido que a habilidade de GRG23 ou GRG51 conferir resistncia a herbicidas pode ser melhorada pelo uso de tais tcnicas nas composies da presente inveno. Por exemplo, GRG23 ou GRG51 podem ser expressados em clulas hospedeiras que exibem altas taxas de falta de incorporao de base durante a replicao de DNA, tais como XL-I Red (Stratagene, La Jolla, CA) . Aps a propagao em tais linhagens, DNA de grg23 ou grg51 pode ser isolado (por exemplo, preparando-se DNA de plasmidio, ou amplificando por PCR e clonando o fragmento de PCR resultante em um vetor) e cultivado em linhagens no mutagnicas. Clones contendo mutaes em grg23 ou grg51 podem ser identificados medindo-se a resistncia melhorada a um herbicida, tal como glifosato, por exemplo, cultivando clulas em concentraes aumentadas de glifosato e testando para clones que conferem tolerncia a concentraes aumentadas glifosato. Alternativamente, alteraes podem ser feitas  seqncia de protenas de vrias protenas no terminal amino ou carboxi, sem afetar substancialmente a atividade. Essas alteraes podem incluir inseres, delees, ou alteraes introduzidas por mtodos moleculares modernos, tais como PCR, incluindo amplificaes por PCR que alteram ou estendem a seqncia codificadora de . protena em virtude da incluso de seqncias	codificadoras	de	aminocidos	nos oligonucleotdeos utilizados na amplificao por PCR. Alternativamente, as seqncias de protenas adicionadas podem incluir seqncias codificadoras de protenas inteiras, tais como aquelas usadas comumente na arte para     gerar fuses de protenas. Tais fuses de protenas so freqentemente usadas para (1) aumentar a expresso de uma protena de interesse; (2) introduzir um domnio de ligao, atividade enzimtica, ou epitopo para facilitar tanto purificao de protena, deteco de protena, ou outros usos experimentais conhecidos na arte; ou, (3) secreo alvo ou traduo de uma protena a uma organela sub-celular, tal como o espao periplsmico de bactrias gram-negativas, ou o retculo endoplasmtico de clulas eucariontes, o ltimo dos quais freqentemente resulta em glicosilao da protena.</span>It is recognized that the DNA sequence of grg23 or grg51 can be altered by various methods, and that these alterations can result in DNA sequences encoding proteins with amino acid sequences different from those encoded by grg23 or grg51. This protein can be altered in many ways, including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of the GRG23 or GRG51 protein may be prepared by mutations in the DNA. This can also be achieved by one of several forms of mutagenesis and / or by directed evolution. In some respects, changes encoded in the amino acid sequence will not substantially affect protein function. Such variants will possess the desired herbicide resistance activity. However, it is understood that the ability of GRG23 or GRG51 to confer herbicide resistance may be enhanced by the use of such techniques in the compositions of the present invention. For example, GRG23 or GRG51 may be expressed in host cells that exhibit high rates of lack of base uptake during DNA replication, such as XL-I Red (Stratagene, La Jolla, CA). Following propagation in such strains, grg23 or grg51 DNA can be isolated (e.g., by preparing plasmid DNA, or amplifying by PCR and cloning the resulting PCR fragment into a vector) and cultured in non-mutagenic strains. Clones containing mutations in grg23 or grg51 can be identified by measuring improved resistance to a herbicide such as glyphosate, for example by growing cells at increased glyphosate concentrations and testing for clones that confer tolerance to increased glyphosate concentrations. Alternatively, changes may be made to the protein sequence of various proteins at the amino or carboxy terminus without substantially affecting activity. Such changes may include insertions, deletions, or changes introduced by modern molecular methods, such as PCR, including PCR amplifications that alter or extend the coding sequence of. by virtue of the inclusion of amino acid coding sequences in oligonucleotides used for PCR amplification. Alternatively, added protein sequences may include entire protein coding sequences, such as those commonly used in the art to generate protein fusions. Such protein fusions are often used to (1) increase expression of a protein of interest; (2) introducing a binding domain, enzyme activity, or epitope to facilitate either protein purification, protein detection, or other experimental uses known in the art; or, (3) targeting secretion or translation of a protein to a subcellular organelle, such as the periplasmic space of gram-negative bacteria, or the endoplasmic reticulum of eukaryotic cells, the latter of which often results in protein glycosylation.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Seqncias de nucleotdeos e de aminocidos variantes da presente inveno tambm englobam seqncias derivadas de procedimentos mutagnicos e recombinognicos, tais como embaralhamento de DNA. Com tal procedimento, uma ou mais diferentes regies codificadoras de protenas de resistncia a herbicidas podem ser usadas para criar uma nova protena de resistncia a herbicidas possuindo as propriedades desejadas. Dessa maneira, bibliotecas de polinucleotdeos recombinantes so geradas a partir de uma populao de polinucleotdeos de seqncia relacionados compreendendo regies que possuem identidade de seqncia substancial e podem ser homologamente recombinados in vitro ou in vivo. Por exemplo, usando essa abordagem, motivos de seqncia codificando um domnio de interesse podem ser embaralhados entre o gene de resistncia a herbicidas da inveno e outros genes de resistncia a herbicidas conhecidos para se obter um novo gene codificando uma     protena com uma propriedade de interesse melhorada, tal como uma atividade aumentada de resistncia a glifosato. Estratgias para tal embaralhamento de DNA so conhecidas na arte. Ver, por exemplo, Stemmer (1994) Proc. Natl. Acad.</span>Variant nucleotide and amino acid sequences of the present invention also encompass sequences derived from mutagenic and recombinogenic procedures, such as DNA shuffling. With such a procedure, one or more different herbicide resistance protein coding regions can be used to create a new herbicide resistance protein having the desired properties. Thus, recombinant polynucleotide libraries are generated from a population of related sequence polynucleotides comprising regions that have substantial sequence identity and can be homologously recombined in vitro or in vivo. For example, using this approach, sequence motifs encoding a domain of interest may be shuffled between the herbicide resistance gene of the invention and other known herbicide resistance genes to obtain a new gene encoding a protein with an improved property of interest. , such as increased glyphosate resistance activity. Strategies for such DNA shuffling are known in the art. See, for example, Stemmer (1994) Proc. Natl. Acad.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sei. USA 91 :10747-10751; Stemmer (1994) Nature 370:389- 391; Crameri et al. (1997) Nature Biotech. 15:436-438; Moore et al (1997) J MoI. Biol. 272:336-347; Zhang et al. (1997) Proc. Natl. Acad. Sei. USA 94:4504-4509; Crameri et al. (1998) Nature 391 :288-291; e U.S. Patent Nos. 5.605.793 e 5.837.458.</span>Know. USA 91: 10747-10751; Stemmer (1994) Nature 370: 389-391; Crameri et al. (1997) Nature Biotech. 15: 436-438; Moore et al (1997) J MoI. Biol. 272: 336-347; Zhang et al. (1997) Proc. Natl. Acad. Know. USA 94: 4504-4509; Crameri et al. (1998) Nature 391: 288-291; and U.S. Patent Nos. 5,605,793 and 5,837,458.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Transformao de Clulas Bacterianas ou Vegetais</span>Bacterial or Vegetable Cell Transformation</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">So aqui providos novos genes isolados que conferem resistncia a um herbicida. Tambm providos esto seqncias de aminocidos das protenas GRG23 e GRG51. A protena resultante da traduo desse gene permite s clulas funcionar na presena de concentraes de um herbicida que , de outra forma, txico a clulas incluindo clulas vegetais e clulas bacterianas.</span>New isolated genes providing resistance to a herbicide are provided herein. Also provided are amino acid sequences of the GRG23 and GRG51 proteins. The protein resulting from the translation of this gene allows cells to function in the presence of concentrations of an herbicide that is otherwise toxic to cells including plant cells and bacterial cells.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Em um aspecto da inveno, o gene grg23 ou grg51  til como um marcador para avaliar a transformao de clulas bacterianas ou vegetais. Manipulando grg23 ou grg51 a ser (1) expressado de um promotor bacteriano conhecido por estimular a transcrio no organismo a ser testado, (2) corretamente traduzido para gerar um peptdeo GRG23 ou GRG51 intacto, e (3) colocar as clulas em uma concentrao, ao contrrio, txica de herbicida, clulas     que foram transformadas com DNA em virtude de sua resistncia a herbicida podem ser identificadas. Por "promotor" pretende-se uma seqncia de cidos nuclicos que funcione para direcionar a transcrio de uma seqncia codificadora abaixo. O promotor, junto com outras seqncias de cidos nuclicos reguladoras de transcrio e traduo, (tambm chamadas "seqncias controle")  necessrio para a expresso de uma seqncia de DNA de interesse.</span>In one aspect of the invention, the grg23 or grg51 gene is useful as a marker for evaluating bacterial or plant cell transformation. Manipulating grg23 or grg51 to be (1) expressed from a bacterial promoter known to stimulate transcription in the organism to be tested, (2) correctly translated to generate an intact GRG23 or GRG51 peptide, and (3) place cells in a concentration, In contrast, herbicide toxic, cells that have been transformed with DNA due to their herbicide resistance can be identified. By "promoter" is meant a nucleic acid sequence that functions to direct the transcription of a coding sequence below. The promoter, along with other transcriptional and regulatory regulatory nucleic acid sequences (also called "control sequences") is required for the expression of a DNA sequence of interest.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A transformao de clulas bacterianas  conseguida por uma de diversas tcnicas conhecidas na arte, incluindo, mas no limitando-se a, eletroporao ou transformao qumica (Ver, por exemplo, Ausubel (ed.) (1994) Current Protocols in Molecular Biology (John Wiley and Sons, Inc., Indianapolis, IN)) . Marcadores conferindo resistncia a substncias txicas so teis para identificar clulas transformadas (tendo incorporado e expressado o DNA de teste) a partir de clulas no transformadas (aquelas no contendo ou no expressando o DNA de teste). Em um aspecto da inveno, o gene grg23 ou grg51  til como um marcador para avaliar a transformao de clulas bacterianas ou vegetais.</span>Bacterial cell transformation is accomplished by one of several techniques known in the art, including, but not limited to, electroporation or chemical transformation (See, for example, Ausubel (ed.) (1994) Current Protocols in Molecular Biology (John Wiley and Sons, Inc., Indianapolis, IN)). Markers conferring resistance to toxic substances are useful for identifying transformed cells (having incorporated and expressed test DNA) from untransformed cells (those not containing or expressing test DNA). In one aspect of the invention, the grg23 or grg51 gene is useful as a marker for evaluating bacterial or plant cell transformation.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A transformao de clulas vegetais pode ser conseguida de modo similar. Por "vegetal" pretende-se plantas inteiras, rgos vegetais (e.g., folhas, caules, razes, etc.), sementes, clulas vegetais, propgulos, embries e prognie das mesmas. Clulas vegetais podem ser     diferenciadas ou no diferenciadas (e.g. calo, clulas de cultura em suspenso, protoplastos, clulas foliares, clulas radiculares, clulas do floema, plen). "Plantas transgnicas" ou "plantas transformadas" ou plantas  "estavelmente transformadas", clulas ou tecidos referem-se a plantas que incorporaram ou integraram seqncias de cidos nuclicos exgenas ou fragmentos de DNA na clula vegetal. Por "transformao estvel" pretende-se que o constructo de nucleotideos introduzido em uma planta se  integre no genoma da planta e seja capaz de ser herdado pela prognie dessa.</span>Plant cell transformation can be similarly achieved. By "plant" is meant whole plants, plant organs (e.g., leaves, stems, roots, etc.), seeds, plant cells, propagules, embryos and progenies thereof. Plant cells may be differentiated or undifferentiated (e.g. callus, suspension culture cells, protoplasts, leaf cells, root cells, phloem cells, pollen). "Transgenic plants" or "transformed plants" or "stably transformed" plants, cells or tissues refer to plants that have incorporated or integrated exogenous nucleic acid sequences or DNA fragments into the plant cell. By "stable transformation" is meant that the nucleotide construct introduced into a plant integrates into the plant genome and is capable of being inherited by its progeny.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O gene grg23 ou grg51 da inveno pode ser modificado para obter ou aumentar a expresso em clulas vegetais. As seqncias de resistncia a herbicidas da inveno podem ser providas em cassetes de expresso para expresso na planta de interesse. "Cassete de expresso vegetal" inclui constructos de DNA que so capazes de resultar na expresso de uma protena a partir de um quadro de iniciao de  leitura em uma clula vegetal. O cassete incluir na direo de transcrio 5'-3', uma regio de iniciao transcricional (i.e., promotor) operacionalmente ligada a uma seqncia de DNA da inveno, e uma regio de terminao de traduo e transcrio (i.e., regio de terminao) funcional em plantas. O cassete pode conter, adicionalmente, pelo menos um gene adicional a ser co- transformado no organismo, tal como um gene marcador de seleo. Alternativamente, o(s) gene(s) adicional(is) pode ser provido em mltiplos cassetes de expresso. Tal cassete     de expresso  provido com uma pluralidade de stios de restrio para insero da seqncia de resistncia a herbicidas a estar sob regulao transcricional das regies reguladoras.</span>The grg23 or grg51 gene of the invention may be modified to obtain or increase expression in plant cells. The herbicide resistance sequences of the invention may be provided on expression cassettes for expression in the plant of interest. "Plant expression cassette" includes DNA constructs that are capable of resulting in the expression of a protein from a reading primer in a plant cell. The cassette will include in the 5'-3 'transcription direction, a transcriptional initiation region (ie, promoter) operably linked to a DNA sequence of the invention, and a functional translation and transcription termination region (ie, termination region) in plants. The cassette may additionally contain at least one additional gene to be co-transformed in the organism, such as a selection marker gene. Alternatively, the additional gene (s) may be provided in multiple expression cassettes. Such an expression cassette is provided with a plurality of restriction sites for insertion of the herbicide resistance sequence to be under transcriptional regulation of the regulatory regions.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0 promotor pode ser nativo ou anlogo, ou estrangeiro ou heterlogo,  planta hospedeira e/ou  seqncia de DNA da inveno. Adicionalmente, o promotor pode ser a seqncia natural ou, alternativamente, a seqncia sinttica. Onde o promotor  "nativo" ou "homlogo"  planta hospedeira, o promotor deve ser encontrado na planta nativa na qual o promotor  introduzido. Onde o promotor  "estrangeiro" ou "heterlogo"  seqncia de DNA da inveno, o promotor no deve ser um promotor nativo ou naturalmente ocorrente para a seqncia de DNA operacionalmente ligada da inveno. "Heterlogo" geralmente refere-se s seqncias de cidos nuclicos que no so endgenas  clula ou parte do genoma nativo na qual esto presentes, e foram adicionadas  clula por infeco, transfeco, micro-injeo, eletroporao, microprojeo, ou similares. Por "operacionalmente ligado" pretende-se uma ligao funcional entre um promotor e uma segunda seqncia, caracterizado pelo fato de que a seqncia promotora inicia e media a transcrio da seqncia de DNA correspondente  segunda seqncia. Geralmente, operacionalmente ligado significa que as seqncias de cidos nuclicos sendo ligadas so contguas e, onde necessrio para juntar duas regies codificadoras de protena, contguas no mesmo quadro de leitura.     Freqentemente, tais constructos tambm contero regies 5' e 3' no traduzidas. Tais constructos podem conter uma "seqncia sinal" ou "seqncia lder" para facilitar o transporte de co-traduo ou ps-traduo do peptdeo de interesse para certas estruturas intracelulares, tais como o cloroplasto (ou outro plastdio), retculo endoplasmtico, ou aparelho de Golgi, ou para ser secretado. Por exemplo, o gene pode ser construdo para conter um peptdeo sinal para a transferncia do peptdeo para o retculo endoplasmtico. Por "seqncia sinal" pretende-se uma seqncia que  conhecida ou suspeita de resultar em transporte de co- traduo ou ps-traduo de peptdeo atravs da membrana celular. Em eucariotos, esse transporte envolve, tipicamente, secreo no aparelho de Golgi, com alguma glicosilao resultante. Por "seqncia lder" pretende-se qualquer seqncia que, quando traduzida, resulte em uma seqncia de aminocidos suficiente para disparar o transporte de co-traduo da cadeia peptdica para uma organela sub-celular. Assim, isso inclui seqncias lder direcionando o transporte e/ou glicosilao por passagem no retculo endoplasmtico, passagem para vacolos, plastdios, incluindo cloroplastos, mitocndria, e similares. O cassete de expresso vegetal pode ser tambm construdo para conter um ntron, de forma que o processamento de RNAm do ntron seja necessrio para a expresso.     Por "regio 3' no traduzida" pretende-se uma seqncia de nucleotideos localizada abaixo de uma seqncia codificadora. So regies 3' no traduzidas seqncias de sinais de poliadenilao e outras seqncias codificando sinais reguladores capazes de afetar a adio de traos de cido poliadenilico  extremidade 3' do RNAm precursor. Por "regio 5' no traduzida" pretende-se uma seqncia de nucleotideos localizada acima de uma seqncia codificadora.</span>The promoter may be native or analogous, or foreign or heterologous, to the host plant and / or the DNA sequence of the invention. Additionally, the promoter may be the natural sequence or alternatively the synthetic sequence. Where the promoter is "native" or "homologous" to the host plant, the promoter must be found in the native plant into which the promoter is introduced. Where the promoter is "foreign" or "heterologous" to the DNA sequence of the invention, the promoter should not be a native or naturally occurring promoter for the operably linked DNA sequence of the invention. "Heterologous" generally refers to nucleic acid sequences that are not endogenous to the cell or part of the native genome in which they are present, and were added to the cell by infection, transfection, microinjection, electroporation, microprojection, or the like. By "operably linked" is meant a functional link between a promoter and a second sequence, characterized in that the promoter sequence initiates and mediates the transcription of the DNA sequence corresponding to the second sequence. Generally, operably linked means that the nucleic acid sequences being linked are contiguous and, where necessary to join two contiguous protein coding regions in the same reading frame. Often such constructs will also contain untranslated 5 'and 3' regions. Such constructs may contain a "signal sequence" or "leader sequence" to facilitate the transport of co-translation or post-translation of the peptide of interest to certain intracellular structures, such as chloroplast (or other plastid), endoplasmic reticulum, or apparatus. Golgi, or to be secreted. For example, the gene may be constructed to contain a signal peptide for transfer of the peptide to the endoplasmic reticulum. By "signal sequence" is meant a sequence that is known or suspected to result in transport of peptide co-translation or post-translation across the cell membrane. In eukaryotes, this transport typically involves secretion into the Golgi apparatus with some resulting glycosylation. By "leader sequence" is meant any sequence which, when translated, results in a sufficient amino acid sequence to trigger the co-translation transport of the peptide chain to a subcellular organelle. Thus, this includes leader sequences directing transport and / or glycosylation by passage into the endoplasmic reticulum, passage to vacuoles, plastids, including chloroplasts, mitochondria, and the like. The plant expression cassette may also be constructed to contain an intron, so that intron mRNA processing is required for expression. By "untranslated 3 'region" is meant a nucleotide sequence located below a coding sequence. These 3 'regions are untranslated sequences of polyadenylation signals and other sequences encoding regulatory signals capable of affecting the addition of traces of polyadenylic acid to the 3' end of the precursor mRNA. By "untranslated 5 'region" is meant a nucleotide sequence located above a coding sequence.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Outros elementos acima e abaixo no traduzidos incluem intensificadores. Intensificadores so seqncias de nucleotideos que atuam para aumentar a expresso de uma regio promotora. Intensificadores so bem conhecidos na arte e incluem, mas no so limitados a, a regio intensificadora SV40 e o elemento intensificador 35S.</span>Other elements not translated above and below include enhancers. Enhancers are nucleotide sequences that act to increase expression of a promoter region. Enhancers are well known in the art and include, but are not limited to, the SV40 enhancer region and the 35S enhancer element.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A regio de terminao pode ser nativa em relao  regio de iniciao transcricional, pode ser nativa em relao  seqncia de resistncia a herbicidas da presente inveno, ou pode ser derivada de outra fonte. Regies de terminao convenientes esto disponveis do plasmdio Ti de A. tumefaciens, tais como regies de terminao de octopina sintase e nopalina sintase. Ver, tambm Guerineau et al. (1991) Mo/. Gen. Genet. 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al (1991) Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene 91:151-158; Bailas et al. (1989)     Nucleic Aeids Res. 17:7891-7903; e Joshi et al. (1987) Nucleie Aeid Res. 25 15:9627-9639.</span>The termination region may be native to the transcriptional initiation region, may be native to the herbicide resistance sequence of the present invention, or may be derived from another source. Convenient termination regions are available from A. tumefaciens Ti plasmid, such as octopin synthase and nopaline synthase termination regions. See also Guerineau et al. (1991) Mo. Gen. Genet. 262: 141-144; Proudfoot (1991) Cell 64: 671-674; Sanfacon et al (1991) Genes Dev. 5: 141-149; Mogen et al. (1990) Plant Cell 2: 1261-1272; Munroe et al. (1990) Gene 91: 151-158; Bailas et al. (1989) Nucleic Aeids Res. 17: 7891-7903; and Joshi et al. (1987) Nucleie Aeid Res. 25 15: 9627-9639.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Onde apropriado, o(s) gene(s) pode ser otimizado para expresso aumentada na clula hospedeira transformada. Isto , os genes podem ser sintetizados usando cdons preferenciais de clula hospedeira para expresso melhorada, ou podem ser sintetizados usando cdons a uma freqncia de cdons preferida de hospedeiro. Geralmente, o contedo GC do gene ser aumentado. Ver, por exemplo, Campbell and Gowri (1990) Plant Physiol. 92:1-11 para uma discusso do uso de cdons preferidos de hospedeiro. Mtodos para sintetizar genes preferidos de hospedeiro so conhecidos na arte. Ver, por exemplo, U.S. Patent Nos. 6.320.100; 6.075.185; 5.380.831; e 5.436.391, U.S. Published Application Nos. 20040005600 e 20010003849, e Murray et al. (1989) Nucleic Acids Res. 17:477-498, aqui incorporados por referncia. Em um avano, os cidos nuclicos de interesse so direcionados para o cloroplasto para expresso. Dessa maneira, onde o cido nuclico de interesse no  diretamente inserido no cloroplasto, o cassete de expresso conter, adicionalmente, um cido nuclico codificando um peptideo de trnsito para direcionar o produto gnico de interesse para os cloroplastos. Tais peptideos de trnsito so conhecidos na arte. Ver, por exemplo, Von Heijne et al. (1991) Plant MoI. Biol. Rep. 9:104-126; Clark et al. (1989) J. Biol. Chem. 264:17544-17550; Della-Cioppa et al. (1987) Plant Physiol. 84:965-968; Romer et al. (1993) Biochem. Biophys. Res.     Commun. 196:1414-1421; e Shah et al. (1986) Science 233:478-481.</span>Where appropriate, the gene (s) may be optimized for increased expression in the transformed host cell. That is, the genes may be synthesized using host cell preferred codons for enhanced expression, or they may be synthesized using codons at a preferred host codon frequency. Generally, the GC content of the gene will be increased. See, for example, Campbell and Gowri (1990) Plant Physiol. 92: 1-11 for a discussion of the use of preferred host codons. Methods for synthesizing preferred host genes are known in the art. See, for example, U.S. Patent Nos. 6,320,100; 6,075,185; 5,380,831; and 5,436,391, U.S. Published Application Nos. 20040005600 and 20010003849, and Murray et al. (1989) Nucleic Acids Res. 17: 477-498, incorporated herein by reference. In one advance, the nucleic acids of interest are directed to the chloroplast for expression. Thus, where the nucleic acid of interest is not directly inserted into the chloroplast, the expression cassette will additionally contain a nucleic acid encoding a transit peptide to direct the gene product of interest to the chloroplasts. Such transit peptides are known in the art. See, for example, Von Heijne et al. (1991) Plant MoI. Biol. Rep. 9: 104-126; Clark et al. (1989) J. Biol. Chem. 264: 17544-17550; Della-Cioppa et al. (1987) Plant Physiol. 84: 965-968; Romer et al. (1993) Biochem. Biophys. Res. Commun. 196: 1414-1421; and Shah et al. (1986) Science 233: 478-481.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Os cidos nuclicos de interesse a serem direcionados para o cloroplasto podem ser otimizados para expresso no cloroplasto para contabilizar diferenas no uso de cdon entre o ncleo da planta e essa organela. Dessa maneira, os cidos nuclicos de interesse podem ser sintetizados usando cdons preferenciais de cloroplasto. Ver, por exemplo, U.S. Patent No. 5.380.831, aqui incorporada por referncia.</span>The nucleic acids of interest to be directed to the chloroplast can be optimized for chloroplast expression to account for differences in codon usage between the plant nucleus and this organelle. In this way, the nucleic acids of interest can be synthesized using chloroplast preferred codons. See, for example, U.S. Patent No. 5,380,831, incorporated herein by reference.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tipicamente esse "cassete de expresso vegetal" ser inserido em um "vetor de transformao vegetal." Por "vetor de transformao" pretende-se uma molcula de DNA que  necessria para transformao eficiente de uma clula. Tal molcula pode consistir de um ou mais cassetes de expresso, e pode ser organizada em mais de uma molcula de DNA "vetor". Por exemplo, vetores binrios so vetores de transformao vegetal que utilizam dois DNA vetores no contguos para codificar todas funes requisito eis e trans para transformao de clulas vegetais (Hellens and Mullineaux (2000) Trends in Plant Science 5:446-451). "Vetor" refere-se a um constructo de cido nuclico projetado para se transferir entre clulas hospedeiras diferentes. "Vetor de expresso" refere-se a um vetor que possui a habilidade de incorporar, integrar e expressar seqncias de DNA heterlogas ou fragmentos em uma clula estrangeira.     Esse vetor de transformao vegetal pode ser compreendido de um ou mais DNA vetores necessrios para alcanar a transformao vegetal. Por exemplo,  uma comum na arte to utilizar vetores de transformao vegetais que so compreendidos de um ou mais segmentos de DNA contguos. Esses vetores so freqentemente referidos na arte como "vetores binrios." Vetores binrios, assim como vetores com plasmdios ajudantes, so mais freqentemente usados para transformao mediada por Agrobacterium, onde  bem grande o tamanho e a complexidade de segmentos de DNA necessrios para alcanar transformao eficiente, e  vantajoso separar funes em molculas de DNA separadas. Vetores binrios contm tipicamente um vetor de plasmdio que contm as seqncias eis necessria para transferncia de T-DNA (tais como fronteira esquerda e fronteira direita), um marcador selecionvel que  construdo para ser capaz de expresso em uma clula vegetal, e um gene de interesse (um gene construdo para ser capaz de expresso em uma clula vegetal para a qual a gerao de plantas transgnicas . desejada). Tambm presentes nesse vetor de plasmdio esto seqncias necessrias para replicao bacteriana. As seqncias eis so arranjadas de modo a permitir transferncia eficiente em clulas vegetais e expresso nestas. Por exemplo, o gene marcador de seleo e o gene de interesse esto localizados entre as fronteiras esquerda e direita. Freqentemente um segundo vetor de plasmdio contm os fatores trans que mediam a transferncia de T-DNA de Agrobacterium para clulas vegetais. Esse plasmdio freqentemente contm as funes     de virulncia (genes Vir) que permitir a infeco de clulas vegetais por Agrobacterium, e transferncia de DNA por clivagem nas seqncias de fronteira e transferncia de DNA mediada por vir, como entendido na arte (Hellens and Mullineaux (2000) Trends in Plant Science, 5:446- 451). Diversos tipos de linhagens de Agrobacterium (e.g. LBA4404, GV3101, EHAlOl, EHA 105, etc.) podem ser usados para transformao vegetal. O segundo vetor de plasmidio no  necessrio para transformar as plantas pode outros mtodos, tais como microprojeo, micro-injeo, eletroporao, polietileno glicol, etc.</span>Typically this "plant expression cassette" will be inserted into a "plant transformation vector." By "transformation vector" is meant a DNA molecule that is required for efficient transformation of a cell. Such a molecule may consist of one or more expression cassettes, and may be organized into more than one "vector" DNA molecule. For example, binary vectors are plant transformation vectors that use two noncontiguous DNA vectors to encode all requisite and trans requisite functions for plant cell transformation (Hellens and Mullineaux (2000) Trends in Plant Science 5: 446-451). "Vector" refers to a nucleic acid construct designed to transfer between different host cells. "Expression vector" refers to a vector that has the ability to incorporate, integrate, and express heterologous DNA sequences or fragments into a foreign cell. This plant transformation vector may be comprised of one or more DNA vectors necessary to achieve plant transformation. For example, it is common in the art to use plant transformation vectors that are comprised of one or more contiguous DNA segments. These vectors are often referred to in the art as "binary vectors." Binary vectors, as well as helper plasmid vectors, are most often used for Agrobacterium-mediated transformation, where the size and complexity of DNA segments required to achieve efficient transformation is very large, and it is advantageous to separate functions into separate DNA molecules. Binary vectors typically contain a plasmid vector that contains the sequences necessary for T-DNA transfer (such as left boundary and right boundary), a selectable marker that is constructed to be capable of expression in a plant cell, and a interest (a gene constructed to be capable of expression in a plant cell for which generation of transgenic plants is desired). Also present in this plasmid vector are sequences required for bacterial replication. The useful sequences are arranged to allow efficient transfer into and expression of plant cells. For example, the selection marker gene and the gene of interest are located between the left and right borders. Often a second plasmid vector contains the trans factors that mediate the transfer of Agrobacterium T-DNA to plant cells. This plasmid often contains virulence functions (Vir genes) that allow plant cell infection by Agrobacterium, and DNA transfer by cleavage in boundary sequences and vir-mediated DNA transfer, as understood in the art (Hellens and Mullineaux (2000)). ) Trends in Plant Science, 5: 446-451). Various types of Agrobacterium strains (e.g. LBA4404, GV3101, EHA101, EHA 105, etc.) can be used for plant transformation. The second plasmid vector is not required to transform plants can other methods such as microprojection, microinjection, electroporation, polyethylene glycol, etc.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Transformao Vegetal</span>Vegetable Transformation</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mtodos da inveno envolvem introduzir um constructo de nucleotideos em uma planta. Por "introduzir" pretende-se apresentar  planta o constructo de nucleotideos de modo que o constructo ganhe acesso ao interior de uma clula da planta. Os mtodos da inveno no necessitam que seja usado um mtodo em particular para introduzir um constructo de nucleotideos em uma planta, apenas que o constructo de nucleotideos ganhe acesso ao interior de pelo menos uma clula da planta. Mtodos para introduzir constructos de nucleotideos em plantas so conhecidos na arte incluindo, mas no se limitando a, mtodos de transformao estvel, mtodos de transformao transiente, e mtodos mediados por virus.     Em geral, mtodos de transformao vegetal envolvem transferir DNA heterlogo em clulas vegetais alvo (e.g. embries maduros ou imaturos, culturas em suspenso, calos no diferenciados, protoplastos, etc.), seguido pela aplicao de um nivel limite mximo de seleo apropriada (dependendo do gene marcador de seleo e, neste caso, "glifosato") para recuperar as clulas vegetais transformadas a partir de um grupo de massa de clulas no transformadas. Explantes so tipicamente transferidos para um suprimento fresco do mesmo meio e cultivados rotineiramente. Subseqentemente, as clulas transformadas so diferenciadas em brotos aps a colocao em meio de regenerao suplementado com um nivel limite mximo de agente de seleo (e.g. "glifosato"). Os brotos so, ento, transferidos para um meio seletivo enraizador para recuperar o broto com raiz ou plntula. As plntulas transgnicas, ento crescidas em plantas maduras, produzem sementes frteis (e.g. Hiei et al. (1994) The Plant Journal 6:271- 282; Ishida et al. (1996) Nature Biotechnology 14:745-750). Explantes so tipicamente transferidos para um suprimento fresco do mesmo meio e cultivados rotineiramente. Uma descrio geral das tcnicas e mtodos para gerar plantas transgnicas  encontrada em Ayres and Park (1994) Criticai Reviews in Plant Science 13:219-239 e Bommineni and Jauhar (1997) Maydica 42:107-120. Como o material transformado contm vrias clulas; ambas clulas transformadas e no transformadas esto presentes em qualquer pedao do calo alvo ou tecido ou grupo de clulas em questo. A habilidade de matar clulas no transformadas     e permitir que clulas transformadas se proliferem resulta em culturas vegetais transformadas. Freqentemente, a habilidade de remover clulas no transformadas  uma limitao para rpida recuperao de clulas vegetais  transformadas e gerao bem-sucedida de plantas transgnicas. Mtodos moleculares e bioqumicos podem ser usados para confirmar a presena do gene heterlogo integrado de interesse no genoma da planta transgnica.</span>Methods of the invention involve introducing a nucleotide construct into a plant. By "introducing" is meant to present the nucleotide construct to the plant so that the construct gains access to the interior of a plant cell. The methods of the invention do not require that a particular method of introducing a nucleotide construct into a plant be used, only that the nucleotide construct gain access to the interior of at least one plant cell. Methods for introducing nucleotide constructs into plants are known in the art including, but not limited to, stable transformation methods, transient transformation methods, and virus mediated methods. In general, plant transformation methods involve transferring heterologous DNA to target plant cells (eg mature or immature embryos, suspension cultures, undifferentiated callus, protoplasts, etc.), followed by applying an appropriate upper limit level of selection (depending on the selection marker gene and, in this case, "glyphosate") to recover transformed plant cells from a group of unprocessed cell masses. Explants are typically transferred to a fresh supply of the same medium and routinely grown. Subsequently, transformed cells are differentiated into buds after placement in regeneration medium supplemented with a maximum limiting level of selection agent (e.g. "glyphosate"). The shoots are then transferred to a selective rooting medium to recover the root or seedling shoot. Transgenic seedlings, then grown on mature plants, produce fertile seeds (e.g. Hiei et al. (1994) The Plant Journal 6: 271-282; Ishida et al. (1996) Nature Biotechnology 14: 745-750). Explants are typically transferred to a fresh supply of the same medium and routinely grown. A general description of the techniques and methods for generating transgenic plants is found in Ayres and Park (1994) Critical Reviews in Plant Science 13: 219-239 and Bommineni and Jauhar (1997) Maydica 42: 107-120. As the transformed material contains several cells; Both transformed and untransformed cells are present in any piece of the target callus or tissue or group of cells in question. The ability to kill unprocessed cells and allow transformed cells to proliferate results in transformed plant cultures. Often, the ability to remove unprocessed cells is a limitation for rapid recovery of transformed plant cells and successful generation of transgenic plants. Molecular and biochemical methods can be used to confirm the presence of the integrated heterologous gene of interest in the genome of the transgenic plant.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A gerao de plantas transgnicas pode ser realizada por um dos diversos mtodos, incluindo, mas no se limitando a, introduo de DNA heterlogo por Agrobacterium em clulas vegetais (transformao mediada por Agrobacterium), bombardeamento de clulas vegetais com DNA  estrangeiro heterlogo aderido a partculas, e vrios outros mtodos sem uso de partculas ou diretamente mediados (e.g. Hiei et al. (1994) The Plant Journal 6:271- 282; Ishida et al. (1996) Nature Biotechnology 14:745-750; Ayres and Park (1994) Criticai Reviews in Plant Science  13:219-239; Bommineni and Jauhar (1997) Maydica 42:107-120) para transferir DNA.</span>Transgenic plant generation can be accomplished by one of several methods, including, but not limited to, introducing Agrobacterium heterologous DNA into plant cells (Agrobacterium-mediated transformation), bombarding plant cells with particle-adhered heterologous foreign DNA, and various other particle-free or directly mediated methods (eg Hiei et al. (1994) The Plant Journal 6: 271-282; Ishida et al. (1996) Nature Biotechnology 14: 745-750; Ayres and Park (1994) Critical Reviews in Plant Science 13: 219-239; Bommineni and Jauhar (1997) Maydica 42: 107-120) to transfer DNA.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mtodos para transformao de cloroplastos so conhecidos na arte. Ver, por exemplo, Svab et al. (1990) Proc. Natl. Acad. Sei. USA 87:8526-8530; Svab and Maliga (1993) Proc. Natl. Acad. Sei. USA 90:913-917; Svab and Maliga (1993) EMBO J. 12:601-606. 0 mtodo confia na distribuio de DNA contendo um marcador selecionvel por pistola de partculas e direcionamento do DNA para o genoma     do plastdio atravs de recombinao homloga. Adicionalmente, transformao de plastidio pode ser conseguida por ativao de um transgene transmitido por plastidio silencioso por expresso preferencial de tecido de uma RNA polimerase nuclearmente codificada e direcionada por plastidio. Tal sistema foi relatado em McBride et al. (1994) Proc. Natl. Acad. Sci. USA 91 :7301-7305.</span>Methods for chloroplast transformation are known in the art. See, for example, Svab et al. (1990) Proc. Natl. Acad. Know. USA 87: 8526-8530; Svab and Maliga (1993) Proc. Natl. Acad. Know. USA 90: 913-917; Svab and Maliga (1993) EMBO J. 12: 601-606. The method relies on DNA distribution containing a particle gun selectable marker and targeting DNA to the plastid genome by homologous recombination. Additionally, plastid transformation can be accomplished by activating a silent plastid-transmitted transgene by preferential tissue expression of a plastid-directed nuclear-encoded RNA polymerase. Such a system has been reported in McBride et al. (1994) Proc. Natl. Acad. Sci. USA 91: 7301-7305.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">As clulas que foram transformadas podem ser cultivadas em plantas em concordncia com meios convencionais. Ver, por exemplo, McCormick et al. (1986) Plant Cell Reports 5:81-84. Essas plantas podem ser, ento, crescidas, e tanto polinizadas com a mesma linhagem transformada ou diferentes linhagens, e o hbrido resultante tendo expresso constitutiva da caracterstica fenotpica desejada identificada. Duas ou mais geraes podem ser cultivadas para garantir que a expresso da caracterstica fenotpica desejada seja estavelmente mantida e herdada e, ento, as sementes colhidas para assegurar que a expresso da caracterstica fenotpica desejada foi alcanada. Dessa maneira, a presente inveno prov sementes transformadas (tambm referidas como "sementes transgnicas") tendo um constructo de nucleotdeos da inveno, por exemplo, um cassete de expresso da inveno, estavelmente incorporado em seu genoma.</span>Cells that have been transformed can be grown in plants in accordance with conventional media. See, for example, McCormick et al. (1986) Plant Cell Reports 5: 81-84. These plants can then be grown, and either pollinated with the same transformed strain or different strains, and the resulting hybrid having constitutive expression of the desired phenotypic trait identified. Two or more generations may be grown to ensure that expression of the desired phenotypic trait is stably maintained and inherited, and then seeds harvested to ensure that expression of the desired phenotypic trait has been achieved. Accordingly, the present invention provides transformed seeds (also referred to as "transgenic seeds") having a nucleotide construct of the invention, for example, an expression cassette of the invention, stably incorporated into its genome.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Medio de atividade de EPSPS     Em um avano da presente inveno, a enzima EPSPS resistente a glifosato possui uma Km para fosfoenolpiruvato (PEP) entre cerca de 1 e cerca de 150uM, incluindo cerca de 2 uM, cerca de 3, 4, 5, 6, 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130 ou cerca de 140 uM, e uma Ki (glifosato)/ Krri (PEP) entre cerca de 500 e cerca de 1000, cerca de 550, cerca de 600, 650, 700, 750, 800, 850, 900, 950, ou at cerca de 1000. Como aqui usado, Km and Ki so medidas sob condies nas quais a enzima obedece a cintica de Michaelis-Menten, em torno de pH 7. Uma tcnica de medio no limitante usa a enzima na forma purificada em cloreto de potssio e tampo HEPES em pH 7 em temperatura ambiente e usa concentraes de glifosato de 0 a IOmM.</span>Measurement of EPSPS Activity In a breakthrough of the present invention, the glyphosate resistant EPSPS enzyme has a Km for phosphoenolpyruvate (PEP) of between about 1 and about 150uM, including about 2 M, about 3, 4, 5, 6 , 7, 8, 9, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130 or about 140 M, and a Ki (glyphosate) / Krri (PEP) between about 500 and about 1000, about 550, about 600, 650, 700, 750, 800, 850, 900, 950, or even about 1000. As used herein, Km and Ki are measured under conditions in which the The enzyme follows Michaelis-Menten kinetics around pH 7. A non-limiting measurement technique uses the enzyme as purified potassium chloride and HEPES buffer at pH 7 at room temperature and uses glyphosate concentrations from 0 to 10mM.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A atividade cintica de EPSPS pode ser testada, por exemplo, medindo-se a liberao de fosfato que resulta durante a catlise de um substrato de EPSPS (por exemplo, PEP e S3P) para seu subseqente produto de reao (por exemplo, cido 5-enolpiruvil-3-fosfochiquimico) usando um teste fluorescente descrito por Vazquez et al. (2003) Anal. Biochem. 320 (2) :292-298. Esse teste  baseado na oxidao do	composto	no	fluorescente	N-acetil-3,7- dihidroxifenoxacina (Amplex Red, Invitrogen, Carlsbad, CA) para o composto fluorescente resorufina por perxido de hidrognio (Zhou and Panchuk-Voloshina (1997) Anal. Biochem. 253:169-174). A reao confia na utilizao de fosfato por purina nucleosideo fosforilase (PNP), xantina oxidase (XOD), e peroxidase de raiz forte (HRP). A liberao de fosfato est ligada ao nivel de fluorescncia     que resulta da converso de Amplex Red para resorufina. A fluorescncia pode ser medida, por exemplo, usando um filtro fluormetro, leitor de placa, espectrofluormetro, espectrofotmetro, ou similares, usando mtodos bem conhecidos na arte. A fluorescncia gerada pela reao pode ser detectada usando um fluormetro para excitao na faixa de cerca de 530 a cerca de 560 nm e uma emisso de cerca de 590 nm. A absorbncia pode ser detectada (por exemplo, usando um espectrofotmetro ou leitor de placa) a cerca de 565 nm.</span>The kinetic activity of EPSPS can be tested, for example, by measuring the phosphate release that results during catalysis of an EPSPS substrate (eg PEP and S3P) for its subsequent reaction product (eg 5-acid). enolpyruvyl-3-phosphochiquimimer) using a fluorescent test described by Vazquez et al. (2003) Anal. Biochem. 320 (2): 292-298. This test is based on the oxidation of the non-fluorescent compound N-acetyl-3,7-dihydroxyphenoxacin (Amplex Red, Invitrogen, Carlsbad, CA) to the hydrogen peroxide resorufin fluorescent compound (Zhou and Panchuk-Voloshina (1997) Anal. Biochem 253: 169-174). The reaction relies on the use of phosphate by purine nucleoside phosphorylase (PNP), xanthine oxidase (XOD), and strong root peroxidase (HRP). Phosphate release is linked to the level of fluorescence that results from the conversion of Amplex Red to resorufin. Fluorescence can be measured, for example, using a fluorometer filter, plate reader, spectrophotometer, spectrophotometer, or the like, using methods well known in the art. The fluorescence generated by the reaction can be detected using an excitation fluorometer in the range of about 530 to about 560 nm and an emission of about 590 nm. Absorbance can be detected (eg using a spectrophotometer or plate reader) at about 565 nm.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Em um avano, a presente inveno engloba uma alterao das condies de este previamente relatadas para estender a faixa dinmica do teste para acomodar uma amplitude mais ampla de concentraes de substrato. A alterao compreende uma concentrao de XOD de pelo menos 1 U/ml, cerca de 1 a cerca de 1,25 U/ml, cerca de 1,25 a cerca de 1,5 U/ml, cerca de 1,5 a cerca de 2 U/ml, ou maior do que 2 U/ml; uma concentrao de PNP maior do que 0,1 U/ml, cerca de 0,1 a cerca de 0,5 U/ml, cerca de 0,5 a cerca de 1 U/ml, cerca de 1 a cerca de 1,5 U/ml, cerca de 1,5 a cerca de 2 U/ml, ou maior do que 2 U/ml; e uma concentrao de Amplex Red maior do que 100 , cerca de 100 a cerca de 200 , cerca de 200 a cerca de 300 , cerca de 300 a cerca de 400 , cerca de 400 a cerca de 500 , cerca de 500 a cerca de 600 , cerca de 700 a cerca de 800 , cerca de 800 a cerca de 900 , cerca de 900 a cerca de 1000 , ou maior do que cerca de 1000 . Essa modificao pode ser aplicada para testes medindo a     atividade cintica de qualquer enzima na qual fosfato  liberado durante uma reao catalisada pela enzima.</span>In an advance, the present invention encompasses a change in the conditions previously reported to extend the dynamic range of the test to accommodate a wider range of substrate concentrations. The change comprises an XOD concentration of at least 1 U / ml, about 1 to about 1.25 U / ml, about 1.25 to about 1.5 U / ml, about 1.5 to about 2 U / ml, or greater than 2 U / ml; a PNP concentration greater than 0.1 U / ml, about 0.1 to about 0.5 U / ml, about 0.5 to about 1 U / ml, about 1 to about 1, 5 U / ml, about 1.5 to about 2 U / ml, or greater than 2 U / ml; and a Amplex Red concentration greater than 100 , about 100 to about 200 , about 200 to about 300 , about 300 to about 400 , about 400 to about 500 , about from 500 to about 600 , about 700 to about 800 , about 800 to about 900 , about 900 to about 1000 , or greater than about 1000 . This modification can be applied to tests by measuring the kinetic activity of any enzyme in which phosphate is released during an enzyme catalyzed reaction.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Plantas</span>Plants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A presente inveno pode ser usada para transformao de qualquer espcie de planta, incluindo, mas no limitado a, monocotiledneas e dicotiledneas. Exemplos de plantas de interesse incluem, mas no so limitados a, milho, sorgo, trigo, girassol, tomate, cruciferas, pimentas, batata, algodo, arroz, soja, beterraba, cana-de-aucar, tabaco, cevada, couve e Brassica sp. , alfafa, centeio, milhete, crtamo, amendoim, batata-doce, mandioca, caf, coco, abacaxi, rvores citrica, cacau, ch, banana, abacate, figo, goiaba, manga, oliveira, mamo-papaia, caju, macadmia, amndoa, aveia, verduras, ornamentais, e coniferas.</span>The present invention may be used for transformation of any plant species, including, but not limited to, monocotyledons and dicotyledons. Examples of plants of interest include, but are not limited to, corn, sorghum, wheat, sunflower, tomato, crucifer, pepper, potato, cotton, rice, soybean, sugar cane, tobacco, barley, kale and Brassica. sp. , alfalfa, rye, millet, safflower, peanut, sweet potato, cassava, coffee, coconut, pineapple, citrus trees, cocoa, tea, banana, avocado, fig, guava, mango, olive, papaya, cashew, macadamia, almond, oats, greens, ornamentals, and conifers.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Verduras incluem, mas no so limitados a, tomates, alface, feijes verdes, feijes lima, ervilhas, e membros do gnero Curcumis, tais como pepino, cantalupo, e melo. Ornamentais incluem, mas no so limitados a, azalia, hortnsia, hibisco, rosas, tulipas, narcisos, petnias, cravo, bico-de-papagaio, e crisntemo. Preferencialmente, plantas da presente inveno so plantas de cultivo (por exemplo, milho, sorgo, trigo, girassol, tomate, cruciferas, pimentas, batata, algodo, arroz, soja, beterraba, cana-de- acar, tabaco, cevada, couve, etc.).     Esta inveno  particularmente adequada para qualquer membro da famlia de plantas monocotiledneas incluindo, mas no limitado a, milho, arroz, cevada, aveia, trigo, sorgo, centeio, cana-de-acar, abacaxi, inhame, cebola, banana, coco, e tmaras.</span>Vegetables include, but are not limited to, tomatoes, lettuce, green beans, lime beans, peas, and members of the genus Curcumis, such as cucumber, cantaloupe, and melon. Ornamentals include, but are not limited to, azalea, hydrangea, hibiscus, roses, tulips, daffodils, petunias, carnation, parrot's beak, and chrysanthemum. Preferably, plants of the present invention are cultivation plants (e.g., corn, sorghum, wheat, sunflower, tomato, crucifer, pepper, potato, cotton, rice, soybean, sugar cane, tobacco, barley, cabbage, etc.). This invention is particularly suitable for any member of the monocot family including, but not limited to, maize, rice, barley, oats, wheat, sorghum, rye, sugar cane, pineapple, yam, onion, banana, coconut, and dates.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Avaliao de Transformao Vegetal</span>Plant Transformation Assessment</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Aps a introduo de DNA estrangeiro heterlogo em clulas vegetais, a transformao ou integrao do gene heterlogo no genoma da planta  confirmada por vrios mtodos, tais como anlise de cidos nuclicos, protenas e metablitos associados com o gene integrado.</span>Following the introduction of foreign heterologous DNA into plant cells, transformation or integration of the heterologous gene into the plant genome is confirmed by various methods, such as analysis of nucleic acids, proteins and metabolites associated with the integrated gene.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A anlise de PCR  um mtodo rpido de rastrear clulas transformadas, tecidos ou brotos para a presena do gene incorporado no estgio inicial antes de transplantar paro o solo (Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY)). PCR  conduzido usando primers de oligonucleotdeos especficos para o gene de interesse ou uma base de vetor de Agrobacteriumf etc.</span>PCR analysis is a rapid method of screening transformed cells, tissues or buds for the presence of the early-stage incorporated gene before transplanting into the soil (Sambrook and Russell (2001). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press , Cold Spring Harbor, NY)). PCR is conducted using oligonucleotide primers specific for the gene of interest or an Agrobacterium vector base etc.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A transformao vegetal pode ser confirmada por anlise de Southern blot de DNA genmico (Sambrook and Russell (2001) supra) . Em geral, DNA total  estrado do transformante, digerido com enzimas de restrio apropriadas, fracionado em gel de agarose e transferido para uma membrana de nitrocelulose ou nilon. A membrana ou     "blot" pode ser, ento, sondada com, por exemplo, fragmento de DNA alvo radio-rotulado com 32P para confirmar a integrao do gene introduzido no genoma vegetal de acordo com tcnicas padro (Sambrook and Russell, 2001, supra).</span>Plant transformation can be confirmed by Southern blot analysis of genomic DNA (Sambrook and Russell (2001) supra). In general, total DNA is extracted from the transformant, digested with appropriate restriction enzymes, fractionated on agarose gel and transferred to a nitrocellulose or nylon membrane. The membrane or blot can then be probed with, for example, 32P radiolabeled target DNA fragment to confirm integration of the introduced gene into the plant genome according to standard techniques (Sambrook and Russell, 2001, supra). .</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Na anlise Northern, RNA  isolado a partir de tecidos especficos de transformante, fracionado em um gel de formaldedo agarose, e passado para blot em um filtro de nilon de acordo com procedimentos padro que so rotineiramente usados na arte (Sambrook and Russell (2001) supra). A expresso de RNA codificado por grg23 ou grg51  ento testada hibridizando o filtro a uma sonda radioativa derivada de um GDC por mtodos conhecidos na arte (Sambrook and Russell (2001) supra). Testes de Western blot e bioqumicos e similares pode ser conduzidos nas plantas transgnicas para determinar a presena de protena codificada pelo gene de resistncia a herbicidas por procedimentos padro (Sambrook and Russell (2001) supra) usando anticorpos que se ligam a um ou mais epitopos presentes na protena de resistncia a herbicidas.</span>In Northern analysis, RNA is isolated from transformant specific tissues, fractionated on a formaldehyde agarose gel, and blotted onto a nylon filter according to standard procedures that are routinely used in the art (Sambrook and Russell (2001)). above). Expression of grg23 or grg51-encoded RNA is then tested by hybridizing the filter to a GDC-derived radioactive probe by methods known in the art (Sambrook and Russell (2001) supra). Western blot and biochemical tests and the like can be conducted on transgenic plants to determine the presence of protein encoded by the herbicide resistance gene by standard procedures (Sambrook and Russell (2001) supra) using antibodies that bind to one or more epitopes present. on herbicide resistance protein.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Os seguintes exemplos so oferecidos por meio de ilustrao e no por meio de limitao.</span>The following examples are offered by way of illustration and not by way of limitation.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Experimental</span>Experimental</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 1: Isolamento de ATX21308     ATX 21308 foi isolado colocando-se as amostras de solo em placas em Meio Minimo Enriquecido 3 (EMM3) contendo fosfatos e glifosato a 50 mM. Como EMM3 contm 5 aminocidos aromticos, a linhagem deve ser resistente a glifosato para crescer neste meio.</span>Example 1: Isolation of ATX21308 ATX 21308 was isolated by plating the soil samples in Enriched Minimum Medium 3 (EMM3) containing 50 mM phosphates and glyphosate. As EMM3 contains 5 aromatic amino acids, the strain must be glyphosate resistant to grow in this medium.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Aproximadamente um grama de solo  suspenso em aproximadamente 10 mL de gua, e misturado em misturador tipo vrtex por 5 segundos. 100 pL desta suspenso  adicionada a 1 mL de EMM3 com fosfato mas sem glifosato. EMM3 contm (por litro, pH 7,0): 10 g de sacarose, 1 g de NH4Cl, 0,2 g de MgS04-7H20, 0,01 g de FeS04-7H20, 0, 007 g de MnSO4-H2O e 10 ml de soluo de fosfato contendo (por litro, pH 7,0) 210 g de Na2HPO4 e 90 g de NaH2PO4. A cultura  chacoalhada em tambor rolador para cultura de tecidos a 21C de um dia para outro e ento colocada em placas em gar EMM3 contendo glifosato a 50 mM. Aps 3 dias, o isolado  colocado em placas em gar Luria Bertani (LB) para confirmar a morfologia individual. Aps seis dias, a colnia individual  traada em gar EMM3 contendo glifosato a 50 mM. O isolado cresceu de um dia para o outro em placas glifosato a 50 mM. Uma linhagem particular, designada ATX21308, foi selecionada em virtude de sua habilidade de crescer na presena de altas concentraes de glifosato. Esta linhagem  testada para sua habilidade de crescer na presena de glifosato em cultura lquida e  capaz de crescer at em concentraes de glifosato de aproximadamente 300 mM nas condies testadas.     Exemplo 2. Preparao e Rastreamento de Bibliotecas de Cosmideos</span>Approximately one gram of soil is suspended in approximately 10 mL of water and mixed in a vortex mixer for 5 seconds. 100 l of this suspension is added to 1 ml phosphate-free but glyphosate EMM3. EMM3 contains (per liter pH 7.0): 10 g sucrose, 1 g NH4Cl, 0.2 g MgSO4-7H20, 0.01 g FeSO4-7H20, 0.007 g MnSO4-H2O and 10 ml phosphate solution containing (per liter pH 7.0) 210 g of Na2HPO4 and 90 g of NaH2PO4. The culture is shaken on a tissue culture roller at 21  C overnight and then plated on EMM3 agar containing 50 mM glyphosate. After 3 days, the isolate is plated on Luria Bertani (LB) agar to confirm individual morphology. After six days, the individual colony is plotted on EMM3 agar containing 50 mM glyphosate. The isolate was grown overnight in 50 mM glyphosate plates. One particular strain, designated ATX21308, was selected because of its ability to grow in the presence of high glyphosate concentrations. This strain is tested for its ability to grow in the presence of glyphosate in liquid culture and is capable of growing up to approximately 300 mM glyphosate concentrations under the tested conditions. Example 2. Preparation and Tracking of Cosmid Libraries</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">DNA total foi extrado de uma cultura de ATX21308 usando mtodos comumente conhecidos na arte. O DNA foi parcialmente digerido com enzima de restrio Sau3Al e ligado com fragmento de vetor SuperCos (Stratagene) de acordo com as diretrizes do fabricante. Produtos da ligao foram empacotados em partculas fago usando extrato de empacotamento GigaPack III XL (Stratagene), transfectados em clulas E. coli, e colocados em placas em gar LB contendo canamicina a 50 g/mL para selecionar para colnias contendo cosmdeos.</span>Total DNA was extracted from an ATX21308 culture using methods commonly known in the art. The DNA was partially digested with Sau3Al restriction enzyme and ligated with SuperCos vector fragment (Stratagene) according to the manufacturer's guidelines. Binding products were packaged into phage particles using GigaPack III XL packing extract (Stratagene), transfected into E. coli cells, and plated on LB agar containing 50 g / mL kanamycin to select for cosmid containing colonies.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Colnias individuais foram coletadas para placas de 384 poos contendo caldo LB e canamicina a 50 g/mL, e crescidas at saturao. As clulas destas culturas foram diludas 1:10, em seguida alfinetadas em placas de gar MG63 contendo canamicina a 50 pg/mL, e glifosato a 0 mM, 10 mM, 20 mM, ou 50 mM. [meio de gar M63 KH2PO4 a IOOmM, (NH4) 2S04 a 15 mM, CaCl2 a 50 , FeSO4 a 1 , MgCl2 a 50 , glicose a 55 mM, L-prolina a 25 mg/litro, tiamina HCl a 10 mg/litro, NaOH suficiente para ajustar o pH para 7,0, e gar a 15 g/litro] .</span>Individual colonies were collected into 384-well plates containing LB broth and kanamycin at 50 g / mL and grown to saturation. Cells from these cultures were diluted 1:10, then pinned onto MG63 agar plates containing 50 pg / ml kanamycin, and 0 mM, 10 mM, 20 mM, or 50 mM glyphosate. [100 mM M63 KH2PO4 agar medium, 15 mM (NH4) 2 SO4, 50  CaCl2, 1  FeSO4, 50  MgCl2, 55 mM glucose, 25 mg / liter L-proline, 10 thiamine HCl mg / liter, sufficient NaOH to adjust pH to 7.0, and agar to 15 g / liter].</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Os transformantes que crescem mais rpido nas concentraes mais altas de glifosato foram isolados e digeridos com enzima de restrio EcoR I para identificar     cosmdeos com padres de restrio divididos. Diversos clones que cresceram na presena de glifosato e dividem padres de restrio por EcoR I similares foram identificados. Um destes clones de cosmideo, pAX1924, foi selecionado para mais experimentos.</span>The fastest growing transformants at the highest glyphosate concentrations were isolated and digested with restriction enzyme EcoR I to identify cosmids with split restriction patterns. Several clones that grew in the presence of glyphosate and split similar EcoR I restriction patterns were identified. One of these cosmid clones, pAX1924, was selected for further experiments.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 3. Identificao de grg23 no cosmideo pAX1924</span>Example 3. Identification of grg23 in cosmid pAX1924</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para identificar o(s) gene(s) responsvel(is) pela resistncia a glifosato mostrado pelo cosmideo pAX1924, o DNA deste clone  mutagenizado com elementos tipo transposon. Neste mtodo, clones que sofreram inseres de transposon e perderam a habilidade de conferir resistncia a glifosato so identificados. A localizao das inseres de transposon identifica o quadro de iniciao de leitura responsvel pelo fentipo de resistncia ao glifosato.</span>To identify the gene (s) responsible for glyphosate resistance shown by cosmid pAX1924, the DNA of this clone is mutagenized with transposon-like elements. In this method, clones that have undergone transposon insertions and have lost the ability to confer glyphosate resistance are identified. The location of the transposon inserts identifies the reading initiation frame responsible for the glyphosate resistance phenotype.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O cosmideo pAX1924  sujeito a mutagnese in vitro por transposon usando um kit de insero EZ::TN (Epicentre, Madison, WI) de acordo com o protocolo do fabricante. Este processo insere aleatoriamente um fragmento de transposon no DNA do cosmideo e assim interrompe aleatoriamente a funo de genes no cosmideo. Este transposon em particular contm um gene que codifica resistncia a trimetoprim, de modo que clones com insero do transposon podem ser selecionados pela habilidade de crescer na presena daquele antibitico. Os locais de insero do transposon podem ser determinados por mapeamento de fragmentos de restrio ou por seqenciamento com primers que anelam no transposon.     Clones de pAX1924 com insero de transposon so colocados em placas em meio M63 contendo glifosato. Mltiplos clones contendo transposons so identificados, os quais perderam a habilidade de crescer na presena de glifosato, indicando que o transposon interrompeu o gene responsvel pela resistncia.</span>Cosmid pAX1924 is subjected to in vitro transposon mutagenesis using an EZ :: TN insertion kit (Epicentre, Madison, WI) according to the manufacturer's protocol. This process randomly inserts a transposon fragment into the cosmid DNA and thus randomly disrupts the function of genes in the cosmid. This particular transposon contains a gene that encodes trimethoprim resistance, so that clones with transposon insertion can be selected for the ability to grow in the presence of that antibiotic. Transposon insertion sites can be determined by restriction fragment mapping or sequencing with transposon ringing primers. Transposon insert pAX1924 clones are plated in M63 medium containing glyphosate. Multiple transposon clones are identified which have lost the ability to grow in the presence of glyphosate, indicating that the transposon disrupted the resistance gene.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A seqncia de DNA  determinada para a regio de pAXl924 contendo as inseres de transposon usando mtodos de seqenciamento bem conhecidos na arte. Usando esta informao de seqncia, prmers de DNA so sintetizados e utilizados para determinar a seqncia de DNA de pAX1924 na regio que engloba as inseres de transposon. A anlise da seqncia de DNA resultante mostra que essa regio contm um nico gene. Este gene  designado aqui como grg23. Anlise de grg23 mostra que ele  capaz de gerar duas protenas possveis em clulas bacterianas por conta da presena stios de incio de traduo potencialmente alternativos. O primeiro ORF (ORFl) inicia com um cdon de incio GTG nas posies 109-111 da SEQ ID NO:1, e acaba em um cdon de parada TAG nos nucleotdeos 1417-14-19 de SEQ ID NO:1. O segundo ORF (0RF2) inicia em um cdon de incio ATG nos nucleotdeos 178-180 da SEQ ID NO:1, e acaba no cdon de parada TAG nos nucleotdeos 1417-1419 do SEQ ID NO:1. A traduo do ORFl gera a seqncia de aminocidos apresentada em SEQ ID NO: 2. A traduo do 0RF2 gera a seqncia de aminocidos apresentada em SEQ ID NO:4.     Anlise da regio de DNA que cerca grg23 sugere que 0RF2  precedida por um sitio de ligao a ribossomo, enquanto no h sitio bvio de ligao a ribossomo precedendo o inicio de traduo de ORFl. Alm disso, alinhamento de ambos os quadros de leitura aberta com enzimas representativas EPSPS mostra que poucas enzimas EPSPS contm esta extenso N-terminal codificadas dentro de ORF1. Assim, o ORF funcional codificado por grg23 em bactria  0RF2. Portanto, como usado aqui, GRG23 refere-se quela que  codificada por 0RF2 (nucleotideos 178-1419 da SEQ ID NO: 1) . De todo modo,  bem conhecido na arte que enzimas EPSPS so um tanto tolerantes a aminocidos adicionais em seus terminais N. Portanto, a expresso de ORF1 (nucleotideos 109-1419 da SEQ ID N0:1) tambm deve gerar um EPSPS que confere resistncia a glifosato.</span>The DNA sequence is determined for the region of pAX1924 containing the transposon insertions using sequencing methods well known in the art. Using this sequence information, DNA primers are synthesized and used to determine the pAX1924 DNA sequence in the region encompassing the transposon insertions. Analysis of the resulting DNA sequence shows that this region contains a single gene. This gene is referred to herein as grg23. Analysis of grg23 shows that it is capable of generating two possible proteins in bacterial cells because of the presence of potentially alternative translation initiation sites. The first ORF (ORFl) starts with a GTG start codon at positions 109-111 of SEQ ID NO: 1, and ends in a TAG stop codon at nucleotides 1417-14-19 of SEQ ID NO: 1. The second ORF (0RF2) starts at an ATG start codon on nucleotides 178-180 of SEQ ID NO: 1, and ends at the TAG stop codon on nucleotides 1417-1419 of SEQ ID NO: 1. The translation of ORFl generates the amino acid sequence shown in SEQ ID NO: 2. The translation of 0RF2 generates the amino acid sequence shown in SEQ ID NO: 4. Analysis of the DNA region surrounding grg23 suggests that RRF2 is preceded by a ribosome binding site, while there is no obvious ribosome binding site preceding the initiation of ORFl translation. In addition, alignment of both open reading frames with representative EPSPS enzymes shows that few EPSPS enzymes contain this N-terminal extension encoded within ORF1. Thus, the functional ORF encoded by grg23 in bacteria is 0RF2. Therefore, as used herein, GRG23 refers to that which is encoded by 0RF2 (nucleotides 178-1419 of SEQ ID NO: 1). However, it is well known in the art that EPSPS enzymes are somewhat tolerant of additional amino acids at their N-termini. Therefore, expression of ORF1 (nucleotides 109-1419 of SEQ ID NO: 1) should also generate an EPSPS that confers resistance. glyphosate.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para testar a habilidade de 0RF2 funcionar como um EPSPS e conferir s clulas resistncia a glifosato, este quadro de iniciao de leitura pode ser subclonado e expresso em E. coli.</span>To test the ability of 0RF2 to function as an EPSPS and to give cells glyphosate resistance, this reading initiation frame can be subcloned and expressed in E. coli.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 4. Subclonagem de grg23 em vetores para expresso em E. coli</span>Example 4. Subcloning of grg23 into Vectors for Expression in E. coli</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O gene que codifica o 0RF2 de GRG2 3 (iniciando com ATG (posies 178-180 da SEQ ID N0:1), expressando uma protena de 413 aminocidos) foi subclonado em pUC18 e pRSF1b usando a mesma estratgia de clonagem descrita acima. Um primer de PCR [5' CAGGGATCCGGCATGGAAACTGATCGACTAGTG 3'] foi     sintetizado que adiciona um sitio BamHI seguido de GCC (5'- GGATCCGGC-3' ) imediatamente 5' do sitio de inicio. Um 2 primer foi sintetizado [5' ATTGGCGCGCCCTAGCCGGGGAGCGTAAG 3'] que adicionou um sitio AscI imediatamente 3'da seqncia de parada (5'-GGCGCGCC-3') . A regio de codificao de grg23  amplificada por PCR usando DNA polimerase PFUULTRA (Stratagene). Em seguida a amplificao de grg23 por PCR usando estes primers e digesto de restrio com BamHI/AscI, o produto do PCR foi ligado em pUC19 (digerido com BamHI e AscI) e pRSFlb (digerido com BamHI e Asei), e colnias contendo inseres foram obtidas. O clone pUC18-grg23 (aqui designado como pAX1927) foi confirmado por digesto de restrio e por seqenciamento e DNA.</span>The gene encoding GRG23 0RF2 (starting with ATG (positions 178-180 of SEQ ID NO: 1), expressing a 413 amino acid protein) was subcloned into pUC18 and pRSF1b using the same cloning strategy described above. A PCR primer [5 'CAGGGATCCGGCATGGAAACTGATCGACTAGTG 3'] has been synthesized that adds a BamHI site followed by GCC (5'-GGATCCGGC-3 ') immediately 5' from the start site. A 2nd primer was synthesized [5 'ATTGGCGCGCCCTAGCCGGGGAGCGTAAG 3'] which added an AscI site immediately 3 'of the stop sequence (5'-GGCGCGCC-3'). The grg23 coding region is PCR amplified using PFUULTRA  DNA polymerase (Stratagene). Following grg23 amplification by PCR using these primers and restriction digestion with BamHI / AscI, the PCR product was ligated into pUC19 (digested with BamHI and AscI) and pRSFlb (digested with BamHI and Asei), and insert-containing colonies were ligated. obtained. Clone pUC18-grg23 (referred to herein as pAX1927) was confirmed by restriction digestion and sequencing and DNA.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Similarmente, o vetor de expresso pAX1909 foi digerido com BamHI e AscI, e o vetor contendo o fragmento foi purificado em gel por mtodos bem conhecidos na arte. O vetor pAX1909  um derivado de PRSF-Ib (Novagen, San Diego, CA), modificado para conter um sitio para BamHI diretamente 3' da regio que codifica o "marcador-His" rico em histidina. Assim, protenas clonadas em pAX1909 so fuses em quadro que contm os aminocidos adicionais MAHHHHHHGSG. Vetores como pAX1909 so tipicamente desenvolvidos para expresso de protenas e purificao, e esses mtodos so bem conhecidos na arte.</span>Similarly, the pAX1909 expression vector was digested with BamHI and AscI, and the vector containing the fragment was gel purified by methods well known in the art. The pAX1909 vector is a PRSF-Ib derivative (Novagen, San Diego, CA), modified to contain a BamHI site directly 3 'from the histidine-rich "His-marker" coding region. Thus, proteins cloned into pAX1909 are frame fusions containing the additional amino acids MAHHHHHHGSG. Vectors such as pAX1909 are typically developed for protein expression and purification, and such methods are well known in the art.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O produto de PCR digerido resultante acima foi ligado em vetor pAX1909 digerido, e colnias contendo inseres     foram obtidas. 0 clone pAX1909-grg23 (aqui designado pAX1926) foi confirmado por digesto de restrio e por seqenciamento de DNA. A maneira de construo de pAX1926  de forma que o produto de traduo GRG23 previsto contm uma extenso amino-terminal composta de MAHHHHHH. Esta extenso N-terminal compe uma 'marca de histidina' ou 'marca de seis His' que  til para facilitar a purificao da protena GRG23, como  bem conhecido na arte.</span>The resulting digested PCR product above was ligated into digested pAX1909 vector, and colonies containing insertions were obtained. Clone pAX1909-grg23 (herein designated pAX1926) was confirmed by restriction digestion and DNA sequencing. The manner of construction of pAX1926 is such that the predicted GRG23 translation product contains an amino terminal extension composed of MAHHHHHH. This N-terminal extension composes a 'histidine tag' or 'six His tag' which is useful for facilitating purification of GRG23 protein, as is well known in the art.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O plasmdio pAX192 6 contendo o 0RF2 de grg23 foi depositado na coleo da autoridade depositria internacional Agricultural Research Service Culture Collection (NRRL) em 18 de novembro, 2005, e atribuda No. de Acesso NRRL B-30888.</span>Plasmid pAX1926 containing the grg23 0RF2 was deposited in the collection of the International Agricultural Research Service Culture Collection (NRRL) depository authority on November 18, 2005, and assigned Accession No. NRRL B-30888.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 5. grg23 Confere Resistncia a Altos Nveis de Glifosato</span>Example 5. grg23 Gives Resistance to High Glyphosate Levels</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A construo pUC18-Grg23 (pAX1927) foi transformada na linhagem DH5a de E. coli e colocada em placas de gar LB suplementadas com carbenicilina (0,1 mg/ml). Duas colnias foram selecionadas, ressuspendidas em gua estril, e traadas em placas M63 contendo glifosato a 0 mM, 25 mM, 50 mM ou 100 mM. Isopropil-B-D-tiogalactopiranosdeo (IPTG; 0,1 mM) tambm foi adicionado s placas. Como controle, clulas contendo apenas o vetor pUC18 foram transformadas e traadas em placas com glifosato. Aps 2 dias de crescimento, estas placas foram examinadas para crescimento (Tabela 1).     Tabela 1.</span>The pUC18-Grg23 (pAX1927) construct was transformed into E. coli DH5a strain and placed on carbenicillin-supplemented LB agar plates (0.1 mg / ml). Two colonies were selected, resuspended in sterile water, and plotted on M63 plates containing 0 mM, 25 mM, 50 mM or 100 mM glyphosate. Isopropyl-B-D-thiogalactopyranoside (IPTG; 0.1 mM) was also added to the plates. As a control, cells containing only the pUC18 vector were transformed and plotted on glyphosate plates. After 2 days of growth, these plates were examined for growth (Table 1). Table 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 56&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 56 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Este resultado confirma que a expresso de grg23 para produzir GRG23-ORF2 confere resistncia a glifosato em E. coli a pelo menos 100 mM. Adicionalmente, o crescimento de E. coli contendo pAX1927  mais forte na presena de glifosato do que na ausncia de glifosato.</span>This result confirms that expression of grg23 to produce GRG23-ORF2 confers glyphosate resistance in E. coli to at least 100 mM. Additionally, the growth of E. coli containing pAX1927 is stronger in the presence of glyphosate than in the absence of glyphosate.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 6. Homologia de GRG23 com Outras Protenas</span>Example 6. Homology of GRG23 to Other Proteins</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A seqncia de aminocidos deduzida de GRG23 tem homologia com enzimas EPSPS, indicando que grg23 codifica uma EPSPS.</span>The deduced amino acid sequence of GRG23 has homology with EPSPS enzymes, indicating that grg23 encodes an EPSPS.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exame da seqncia de aminocidos deduzida de GRG-0RF2 SEQ ID NO:4) revela que ela no contm quatro domnios tpicos de enzimas EPSPS Classe II. Portanto  uma nova EPSPS resistente a glifosato no pertencente  Classe II.</span>Examination of the deduced amino acid sequence of GRG-0RF2 (SEQ ID NO: 4) reveals that it does not contain four typical EPSPS Class II enzyme domains. It is therefore a new non-Class II glyphosate resistant EPSPS.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Procuras em bases de dados de protenas disponveis publicamente, como SWISSPROT, revelam que GRG23 tem similaridade de aminocidos com uma vasta classe de enzimas     EPSPS. Entretanto, nenhuma protena e qualquer base de dados tm identidade maior do que 50% com a seqncia de aminocidos de GRG23. Um alinhamento representativo de GRG23 com outras enzimas EPSPS  apresentado na Figura 1.</span>Searches in publicly available protein databases, such as SWISSPROT, reveal that GRG23 has amino acid similarity to a broad class of EPSPS enzymes. However, no protein and any database has an identity greater than 50% with the GRG23 amino acid sequence. A representative alignment of GRG23 with other EPSPS enzymes is shown in Figure 1.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 7. Purificao de GRG23</span>Example 7. GRG23 Purification</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A construo pRSFlb-grg23 (pAX1926) foi expressa em E. coli aps induo com IPTG, e purificada em um nico passo usando coluna de cromatografia de cobalto como conhecido na arte. Aps eluio da coluna, GRG23 purificada foi dialisada contra HEPES a 50 mM/KCl a 100 mM, PH 7,0. A protena era mais do que 95% pura como avaliado por PAGE. A quantidade de GRG23 foi quantificada usando o mtodo de Bradford, como  bem conhecido na arte (Bradford (1976) Anal. Biochem. 72:248-254) .</span>The pRSF1b-grg23 (pAX1926) construct was expressed in E. coli following IPTG induction, and purified in a single step using cobalt chromatography column as known in the art. After column elution, purified GRG23 was dialyzed against 50 mM HEPES / 100 mM KCl, pH 7.0. The protein was more than 95% pure as rated by PAGE. The amount of GRG23 was quantified using the Bradford method, as is well known in the art (Bradford (1976) Anal. Biochem. 72: 248-254).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 8. Ensaios Cinticos da Atividade de GRG23</span>Example 8. Kinetic Assays for GRG23 Activity</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Amostras de protenas purificadas foram ensaiadas para atividade de EPSPS usando ensaios cinticos que envolvem incubao de PEP (Sigma, St. Louis, MO) e S3P em um tampo contendo cloreto de potssio e HEPES a PH 7,0. Liberao de fosfato foi detectada usando ensaio acoplado para a deteco fluorescente baseado em fosfato na gerao de AMPLEX RED, como  conhecido na arte (Vazquez et al (2003) Anal. Biochem. 320: 292-298). As condies de ensaio publicadas podem levar  saturao do ensaio em experimentos onde fosfato  liberado muito rapidamente.     Esta saturao meio que limita a escala dinmica do ensaio, e requer uma escala definida de concentraes de enzimas. Foi determinado que a limitao cintica do ensaio de fosfato fluorescente  aparentemente por causa de uma combinao de fatores, incluindo a limitao de inosina e PNP. Na inveno presente, as condies ensaio foram desenvolvidas para gerar uma escala dinmica substancialmente melhorada e permitir o uso de uma escala mais larga de concentraes de enzimas e substratos. As condies de ensaio que foram significativamente modificadas incluem as concentraes de purina nucleosideo fosforilase (PNP), xantina oxidase (XOD), AMPLEX RED, e inosina, cada qual foi aumentado em concentrao no ensaio para acomodar taxas mais altas de retorno de fosfato. Esse ensaio foi adaptado para uso na medida da atividade de EPSPS em um formato de 96 poos com os seguintes melhoramentos:</span>Purified protein samples were assayed for EPSPS activity using kinetic assays involving incubation of PEP (Sigma, St. Louis, MO) and S3P in a buffer containing potassium chloride and HEPES at pH 7.0. Phosphate release was detected using coupled assay for phosphate-based fluorescent detection in the generation of AMPLEX RED, as is known in the art (Vazquez et al (2003) Anal. Biochem. 320: 292-298). Published assay conditions may lead to assay saturation in experiments where phosphate is released very rapidly. This saturation somewhat limits the dynamic range of the assay, and requires a defined range of enzyme concentrations. It has been determined that the kinetic limitation of the fluorescent phosphate assay is apparently due to a combination of factors including inosine and PNP limitation. In the present invention, the test conditions were developed to generate a substantially improved dynamic range and allow the use of a wider range of enzyme and substrate concentrations. Assay conditions that were significantly modified include concentrations of purine nucleoside phosphorylase (PNP), xanthine oxidase (XOD), AMPLEX RED, and inosine, each of which was increased in concentration in the assay to accommodate higher phosphate return rates. This assay has been adapted for use in measuring EPSPS activity in a 96-well format with the following enhancements:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 2. Ensaio de fluorescncia melhorada</span>Table 2. Enhanced Fluorescence Assay</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 58&lt;/column&gt;&lt;/row&gt;&lt;table&gt;     &lt;table&gt;table see original document page 59&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 58 &lt;/column&gt; &lt;/row&gt; &lt;table&gt; &lt;table&gt; table see original document page 59 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ensaios enzimticos foram realizados em placas de 96 poos com volume total de 50 pL. Reaes foram realizadas em temperatura ambiente em pH 7,0. Todos os componentes do ensaio exceto PEP, EPSPS, e S3P foram combinados em um Master Mix e alquotas colocadas em placa de 96 poos usando um pipetador multi-canal. Concentraes apropriadas de PEP foram ento adicionadas a cada poo. Diluies frescas de EPSPS foram preparadas e adicionadas aos poos apropriados. Cada ensaio foi iniciado pela adio de S3P.</span>Enzymatic assays were performed in 96-well plates with a total volume of 50 pL. Reactions were performed at room temperature at pH 7.0. All assay components except PEP, EPSPS, and S3P were combined in a Master Mix and aliquots plated into a 96-well plate using a multi-channel pipettor. Appropriate PEP concentrations were then added to each well. Fresh EPSPS dilutions were prepared and added to appropriate wells. Each assay was initiated by the addition of S3P.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Dados de taxas foram traados e os parmetros cinticos Km e Kcat foram determinados por uso da aplicao da equao de Michaelis-Menten usando programa de ajuste de curva no-linear (KALEIDAGRAPH, Synergy Sofware). Dados e Ki foram determinados pela medida de Km(app) em concentraes mltiplas de glifosato, e traando Km(app) como funo da concentrao do inibidor.</span>Rate data were plotted and the Km and Kcat kinetic parameters were determined using the Michaelis-Menten equation using a nonlinear curve fitting program (KALEIDAGRAPH, Synergy Sofware). Data and Ki were determined by measuring Km (app) at multiple glyphosate concentrations, and plotting Km (app) as a function of inhibitor concentration.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 3. Efeito do Glifosato no Km(app) de GRG23</span>Table 3. Effect of Glyphosate on GRG23 Km (app)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 59&lt;/column&gt;&lt;/row&gt;&lt;table&gt;     Plotando-se Km(app) em funo da concentrao de glifosato, uma representao linear da resistncia de GRG23 a glifosato pode ser obtida. A interceptao em X da linha resultante representa -Ki. Plotar essa linha com os dados  apresentados na Tabela 3 gera o seguinte dado:</span>&lt;table&gt; table see original document page 59 &lt;/column&gt; &lt;/row&gt; &lt;table&gt; By plotting Km (app) as a function of glyphosate concentration, a linear representation of GRG23 resistance to glyphosate can be obtained. The X-trap of the resulting line represents -Ki. Plotting this line with the data presented in Table 3 yields the following data:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 4. Valores cinticos para GRG23</span>Table 4. Kinetic values for GRG23</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 60&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 60 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">GRG23  altamente resistente a glifosato, com um Ki de mais de 9 mM, e uma razo Ki/Km maior que 800.</span>GRG23 is highly glyphosate resistant, with a Ki of more than 9 mM, and a Ki / Km ratio greater than 800.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 9. Isolamento de ATX21313</span>Example 9. ATX21313 Isolation</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Para a linhagem ATX21313, aproximadamente um grama de solo foi suspendida em 10 mL e gua, e 100  foi usado para inocular uma cultura de 1 mL de Meio de Sais Minerais A (MSMA) e nenhum glifosato. MSMA contm (por litro, pH 7,0) Ig de NH4Cl, 10 g de sacarose, 0,2 g de MgS04-7H20,  0, 01 g de FeSO4-7H20, 0, 007 g de MnSO4-H2O suplementado com fosfatos. Aps incubao de um dia para outro, a cultura foi colocada em placas em meio slido contendo MSMA e glifosato a 50 mM, incubada por alguns dias, e inoculada em placas de gar Luria Bertani para confirmar o tipo de  colnia individual. 0 crescimento na presena de glifosato a 50 mM foi reconfirmado pelo recrescimento em MSMA, placas     de gar a 50 mM. Este mtodo de isolamento gerou a linhagem 21313, a qual foi capaz de crescer bem nestas condies.</span>For ATX21313 strain, approximately one gram of soil was suspended in 10 mL and water, and 100  was used to inoculate a 1 mL culture of Mineral Salts Medium A (MSMA) and no glyphosate. MSMA contains (per liter pH 7.0) NH 4 Cl Ig, 10 g sucrose, 0.2 g MgSO 4 - 7 H 2 O, 0.01 g FeSO 4 - 7 H 2 O, 0.007 g MnSO 4 -H 2 O supplemented with phosphates. After overnight incubation, the culture was plated on solid medium containing MSMA and 50 mM glyphosate, incubated for a few days, and inoculated on Luria Bertani agar plates to confirm the individual colony type. Growth in the presence of 50 mM glyphosate was reconfirmed by growth on MSMA, 50 mM agar plates. This isolation method generated the 21313 strain, which was able to grow well under these conditions.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 10. Clonagem de EPSP sintases resistentes a glifosato</span>Example 10. Cloning of glyphosate resistant EPSP synthases</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">DNA genmico foi extrado da linhagem ATX21313 e o DNA resultante foi parcialmente digerido com enzima de restrio Sau3A 1 para gerar fragmentos de DNA com aproximadamente 5 quilobases em tamanho. Estas molculas de DNA foram selecionadas por tamanho em gis de agarose, purificadas, e ligadas em braos de vetor LAMBDA ZAP pr- digeridos com BamHI. Os braos ligados foram ento empacotados em partculas fago, e titulaes de fagos foram determinadas como conhecido na arte. As bibliotecas resultantes foram amplificadas por mtodos conhecidos na arte para gerar uma titulao de biblioteca entre 3  IO7 e 3  IO8 PFU/ml. Para cada biblioteca independente, E. Coli (XLl Blue MRF' ) foi ento co-transfectada com fago de uma biblioteca amplificada assim como por fago ajudante M13 para permitir exciso em massa da biblioteca na forma de um ssDNA circular, infeccioso, como conhecido na arte (Short et al. (1988) Nucleic Acids Research 16:7583-7 600). Aps centrifugao das clulas co-infectadas, o sobrenadante contendo fagos foi aquecido a 65-70C por 15-20 minutos para incapacitar qualquer partcula residual de fago lambda. Diluies da biblioteca de plasmdios ssDNA resultante foram transfectadas em culturas frescas de clulas E. coli XLl Blue MRF' competentes e tambm clulas     XL-Blue MRF' (aroA) (XL1 Blue MRF'). As clulas transfectadas resultantes foram colocadas em placas M63 contendo canamicina, IPTG a 0,1 mM e glifosato a 0 mM, 20 mM ou 50 mM. Este mtodo de rastreamento permite a identificao de clones contendo EPSP sintases tolerantes a glifosato. Colnias crescendo em glifosato a 20 mM ou 50 mM na linhagem AaroA ou XL-Blue MRF' foram recolhidas e seus plasmidios analisados por digesto de restrio para identificar plasmidios com padres de restrio compartilhados. Plasmidios individuais foram seqenciados por mtodos conhecidos na arte, com preferncia dada a plasmidios que conferiam resistncia a glifosato a 50 mM.</span>Genomic DNA was extracted from the ATX21313 strain and the resulting DNA was partially digested with restriction enzyme Sau3A 1 to generate DNA fragments approximately 5 kilobases in size. These DNA molecules were size-selected on purified agarose gels and ligated into BamHI pre-digested LAMBDA ZAP vector arms. Bound arms were then packaged into phage particles, and phage titrations were determined as known in the art. The resulting libraries were amplified by methods known in the art to generate a library titration between 3  107 and 3  108 PFU / ml. For each independent library, E. Coli (XL1 Blue MRF ') was then co-transfected with phage from an amplified library as well as M13 helper phage to allow for mass excision of the library in the form of an infectious circular ssDNA as known in the art. art (Short et al. (1988) Nucleic Acids Research 16: 7583-7 600). After centrifugation of the co-infected cells, the phage-containing supernatant was heated at 65-70  C for 15-20 minutes to incapacitate any residual lambda phage particles. Dilutions of the resulting ssDNA plasmid library were transfected into fresh cultures of competent E. coli XL1 Blue MRF 'cells as well as XL-Blue MRF' (aaroA) cells (XL1 Blue MRF '). The resulting transfected cells were plated on M63 plates containing kanamycin, 0.1 mM IPTG and 0 mM, 20 mM or 50 mM glyphosate. This screening method allows the identification of clones containing glyphosate tolerant EPSP synthases. Colonies growing on 20 mM or 50 mM glyphosate in the AaroA or XL-Blue MRF 'strain were collected and their plasmids analyzed by restriction digestion to identify plasmids with shared restriction patterns. Individual plasmids were sequenced by methods known in the art, with preference given to plasmids that confer glyphosate resistance at 50 mM.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Usando esta abordagem, s vezes modificado para cada biblioteca como conhecido e apreciado na arte, clones da biblioteca contendo genes EPSP sintase foram identificados.</span>Using this approach, sometimes modified for each library as known and appreciated in the art, library clones containing EPSP synthase genes were identified.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">As seqncias das regies dos clones resultantes foram determinadas na regio da EPSP sintase.</span>The sequences of the resulting clone regions were determined in the EPSP synthase region.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 11. Seqncias de DNA e protena das EPSP sintases</span>Example 11. DNA and Protein Sequences of EPSP Synthases</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A seqncia de DNA da EPSP sintase resistente a glifosato foi determinada para pAX1967 por mtodos bem conhecidos na arte. A seqncia de DNA de grg51  fornecida aqui como SEQ ID NO: 5. O produto de traduo presumido de grg51 (GRG51)  fornecido aqui como SEQ ID NO: 6. GRG51     mostra 97% de identidade de aminocidos para GRG23 (SEQ ID NO:2).</span>The glyphosate resistant EPSP synthase DNA sequence has been determined for pAX1967 by methods well known in the art. The grg51 DNA sequence is provided here as SEQ ID NO: 5. The presumed grg51 translation product (GRG51) is provided here as SEQ ID NO: 6. GRG51 shows 97% amino acid identity for GRG23 (SEQ ID NO :2).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Plasmidio pAX1967 contendo grg51 foi depositado na coleo da autoridade depositria internacional Agricultural Research Service Culture Collection (NRRL) em 26 de junho, 2006, a atribudo No. De Acesso NRRL B-30949. Tabela 5 resume a homologia de GRG23 e GRG51 com outras enzimas EPSP sintase.</span>Plasmid pAX1967 containing grg51 was deposited in the collection of the International Depositary Authority Agricultural Research Service Culture Collection (NRRL) on June 26, 2006, to assigned Accession No. NRRL B-30949. Table 5 summarizes the homology of GRG23 and GRG51 with other EPSP synthase enzymes.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 5. Identidade de aminocidos de GRG23-ORF1 e GRG51 para enzimas EPSPS representativas_</span>Table 5. GRG23-ORF1 and GRG51 amino acid identity for representative EPSPS enzymes_</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 63&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 63 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 12. Clonagem de Nova EPSP Sintase Resistente a Glifosato em Vetor de Expresso E. coli</span>Example 12. Cloning of New Glyphosate Resistant EPSP Synthase in E. coli Expression Vector</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0 gene grg51 contido em pAX1967 foi sub-clonado em vetor de expresso E. coli pRSFlb (Invitrogen). Clones resultantes foram confirmados por seqenciamento de DNA, e usados para induzir a expresso de grg51 em E. coli. A     protena marcada com expresso His foi ento purificada como conhecido na arte.</span>The grg51 gene contained in pAX1967 was subcloned into E. coli pRSF1b expression vector (Invitrogen). Resulting clones were confirmed by DNA sequencing, and used to induce grg51 expression in E. coli. The His tagged protein was then purified as known in the art.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 13. Resistncia a Glifosato de EPSP sintases</span>Example 13. Glyphosate Resistance of EPSP Synthases</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clulas contendo pAX1967 foram colocadas em placas M63+ contendo antibiticos e glifosato O mM ou 20 mM. 0 crescimento foi pontuado aps dois dias de crescimento a 37C. GRG51 foi observada por conferir resistncia a glifosato a 20 mM em clulas E. coli (Tabela 6).</span>Cells containing pAX1967 were plated on M63 + plates containing antibiotics and O mM or 20 mM glyphosate. Growth was scored after two days of growth at 37  C. GRG51 was observed to confer glyphosate resistance at 20 mM in E. coli cells (Table 6).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 6. Rastreamento de G^		_if osato</span>Table 6. G ^ _phosate tracing</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 64&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 64 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 14. Expresso e projeto de syngrg23</span>Example 14. Syngrg23 Expression and Design</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Uma nova seqncia gnica codificando a protena GRG23 (SEQ ID NO:2; U.S. Patent ApplicationNo. 60/741.166 arquivada em Io de dezembro, 2005) foi projetada e sintetizada. Esta seqncia  fornecida como SEQ ID NO:12. Este quadro de iniciao de leitura, aqui designado "syngrg23", foi clonado em vetor de expresso pRSFlb (Invitrogen), por mtodos conhecidos na arte.</span>A new gene sequence encoding the GRG23 protein (SEQ ID NO: 2; U.S. Patent Application No. 60 / 741,166 filed December 1, 2005) has been designed and synthesized. This string is provided as SEQ ID NO: 12. This read primer, hereinafter referred to as "syngrg23", was cloned into pRSF1b expression vector (Invitrogen) by methods known in the art.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O gene syngrg23 foi clonado em vetor pUC19 para criar pAX748. Primers de PCR que flanqueiam syngrg23 neste vetor     foram usados para amplificar syngrg23 de pAX748 usando o sistema MUTAZYME II (Stratagene) para introduzir mutaes aleatrias na regio codificante de syngrg23. 0 modelo foi diludo 1:50 em reao de PCR error-prone, e a amplificao foi realizada por 30 ciclos. 0 produto de PCR resultante foi digerido com enzimas de restrio BamHI e Sgs I, purificada em gel, e ligada em vetor pRSFlb para criar uma biblioteca de syngrg23 mutagenizado.</span>The syngrg23 gene was cloned into pUC19 vector to create pAX748. PCR primers flanking syngrg23 in this vector were used to amplify pAX748 syngrg23 using the MUTAZYME II system (Stratagene) to introduce random mutations into the syngrg23 coding region. The model was diluted 1:50 in error-prone PCR reaction, and amplification was performed for 30 cycles. The resulting PCR product was digested with gel purified BamHI and Sgs I restriction enzymes and ligated into pRSF1b vector to create a mutagenized syngrg23 library.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">As bibliotecas de syngrg23 mutagenizadas foram transformadas em linhagem BL21*DE3 estrela de E. coli (Invitrogen). Aps transformao, colnias individuais foram colocadas em placas com meio M63 Ix contendo glifosato a 150 mM para selecionar clones que teriam retido atividade enzimtica e tolerncia no crescimento.</span>The mutagenized syngrg23 libraries were transformed into E. coli star BL21 * DE3 lineage (Invitrogen). After transformation, individual colonies were plated on M63 Ix medium containing 150 mM glyphosate to select clones that would have retained enzymatic activity and growth tolerance.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 15. Rastreamento para resistncia a glifosato em placas</span>Example 15. Screening for plate glyphosate resistance</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ligaes da biblioteca foram transformados em clulas E. coli BL21*DE3 competentes (Invitrogen). As transformaes foram executadas de acordo com instrues do fabricante com as seguintes modificaes. Aps incubao por 1 hora a 37C em meio SOC, as clulas eram sedimentadas por centrifugao (5 minutos, 1OOOxg, 4C). As clulas foram lavadas com 1 mL de M63+, centrifugadas novamente, e o sobrenadante decantado. As clulas foram lavadas uma segunda vez com 1 mL de M63+ e ressuspendidas em 200 L de M63+.     Para seleo de enzimas GRG23 mutantes conferindo resistncia a glifosato em E. coli, as clulas foram colocadas em placas de meio gar M63+ contendo glifosato a 150 mM, IPTG (isopropil-beta-D-tiogalactopiranosideo) a 0,05 mM, e canamicina a 50 pg/ml. Meio M63+ contm KH2PO4 a 100 mM, (NH4)2SO4 a 15 mM, CaCl2 a 50 , FeSO4 a 1 , MgCl2 a 50 , glicose a 55 mM, L-prolina a 25 mg/litro, tiamina HCl a 10 mg/litro, NaOH suficiente para ajustar o pH para 7,0, e gar a 15 g/litro.</span>Library ligations were transformed into competent E. coli BL21 * DE3 cells (Invitrogen). Transformations were performed according to manufacturer's instructions with the following modifications. After incubation for 1 hour at 37  C in SOC medium, cells were pelleted by centrifugation (5 minutes, 100xg, 4  C). The cells were washed with 1 ml M63 +, centrifuged again, and the supernatant decanted. The cells were washed a second time with 1 mL M63 + and resuspended in 200 L M63 +. For selection of mutant GRG23 enzymes conferring glyphosate resistance in E. coli, cells were plated on M63 + agar plates containing 150 mM glyphosate, 0.05 mM IPTG (isopropyl beta-D-thiogalactopyranoside), and kanamycin a. 50 pg / ml. Medium M63 + contains 100 mM KH2PO4, 15 mM (NH4) 2 SO4, 50  CaCl2, 1  FeSO4, 50  MgCl2, 55 mM glucose, 25 mg / liter L-proline, 10 mg thiamine / liter, sufficient NaOH to adjust pH to 7.0, and agar to 15 g / liter.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Colnias individuais foram coletadas e postas em placas de 384 poos. Duas placas de 384 poos foram criadas desta maneira. Uma terceira placa de 384 clones foi coletada a partir de colnias que cresceram em placas sem glifosato.</span>Individual colonies were collected and plated in 384 well plates. Two 384-well plates were created this way. A third plate of 384 clones was collected from colonies grown on glyphosate-free plates.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 16. Isolamento e anlise de variantes de GRG23 resistentes a glifosato</span>Example 16. Isolation and Analysis of Glyphosate Resistant GRG23 Variants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clulas BL21*DE3 transformadas com syngrg23 mutagenizado e/ou variantes de grg23 foram identificadas por crescimento em placas de glifosato. Extratos de syngrg23 mutagenizados e variantes de grg23 foram preparados e ensaiados para atividade enzimtica melhorada. Colnias identificadas em placas de glifosato presas em blocos de 96 poos contendo meio LB foram crescidas at uma D.O. em torno de 0,6. IPTG foi ento adicionado (0,5 mM) e os blocos foram incubados de um dia para outro a 20C para     induzir a expresso de protena. Extratos de protena foram preparados a partir de precipitados celulares usando reagente de cultura POP (Novagen) e Lysonase (Novagen), e a atividade enzimtica nos lisados crus foi mensurada aps o aquecimento dos extratos por 30 min a 37 C. Extratos com atividade maior do que dois desvios padro acima da mdia de um conjunto de extratos contendo a protena controle apropriada (por exemplo, GRG23) foram selecionados para mais anlises.</span>Mutagenized syngrg23-transformed BL21 * DE3 cells and / or grg23 variants were identified by growth in glyphosate plates. Mutagenized syngrg23 extracts and grg23 variants were prepared and assayed for enhanced enzymatic activity. Colonies identified on glyphosate plates trapped in 96-well blocks containing LB medium were grown to one O.D. around 0.6. IPTG was then added (0.5 mM) and blocks were incubated overnight at 20  C to induce protein expression. Protein extracts were prepared from cell precipitates using POP (Novagen) and Lysonase (Novagen) culture reagent, and enzymatic activity in crude lysates was measured after heating the extracts for 30 min at 37  C. Extracts with activity greater than two above average standard deviations from a set of extracts containing the appropriate control protein (eg GRG23) were selected for further analysis.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Clones apresentando atividade aumentada aps incubao como extratos crus foram crescidos em culturas de 250 mL de LB, e a expresso de protena induzida por IPTG. Aps induo, a protena GRG23 mutante foi purificada de cada cultura por cromatografia de afinidade usando resina de cobalto (Novagen). As protenas purificadas foram ento testadas para atividade enzimtica aps aquecimento por 0, 2, 4, e aproximadamente 16 horas a 37C.</span>Clones showing increased activity after incubation as raw extracts were grown in 250 mL LB cultures, and protein expression induced by IPTG. After induction, mutant GRG23 protein was purified from each culture by affinity chromatography using cobalt resin (Novagen). The purified proteins were then tested for enzymatic activity after heating at 0, 2, 4, and approximately 16 hours at 37  C.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 17. Variantes de GRG23 melhoradas</span>Example 17. Improved GRG23 Variants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">De uma biblioteca de syngrg23 mutagenizados, vrios clones com atividade melhorada foram identificados. As seqncias de DNA dos clones correspondentes a estes 30 25 extratos foram determinadas. A Tabela 7 mostra as mudanas de aminocidos identificadas em seis variantes de GRG23 que retiveram a resistncia a glifosato: grg23(L3P1.B20) (SEQ ID NO:26) codificando a seqncia de aminocidos GRG23(L3P1.B20) (SEQ ID NO:27); grg23(L3P1.B3) (SEQ ID     NO:28) codificando a seqncia de aminocidos GRG23(L3P1.B3) (SEQ ID NO:29); grg23(L3P1.F18) (SEQ ID NO:30) codificando a seqncia de aminocidos GRG23 (L3P1. F18) (SEQ ID NO:31); e grg23 (L3P1. 023) SEQ ID NO:31, codificando a seqncia de aminocidos GRG23(L3P1.023) SEQ ID NO:32).</span>From a mutagenized syngrg23 library, several clones with enhanced activity were identified. The DNA sequences of the clones corresponding to these extracts were determined. Table 7 shows the amino acid changes identified in six GRG23 variants that retained glyphosate resistance: grg23 (L3P1.B20) (SEQ ID NO: 26) encoding the amino acid sequence GRG23 (L3P1.B20) (SEQ ID NO: 27); grg23 (L3P1.B3) (SEQ ID NO: 28) encoding the amino acid sequence GRG23 (L3P1.B3) (SEQ ID NO: 29); grg23 (L3P1.F18) (SEQ ID NO: 30) encoding the amino acid sequence GRG23 (L3P1. F18) (SEQ ID NO: 31); and grg23 (L3P1.023) SEQ ID NO: 31, encoding amino acid sequence GRG23 (L3P1.023) SEQ ID NO: 32).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 7. Mutaes identificadas em variantes de GRG23 _resistentes a glifosato_</span>Table 7. Mutations identified in _glyphosate resistant_ GRG23 variants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 68&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 68 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Os clones foram crescidos em culturas de 250 mL de LB, e a expresso de protena induzida e isolada como descrito acima. As protenas purificadas foram ento testadas para atividade enzimtica aps aquecimento por 0, 2 e 4, e aproximadamente 16 horas a 37C. Um dos clones, denominado "M5", foi capaz de reter uma proporo aumentada de sua atividade enzimtica depois de prolongada incubao a 37C (Tabela 8). A seqncia de DNA deste clone foi determinada, e o gene  designado aqui como grg23(acel) (SEQ ID 0:14). A protena expressa de grg23(ace1)  designada GRG23(ACE1) SEQ ID NO:15).     Tabela 8. Meia-vida de GRG23(ACEl) vs GRG23 em temperatura elevada</span>Clones were grown in 250 ml LB cultures, and protein expression induced and isolated as described above. The purified proteins were then tested for enzymatic activity after heating at 0, 2 and 4, and approximately 16 hours at 37  C. One of the clones, named "M5", was able to retain an increased proportion of its enzymatic activity after prolonged incubation at 37  C (Table 8). The DNA sequence of this clone has been determined, and the gene is designated herein as grg23 (acel) (SEQ ID 0:14). The expressed protein of grg23 (ace1) is designated GRG23 (ACE1) SEQ ID NO: 15). Table 8. GRG23 (ACEl) vs GRG23 half-life at elevated temperature</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 69&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 69 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">GRG23(ACEl) contm 2 substituies de aminocidos relativas  protena GRG2 3 selvagem: A49-^T e S276-&gt;T. 0 vetor pRSFlb que contm este gene  designado pAX3801. Figura 1 mostra a estabilidade relativa de GRG23(ACEl) vs GRG23 em temperaturas elevadas.</span>GRG23 (ACE1) contains 2 amino acid substitutions for wild GRG23 protein: A49-4 T and S276-&gt; T. The pRSF1b vector containing this gene is called pAX3801. Figure 1 shows the relative stability of GRG23 (ACEl) vs GRG23 at elevated temperatures.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 18. Determinao da atividade EPSPS de variantes de GRG-23</span>Example 18. Determination of EPSPS Activity of GRG-23 Variants</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Extratos contendo protenas de variantes de GRG23 foram ensaiados para atividade de EPSP sintase como descrito na U.S. Patent Application No. 60/741.166, arquivada em Io de dezembro de 2005, aqui incorporada por referncia em sua integridade. Ensaios foram realizados em um volume final de 50  contendo chiquimato-3-f osf ato a 0,5 mM, fosfoenolpiruvato (PEP) a 200 , xantina oxidase a 1 U/ml, nucleosdeo fosforilase a 2 U/ml, inosina a 2,25 mM, peroxidase de raiz-forte a 1 U/ml, glifosato a 0-2 mM, HEPES/KOH a 50 mM pH 7,0, KCl a 100 mM, e AMPLEX RED (Invitrogen) de acordo com as instrues do fabricante. Extratos foram incubados como todos os componentes do ensaio exceto chiquimato-3-fosfato por 5 minutos a temperatura ambiente, e ensaios foram iniciados pela adio     de chiquimato-3-fosfato. Atividade de EPSP sintase foi mensurada usando um espectrmetro de fluorescncia Spectramex Gemini XPS (Molecular Dynamics, excitao: 555 nm; emisso: 590 nm).</span>Extracts containing GRG23 variant proteins were assayed for EPSP synthase activity as described in U.S. Patent Application No. 60 / 741,166, filed December 1, 2005, incorporated herein by reference in its entirety. Assays were performed in a final volume of 50  containing 0.5 mM shikimate-3-phosphate, 200  phosphoenolpyruvate (PEP), 1 U / ml xanthine oxidase, 2 U / ml nucleoside phosphorylase, inosine a 2.25 mM, 1 U / ml horseradish peroxidase, 0-2 mM glyphosate, 50 mM HEPES / KOH pH 7.0, 100 mM KCl, and AMPLEX RED (Invitrogen) according to manufacturer's instructions. Extracts were incubated as all assay components except shikimate-3-phosphate for 5 minutes at room temperature, and assays were initiated by the addition of shikimate-3-phosphate. EPSP synthase activity was measured using a Spectramex Gemini XPS fluorescence spectrometer (Molecular Dynamics, excitation: 555 nm; emission: 590 nm).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Aps completa determinao dos parmetros cinticos terem sido executadas com protena purificada como descrito anteriormente (U.S. Patent Application No. 60/741.166, arquivada em Io de dezembro de 2005), ajuste da quantidade de protena determinada por ensaio de Bradford como conhecido na arte. Para qualquer concentrao de glifosato, a atividade de EPSP sintase foi mensurada em funo de uma larga escala de concentraes de PEP. Os dados foram ajustados  equao de Michaelis-Menten usando o programa KALEIDAGRAPH (Synergy Software) e usados para determinar Km (Km aparente) da EPSP sintase naquela concentrao de glifosato. Km, valores aparentes foram determinados em no menos do que 4 concentraes de glifosato, e Ki do EPSPS para glifosato foram calculados da curva do Km aparente vs. Concentrao de glifosato, usando a equao (ml*X/(m2+x); Ml = 1; m2 = 1) como conhecido na arte.</span>After complete determination of the kinetic parameters have been performed with purified protein as described above (U.S. Patent Application No. 60 / 741,166, filed December 1, 2005), adjusting the amount of protein determined by Bradford assay as known in the art. For any glyphosate concentration, EPSP synthase activity was measured against a large scale of PEP concentrations. Data were fitted to the Michaelis-Menten equation using the KALEIDAGRAPH (Synergy Software) program and used to determine EPSP synthase Km (apparent Km) at that glyphosate concentration. Km, apparent values were determined at no less than 4 glyphosate concentrations, and EPSi Ki for glyphosate were calculated from the apparent Km curve. Glyphosate concentration using the equation (ml * X / (m2 + x); M1 = 1; m2 = 1) as known in the art.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 9. Cintica de GRG23(ACEl) vs GRG2 3</span>Table 9. GRG23 (ACEl) vs GRG2 kinetics 3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 70&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 70 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 19. Identificao de grg23 (ace2)     GRG23(ACEl) contm duas modificaes de aminocidos em relao a GRG23. Para determinar se substituies adicionais nestas posies podem melhorar ainda mais a atividade, uma biblioteca de DNA foi gerada que resultou em clones expressando protenas que eram substancialmente mutadas em ambas as posies 49 e 276 do GRG23. Clones conferindo resistncia a glifosato foram selecionados por crescimento em placas de glifosato, e crescidos e ensaiados para propriedades cinticas como descrito.</span>Example 19. Identification of grg23 (ace2) GRG23 (ACE1) contains two amino acid modifications relative to GRG23. To determine if further substitutions at these positions could further enhance activity, a DNA library was generated that resulted in clones expressing proteins that were substantially mutated at both positions 49 and 276 of GRG23. Clones conferring glyphosate resistance were selected by growth on glyphosate plates, and grown and assayed for kinetic properties as described.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Surpreendentemente, um clone, aqui designado grg23(ace2) (SEQ ID N0:16), codificando a protena GRG(ACE2) (SEQ ID NO:17) foi identificado como tendo termoestabilidade melhorada. A seqncia de DNA de grg23(ace2) mostra que GRG23(ACE2) contm uma nica mudana de aminocido (resduo 276 de GRG23 para arginina).</span>Surprisingly, a clone, herein designated grg23 (ace2) (SEQ ID NO: 16), encoding the GRG protein (ACE2) (SEQ ID NO: 17) has been identified as having improved thermostability. The DNA sequence from grg23 (ace2) shows that GRG23 (ACE2) contains a single amino acid change (GRG23 to arginine residue 276).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 20. Comparao entre GRG23 e GRG51, e mutagnese de diferentes resduos</span>Example 20. Comparison between GRG23 and GRG51, and mutagenesis of different residues</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Duas bibliotecas foram geradas para avaliar as permutaes de seqncias de aminocidos possveis a partir da comparao com as seqncias de aminocidos de GRG23 e GRG51. A primeira biblioteca introduziu variao da seqncia de aminocidos de GRG51 na regio codificadora de grg23(ace2). A segunda biblioteca introduziu variao da seqncia de aminocidos de GRG23(ACE2) na regio codificadora de grg51.     Clones das bibliotecas resultantes foram avaliados quanto a (1) habilidade de conferir resistncia a glifosato na clula, e (2) atividade aps incubao prolongada a 37C. Um total de dez clones foram seqenciados e analisados em mais detalhe. Um clone em particular, aqui designado grg51.4 (SEQ ID NO:18), codificando a protena GRG51.4 (SEQ ID NO:19), contm vrias alteraes de aminocidos em relao tanto a GRG23(ACE2) e GRG51. As mudanas de aminocidos presentes em GRG51.4 em relao a GRG23(ACE2) foram subseqentemente introduzidas no gene grg23{ace2), para gerar grg23(ace3) (SEQ ID N0:20), que codifica a protena GRG(ACE3) (SEQ S N0:21). GRG23(ACE3) exibe atividade e termoestabilidade superior em relao a GRG2 3, e GRG23(ACE2).</span>Two libraries were generated to evaluate possible amino acid sequence permutations from comparison with the GRG23 and GRG51 amino acid sequences. The first library introduced GRG51 amino acid sequence variation in the grg23 coding region (ace2). The second library introduced GRG23 (ACE2) amino acid sequence variation into the grg51 coding region. Clones from the resulting libraries were evaluated for (1) ability to confer glyphosate resistance in the cell, and (2) activity after prolonged incubation at 37  C. A total of ten clones were sequenced and analyzed in more detail. One particular clone, herein designated grg51.4 (SEQ ID NO: 18), encoding the GRG51.4 protein (SEQ ID NO: 19), contains several amino acid changes from both GRG23 (ACE2) and GRG51. The amino acid changes present in GRG51.4 relative to GRG23 (ACE2) were subsequently introduced into the grg23 (ace2) gene to generate grg23 (ace3) (SEQ ID NO: 20), which encodes the GRG protein (ACE3) (SEQ) S NO: 21). GRG23 (ACE3) exhibits superior activity and thermostability compared to GRG2 3, and GRG23 (ACE2).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">GRG23(acel) foi mutagenizado, e clones foram testados para identificar clones expressando variantes com termoestabilidade e/ou atividade melhorada. Um clone, grg23(L5P2.J2) (SEQ ID NO:22), codificando GRG23(L5P2.J2) (SEQ ID NO:23), foi identificado por virtude de suas propriedades cinticas melhoradas. GRG23 (L5P2.J2) contm trs alteraes de aminocidos em relao a GRG23(ACEl), como mostrado na seguinte Tabela 10.</span>GRG23 (acel) was mutagenized, and clones were tested to identify clones expressing variants with thermostability and / or enhanced activity. A clone, grg23 (L5P2.J2) (SEQ ID NO: 22), encoding GRG23 (L5P2.J2) (SEQ ID NO: 23), has been identified by virtue of its improved kinetic properties. GRG23 (L5P2.J2) contains three amino acid changes from GRG23 (ACE1), as shown in the following Table 10.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 10. Alteraes de aminocidos em GRG23(L5P2.J2)</span>Table 10. Amino Acid Changes in GRG23 (L5P2.J2)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 72&lt;/column&gt;&lt;/row&gt;&lt;table&gt;     &lt;table&gt;table see original document page 73&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 72 &lt;/column&gt; &lt;/row&gt; &lt;table&gt; &lt;table&gt; table see original document page 73 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Mutagnese de oligonucleotdeos foi usada para criar clones que contenham cada uma das alteraes de aminocidos identificadas em GRG23(L5P2.J2) na regio codificadora de grg23(ace3). Um clone foi identificado como codificando uma protena tendo propriedades cinticas melhoradas sobre GRG23(ACE3), e designado grg23{ace4) (SEQ ID NO:24). A protena codificada por grg23(ace4)  designada como GRG23(ACE4) (SEQ ID NO:25) contm uma nica alterao de aminocido em relao a GRG23(ACE3) (valina 101 para fenilalanina). Baseado neste resultado, uma mutagnese por oligonucleotdeo separada foi realizada para testar as cinticas de cada substituio de aminocido possvel na posio 101. Nenhuma das alteraes de aminocidos resultou em melhorias maiores nas propriedades cinticas comparadas a GRG23(ACE4).</span>Oligonucleotide mutagenesis was used to create clones containing each of the amino acid changes identified in GRG23 (L5P2.J2) in the coding region of grg23 (ace3). One clone has been identified as encoding a protein having improved kinetic properties over GRG23 (ACE3), and is designated grg23 (ace4) (SEQ ID NO: 24). The protein encoded by grg23 (ace4) is designated as GRG23 (ACE4) (SEQ ID NO: 25) contains a single amino acid change from GRG23 (ACE3) (valine 101 for phenylalanine). Based on this result, a separate oligonucleotide mutagenesis was performed to test the kinetics of each possible amino acid substitution at position 101. None of the amino acid changes resulted in greater improvements in kinetic properties compared to GRG23 (ACE4).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tabela 11. Cintica de variantes melhorados</span>Table 11. Enhanced Variant Kinetics</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 73&lt;/column&gt;&lt;/row&gt;&lt;table&gt;     &lt;table&gt;table see original document page 74&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 73 &lt;/column&gt; &lt;/row&gt; &lt;table&gt; &lt;table&gt; table see original document page 74 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 21. Engenharia de grg23 ou grg51 para Transformao de Plantas</span>Example 21. Engineering grg23 or grg51 for Plant Transformation</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O quadro de leitura aberto (ORF) de grg23 ou grg51  amplificado por PCR de um molde de cDNA de tamanho completo. Sitios de restrio Hind III so adicionados em cada fim do ORF durante PCR. Adicionalmente, a seqncia de nucleotideos ACC  adicionada imediatamente 5'do cdon de inicio do gene para aumentar a eficincia de traduo (Kozak (1987) Nucleic Acids Research 15:8125-814 8; Joshi (1987) Nucleic Acids Research 15:6643-6653). O produto de PCR  clonado e seqenciado usando tcnicas bem conhecidas na arte para assegurar que nenhuma mutao  introduzida durante o PCR.</span>The grg23 or grg51 open reading frame (ORF) is PCR amplified from a full length cDNA template. Hind III restriction sites are added at each end of the ORF during PCR. Additionally, the ACC nucleotide sequence is added immediately 5 'from the gene start codon to increase translation efficiency (Kozak (1987) Nucleic Acids Research 15: 8125-8148; Joshi (1987) Nucleic Acids Research 15: 6643- 6653). The PCR product is cloned and sequenced using techniques well known in the art to ensure that no mutations are introduced during PCR.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O plasmidio contendo o produto de PCR grg23 ou grg51  digerido com Hind III e o fragmento contendo o ORF intacto  isolado. Este fragmento  clonado no sitio Hind III do plasmidio pAX200, um vetor de expresso em planta contendo o promotor de actina de arroz (McElroy et al. (1991) Molec. Gen. Genet. 231:150-160) e o terminador PinII (An et al. (1989) The Plant Cell 1:115-122). O fragmento promotor- gene-terminador deste plasmidio intermedirio  subclonado no plasmidio pSBll (Japan Tobacco, Inc.) para formar o plasmidio final, por exemplo, pSBHGRG23. pSBHGRG23  organizado tal que o fragmento de DNA de 3,91 kb contendo a     construo promotor-grg23-terminador pode ser excisado por dupla digesto com Kpn I e Pme I e usado para transformao em plantas por injeo de feixe aerossol. A estrutura de pSBHGRG23  verificada por digesto de restrio e eletroforese em gel, e por seqenciamento ao longo de vrias junes de clonagem.</span>The plasmid containing the grg23 or grg51 PCR product is digested with Hind III and the intact ORF-containing fragment is isolated. This fragment is cloned into the Hind III site of plasmid pAX200, a plant expression vector containing the rice actin promoter (McElroy et al. (1991) Molec. Gen. Genet. 231: 150-160) and the PinII terminator ( An et al (1989) The Plant Cell 1: 115-122). The promoter-gene terminator fragment of this intermediate plasmid is subcloned into plasmid pSB11 (Japan Tobacco, Inc.) to form the final plasmid, for example, pSBHGRG23. pSBHGRG23 is organized such that the 3.91 kb DNA fragment containing the promoter-grg23-terminator construct can be excised by double digestion with Kpn I and Pme I and used for plant transformation by aerosol beam injection. The structure of pSBHGRG23 is verified by restriction digestion and gel electrophoresis, and by sequencing over various cloning junctions.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">O plasmidio  mobilizado na linhagem LBA4404 de Agrobacterium tumefaciens o qual tambm contm o plasmidio pSBl (Japan Tobacco, Inc.), usando procedimentos de cruzamento triparental bem conhecidos na arte, e plaqueando em meio contendo espectinomicina. O plasmidio pSBHGRG23 carrega resistncia a espectinomicina mas  um plasmideo de escala estreita em hospedeiro e no pode se replicar em Agrobacterium. Colnias resistentes a espectinomicina surgem quando pSBHGRG23 se integra no plasmidio pSBl de escala larga em hospedeiro atravs de recombinao homloga. O produto co-integrado de pSBl e pSBHGRG23  verificado por hibridizao Southern. A linhagem de Agrobacterium contendo o co-integrado  usada para transformar milho pelo mtodo PureIntro (Japan Tobacco).</span>The plasmid is mobilized in Agrobacterium tumefaciens strain LBA4404 which also contains plasmid pSB1 (Japan Tobacco, Inc.) using triparental crossing procedures well known in the art and plating on spectinomycin-containing medium. Plasmid pSBHGRG23 carries spectinomycin resistance but is a narrow-scale host plasmid and cannot replicate in Agrobacterium. Spectinomycin-resistant colonies arise when pSBHGRG23 integrates into the host large-scale pSB1 plasmid through homologous recombination. The co-integrated product of pSB1 and pSBHGRG23 is verified by Southern hybridization. The Agrobacterium strain containing the cointegrated is used to transform maize by the PureIntro method (Japan Tobacco).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 22. Transformao de grg23 ou_grg51 em clulas de Plantas</span>Example 22. Transformation of grg23 or_grg51 into Plant Cells</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Espigas de milho so coletadas 8-12 dias aps polinizao. Embries so isolados das espigas, e aqueles embries com 0,8-1,5 mm de tamanho so usados para transformao. Embries so plaqueados com o escutelo     virado para cima em meio de incubao apropriado, como meio DN62A5S (Sais N6 a 3,98 g/L; vitaminas N6 a 1 mL/L (de estoque IOOOx); L-Asparagina a 800 mg/L; Mio-inositol a 100 mg/L; L-Prolina a 1.4 g/L; Casaminocidos a 100 mg/L; sacarose a 50 g/L; 2,4-D a 1 mL/L (de estoque a 1 mg/mL) ) . Entretanto, meio e sais outros que no DN62A5S so apropriados e so conhecidos na arte. Embries so incubados de um dia para outro a 25C no escuro.</span>Corncobs are collected 8-12 days after pollination. Embryos are isolated from the ears, and those 0.8-1.5 mm in size are used for transformation. Embryos are plated with the scutellum facing up in appropriate incubation medium as DN62A5S medium (Salts N6 at 3.98 g / L; Vitamins N6 at 1 mL / L (10000 stock); L-Asparagine at 800 mg / L ; 100 mg / L myo-inositol; 1.4 g / L L-Proline; 100 mg / L Casamino acids; 50 g / L sucrose; 1 mL / L 2,4-D (1 mg / L stock) mL)). However, media and salts other than DN62A5S are suitable and are known in the art. Embryos are incubated overnight at 25  C in the dark.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Os explantes resultantes so transferidos para malhas quadradas (30-40 por placa), transferidos para meio osmtico por 30-45 minutos, ento transferidos para placa irradiante (veja, por exemplo, Publicao PCT No. W0/0138514 e Patente E.U No. 5,240,842).</span>The resulting explants are transferred to square meshes (30-40 per plate), transferred to osmotic medium for 30-45 minutes, then transferred to irradiating plate (see, for example, PCT Publication No. W0 / 0138514 and EU Patent No. 5,240,842). ).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Construes de DNA para expressar GRG23 em clulas de planta so aceleradas em tecido de planta usando um acelerador de feixe aerossol, usando condies essencialmente como descrito na Publicao PCT NO. WO/0128514. Aps irradiao, embries so incubados por 30 min em meio osmtico, e colocados em meio de incubao de um dia para outro a 25C no escuro. Para evitar danos imprprios a explantes irradiados, eles so incubados por pelo menos 24 horas antes de transferir para meio de recuperao. Embries so ento espalhados em meio de perodo de recuperao por 5 dias a 25C no escuro, depois transferidos para um meio de seleo. Explantes so incubados em meio de seleo por at oito semanas, dependendo da natureza e caractersticas de seleo     particular utilizada. Aps o perodo de seleo, o calo resultante  transferido para meio de maturao de embrio at a observao da formao de embries somticos maduros. Os embries somticos maduros resultantes so ento colocados em luz baixa e o processo de regenerao  iniciado por mtodos conhecidos na arte. Aos brotos resultantes so permitidos o enraizamento em meio de enraizamento, e as plantas resultantes so transferidas para potes berrios e propagadas como plantas transgnicas.</span>DNA constructs to express GRG23 in plant cells are accelerated in plant tissue using an aerosol beam accelerator, using conditions essentially as described in PCT Publication NO. WO / 0128514. After irradiation, embryos are incubated for 30 min in osmotic medium, and placed in overnight incubation medium at 25  C in the dark. To prevent improper damage to irradiated explants, they are incubated for at least 24 hours before transferring to recovery medium. Embryos are then spread in the recovery period for 5 days at 25  C in the dark, then transferred to a selection medium. Explants are incubated in selection medium for up to eight weeks, depending on the nature and characteristics of the particular selection used. After the selection period, the resulting callus is transferred to embryo maturation medium until the formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed in low light and the regeneration process is initiated by methods known in the art. The resulting shoots are allowed rooting in rooting medium, and the resulting plants are transferred to nursery pots and propagated as transgenic plants.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Materiais Meio DN62A5S</span>DN62A5S Medium Materials</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">&lt;table&gt;table see original document page 77&lt;/column&gt;&lt;/row&gt;&lt;table&gt;     &lt;table&gt;table see original document page 78&lt;/column&gt;&lt;/row&gt;&lt;table&gt;</span>&lt;table&gt; table see original document page 77 &lt;/column&gt; &lt;/row&gt; &lt;table&gt; &lt;table&gt; table see original document page 78 &lt;/column&gt; &lt;/row&gt; &lt;table&gt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ajuste o pH da soluo para pH 5,8 com KOH a 1N/KC1 a 1N, adicione Gelrite (Sigma) para 3g/L, e autoclave. Aps resfriamento para 50C, adicione 2 mL/L de uma soluo  estoque de Nitrato de Prata a 5 mg/mL (Phytotechnology Labs). A receita gera em torno de 20 placas.</span>Adjust the pH of the solution to pH 5.8 with 1N KOH / 1N KCl, add Gelrite (Sigma) to 3g / L, and autoclave. After cooling to 50  C, add 2 mL / L of a 5 mg / mL Silver Nitrate stock solution (Phytotechnology Labs). The revenue generates around 20 plates.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Exemplo 23. Transformao de grg23 ou grg51 em Clulas de Plantas de Milho por Transformao Mediada por  Agrobacterium</span>Example 23. Transformation of grg23 or grg51 into Corn Plant Cells by Agrobacterium Mediated Transformation</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Espigas de milho so coletadas 8-12 dias aps polinizao. Embries so isolados das espigas, e aqueles embries com 0,8-1,5 mm de tamanho so usados para transformao. Embries so colocados em placas com o escutelo virado para cima em meio de incubao apropriado, e incubados de um dia para outro a 25C no escuro. Entretanto, no  necessrio per se incubar os embries de um dia para outro. Embries so contatados com uma linhagem  de Agrobacterium contendo os vetores apropriados para transferncia medida por plasmidio Ti por 5-10 min, e ento plaqueados em meio de co-cultivo por 3 dias (25C no escuro). Aps co-cultivo, os explantes so transferidos para meio de perodo de incubao por cinco dias (25C no  escuro). Os explantes so incubados em meio de seleo por at oito semanas, dependendo da natureza e caractersticas     da seleo particular utilizada. Aps o perodo de seleo, o calo resultante  transferido para meio de maturao de embrio, at que a formao de embries somticos maduros seja observada. Os embries somticos maduros resultantes so ento colocados em luz baixa, e o processo de regenerao  iniciado por mtodos conhecidos na arte. Aos brotos resultantes so permitidos o enraizamento em meio de enraizamento, e as plantas resultantes so transferidas para potes berrios e propagadas como plantas transgnicas.</span>Corncobs are collected 8-12 days after pollination. Embryos are isolated from the ears, and those 0.8-1.5 mm in size are used for transformation. Embryos are plated upwards in appropriate incubation medium, and incubated overnight at 25  C in the dark. However, it is not necessary to incubate the embryos overnight. Embryos are contacted with an Agrobacterium strain containing appropriate vectors for transfer measured by Ti plasmid for 5-10 min, and then plated in co-culture medium for 3 days (25  C in the dark). After co-cultivation, the explants are transferred to the middle incubation period for five days (25  C in the dark). Explants are incubated in selection medium for up to eight weeks, depending on the nature and characteristics of the particular selection used. After the selection period, the resulting callus is transferred to embryo maturation medium until formation of mature somatic embryos is observed. The resulting mature somatic embryos are then placed in low light, and the regeneration process is initiated by methods known in the art. The resulting shoots are allowed rooting in rooting medium, and the resulting plants are transferred to nursery pots and propagated as transgenic plants.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Todas as publicaes e aplicaes de patentes mencionadas na especificao so indicativas do nvel de percia daqueles especialistas na arte a qual esta inveno pertence. Todas as publicaes e aplicaes de patentes so aqui incorporadas por referncia na mesma medida como se cada publicao ou aplicao de patente individual fosse especificamente e individualmente indicada para ser incorporada por referncia.</span>All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention belongs. All publications and patent applications are incorporated herein by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Apesar da inveno precedente ter sido descrita em algum detalhe por meio de ilustrao e exemplo para finalidades de claridade e compreenso, ser bvio que certas alteraes e modificaes podem ser praticadas dentro do escopo das reivindicaes em anexo.     LISTAGEM DE SEQNCIAS</span>Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. LIST OF SEQUENCES</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1) INFORMAES GERAIS:</span>1) GENERAL INFORMATION:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I.a) Requerente: Cheryl Peters</span>I.a) Applicant: Cheryl Peters</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jill Burdette Philip E. Hammer Brian Vande Berg Laura Cooper Schouten Brian Carr</span>Jill Burdette Philip E. Hammer Brian Vande Berg Laura Cooper Schouten Brian Carr</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Titulo da Inveno: MOLCULA DE CIDO NUCLICO ISOLADA, POLIPEPTDEO ISOLADO, VETOR, CLULA HOSPEDEIRA, PLANTA TRANSGNICA, SEMENTE, MTODO PARA PRODUZIR POLIPEPTDEO COM ATIVIDADE DE RESISTNCIA A HERBICIDAS, MTODO PARA CONFERIR RESISTNCIA A HERBICIDA PARA PLANTA, MTODO PARA MEDIR A LIBERAO DE FOSFATO POR ENZIMA</span>II) Title of the Invention: INSULATED NUCLEIC ACID MOLECULA, ISOLATED POLYPEPTIDE, VECTOR, HOST CELL, TRANSGENIC PLANT, SEED, METHOD FOR PRODUCING HERBYCEDITY RESISTANCE MATERIALITY FOR HERBYCEDITY MEASURES, PLANT Phosphate Per Enzyme</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Arquivo de Referncia: 45600/320129</span>III) Reference File: 45600/320129</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV.a) Dados de Prioridade Unionista: 60/741.166</span>IV.a) Unionist Priority Data: 60 / 741,166</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV.b) Data de preenchimento do formulrio anterior:</span>IV.b) Date of completion of previous form:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">01/12/2005</span>12/01/2005</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV.a) Dados de Prioridade Unionista: 60/817.799</span>IV.a) Unionist Priority Data: 60 / 817,799</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV.b) Data de preenchimento do formulrio anterior: 30/06/2006</span>IV.b) Date of completion of previous form: 30/06/2006</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">V)Nmero	de Seqncias: 33 (trinta e trs)</span>V) Number of Sequences: 33 (thirty three)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">VI)Programa	para leitura: FastSEQ for Windows Version 4.0</span>VI) Program for reading: FastSEQ for Windows Version 4.0</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2) INFORMAES GERAIS DAS SEQNCIAS:</span>2) GENERAL SEQUENCE INFORMATION:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I.a)	Nmero identificador da seqncia: SEQ ID No: 1</span>I.a) Sequence identifier number: SEQ ID No: 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1892</span>II.a) Size: 1892</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Il.b) tipo: DNA</span>Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Arthrobacter globiformis</span>II.c) organism: Arthrobacter globiformis</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Caracterstica:     III.a)	Nome/Legenda: incerto</span>III) Characteristic: III.a) Name / Legend: uncertain</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: (0)...(0)</span>III.b) Location: (0) ... (0)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: Linhagem ATX21308</span>III.c) Other information: ATX21308 strain</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a)	Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: (109) ... (1419)</span>Location: (109) ... (1419)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a)	Nome/Legenda: incerto</span>III.a) Name / Legend: uncertain</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: 1801</span>III.b) Location: 1801</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes:  = A,,C or G</span>III.c) Other information:  = A, , C or G</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a)	Nome/Legenda: incerto</span>III.a) Name / Legend: uncertain</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: 1801</span>III.b) Location: 1801</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: n = A,,C or G</span>III.c) Other information: n = A, , C or G</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 1</span>IV) Sequence: SEQ ID NO. 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gggaccacat gctgctcctg atttcagggc tgctgccggt atggaccagg gtttagagag 60 ggacggcacg catccgggcc cttatcggac caacgccaac agcggtcg gtg gcc ttg 117</span>gggaccacat gctgctcctg atttcagggc tgctgccggt atggaccagg gtttagagag 60 ggacggcacg catccgggcc cttatcggac caacgccaac agcggtcg gtg gcc ttg 117</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Ala Leu 1</span>Met Wing Leu 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cgg ggc cag cac ggc cga tca cgt aga ctc ttt gga gct tcg ctc 165 Glu Arg Gly Gln His Gly Arg Ser Arg Arg Leu Phe Gly Ala Ser Leu 5	10	15</span>gg cgg ggc cag cac ggc cga tca cgt aga ctc ttt gga gct tcg ctc 165 Glu Arg Gly Gln His Gly Arg Ser Arg Arg Leu Phe Gly Ala Ser Leu 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gaa agg ate acc atg gaa act gat cga cta gtg ate cca gga tcg aaa 213 Glu Arg Xle Thr Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys 20	25	30	35     "age"^tSb-CiSS' aaclg^gE ttg ctt ttg gct gcc gea gcg aag ggc acg 261 Ser Ile Thr Asn Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr 40	45	SO</span>gaa agg till acc atg gaa act gat cga cta gtg till cca gga tcg aaa 213 Glu Arg Xle Thr Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys 20 25 30 35 "age" ^ tSb-CiSS 'aaclg ^ gE ttg ctt ttg gct gcc gea gcg aag ggc acg 261 Ser Ile Thr Asn Arg Wing Wing Read Wing Wing Wing Wing Wing Wing Lys Gly Thr 40 45 SO</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tcg gtc ctg gtg aga cca ttg gtc age gcc gat acc tca gea ttc aaa 309 Ser Val Leu Val Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys SS	60	65</span>tcg gtc ctg gtg aga cca ttg gtc age gcc gat acc tca gea ttc aaa 309 Ser Val Leu Val Arg Pro Leu Val Ser Wing Asp Thr Ser Wing Phe Lys SS 60 65</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">act gea att cag gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat 357 Thr Ala Ile Gln Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn 70	75	80</span>act gea att cag gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat 357 Thr Ala Ile Gln Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tgg gtc gtt gaa ggc ctg ggt cag gea cce eac ctc gac gcc gac ate 405 Trp Val Val Glu Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile 85	90	95</span>tgg gtc gtt gaa ggc ctg ggt cag gea cce eac ctc gac gcc gac up to 405 Trp Val Val Glu Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tgg tgc gag gat gea ggt acc gtg gcc cgg ttc ctc cct cca ttc gtc 453 Trp Cys Glu Asp Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val 100	105	110	115</span>tgg tgc gag gat gea ggt acc gtg gcc cgg ttc ctc cct cca ttc gtc 453 Trp Cys Glu Asp Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val 100 105 110 115</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc gea gga cag ggg aag ttc acc gtc gac gga age gag cag ctg cgg 501 Ala Ala Gly Gln Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg 120	125	130</span>gcc gea gga cag ggg aag ttc acc gtc gac gga age gag cag ctg cgg 501 Wing Gly Wing Gly Gln Gly Lys Phe Thr Val Asp Gly Ser Glu Glu Leu Arg 120 125 130</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg cgc ccg ctt cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc 549 Arg Arg Pro Leu Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala 135	140	145</span>cgg cgc ccg ctt cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc 549 Arg Arg Pro Leu Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala 135 140 145 145</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgc gtc tec tcc gag cag ctg ccc cta aca att gaa gcg age ggg ctg 597 Arg Val Ser Ser Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu 150	155	160</span>cgc gtc tec tcc gag cag ctg ccc cta aca att gaa gcg age ggg ctg 597 Arg Val Ser Ser Glu Glu Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu 150 155 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggc ggg gag tac gaa att gaa gcc cat cag age age eag ttc gcc 64S Ala Gly Gly Glu Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala 165	170	175</span>gea ggg ggg gag tac gag att gaa gcc cat cag age age eag ttc gcc 64S Wing Gly Gly Glu Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tcc ggc ctg ate atg gcc gce ccg tac gcg cga eaa ggc ctg cgt gtg 693 Ser Gly Leu Ile Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val 180	185	190	195</span>tcc ggc ctg to atg gcc gce ccg tac gcg cga eaa ggc ctg cgt gtg 693 Ser Gly Leu Ile Met Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val 180 185 190 195</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ata cca aat ccc gtg age cag ccc tac ctc acg atg aca ctg cgg 741 Arg Ile Pro Asn Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg 200	205	210</span>cgg ata cca aat ccc gtg age cag ccc tac ctc acg atg aca ctg cgg 741 Arg Ile Pro Asn Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg 200 205 210</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg atg agg gac ttc ggc ctt gag acc age acc gac gga gcc acc gtc 789 Met Met Arg Asp Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val 215	220	225</span>atg atg agg gac ttc ggc ctt gag acc ac acc gac gga gcc acc gtc 789 Met Met Arg Asp Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val 215 220 225</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">age gtc cct ccc ggg cgc tac aca gcc cgg cgg tat gaa att gaa ccg 837 Ser Val Pro Pro Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro 230	235	240</span>age gtc cct ccc ggg cgc tac aca gcc cgg cgg tat gaa att gaa ccg 837 Ser Val Pro Pro Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac gcg tca act gcg tcg tac ttc gcc gce gct tcc gcc gtc tet ggc 885 Asp Ala Ser Thr Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly 245	250	255</span>gac gcg tca act gcg tcg tac ttc gcc gce gct tcc gcc gtc tet ggc 885 Asp Ala Ser Thr Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cga age ttc gaa ttc cag ggc ctt ggc aca gac age ate caa ggc gac 933 Arg Ser Phe Glu Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp 260	265	270	275</span>cga age ttc gaa ttc cag ggc ctt ggc aca gac act until caa ggc gac 933 Arg Ser Phe Glu Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp 260 265 270 275</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acg tca ttc ttc aat gta ctt ggg cgg ctc ggt gea gag gtc cac tgg 981     Thr Ser Phe Phe Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp 280	285	290</span>acg tca ttc ttc aat gta ctt ggg cgg ctc ggt gea gag gtc cac tgg 981 Thr Ser Phe Phe Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp 280 285 290</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gca ccc aac tcg gtc acc ata tcc gga ccg gaa agg ctg aac ggc gac 1029 Ala Pro Asn Ser Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp 295	300	305</span>gca ccc aac tcg gtc acc ata tcc gga ccg gaa agg ctg aac ggc gac 1029 Pro Wing Asn Ser Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp 295 300 305</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">att gaa gtg gat atg ggc gag ata tcg gac acc ttc atg aca ctc gcg 1077 Ile Glu Val Asp Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala 310	315	320</span>att gaa gtg gat atg ggc gag ata tcg gac acc ttc atg aca ctc gcg 1077 Ile Glu Val Asp Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg att gcc cct cta gcc gat gga ccc ate acg ata acc aac att ggc 1125 Ala Ile Ala Pro Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly 325	330	335</span>gcg att gcc cct cta gcc gat gga ccc till acg ata acc aac att ggc 1125 Ile Wing Ala Pro Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cat gca cgg ttg aag gaa tcc gac cgc ate tcg gcg atg gaa acc aac 1173 His Ala Arg Leu Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn 340	345	350	355</span>cat gca cgg ttg aag gaa tcc gac cgc up to tcg gcg atg gaa acc aac 1173 His Ala Arg Leu Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn 340 345 350 355</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ctg cga acg ctc ggt gta caa acc gac gtc gga cac gac tgg atg cga 1221 Leu Arg Thr Leu Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg 360	365	370</span>ctg cga acg ctc ggt gta caa acc gac gtc gga cac gac tgg atg cga 1221 Leu Arg Thr Leu Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg 360 365 370 370</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ate tac ccc tet acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac 1269 Ile Tyr Pro Ser Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp 375	380	385</span>up to ccc tet acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac 1269 Ile Tyr Pro Ser Thr His Gly Gly Arg Val Asn Cys His Arg Asp 375 380 385</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cac agg ate gcc atg gcg ttt tca ate ctg gga ctg cga gtg gac ggg 1317 His Arg Ile Ala Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly 390	395	400</span>cac agg up to gcc atg gcg ttt tca up to ctg gga ctg cga gtg gac ggg 1317 His Arg Ile Ala Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">att acc etc gac gac cct caa tgt gtc ggg aag acc ttt cot ggc ttc 1365 Ile Thr Leu Asp Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe 405	410	415</span>att acc etc gac gac cct caa tgt gtg ggg aag acc ttt cot ggc ttc 1365 Ile Thr Leu Asp Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe 405 410 415</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc gac tac ctt gga cgc ctt tte ccc gaa aag gcg ctt acg ctc ccc 1413 Phe Asp Tyr Leu Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro 420	425	430	435</span>ttc gac tac ct gga cgc ctt tte ccc gaa aag gcg ctt acg ctc ccc 1413 Phe Asp Tyr Leu Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro 420 425 430 435</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc tag tgacttectc tccggcggac gctaggcatc ggaaaacgaa tectgacatg 1469 Gly *</span>ggc tag tgacttectc tccggcggac gctaggcatc ggaaaacgaa tectgacatg 1469 Gly *</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">accgacctcc tcgcgtcacg gcgtgtctgc ccgcggcccc ttatgctttc tggttgtcca agcagggcaa tcagctgttc agcactgtca gctgccacgt cggcggctct catcgctgtc tcaggatccg ccctcgtcgc ctgatcctga ggcggccaga gccgaagcaa taaggagttt ggcgatatgg gcttcatgct gaactatggg cca</span>accgacctcc tcgcgtcacg gcgtgtctgc ccgcggcccc ttatgctttc tggttgtcca agcagggcaa tcagctgttc agcactgtca gctgccacgt cggcggctct catcgctgtc tcaggatccg ccctcgtcgc ctgatcctga ggcggccaga gccgaagcaa taaggagttt ggcgatatgg gcttcatgct gaactatggg cca</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cggtacccaa gcattctgcc ttagccgctt 1529 gattttcatc cgggatgttg cctgaccttg 1589 atggtgtggg ccctgaaggc ggcttcgatg 1649 acgacacgca gatgcgcttc ataggcacgt 1709 gccaaggcaa tagttagatg tgcctccgtt 1769 tncgaggcca cccagattcc ccgggtggaa 1829 gtccggatgg aagtgacttt tcaactctgc 1889</span>cggtacccaa gcattctgcc ttagccgctt 1529 gattttcatc cgggatgttg cctgaccttg 1589 atggtgtggg ccctgaaggc ggcttcgatg 1649 acgacacgca gatgcgcttc ataggcacgt 1709 gccaaggcaa tagttagatg tgcctccgtt 1769 tncgaggcca cccagattcc ccgggtggaa 1829 gtccggatgg aagtgacttt tcaactctgc 1889</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1892     I.a) Nmero identificador da seqncia: SEQ ID No: 2</span>1892 I.a) Sequence identifier number: SEQ ID No: 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 436 II.b) tipo: PRT</span>II.a) Size: 436 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Arthrobacter globiformis IV) Seqncia: SEQ ID NO. 2</span>II.c) organism: Arthrobacter globiformis IV) sequence: SEQ ID NO. 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Ala Leu	Glu	Arg	Gly Gln		His Gly	Arg	Ser Arg		Arg	Leu	Phe	Gly 1			5				10					15	 Ala	Ser Leu	Glu	Arg	Ile	Thr	Met Glu	Thr	Asp Arg		Leu	Val	Ile	Pro 		'20	 ~			25					30		 Gly	Ser Lys	Ser	Ile	Thr	Asn	Arg Ala	Leu	Leu	Leu	Ala	Ala	Ala	Ala 	35					40				45			 Lys	Gly Thr	Ser	Val	Leu	Val	Arg Pro	Leu	Val	Ser	Ala	Asp	Thr	Ser 	50				55				60				 Ala	Phe Lys	Thr	Ala	Ile	Gln	Ala Leu	Gly	Ala	Asn	Val	Ser	Ala	Asp 65				70				75					80 Gly	Asp Asn Trp		Val	Val	Glu	Gly Leu	Gly	Gln	Ala	Pro	His	Leu	Asp 			85				90					95	 Ala	Asp Ile	Trp	Cys Glu Asp			Ala Gly	Thr	Val	Ala	Arg	Phe	Leu	Pro 		100				105					110		 Pro	Phe Val	Ala	Ala Gly Gln			Gly Lys	Phe	Thr	Val	Asp	Gly	Ser	Glu 	115					120				125			 Gln	Leu Arg	Arg	Arg	Pro	Leu	Arg Pro	Leu	Val	Asp	Gly	Ile	Arg	His 	130				135				140				 Leu	Gly Ala Arg		Val	Ser	Ser	Glu Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala 145				150				155					160 Ser	Gly Leu	Ala	Gly Gly Glu			Tyr Glu	Ile	Glu	Ala	His	Gln	Ser	Ser 			165				170					175	 Gln	Phe Ala	Ser	Gly Leu		Ile	Met Ala	Ala	Pro	Tyr	Ala	Arg	Gln	Gly 		180				185					190		 Leu	Arg Val	Arg	Ile	Pro	Asn	Pro Val	Ser	Gln	Pro	Tyr	Leu	Thr	Met 	195					200				205			 Thr	Leu Arg	Met	Met	Arg	Asp	Phe Gly	Leu	Glu	Thr	Ser	Thr	Asp	Gly 	210				215				220				 Ala	Thr Val	Ser	Val	Pro	Pro	Gly Arg	Tyr	Thr	Ala	Arg	Arg	Tyr	Glu 225				230				235					240 Ile	Glu Pro	Asp	Ala	Ser	Thr	Ala Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala 			245				250					255	 Val	Ser Gly Arg		Ser	Phe	Glu	Phe Gln	Gly	Leu	Gly	Thr	Asp	Ser	Ile 		260				265					270		 Gln	Gly Asp	Thr	Ser	Phe	Phe	Asn Val	Leu	Gly	Arg	Leu	Gly	Ala	Glu 	275					280				285			 Val	His Trp	Ala	Pro	Asn	Ser	Val Thr	Ile	Ser	Gly	Pro	Glu	Arg	Leu 	290				295				300				 Asn	Gly Asp	Ile	Glu	Val	Asp	Met Gly	Glu	Ile	Ser	Asp	Thr	Phe	Met 305				310				315					320 Thr	Leu Ala	Ala	Ile	Ala	Pro	Leu Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr 			325				330					335	 Asn	Ile Gly His		Ala	Arg	Leu	Lys Glu	Ser	Asp	Arg	Ile	Ser	Ala	Met 		340				345					350		 Glu	Thr Asn	Leu	Jtfg	Thr	Leu	Gly Val	Gln	Thr	Asp	Val	Gly	His	Asp 	355					360				365			 Trp	Met Arg	Ile	Tyr	Pro	Ser	Thr Pro	His	Gly	Gly	Arg	Val	Asn	Cys 	370				375				380				 His	Arg Asp	His	Arg	Ile	Ala	Met Ala	Phe	Ser	Ile	Leu	Gly	Leu	Arg 385				390				395					400 Val	Asp Gly	Ile	Thr	Leu	Asp	Asp Pro	Gln	Cys	Val	Gly	Lys	Thr	Phe 			405				410					415	 Pro	Gly Phe	Phe	ASp	Tyr	Leu	Gly Arg	Leu	Phe	Pro	Glu	Lys	Ala	Leu 		420				425					430</span>Met Wing Leu Glu Arg Gly Gln His Gly Arg Be Arg Arg Leu Phe Gly 1 5 10 15 Wing Being Leu Glu Arg Ile Thr Met Glu Thr Asp Arg Leu Val Ile Pro '20  - ~  25 30 Gly Ser Lys Ser Ile Thr Asn Arg Wing Leu Leu Wing Wing Wing Wing Wing 35 40 45 Lys Gly Thr Be Val Leu Val Arg Pro Leu Val Ser Asp Wing Thr Thr 50 55 60 Phe Lys Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp 65 70 75 80 Gly Asp Asn Trp Val Val Glu Gly Leu Gly Gln Pro Wing His His Asu 85 90 95 Wing Asp Ile Trp Cys Glu Asp Wing Gly Thr Val Wing Arg Phe Leu Pro 100 105 110 Pro Phe Val Wing Gly Gln Gly Lys Phe Thr Val Asp Gly Be Glu 115 120 125 Gln Leu Arg Arg Arg Pro Leu Arg Pro Read Val Asp Gly Ile Arg His 130 135 140 Leu Gly Wing Arg Val Be Ser Glu Gln Leu Pro Leu Thr Ile Glu Wing 145 150 155 160 Ser Gly Leu Wing Gly Gly Glu Tyr Glu Ile Glu Wing His Gln Be Ser 165 170 175 Phe Wing Ser Gly Leu Ile Me t Wing Ala Pro Wing Tyr Arg Wing Gln Gly 180 185 190 Leu Arg Val Arg Ile Pro Asn Pro Val Ser Gln Pro Tyr Leu Thr Met 195 200 205 Thr Leu Arg Met Met Arg Asp Phe Gly Leu Glu Thr Be Thr Asp Gly 210 215 220 Wing Thr Val Be Val Pro Gly Arg Tyr Thr Wing Arg Arg Tyr Glu 225 230 235 240 Ile Glu Pro Asp Wing Be Thr Wing Be Tyr Phe Wing Ward Be Wing 245 250 255 Val Be Gly Arg Be Phe Glu Phe Gln Gly Leu Gly Thr Asp Be Ile 260 265 270 Gln Gly Asp Thr Be Phe Phe Asn Val Leu Gly Arg Leu Gly Wing Glu 275 280 285 Val His Trp Pro Wing Asn Ser Val Thr Ile Be Gly Pro Glu Arg Leu 290 295 300 Asn Gly Asp Ile Glu Val Asp Met Gly Glu Ile Be Asp Thr Phe Met 305 310 315 320 Thr Read Leu Wing Wing Ile Pro Wing Read Asp Gly Pro Wing Ile Thr 325 330 335 Asn Ile Gly His Wing Arg Leu Lys Glu Be Asp Arg Ile Be Wing Met 340 345 350 Glu Thr Asn Leu Jtfg Thr Leu Gly Val 355 360 365 Trp Met Arg Ile Tyr Pro Be Thr Pro His Gly Gly Arg Val Asn Cys 370 375 380 His Arg Asp His Arg Ile Wing Met Met Wing Phe Be Ile Read Gly Leu Arg 385 390 395 400 Val Asp Gly Ile Thr Read Asp Asp Pro Gln Cys Val Gly Lys Thr Phe 405 410 415 Pro Gly Phe Phe ASp Tyr Leu Gly Arg Read Phe</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Thr Leu Pro Gly 435     I.a)	Nmero identificador da seqncia: SEQ ID No: 3</span>Thr Leu Pro Gly 435 I.a) Sequence identifier number: SEQ ID No: 3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 18 92 II.b) tipo: DNA</span>II.a) Size: 18 92 II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Arthrobacter globiformis</span>II.c) organism: Arthrobacter globiformis</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a)	Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: (178) ... (1419)</span>Location: (178) ... (1419)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a)	Nome/Legenda: misc_feature</span>III.a) Name / Caption: misc_feature</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b)	Localizao: 1801</span>III.b) Location: 1801</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes:  = A,,C or G</span>III.c) Other information:  = A, , C or G</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 3</span>IV) Sequence: SEQ ID NO. 3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gggaccaeat gctgctcctg atttcagggc tgctgccggt atggaccagg gtttagagag 60 ggacggcacg catccgggcc cttatcggac caacgccaac agcggtcggt ggccttggag 120 cggggccagc acggccgatc acgtagactc tttggagctt cgctcgaaag gatcacc atg 180</span>gggaccaeat gctgctcctg atttcagggc tgctgccggt atggaccagg gtttagagag 60 ggacggcacg catccgggcc cttatcggac caacgccaac agcggtcggt ggccttggag 120 cggggccagc acggccgatc acgtagactc tttggagctt cgctcgaaag gatcacc atg 180</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met 1</span>Met 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gaa act gat cga cta gtg ate cca gga tcg aaa age ate acc aac cgg 228 Glu Tbr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn Arg S	10	15</span>gaa act gat cga cta gtg till cca gga tcg aaa age till acc aac cgg 228 Glu Tbr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn Arg S 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg aga 276 Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val Arg 20	25	30</span>gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg aga 276 Wing Leu Leu Leu Wing Wing Ala Wing Lys Gly Thr Ser Val Leu Val Arg 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cca ttg gtc age gcc gat acc tca gea ttc aaa act gea att cag gcc 324 Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln Ala 35	40	45</span>cca ttg gtc age gcc gat acc tca gea ttc aaa act gea att cag gcc 324 Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln Wing 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa ggc 372 Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu Gly 50	55	60	65</span>ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa ggc 372 Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu Gly 50 55 60 65</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ctg ggt cag gea ccc cac ctc gac gcc gac ate tgg tgc gag gat gea 420 Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp Ala 70	75	80</span>ctg ggt cag gea ccc cac ctc gac gcc gac up to tgg tgc gag gat gea 420 Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp Ala 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt acc gtg gcc cgg ttc ctc cet eca ttc gtc gcc gea gga cag ggg 468 Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln Gly 85	90	95</span>ggt acc gtg gcc cgg ttc ctc cet ek ttc gtc gcc gea gga cag ggg 468 Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Wing Wing Gly Gln Gly 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag ttc ace gtc gac gga age gag cag ctg cgg egg cgc ccg ctt cgg 516 Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu Arg 100	105	110</span>aag ttc ace gtc gac gga age gag cag ctg cgg egg cgc ccg ctt cgg 516 Lys Phe Thr Val Asp Gly Ser Glu Glu Leu Arg Arg Arg Pro Leu Arg 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc gag 564 Pro Leu' Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser Glu 115	120	125</span>ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc gag 564 Pro Leu 'Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser Glu 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cag ctg ccc cta aca att gaa gcg age ggg ctg gea ggc ggg gag tac 612 Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu Tyr 130	135	140	145</span>cag ctg ccc cta aca att gaa gcg age ggg ctg gea ggg ggg gag tac 612 Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu Tyr 130 135 140 145</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gaa att gaa gcc cat cag age age cag ttc gcc tee ggc ctg ate atg 660 Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile Met 150	155	160</span>gaa att gaa gcc cat cag age age cag ttc gcc tee ggc ctg till atg 660 Glu Ile Glu Wing His Gln Being Gln Phe Wing Being Gly Leu Ile Met 150 155 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc gcc ccg tac gcg cga caa ggc ctg cgt gtg cgg ata cca aat cee 708 Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn Pro 165	170	175</span>gcc gcc ccg tac gcg cga caa ggc ctg cgt gtg cgg ata cca aat cee 708 Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn Pro 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtg age cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac ttc 756 Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp Phe 180	185	190     ggc ctt gag acc age acc gac gga gcc acc gtc age gtc cct ccc ggg 804 Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro Gly 195	200	205</span>gtg age cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac ttc 756 Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Asp Phe 180 185 190 ggc ctt gag acc age gg gcc acc gtc age gtc ccc ggg 804 Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro Gly 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgc tac aca gcc cgg egg tat gaa att gaa ccg gac gcg tca act gcg 852 Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr Ala 210	215	220	225</span>cgc tac aca gcc cgg egg tat gaa att gaa ccg gac gcg tca act gcg 852 Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr Wing 210 215 220 225</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc cga age ttc gaa ttc 900 Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu Phe 230	235	240</span>tcg tac ttc gcc gcc gcc tcc gcc gcc tet ggc cga age ttc gaa ttc 900 Ser Tyr Phe Ala Wing Ala Ser Ala Val Ser Gly Arg Ser Phe Glu Phe 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cag ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc aat 948 Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe Asn 245	250	255</span>cag ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc aat 948 Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe Asn 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gta ctt ggg cgg etc ggt gea gag gtc cac tgg gea ccc aac tcg gtc 996 Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser Val 260	265	270</span>gta ctt ggg cgg etc ggt gea gag gtc cac tgg gea ccc aac tcg gtc 996 Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Pro Wing Asn Ser Val 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ata tcc gga ccg gaa agg ctg aac ggc gac att gaa gtg gat atg 1044 Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp Met 275	280	285</span>acc ata cc gga ccg gaa agg ctg aac ggc gac att gaa gtg gat atg 1044 Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp Met 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc gag ata tcg gac acc ttc atg aca ctc gcg gcg att gcc cct cta 1092 Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro Leu 290	295	300	305</span>ggc gag ata tcg gac acc ttc atg aca ctc gcg gcg att gcc cct cta 1092 Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro Leu 290 295 300 305</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc gat gga ccc ate acg ata acc aac att ggc cat gea cgg ttg aag 1140 Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu Lys 310	315	320</span>gcc gat gga ccc till acg ata acc aac att ggc cat gea cgg ttg aag 1140 Asp Wing Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu Lys 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gaa tcc gac cgc ate tcg gcg atg gaa acc aac ctg cga acg ctc ggt 1188 Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu Gly 325	330	335</span>gaa tcc gac cgc up to tcg gcg atg gaa acc aac ctg cga acg ctc ggt 1188 Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu Gly 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gta caa acc gac gtc gga cac gac tgg atg cga ate tac ccc tet acc 1236 Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser Thr 340	345	350</span>gta caa acc gac gtc gga cac gac tgg atg cga to tac ccc tet acc 1236 Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser Thr 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg ate gcc atg 1284 Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala Met 355	360	365</span>ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg until gcc atg 1284 Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala Met 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg ttt tca ate ctg gga ctg cga gtg gac ggg att acc ctc gac gac 1332 Ala Phe Ser lie Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp Asp 370	375	380	385</span>gc ttt tca till ctg gga ctg cga gtg gac ggg att acc ctc gac gac 1332 Wing Phe Ser lie Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp Asp 370 375 380 385</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cct caa tgt gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt gga 1380 Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu Gly 390	395	400</span>cct caa tgt gtg ggg aag acc ttt cct ggc ttc ttc gac tac ctt gga 1380 Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Ashe Tyr Leu Gly 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag tgacttccte 1429 Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410</span>cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag tgacttccte 1429 Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405 410</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tccggcggac gctaggcatc gcgtgtctgc cggtacccaa tggttgtcca gattttcatc agcactgtca atggtgtggg</span>tccggcggac gctaggcatc gcgtgtctgc cggtacccaa tggttgtcca gattttcatc agcactgtca atggtgtggg</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggaaaacgaa tcctgacatg gcattctgcc ttagcegctt cgggatgttg cctgaccttg ccctgaaggc ggcttcgatg</span>ggaaaacgaa tcctgacatg gcattctgcc ttagcegctt cgggatgttg cctgaccttg ccctgaaggc ggcttcgatg</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">accgacctcc tcgcgtcacg	1489</span>accgacctcc tcgcgtcacg 1489</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccgcggcccc ttatgctttc	1549</span>ccgcggcccc ttatgctttc 1549</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">agcagggcaa tcagctgttc	1609</span>agcagggcaa tcagctgttc 1609</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gctgccacgt cggcggctct	1669</span>gctgccacgt cggcggctct 1669</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">"catcgctgtc"cgccgc "gatgcgcttc ctgatcctga gccaaggcaa tagttagatg taaggagttt tncgaggcca cccagattcc gaactatggg gtccggatgg aagtgacttt</span>"catcgctgtc" cgccgc "gatgcgcttc ctgatcctga gccaaggcaa tagttagatg taaggagttt tncgaggcca cccagattcc gaactatggg gtccggatgg aagtgacttt</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ataggcacgt tcaggatccg ccctcgtcgc 1729 tgcctccgtt ggcggccaga gccgaagcaa 1789 ccgggtggaa ggcgatatgg gcttcatget 1849 tcaactctgc cca	1892     I.a)	Nmero identificador da seqncia: SEQ ID No: 4</span>ataggcacgt tcaggatccg ccctcgtcgc 1729 tgcctccgtt ggcggccaga gccgaagcaa 1789 ccgggtggaa ggcgatatgg gcttcatget 1849 tcaactctgc cca 1892 I.a) Sequence identifier number: SEQ ID No: 4</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)    Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b)   tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Arthrobacter globformis IV) Seqncia: SEQ ID NO. 4</span>II.c) organism: Arthrobacter globformis IV) Sequence: SEQ ID NO. 4</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Glu	Thr	Asp	Arg	Leu	Val Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1				5				10					15	 Arg	Ala	Leu	I&gt;eu 20	Leu	Ala	Ala Ala	Ala 25	Lys	Gly	Thr	Ser	Val 30	Leu	Val Arg	Pro	Leu 35	Val	Ser	Ala	Asp Thr 40	Ser	Ala	Phe	Lys	Thr 45	Ala	Ile	Gln Ala	Leu Gly		Ala	Asn	Val	Ser Ala	Asp	Gly	Asp	Asn	Trp	Val	Val	Glu 	50					55				60				 Gly	Leu Gly		Gln	Ala	Pro	His Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu	Asp 65					70				75					80 Ala	Gly Thr		Val	Ala	Arg	Phe Leu	Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 				85				90					95	 Gly	Lys	Phe	Thr 100	Val	Asp	Gly Ser	Glu 105	Gln	Leu	Arg	Arg	Arg 110	Pro	Leu Arg	Pro	Leu	Val	Asp Gly		Ile Arg	His	Leu	Gly	Ala	Arg	Val	Ser	Ser 		115				120					125			 Glu	Gln 130	Leu	Pro	Leu	Thr	Ile Glu 135	Ala	Ser	Gly	Leu 140	Ala	Gly	Gly	Glu Tyr	Glu	Ile	Glu	Ala	His	Gln Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145					150				155					160 Met	Ala	Ala	Pro	Tyr Ala		Arg Gln	Gly	Leu	Arg	Val	Arg	Ile	Pro	Asn 				165				170					175	 Pro	Val	Ser	Gln 180	Pro	Tyr	Leu Thr	Met 185	Thr	Leu	Arg	Met	Met 190	Arg	Asp Phe	Gly	Leu 195	Glu	Thr	Ser	Thr Asp 200	Gly	Ala	Thr	Val	Ser 205	Val	Pro	Pro Gly	Arg 210	Tyr	Thr	Ala	Arg	Arg Tyr 215	Glu	Ile	Glu	Pro 220	Asp	Ala	Ser	Thr Ala	Ser	Tyr	Phe	Ala	Ala	Ala Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225					230				235					240 Phe	Gln Gly		Leu	Gly Thr		Asp Ser	Ile	Gln	Gly	Asp	Thr	Ser	Phe	Phe 				245				250					255	 Asn	Val	Leu	Gly 260	Arg	Leu	Gly Ala	Glu 265	Val	Kis	Trp	Ala	Pro 270	Asn	Ser Val	Thr	Ile 275	Ser	Gly	Pro	Glu Arg 280	Leu	Asn	Gly	Asp	Ile 285	Glu	Val	Asp Met	Gly Glu		Ile	Ser	Asp	Thr Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 	290					295				300				 Leu	Ala	Asp	Gly	Pro	Ile	Thr Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305					310				315					320 Lys	Glu	Ser	Asp	Arg 325	Ile	Ser Ala	Met	Glu 330	Thr	Asn	Leu	Arg	Thr 335	Leu Gly	Val	Gln	Thr 340	Asp	Val	Gly His	Asp 345	Trp	Met	Arg	Ile	Tyr 350	Pro	Ser Thr	Pro	Hls	Gly	Gly Arg		Val Asn	Cys	His	Arg	Asp	His	Arg	Ile	Ala 		355				360					365			 Met	Ala 370	Phe	Ser	Ile	Leu	Gly Leu 375	Arg	Val	Asp	Gly 380	Ile	Thr	Leu	Asp Asp	Pro	Gln	Cys	Val	Gly	Lys Thr	Phe	Pro	Gly	Phe	Phe	Asp	Tyr	Leu 385					390				395					400</span>Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu I&gt; i 20 Leu Wing Wing Wing Wing 25 Lys Gly Thr Ser Val 30 Leu Val Arg Pro Leu 35 Val Ser Wing Asp Thr 40 Ser Wing Phe Lys Thr 45 Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr 100 Val Asp Val Ser Ser 115 120 125 Glu Gln 130 Leu Pro Leu Thr Ile Glu 135 Wing Ser Gly Leu 140 Wing Gly Gly Glu Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Pro Tyr Wing Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln 180 Pro Tyr Leu Thr Met 185 Thr Leu Arg Met Met 190 Arg Asp Phe Gly Leu 195 Glu Thr Be Thr Asp 200 Gly Wing Thr Val Ser 205 Val Pro Pro Gly Arg 210 Tyr Thr Wing Arg Arg Tyr 215 Glu Ile Glu Pro 220 Asp Wing Be Thr Wing Be Tyr Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly 260 Arg Leu Gly Wing Glu 265 Val Kis Trp Wing Pro 270 Asn Ser Val Thr Ile 275 Ser Gly Pro Glu Arg 280 Leu Asn Gly Asp Ile 285 Glu Val Asp Met Gly Glu Ile Ser Asp Thr Phe Met Thr Read Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Asle Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg 325 Ile Be Ala Met Glu 330 Thr Asn Leu Arg Thr 335 Leu Gly Val Gln Thr 340 Asp Val Gly His Asp 345 Trp Met Arg Ile Tyr 350 Pro Ser Thr Asp His Arg Ile Wing 355 360 365 Met 370 Wing Phe Ser Ile Leu Gly Leu 375 Arg Val Asp Gly 380 Ile Thr Leu Asp Asp Pro Gln Cys Val Gly Lys hr Phe Pro Gly Phe Phe Asp Tyr Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Eeu Phe "Fr Glu Lys Ala Leu Thr Leu Pro Gly 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 5</span>Gly Arg Eeu Phe "Fru Glu Lys Wing Leu Thr Leu Pro Gly 405 410 I.a) Sequence identifier number: SEQ ID No: 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242 Il.b) tipo: DNA</span>II.a) Size: 1242 Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Desconhecido</span>II.c) organism: Unknown</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c) Outras informaes: III.a) Nome/Legenda: CDS III.b) Localizao: (1)...(</span>III.c) Other information: III.a) Name / Legend: CDS III.b) Location: (1) ... (</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 5</span>IV) Sequence: SEQ ID NO. 5th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Isolada de uma amostra de solo 1242)</span>Isolated from a soil sample 1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cga cta gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15	10	15</span>atg gaa act gat cga cta gtg until cca gga tcg aaa acts till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc gcg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Ala Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc gcg tcg gtc ctg gtg 96 Arg Wing Leu Leu Wing Leu Wing Wing Lys Wing Gly Wing Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat aec tca gea ttc aaa act gea att cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat aec tca gea ttc aaa act gea att cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc etc ggt gcc aac gtc tca gcg gac ggt gat gat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asp Trp Val Val Glu 50	55	60</span>gcc etc ggt gcc aac gtc tca gcg gac ggt gat gat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggc cag gea ccc aac cte gac gcc gac ate tgg tgc gag gat 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp SS	70	75	80</span>ggc ctg ggc cag gea ccc aac cte gac gcc gac up tgg tgc gag gat 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp SS 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ggt acc gtg gcc cgg ttc etc cct cca ttc gtc gcc gea gga cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gcc ggt acc gtg gcc cgg ttc etc cct cca ttc gtc gcc gea gga cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga age gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys -Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga age gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys -Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc gtg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc gtg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc cta acg att gaa gcg age ggg etg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc cta acg att gaa gcg age ggg etg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggt ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggt ctg until 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tae gcg cga caa ggc ctg cgt gtt cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tae gcg cga caa ggc ctg cgt gtt cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg age cag ccc tac etc acg atg aca ctg cgg atg atg agg gac 576     Pro Val Ser Glri Pro Tyx Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg age cag ccc tac etc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Glri Pro Tyx Read Thr Met Thr Read Le Met Met Arg Asp 180 185 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc att gag acc age acc gac gga gcg acc gtc age gtt cct ccc 624 Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc att gag ac acc gac gga gcg acc gtc age gtt cct ccc 624 Phe Gly Ile Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcg cgg cgg tat gag att gaa ccg gac gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcg cgg cgg tat gag att gaa ccg gac gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc cgg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225	230	235	240</span>gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc cgg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225 230 235 240 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc cag ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttc cag ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg etc ggc gea gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260	265	270</span>aat gta ctt ggg cgg etc ggc gea gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata tcc gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata tcc gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag ata tcg gac acc ttc atg aca ctg gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag ata tcg gac acc ttc atg aca ctg gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cta gcc gat gga ccc ate acg ata aca aac att ggc cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>cta gcc gat gga ccc till acg ata acac aac att ggc cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tcg gcg atg gaa age aac ctt cga atg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Met Leu 325	330	335</span>aag gaa tcc gac cgc until tcg gcg atg gaa age aac ctt cga atg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Asa Met Glu Ser Asn Leu Arg Met Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg ega ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg ega until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg ate gcc 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg until gcc 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg cga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg cga gtg gac ggg att acc ctc gac 1152 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgt gtc ggg aag ace ttt cct ggc ttc ttc gac tac ett 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgt gtc ggg aag ace ttt cct ggc ttc ttc gac tac ett 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccg gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct ttc ccg gaa aag gcg ctt acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Axg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 6</span>Gly Axg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No: 6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b) tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Desconhecido</span>II.c) organism: Unknown</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: isolated from soil sample</span>III.c) Other information: isolated from soil sample</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 6</span>IV) Sequence: SEQ ID NO. 6th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn</span>Met Glu Thr Asp Arg Read Val Ile Pro Gly Ser Lys Ser Ile Thr Asn</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15	10	15</span>15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Ala Ser Val Leu Val</span>Arg Wing Leu Leu Leu Wing Wing Wing Wing Lys Wing Gly Wing Ser Val Leu Val</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20	25	30</span>20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln</span>Arg Pro Read Val Be Wing Asp Thr Wing Wing Phe Lys Wing Wing Ile Gln</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">35	40	45</span>35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asp Trp Val Val Glu</span>Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">50	55	60</span>50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>Gly Leu Gly Gln Pro Wing Asn Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln I^k	85	90	95</span>Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln I ^ k 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu</span>Gly Lys Phe Thr Val Asp Gly Be Glu Gln Leu Arg Arg Arg Pro Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">100	105	110</span>100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser</span>Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Wing Arg Val Ser Ser</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">115	120	125</span>115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu</span>Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">130	135	140</span>130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>Tyr Glu Ile Glu Wing His Gln Being Gln Phe Wing Being Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn</span>Met Wing Pro Wing Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">165	170	175</span>165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp</span>Pro Val Ser Gln Pro Tyr Read Thr Met Thr Read Met Arg Met Met Arg Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">180	185	190</span>180 185 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro</span>Phe Gly Ile Glu Thr Be Thr Asp Gly Wing Thr Val Ser Val Pro</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">195	200	205</span>195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr</span>Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">210	215	220</span>210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225	230	235	240</span>Wing Be Tyr Phe Wing Wing Wing Be Wing Val Be Gly Arg Arg Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe</span>Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe Phe</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">245	250	255</span>245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser</span>Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Wing Asn Ser</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">260	265	270</span>260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Val Thr Ile Ser Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp</span>Val Thr Ile Be Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">275	280	285</span>275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro</span>Met Gly Glu Ile Ser Asp Thr Phe Met Thr Read Wing Ala Ile Ala Pro</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">290	295	300</span>290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 	305	310	315	320</span>Leu Asp Wing Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu  305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">'	Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Met Leu</span>'Lys Glu Be Asp Arg Ile Be Wing Met Glu Be Asn Leu Arg Met Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">325	330	335</span>325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser</span>Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">340	345	350</span>340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala</span>Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">355	360	365</span>355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp</span>Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">370	375	380</span>370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>Asp Pro Gln Cys Val Gly Lys Thr Phe Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 7</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 I.a) Sequence identifier number: SEQ ID No: 7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 44 6</span>II.a) Size: 44 6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Bacillus clausii</span>II.c) organism: Bacillus clausii</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 7</span>IV) Sequence: SEQ ID NO. 7th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Val Gln Phe Asp Ser	Gln Ala Arg Ser		Pro	Tip	Thr Pro Leu	Ala 1	5		10			15	 Gly Val Glu Arg Leu Arg		Leu	Thr Pro Ser	Gln	Lys	Arg Ile Asn	Ala 	20		25			30	 Thr	Leu Glu Val Pro Gly	Ser	Lys Ser Ala	Thr	Asn	Arg Ala Leu	Leu 	35		40			45	 Leu	Ala Ala Val Ala Ser	Gly Thr Ser Thr Leu			Arg	Asn Ala Leu	Lys 	50	55			60		 Ser Asp Asp Thr Tyr Trp		Cys	Ile Glu Ala	Leu	Lys	Lys Thr Gly	Val 65	70			75			80 Glu Ile Ala Val Asp Gly		Ser	Asn Val Thr	Val	Tyr	Gly Arg Gly	Gly 	85		90			95	 Val	Phe His Ser Gly Ser	Leu Tyr Ile Gly Ser			Ala	Gly Thr Ala	Gly 	100		105			110	 Arg Phe Leu Pro Gly Met		Leu	Taa Ala Ala	Thr	Gly	Asn Trp His	Val 	115		120			125	 Glu	Ala Ser His Ser Met	Asn	Lys Arg Pro	Ile	Ala	Pro Leu Val	Lys 	130	135			140		 Thr Leu Gln Ala Leu Gly		Ua	Asn Ile Gln	Tyr	Gly	Ser Arg Arg	Gly 145	150			155			160 His	Tyr Pro Leu Ser Ile	Ser Gly Glu Gly Leu			Asn	Gly Gly Lys	Val 	165		170			175	 Asn	Met Ser Gly Gln Leu	Ser	Ser Gln Phe	Ile	Ser	Gly Cys Leu	Leu 	180		185			190	 Ala	Ala Pro Leu Ala Lys	Asn	Pro Val Ser	Ile	Thr	Val Lys Asp	Gly 	195		200			205	 Ile	Val Gln Gln Ala Tyr	Val	Arg Ile Thr	Ile	Asp	Leu Met Ala	Ala 	210	215			220		 Phe	Gly Val Glu Val Lys	Ala	Ala Pro Asp	Trp	Ser	Leu Leu Glu	Val 225	230			235			240 Asn	Pro Ser Pro Tyr Val	Ala	Asn Asp Ile	Ala	Ile	Glu Ala Asp	Ala 	245		250			255	 Ser	Thr Ala Cys Tyr Phe	Leu	Ala Leu Ala	Ala	Ile	Thr Ala Gly	Lys 	260		265			270	 Ile	Arg Ile Arg His Phe	Ser	Thr Lys Thr	Ser	Gln	Pro Asp Ile	Leu 	275		280			285	 Fhe	Val Ser Ile Leu Lys	Arg	Met Gly Cys	Asn	Phe	Glu Ile Gly	Pro 	290	295			300		 Ser	Phe Val Glu Gly Glu	Gly	Pro Thr Arg	Leu	Arg	Gly Gly Phe	Thr 305	310			315			320 Val	Asn Met Asn Glu Leu	Ser	Asp Gln Ala	Leu	Thr	Leu Ala Ala	Ile 	325		330			335	 Ser	Pro Phe Ala Asp Gly	Pro	Ile Ala Ile	Glu	Gly	Val Gly His	Ile 	340		345			350	 Arg	His His Glu Cys Asp	Arg	Ile Arg Ala	Ile	Cys	Thr Glu Leu	Ser 	355		360			365	 Arg Leu Gly Ile Arg Val		Glu Glu Arg His Asp			Gly	Leu Thr Val	Tyr 	370	375			380		 Pro Gly Gln Pro Lys Pro		Thr	Val Val Asn	Thr	Tyr	Asp Asp His	Arg 385	390			395			400 Met	Ala Met Ala Leu Ala	Leu	Ile Gly Ala Lys		Val	Asp Gly Ile	Glu 	405		410			415	 Leu Asp Asp Pro Gly Cys		Val	Ala Lys Thr	Cys	Pro	Ser Tyr Phe	Ser 	425			430	 Met	Leu Ala Gln Thr Gly	Ile Gly Val Lys		Ala	Val	Ser Pro	 	435		440			445     I.a)	Nmero identificador da seqncia: SEQ ID No: 8</span>Met Val Gln Phe Asp Be Gln Ala Arg Be Pro Tip Thr Pro Leu Wing 1 5 10 15 Gly Val Glu Arg Leu Arg Leu Thr Pro Be Gln Lys Arg Ile Asn Ala 20 25 30 Thr Leu Glu Val Pro Gly Ser Lys Be Ala Thr Asn Arg Wing Leu Leu 35 40 45 Leu Wing Wing Val Wing Wing Be Gly Thr Be Thr Wing Le Arg Asn Wing Wing Leu Lys 50 55 60 Ser Asp Asp Thr Tyr Trp Cys Ile Glu Wing Leu Lys Lys Thr Gly Val 65 70 75 80 Glu Ile Wing Val Asp Gly Ser Asn Val Thr Val Tyr Gly Arg Gly Gly 85 90 95 Val Phe His Ser Gly Ser Leu Tyr Ile Gly Ser Wing Gly Thr Ala Gly 100 105 110 Arg Phe Leu Pro Gly Met Lea Ta Wing Ala Thr Gly Asn Trp His Val 115 120 125 Glu Wing Be His Be Met Asn Lys Arg Pro Ile Wing Pro Read Le Val Lys 130 135 140 Thr Leu Gln Wing Read Gly Ua Asn Ile Gln Tyr Gly Be Arg Arg Gly 145 150 155 160 His Tyr Pro Read Be Ser Ile Ser Gly Glu Gly Leu Asn Gly Gly Lys Val 165 170 175 Asn Met Being Gly Gln Leu Being Being Gln Phe Ile Being Gly Cys Leu Leu 180 185 190 Pro Wing Ala Lys Asn Pr Wing Val Ser Ile Thr Val Lys Asp Gly 195 200 205 Ile Val Gln Gln Wing Tyr Val Arg Ile Thr Ile Asp Leu Met Wing Ala 210 215 220 Phe Gly Val Glu Val Lys Wing Pro Asp Trp Ser Leu Glu Val 225 230 235 240 Asn Pro Ser Pro Tyr Val Wing Asn Asp Ile Wing Ile Glu Wing Asp Wing 245 250 255 Ser Thr Wing Cys Tyr Phe Leu Wing Leu Wing Wing Ile Thr Wing Gly Lys 260 265 270 Ile Arg Ile Arg His Phe Ser Thr Lys Thr Ser Gln Pro Asp Ile Leu 275 280 285 Fhe Val Ser Ile Leu Lys Arg Met Gly Cys Asn Phe Glu Ile Gly Pro 290 295 300 Ser Phe Val Glu Gly Pro Glu Gly Pro Thr Arg Leu Arg Gly Ply Thr 305 310 315 320 Val Asn Met Asn Glu Leu Be Asp Gln Wing Leu Thr Leu Wing Wing Ile 325 330 335 Ser Pro Phe Wing Asp Gly Pro Ile Wing Ile Glu Gly Val Gly His Ile 340 345 350 Arg His His Glu Cys Asp Arg Ile Arg Wing Ile Cys Thr Glu Leu Ser 355 360 365 Arg Leu Gly Ile Arg Val Glu Glu Arg His Asp Gly Leu Thr Val Tyr 370 375 380 Pro Gly Gln Pro Lys Pro Thr Val Val Asn Thr Tyr Asp Asp His Arg 385 390 395 400 Met Ala Met Ala Leu Ala Leu Leu Ile Gly Lys Val Asp Gly Ile Glu 405 410 415 Leu Asp Asp Pro Gly Cys Val Lys Thr Cys Pro Be Tyr Phe Ser 425 430 Met Leu Gln Thr Wing Gly Ile Gly Val Lys Val Wing Pro Ser 435 440 445 Ia) Sequence identifier number: SEQ ID No: 8</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 4 47</span>II.a) Size: 4 47</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Rubrobacer xylanophilus</span>II.c) organism: Rubrobacer xylanophilus</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 8</span>IV) Sequence: SEQ ID NO. 8th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Ser	Gly	Val	Ser	Gly	Val	Pro Gly		Val	Asp	Phe	Gly	Ile	Glu	Glu 1				5					10					15	 Val	Arg	Gly	Ser	Phe	Pro	Glu	Glu	Met	Glu	Val	Ala	Pro	Leu	Glu	Arg 			20					25					30		 Pro	Pro	Asp	Ala	Thr	Val	Arg	Leu	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 		35					40					45			 Arg	Ala	Leu	Leu	Val	Ala	Ala	Leu	Ala	Gly	Gly	Thr	Ser	Arg	Ile	Glu 	50					55					60				 Asn	Pro	Leu	Leu	Ala	Asp	Asp	Pro	Phe	Trp	Leu	Met	Asn	Ala	Leu	Val 65					70					75					80 Gly	Leu	Gly	Phe	Gly	Val	Arg	Val	Gly	Glu	Glu	Gly	Ala	Val	Glu	Val 				85					90					95	 Ala	Gly	Gly	Gly	Gly	Gly	Ile	Pro	Ala	Pro	Ser	Ala	Asp	Val	Phe	Val 			100					105					110		 Gly	Asn	Ala	Gly	Thr	Val	Ala	Arg	Phe	Leu	Pro	Pro	Ala	Leu	Ala	Leu 		115					120					125			 Gly	Ser	Gly	Pro	Tyr	Arg	Val	Asp Gly		Thr	Pro	Arg	Met	Arg	Glu	Arg 	130					135					140				 Pro	Val	Ala	Glu	Leu	Val	Glu	Ala	Leu	Arg	Ala	Leu	Gly	Ala	Arg	Val 145					150					155					160 Glu	Cys	Glu	Glu	Arg	Glu	Gly	His	Leu	Pro	Leu	Val	Val	Arg	Gly	Gly 				165					170					175	 Ala	Arg	Gly	Gly	Gly	Glu	Ile	Ser	Val	Ser	Gly	Glu	Arg	Ser	Ser	Gln 			180					185					190		 Phe	Leu	Ser	Gly	Leu	Leu	Ile	Ser	Ala	Pro	Cys	Leu	Pro	Gly	Gly	Leu 		195					200					205			 Thr	Val	Arg	Pro	Arg	Gly	Ala	Leu	Val	Ser	Arg	Pro	Tyr	Val	Asp	Ile 	210					215					220				 Thr	Val	Arg	Val	Met	Arg	Ser	Phe	Gly	Ala	Ser	Val	Glu	Glu	Glu	Pro 225					230					235					240 Ser	Gly	Ala	Ala	Phe	Arg	Val	Ala	Pro	Gly	Ala	Tyr	Arg	Ala	Thr	Ala 				245					250					255	 Tyr	Arg	Val	Glu	Pro	Asp	Ala	Ser	Ala	Ala	Ser	Tyr	Phe	Leu	Ala	Ala 			260					265					270		 Ala	Ala	Leu	Thr	Ala	Gly	Arg	Val	Val	Ile	Pro	Gly	Leu	Gly	Arg	Ser 		275					280					285			 Ser	Leu	Gln	Gly	Asp	Val	Ala	Phe	Ala	Gly	Ile	Leu	Arg	Arg	Met	Gly 	290					295					300				 Cys	Arg	Val	Ser	Leu	Ser	Glu	Asp	Arg	Ile	Glu	Leu	Ala	Gly	Pro	Pro 305					310					315					320 Arg	Leu	Arg	Gly	Val	Glu	Ala	Asp	Met	Asn	Ala	Ile	Ser	Asp	Thr	Met 				325					330					335	 Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro	Phe	Ala	Ser	Ser	Pro	Thr	Leu	Ile 			340					345					350		 Lys	Asn	Val	Ala	His	Thr	Arg	Leu	Gln	Glu	Thr	Asp	Arg	Leu	Ala	Ala 		355					360					365			 Val	Ala	Ala	Glu	Leu	Ser	Arg	Leu Gly		Val	Arg	Val	His	Glu	Thr	Pro 	370					375					380				 Asp	Ser	Leu	Arg	Ile	Ile	Pro	Gly Lys		Val	Arg	Pro	Ala	Ala	Ile	Arg 385					390					395					400 Thr	Tyr	GTy Asp		Hfs	Arg	Met	Ala	Met	Ala	Phe	Ser	Leu	Val	Gly Leu</span>Met Ser Gly Val Ser Gly Val Pro Gly Val Asp Phe Gly Ile Glu Glu 1 5 10 15 Val Arg Gly Ser Phe Pro Glu Glu Met Glu Val Wing Pro Leu Glu Arg 20 25 30 Pro Pro Wing Asp Thr Val Arg Leu Pro Gly Ser Lys Ser Ile Thr Asn 35 40 45 Arg Wing Leu Leu Val Wing Wing Leu Wing Gly Gly Wing Wing Thr Be Arg Ile Glu Wing 50 55 60 Asn Pro Leu Leu Wing Asp Pro Phe Trp Leu Met Asn Wing Leu Val 65 70 75 80 Gly Leu Gly Phe Gly Val Arg Val Val Gly Glu Gly Val Val Val Glu Val 85 90 95 Wing Gly Gly Gly Val Val Gly Ily Pro Pro Val Wing Al Ser Asp Val Val Phe Val 100 105 110 Gly Asn Val Gly Val Val Wing Phe Pro Leu Pro Val Val Leu 115 120 125 Gly Ser Gly Pro Tyr Arg Val Asp Gly Thr Pro Arg Met Arg Glu Arg 130 135 140 Pro Val Val Glu Wing Leu Val Glu Wing Leu Arg Wing Leu Gly Wing Arg Val 145 150 155 160 Glu Cys Glu Glu Arg Glu Gly His Leu Pro Leu Val Val Gly Gly 165 170 175 Ala Arg Gly Gly Gly Val Ser Gly Glu Arg Ser Ser Gln 180 185 190 Phe Leu Ser Gly Leu Leu Ile Ser Pro Pro Cys Leu Pro Gly Gly Leu 195 200 205 Thr Val Arg Pro Arg Gly Wing Leu Val Ser Arg Tyr Val Asp Ile 210 215 220 Thr Val Arg Val Met Arg Be Phe Gly Wing Be Val Glu Glu Glu Pro 225 230 235 240 Be Gly Wing Phe Arg Wing Pro Wing Gly Wing Tyr Arg Wing Thr Wing 245 250 255 Tyr Arg Val Glu Pro Wing Asp Wing Be Wing Phe Leu Wing Ala 260 265 270 Wing Wing Leu Thr Wing Gly Arg Val Val Ile Pro Gly Leu Gly Arg Ser 275 280 285 Ser Leu Gln Gly Asp Val Wing Phe Ala Gly Ile Leu Arg Arg Met Gly 290 295 300 Cys Arg Val Ser Leu Be Glu Asp Arg Ile Glu Leu Wing Gly Pro Pro 305 310 315 320 Arg Leu Arg Gly Val Glu Wing Asp Met Asn Ile Wing Be Asp Thr Met 325 330 335 Met Thr Leu Wing Ile Wing Pro Phe Wing Be Ser Pro Thr Leu Ile 340 345 350 Lys Asn Val Wing His Thr Arg Read Le Gln Glu Thr Asp Arg Leu Wing Ward 355 360 365 Val Wing Wing Glu Leu Be Arg Leu Gly Val Arg Val His Glu Thr Pro 370 375 380 Asp Ser Leu Arg Ile Ile Pro Gly Lys Val Arg Pro Wing Ile Arg 385 390 395 400 Thr Tyr GTy Asp Hfs Arg Met Wing Met Wing Phe Ser Leu Val Gly Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">405	410	415</span>405 410 415</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arg Val Arg Gly Val Arg Ile Leu Asp Pro Gly Cys Val Thr Lys Thr</span>Arg Val Arg Gly Val Arg Ile Read Asp Pro Gly Cys Val Thr Lys Thr</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">420	425	430</span>420 425 430</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Leu Pro Gly Tyr Phe Arg Leu Leu Glu Gly Leu Arg Arg Gly Gly 435	440	445     I.a) Nmero identificador da seqncia: SEQ ID No: 9</span>Leu Pro Gly Tyr Phe Arg Leu Leu Glu Gly Leu Arg Arg Gly Gly 435 440 445 I.a) Sequence identifier number: SEQ ID No: 9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 44 4 II.b) tipo: PRT</span>II.a) Size: 44 4 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Zea mays</span>II.c) organism: Zea mays</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 9</span>IV) Sequence: SEQ ID NO. 9th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ala	Gly Ala		Glu	Glu	Ile	Val	Leu	Gln	Pro	Ile Lys	Glu	Ile	Ser	Gly 1				5					10				15	 Thr	Val	Lys	Leu	Pro	Gly	Ser	Lys	Ser	Leu	Ser Asn	Arg	Ile	Leu	Leu 			20					25				30		 Leu	Ala	Ala	Leu	Ser	Glu	Gly	Thr	Thr	Val	Val Asp	Asn	Leu	Leu	Asn 		35					40				45			 Ser	Glu Asp		Val	His	Tyr	Met	Leu	Gly	Ala	Leu Arg	Thr	Leu	Gly	Leu 	50					55				60				 Ser	Val	Glu	Ala	Asp	Lys	Ala	Ala	Lys	Arg	Ala Val	Val	Val	Gly	Cys 65					70					75				80 Gly	Gly Lys		Phe	Pro	Val	Glu	Asp	Ala	Lys	Glu Glu	Val	Gln	Leu	Phe 				85					90				95	 Leu	Gly Asn		Ala	Gly	Thr	Ala	Met	Arg	Pro	Leu Thr	Ala	Ala	Val	Thr 			100					105				110		 Ala	Ala	Gly	Gly	Asn	Ala	Thr	Tyr	Val	Leu	Asp Gly	Val	Pro	Arg	Met 		115					120				125			 Arg	Glu	Arg	Pro	Ile	Gly	Asp	Leu	Val	Val	Gly Leu	Lys	Gln	Leu	Gly 	130					135				140				 Ala	Asp	Val	Asp	Cys	Phe	Leu	Gly	Thr	Asp	Cys Pro	Pro	Val	Arg	Val 145					150					155				160 Asn	Gly	Ile	Gly	Gly	Leu	Pro	Gly	Gly	Lys	Val Lys	Leu	Ser	Gly	Ser 				165					170				175	 Ile	Ser	Ser	Gln	Tyr	Leu	Ser	Ala	Leu	Leu	Met Ala	Ala	Pro	Leu	Ala 			180					185				190		 Leu	Gly Asp		Val	Glu	Ile	Glu	Ile	Ile	Asp	Lys Leu	Ile	Ser	Ile	Pro 		195					200				205			 Tyr	vai	Glu	Met	Thr	Leu	Arg	Leu	Met	Glu	Arg Phe	Gly	Val	Lys	Ala 	210					215				220				 Glu	His	Ser	Asp	Ser	Trp	Asp	Arg	Phe	Tyr	Ile Lys	Gly	Gly	Gln	Lys 225					230					235				240 Tyr	Lys	Ser	Pro	Lys	Asn	Ala	Tyr	Val	Glu	Gly Asp	Ala	Ser	Ser	Ala 				245					250				255	 Ser	Tyr	Phe	Leu	Ala	Gly	Ala	Ala	Ile	Thr	Gly Gly	Thr	Val	Thr	Val 			260					265				270		 Glu	Gly Cys		Gly	Thr	Thr	Ser	Leu	Gln	Gly	Asp Val	Lys	Phe	Ala	Glu 		275					280				285			 Val	Leu	Glu	Met	Met	Gly	Ala	Lys	Val	Thr	Trp Thr	Glu	Thr	Ser	Val 	290					295				300				 Thr	Val	Thr	Gly	Pro	Pro	Arg	Glu	Pro	Phe	Gly Arg	Lys	His	Leu	Lys 305					310					315				320 Ala	Ile	Asp	Val	Asn	Met	Asn	Lys	Met	Pro	Asp Val	Ala	Met	Thr	Leu 				325					330				335	 Ala	Val	Val	Ala	Leu	Phe	Ala	Asp	Gly	Pro	Thr Ala	Ile	Arg	Asp	Val 			340					345				350		 Ala	Ser	Trp	Arg	Val	Lys	Glu	Thr	Glu	Arg	Met Val	Ala	Ile	Arg	Thr 		355					360				365			 Glu	Leu	Thr	Lys	Leu	Gly	Ala	Ser	Val	Glu	Glu Gly	Pro	Asp	Tyr	Cys 	"370			, -		' 375				380</span>Gly Wing Glu Wing Glu Ile Val Leu Gln Pro Ile Lys Glu Ile Ser Gly 1 5 10 15 Thr Val Lys Leu Pro Gly Ser Lys Being Read Asn Arg Ile Leu Leu 20 25 30 Leu Wing Wing Leu Be Glu Gly Thr Thr Val Val Asp Asn Leu Leu Asn 35 40 45 Ser Glu Asp Val His Tyr Met Leu Gly Wing Leu Arg Thr Thr Leu Gly Leu 50 55 60 Ser Val Glu Wing Asp Lys Wing Wing Lys Arg Wing Val Val Val Gly Cys 65 70 75 80 Gly Gly Lys Phe Pro Val Glu Asp Wing Lys Glu Glu Val Gln Leu Phe 85 90 95 Leu Gly Asn Wing Gly Thr Wing Met Arg Pro Leu Thr Wing Wing Val Thr 100 105 110 Wing Gly Wing Gly Gly Asn Wing Thr Tyr Val Leu Asp Gly Val Pro Arg Met 115 120 125 Arg Glu Arg Pro Ile Gly Asp Leu Val Val Gly Leu Lys Gln Leu Gly 130 135 140 Wing Asp Val Asp Cys Phe Leu Gly Thr Asp Cys Pro Val Val Val 145 150 155 160 Asn Gly Ile Gly Gly Leu Pro Gly Gly Lys Val Lys Leu Be Gly Ser 165 170 175 Ile Ser Be Gln Tyr Leu Ser Ala Leu M et Ala Pro Wing Read Wing 180 185 190 Leu Gly Asp Val Glu Ile Glu Ile Ile Asp Lys Leu Ile Ser Ile Pro 195 200 205 Tyr will Glu Met Thr Leu Arg Glu Arg Phe Gly Val Lys Wing 210 215 220 Glu His Ser Asp Ser Trp Asp Arg Phe Tyr Ile Lys Gly Gly Gly Gln Lys 225 230 235 240 Tyr Lys Be Pro Lys Asn Tyr Val Glu Gly Asp Wing Being Ser Ala 245 250 255 Ser Tyr Phe Leu Gly Wing Ile Thr Gly Gly Thr Val Thr Val 260 265 270 Glu Gly Cys Gly Thr Thr Be Leu Gln Gly Asp Val Lys Phe Ala Glu 275 280 285 Val Leu Glu Met Met Gly Ala Lys Val Thr Trp Thr Glu Thr Be Val 290 295 300 Thr Val Thr Gly Pro Pro Arg Glu Pro Phe Gly Arg Lys His Leu Lys 305 310 315 320 Wing Ile Asp Val Asn Val Asn Met Asn Lys Met Pro Asp Val Wing Met Thr Leu 325 330 335 Wing Val Val Wing Leu Phe Wing Asp Gly Pro Thr Wing Ile Arg Asp Val 340 345 350 Wing Ser Trp Arg Val Lys Glu Thr Glu Arg Met Val Wing Ile Arg Thr 355 360 365 Glu Read Thr Lys Read Gly Wing Be Val Glu Glu Gly Pro Asp Tyr Cys "370 -,  -  '375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ile Ile Thr Pro Pro Glu Lys Leu Asn Val Thr Ala Ile Asp Thr Tyr 385	390	395	400</span>Ile Ile Thr Pro Glu Lys Leu Asn Val Thr Wing Ile Asp Thr Tyr 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asp Asp His Arg Met Ala Met Ala Phe Ser Leu Ala Ala Cys Ala Glu</span>Asp Asp His Arg Met Wing Met Wing Phe Ser Read Leu Wing Cys Wing Glu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">405	410	415</span>405 410 415</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Val Pro Val Thr Ile Arg Asp Pro Gly Cys Thr Arg Lys Thr Phe Pro</span>Val Pro Val Thr Ile Arg Asp Gly Cys Thr Arg Lys Thr Phe Pro</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">420	425	430</span>420 425 430</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asp Tyr Phe Asp Val Leu Ser Thr Phe Val Lys Asn 435	440     I.a)	Nmero identificador da seqncia: SEQ ID No: 10</span>Asp Tyr Phe Asp Val Leu Ser Thr Thr Phe Val Lys Asn 435 440 I.a) Sequence identifier number: SEQ ID No: 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)    Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 4 55 II.b)    tipo: PRT</span>II.a) Size: 4 55 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II. c) organismo: Agrobacterium sp. IV) Seqncia: SEQ ID NO. 10</span>II. c) organism: Agrobacterium sp. IV) Sequence: SEQ ID NO. 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Ser	His	Gly	Ala	Ser	Ser	Arg	Pro	Ala	Thr	Ala	Arg	Lys	Ser	Ser 1				5					10					15	 Gly	Leu	Ser	Gly	Thr	Val	Arg	Ile	Pro	Gly	Asp Lys		Ser	Ile	Ser	His 			20					25					30		 Arg	Ser	Phe	Met	Phe	Gly Gly		Leu	Ala	Ser	Gly Glu		Thr	Arg	Ile	Thr 		35					40					45			 Gly	Leu	Leu	Glu	Gly	Glu Asp		vai	Ile	Asn	Thr Gly		Lys	Ala	Met	Gln 	50					55					60				 Ala	Met	Gly	Ala	Arg	Ile Arg		Lys	Glu	Gly	Asp	Thr	Trp	Ile	Ile	Asp 65					70					75					80 Gly	Val	Gly	Asn	Gly	Gly Leu		Leu	Ala	Pro	Glu	Ala	Pro	Leu	ASp	Phe 				85					90					95	 Gly	Asn	Ala	Ala	Thr	Gly Cys		Arg	Leu	Thr	Met Gly		Leu	Val	Gly	Val 			100					105					110		 Tyr	Asp	Phe	Asp	Ser	Thr	Phe	Ile Gly		Asp	Ala	Ser	Leu	Thr	Lys	Arg 		115					120					125			 Pro	Met 130	Gly	Arg	Val	Leu	Asn 135	Pro	Leu	Arg	Glu	Met 140	Gly	Val	Gln	Val Lys	Ser	Glu	Asp	Gly	Asp Arg		Leu	Pro	Val	Thr	Leu	Arg	Gly	Pro	Lys 145					150					155					160 Thr	Pro	Thr	Pro	Ile 165	Thr	Tyr	Arg	Val	Pro 170	Met	Ala	Ser	Ala	Gln 175	Val Lys	Ser	Ala	Val	Leu	Leu	Ala	Gly Leu		Asn	Thr	Pro	Gly	Ile	Thr	Thr 			180					185					190		 Val	Ile	Glu 195	Pro	Ile	Met	Thr	Arg 200	Asp	His	Thr	Glu	Lys 205	Met	Leu	Gln Gly	Phe 210	Gly	Ala	Asn	Leu	Thr 215	Val	Glu	Thr	Asp	Ala 220	Asp	Gly	Val	Arg Thr	Ile	Arg	Leu	Glu	Gly Arg		Gly Lys		Leu	Thr Gly		Gln	Val	Ile	Asp 225					230					235					240 Val	Pro	Gly	Asp	Pro 245	Ser	Ser	Thr	Ala	Phe 250	Pro	Leu	Val	Ala	Ala 255	Leu Leu	Val	Pro	Gly 260	Ser	Asp	Val	Thr	Ile 265	Leu	Asn	Val	Leu	Met 270	Asn	Pro Thr	Arg	Thr 275	Gly	Leu	Ile	Leu	Thr 280	Leu	Gln	Glu	Met	Gly 285	Ala	Asp	Ile Glu	vai	Ile	Asn	Pro	Arg	Leu	Ala	Gly	Gly	Glu Asp		Val	Ala	Asp	Leu 	290					295					300				 Arg	Val	Arg	Ser	Ser	Thr	Leu	Lys	Gly	Val	Thr	Val	Pro	Glu	Asp	Arg 305					310					315					320 Ala	Pro	Ser	Met	Ile 325	Asp	Glu	Tyr	Pro	Ile 330	Leu	Ala	Val	Ala	Ala 335	Ala Phe	Ala	Glu	Gly 340	Ala	Thr	Val	Met	Asn 345	Gly	Leu	Glu	Glu	Leu 350	Arg	Val</span>Met Be His Gly Wing Be Be Arg Pro Wing Ala Thr Wing Arg Lys Be Ser 1 5 10 15 Gly Read Be Gly Thr Val Arg Ile Pro Gly Asp Lys Be Ile Be His 20 25 30 Arg Be Phe Met Phe Gly Gly Leu Wing Be Gly Glu Thr Arg Ile Thr 35 40 45 Gly Leu Read Le Glu Gly Glu Asp Goes Ile Asn Thr Gly Lys Wing Met Gln 50 55 60 Wing Met Gly Arg Ile Arg Lys Glu Gly Asp Thr Trp Ile Ile Asp 65 70 75 80 Gly Val Gly Asn Gly Gly Leu Leu Read Pro Wing Glu Pro Pro Leu ASp Phe 85 90 95 Gly Asn Wing Ala Thr Gly Cys Arg Leu Thr Met Gly Leu Val Gly Val 100 105 110 Tyr Asp Phe Asp Be Thr Phe Ile Gly Asp Wing Be Thru Lys Arg 115 120 125 Pro Met 130 Gly Arg Val Leu Asn 135 Pro Read Arg Glu Met 140 Gly Val Gln Val Lys Ser Glu Asp Gly Asp Arg Leu Pro Val Thr Leu Arg Gly Pro Lys 145 150 155 160 Thr Pro Thr Ile 165 Thr Tyr Arg Val Pro 170 Met Wing Be Wing Gln 175 Val Lys Wing Wing Val Leu Leu Wing Gly Leu Asn Thr Pro Gly Ile Thr Thr 180 185 190 Val Ile Glu 195 Pro Ile Met Thr Arg 200 Asp His Thr Glu Lys 205 Met Leu Gln Gly Phe 210 Gly Wing Asn Leu Thr 215 Val Glu Thr Asp Wing 220 Asp Gly Val Arg Thr Ile Arg Leu Glu Gly Arg Gly Lys Leu Thr Gly Gln Val Ile Asp 225 230 235 240 Val Pro Gly Asp Pro 245 Ser Ser Thr Wing Phe 250 Pro Leu Val Wing Wing 255 Leu Leu Val Pro Gly 260 Ser Asp Val Thr Ile 265 Leu Asn Val Leu Met 270 Asn Pro Thr Arg Thr 275 Gly Leu Ile Leu Thr 280 Leu Gln Glu Met Gly 285 Wing Asp Ile Glu Go Ile Asn Pro Thr Leu Wing Gly Gly Glu Asp Val Wing Asp Leu 290 295 300 Arg Val Arg Be Ser Thr Leu Lys Gly Val Thr Val Glu Asp Arg 305 310 315 320 Wing Pro Ser Met Ile 325 Asp Glu Tyr Pro Ile 330 Leu Wing Val Wing Wing 335 Wing Phe Wing Glu Gly 340 Wing Thr Val Met Asn 345 Gly Leu Glu Glu Leu 350 Arg Val</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Lye"Glu""Ser Asp ArgmIieu Ser Ala Val Ala Asn Gly Leu Lys Leu Asn 355	360	365</span>Lye "Glu" "Be Asp ArgmIieu Be Wing Val Wing Wing Asn Gly Leu Lys Leu Asn 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Val Asp Cys Asp Glu Gly Glu Thr Ser Leu Val Val Arg Gly Arg</span>Gly Val Asp Cys Asp Glu Gly Glu Thr Being Read Val Val Arg Gly Arg</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">370	375	380</span>370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pro Asp Gly Lys Gly Leu Gly Asn Ala Ser Gly Ala Ala Val Ala Thr 385	390	395	400</span>Pro Asp Gly Lys Gly Leu Gly Asn Wing Ser Gly Wing Wing Val Wing Thr 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">His Leu Asp His Arg Ile Ala Met Ser Phe Leu Val Met Gly Leu Val</span>His Leu Asp His Arg Ile Wing Met Ser Phe Leu Val Met Gly Leu Val</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">405	410	415</span>405 410 415</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ser Glu Asn Pro Val Thr Val Asp Asp Ala Thr Met Ile Ala Thr Ser</span>Ser Glu Asn Pro Val Thr Val Asp Asp Wing Thr Met Ile Wing Thr Be</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">420	425	430</span>420 425 430</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Phe Pro Glu Phe Met Asp Leu Met Ala Gly Leu Gly Ala Lys Ile Glu</span>Phe Pro Glu Phe Met Asp Leu Met Wing Gly Leu Gly Wing Lys Ile Glu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">435	440	445</span>435 440 445</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Leu Ser Asp Thr Lys Ala Ala 450	455     I.a)	Nmero identificador da seqncia: SEQ ID No: 11</span>Leu Ser Asp Thr Lys Wing 450 450 I.a) Sequence identifier number: SEQ ID No: 11</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 427 II.b) tipo: PRT</span>II.a) Size: 427 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: E. coli</span>II.c) organism: E. coli</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 11</span>IV) Sequence: SEQ ID NO. 11</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Glu	Ser	Leu	Thr	Leu	Gln	Pro	Ile Ala Arg			Val	Asp Gly		Thr Ile 1				5					10					15 Asn	Leu	Pro	Gly	Ser	Lys	Thr	Val	Ser Asn Arg			Ala	Leu	Leu	Leu Ala 			20					25					30	 Ala	Leu	Ala	Kis	Gly Lys		Thr	Val	Leu	Thr	Asn	Leu	Leu Asp		Ser Asp 		35					40					45		 Asp	Val	Arg	His	Met	Leu	Asn	Ala	Leu	Thr	Ala	Leu	Gly Val		Ser Tyr 	50					55					60			 Thr	Leu	Ser	Ala	Asp Arg		Thr Arg		Cys	Glu	Ile	Ile	Gly Asn		Gly Gly 5					70					75				80 Pro	Leu	His	Ala	Glu Gly		Ala	Leu	Glu	Leu	Phe	Leu	Gly Asn		Ala Gly 				85					90					95 Thr	Ala	Met	Arg	Pro	Leu	Ala	Ala	Ala	Leu	Cys	Leu	Gly Ser		Asn Asp 			100					105					110	 Ile	Val	Leu	Thr	Gly Glu		Pro	Arg	Met	Lys	Glu	Arg	Pro	Ile	Gly His 		115					120					125		 Leu	Val	Asp	Ala	Leu Arg		Leu Gly Gly Ala				Lys	Ile	Thr	Tyr	Leu Glu 	130					135					140			 Gln	Glu	Asn	Tyr	Pro	Pro	Leu Arg		Leu Gln Gly			Gly	Phe	Thr	Gly Gly 145					150					155				160 Asn	Val	Asp	Val	Asp 165	Gly	Ser	Val	Ser	Ser 170	Gln	Phe	Leu	Thr	Ala Leu 175 Leu	Met	Thr	Ala	Pro	Leu	Ala	Pro	Glu Asp Thr			Val	Ile Arg		Ile Lys 			180					185					190	 Gly	Asp	Leu	Val	Ser	Lys	Pro	Tyr	Ile Asp		Ile	Thr	Leu	Asn	Leu Met 		195					200					205		 Lys	Thr 210	Phe	Gly	Val	Glu	Ile 215	Glu	Asn	Gln	His	Tyr 220	Gln	Gln	Phe Val Val	Lys	Gly	Gly	Gln	Ser	Tyr	Gln	Ser	Pro Gly		Thr	Tyr	Leu	Val Glu 225					230					235				240 Gly	Asp	Ala	Ser	Ser 245	Ala	Ser	Tyr	Phe	Leu 250	Ala	Ala	Ala	Ala	Ile Lys 255 Gly	Gly	Thr	Val	Lys	Val	Thr Gly		Ile	Gly Arg		Asn	Ser	Met	Gln Gly 			260					265					270	 Asp	Ile	Arg	Phe	Ala Asp		Val	Leu	GlU	Lys	Met	Gly	Ala	Thr	Ile Cys 		275					280					285		 Trp	Gly	Asp	Asp	Tyr	Ile	Ser	Cys	Thr Arg Gly			Glu	Leu	Asn	Ala Ile 	290					295					300			 Asp	Met	Asp	Met	Asn	His	Ile	Pro	Asp	Ala	Ala	Met	Thr	Ile	Ala Thr 305				.... -	310					315				320 Ala	Ala	Leu	Phe	Taa 325	Lys	Gly	Thr	Thr	Arg 330	Leu	Arg	Asn	Ile	Tyr Asn 335 Trp	Arg	Val	Lys 340	Glu	Thr	Asp	Arg	Leu 345	Phe	Ala	Met	Ala	Thr 350	Glu Leu Arg	Lys	Val 355	Gly	Ala	Glu	Val	Glu 360	Glu	Gly	His	Asp	Tyr 365	Ile	Arg Ile Thr	Pro 370	Pro	Glu	Lys	Leu	Asn 375	Phe	Ala	GlU	Ile	Ala 380	Thr	Tyr	Asn Asp His	Arg	Met	Ala	Met	Cys	Phe	Ser	Leu	vai	Ala	Leu	Ser	Asp	Thr Pro 385					390					395				400 Val	Thr	Ile	Leu	Asp 405	Pro	Lys	Cys	Thr	Ala 410	Lys	Thr	Phe	Pro	Asp Tyr 415 Phe	Glu	Gln	Leu	Ala	Arg	Ile	Ser	Gln	Ala	Ala</span>Met Glu Ser Leu Thr Leu Gln Pro Ile Arg Wing Val Asp Gly Thr Ile 1 5 10 15 Asn Leu Pro Gly Ser Lys Thr Val Asn Arg Wing Leu Leu Leu Wing 20 25 30 Wing Leu Wing Kis Gly Lys Thr Val Leu Thr Asn Leu Leu Asp Ser Asp 35 40 45 Asp Val Arg His Met Leu Asn Wing Leu Thr Wing Leu Gly Val Ser Tyr 50 55 60 Thr Leu Be Asp Arg Wing Thr Thr Cys Glu Ile Ily Gly Asn Gly Gly  5 70 75 80 Pro Leu His Wing Glu Gly Wing Leu Glu Leu Phe Leu Gly Asn Wing Gly 85 90 95 Thr Wing Met Arg Pro Leu Wing Wing Wing Leu Cys Leu Gly Ser Asn Asp 100 105 110 Ile Val Leu Thr Gly Glu Pro Arg Met Lys Glu Arg Pro Ile Gly His 115 120 125 Leu Val Asp Wing Leu Arg Leu Gly Gly Gly Wing Lys Ile Thr Tyr Leu Glu 130 135 140 Gln Glu Asn Tyr Pro Pro Leu Arg Leu Gln Gly Gly Phe Thr Gly Gly 145 150 155 160 Asn Val Asp Val Asp 165 Gly Ser Val Ser Ser 170 Gln Phe Leu Thr Wing Leu 175 Leu Met Thr Wing Pro Leu Wing Pro Gl u Asp Thr Val Ile Arg Ile Lys 180 185 190 Gly Asp Leu Val Ser Lys Pro Tyr Ile Asp Ile Thr Leu Asn Leu Met 195 200 205 Lys Thr 210 Phe Gly Val Glu Ile 215 Glu Asn Gln His Tyr 220 Gln Gln Phe Val Val Lys Gly Gly Gln Be Tyr Gln Be Pro Gly Thr Tyr Leu Val Glu 225 230 235 240 Gly Asp Wing Be Ser 245 Wing Be Tyr Phe Leu 250 Wing Wing Ward Ile Wing Lys 255 Gly Gly Thr Val Lys Val Thr Gly Ile Gly Arg Asn Ser Met Gln Gly 260 265 270 Asp Ile Arg Phe Ala Asp Val Leu GlU Lys Met Gly Ala Thr Ile Cys 275 280 285 Trp Gly Asp Asp Tyr Ile Ser Cys Thr Arg Gly Glu Leu Asn Ala Ile 290 295 300 Asp Met Asp Met Asn His Ile Pro Asp Ala Wing Met Thr Ile Ala Thr 305 .... - 310 315 320 Ala Wing Leu Phe Taa 325 Lys Gly Thr Thr Arg 330 Leu Arg Asn Ile Tyr Asn 335 Trp Arg Val Lys 340 Glu Thr Asp Arg Leu 345 Phe Wing Met Wing Thr 350 Glu Leu Arg Lys Val 355 Gly Glu Wing Val Glu 360 Glu Gly His Asp Tyr 365 Ile Arg Ile Thr Pro 370 Pro Glu Lys Leu Asn 375 Phe Wing GlU Ile Wing 380 Thr Tyr Asn Asp His Arg Met Wing Met Cys Phe Being Leu Goes Wing Leu Being Asp Thr Pro 385 390 395 400 Val Thr Ile Leu Asp 405 Pro Lys Cys Thr Wing 410 Lys Thr Phe Pro Asp Tyr 415 Phe Glu Gln Read Wing Wing Ile Be Gln Wing Wing</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">420	425     I.a)	Nmero identificador da seqncia: SEQ ID No: 12</span>420 425 I.a) Sequence identifier number: SEQ ID No: 12</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242</span>II.a) Size: 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b)    tipo: DNA</span>II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23 sinttico</span>III.c) Other information: synthetic grg23</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a) Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1) ... (1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 12</span>IV) Sequence: SEQ ID NO. 12</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val lie Pro Gly Ser Lys Ser Xle Thr Asn 1   5 	10	15</span>atg gaa act gat cgc ctt gtg till cca gga tcg aaa age till acc aac 48 Met Glu Thr Asp Arg Leu Val Lie Pro Gly Ser Lys Ser Xle Thr Asn 1 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac ctc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac ctc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gea gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125     gag cagf ctg1' ccc" cttT aca' att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 gag cagf ctg1 'ccc "cttT aca' att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age eag tte gcc tec ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat cag age age eag tte gcc tec ggc ctg up to 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac etc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac etc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tte ggc ctt gag acc age acc gae gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>tte ggc ctt gag ac acc gae gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg teg tac tte gcc gcc gct tcc gcc gtc tet ggc agg age tte gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg teg tac tc gcc gcc tc gcc tc gtc tet ggc agg age tte gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca tte tte 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac act till caa ggc gac acg tca tte tte 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg egg etc ggt gcg gag gtc cac tgg gea ccc aac teg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>aat gta ctt ggg egg etc ggt gcg gag gtc cac tgg gea ccc aac teg 816 Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Wing Pro Asn Ser 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att teg gac acc tte atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att teg gac acc tte atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Wing Ile Wing Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152</span>atg gcg ttt tca till ctg gga ctg aga gtg gac ggg att acc ctc gac 1152</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ftt lXla' TtieT "Ser "fie" 'Keu' Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>ftt lXla 'TtieT "Ser" fie "' Keu 'Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc tte tte gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc tte tte gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt tte ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tt ccc gaa aag gcg ctt acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 13</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No: 13</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23 sinttico</span>III.c) Other information: synthetic grg23</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 13</span>IV) Sequence: SEQ ID NO. 13</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Glu	Thr	Asp Arg		Leu	Val	Ile	Pro Gly		Ser	Lys	Ser	Ile	Thr	Asn 1				5					10					15	 Arg Ala		Leu	Leu	Leu	Ala	Ala	Ala	Ala	Lys	Gly	Thr	Ser	Val	Leu	Val 			20					25					30		 Arg	Pro	Leu 35	Val	Ser	Ala	Asp	Thr 40	Ser	Ala	Phe	Lys	Thr 45	Ala	Ile	Gln Ala	Leu	Gly	Ala	Asn	Val	Ser	Ala	Asp Gly		Asp	Asn	Trp	Val	Val	Glu 	50					55					60				 Gly Leu Gly			Gln	Ala	Pro	His	Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu Asp	 65					70					75					80 Ala Gly Thr			Val	Ala	Arg	Phe	Leu	Pro	Pro	Phe	vai	Ala	Ala	Gly Gln	 				85					90					95	 Gly Lys		Phe	Thr	Val	Asp Gly		Ser	Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 			100					105					110		 Arg	Pro	Leu	Val	Asp	Gly	Ile Arg		His	Leu	Gly Ala		Arg	Val	Ser	Ser 		115					120					125			 Glu	Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala	Gly	Gly Glu	 	130					135					140				 Tyr	Glu	Ile	Glu	Ala	His	Gln	Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145					150					155					160 Met	Ala	Ala	Pro	Tyr	Ala Arg Gln			Gly Leu		Arg	Val	Arg	Ile	Pro	Asn 				165					170					175	 Pro	Val	Ser	Gln	Pro	Tyr Leu		Thr	Met	Thr	Leu	Arg	Met	Met	Arg Asp	 			180					185					190		 Phe	Gly Leu		Glu	Thr	Ser	Thr Asp		Gly Ala		Thr	Val	Ser	Val	Pro	Pro 		195					200					205			 Gly Arg Tyr			Thr	Ala	Arg Arg		Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 	210					215					220				 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225					230					235					240 Phe Gln Gly			Leu Gly		Thr Asp		Ser	Ile	Gln	Gly Asp		Thr	Ser	Phe	Phe 				245					250					255	 Asn	Val	Leu	Gly Arg		Leu Gly Ala			Glu	Val	His	Trp	Ala	Pro	Asn	Ser 			260					265					270		 Val	Thr	Ile	Ser Gly		Pro	Glu	Arg	Leu	Asn	Gly Asp		Ile	Glu	Val	Asp 		275					280					285			 Met	Gly Glu		Ile	Ser	Asp	Thr	Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 	290					295					300				 Leu	Ala	Asp	Gly Pro		Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu</span>Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Leu Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30 Arg Pro Leu 35 Val Ser Asp Thr 40 Ser Wing Phe Lys Thr 45 Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Go Wing Wing Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Be Glu Leu Arg Arg Pro Leu 100 105 110 Arg Pro Read Val Asp Gly Ile Arg His Leu Gly Wing Val Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Thr Met Thr Read Le Arg Met Met Asp 180 185 190 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220 Wing Be Tyr Phe Wing Wing Wing Be Wing Val Be Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly Arg Read Gly Ala Glu Val His Trp Wing Pro Asn Ser 260 265 270 Val Thr Ile Be Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Be Asp Thr Phe Met Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">305	310	 Lys	Glu	Ser	Asp	Arg Ile	Ser Ala 				325	 Gly	Val	Gln	Thr	Asp Val	Gly His 			340		 Thr	Pro	His	Gly	Gly Arg	Val Asn 		355			360 Met	Ala	Phe	Ser	Ile Leu	Gly Leu 	370				375 Asp	Pro Gln Cys Val Gly				Lys Thr 385				390	 Gly	Arg	Leu	Phe	Pro Glu	Lys Ala</span>305 310 Lys Glu Be Asp Arg Ile Be Wing 325 Gly Val Gln Thr Asp Val Gly His 340 Thr Pro His Gly Gly Arg Val Asn 355 360 Met Wing Phe Be Ile Leu Gly Leu 370 375 Asp Pro Gln Cys Val Gly Lys Thr 385 390 Gly Arg Read Phe Pro Glu Lys Wing</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">405</span>405</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">315			320 Met	Glu	Thr	Asn Leu Arg	Thr	Leu 	330			335	 Asp	Trp	Met	Arg Ile Tyr	Pro	Ser 345			350		 Cys	His	Arg	Asp His Arg	Ile	Ala 			365		 Arg	Val	Asp	Gly Ile Thr	Leu	Asp 			380		 Phe	Pro Gly		Phe Phe Asp	Tyr	Leu 		395			400 Leu	Thr	Leu	Pro Gly		 	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 14</span>315 320 Met Glu Thr Asn Leu Arg Thr Leu 330 335 Asp Trp Met Arg Ile Tyr Pro Ser 345 350 Cys His Arg Asp His Arg Ile Wing 365 Arg Val Asp Gly Ile Thr Leu Asp 380 Phe Pro Gly Phe Phe Asp Tyr Leu 395 400 Leu Thr Leu Pro Gly 410 Ia) Sequence identifier number: SEQ ID No: 14</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242 II.b)     tipo: DNA</span>II.a) Size: 1242 II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(acel) III.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (acel) III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 14</span>IV) Sequence: SEQ ID NO. 14th</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1        5	10	15</span>atg gaa act gat cgc ctt gtg till cca gga tcg aaa age till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Thr Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>acc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Thr Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac ctc gac gcc gac ate tgg tgc gag gac 24 0 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac ctc gac gcc gac up to tgg tgc gag gac 24 0 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 2 88 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 2 88 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 3 84 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 3 84 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu     130	135	140</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu lie Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu lie Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc ctt gag acc age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc ctt gag acc ac acc gac gga gcc acc gtc ac gtc cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata act gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Thr Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata act gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Ile Thr Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa ace gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa ace gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">370	375	380</span>370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tc ccc gaa aag gcg ctc acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 15</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No: 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(acel)</span>III.c) Other information: grg23 (acel)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 15	 				 Met	Glu Thr	Asp Arg	Leu Val	Ile	Pro	Gly Ser	Lys	Ser	Ile	Thr	Asn 1		5				10				15	 Arg	Ala Leu	Leu Leu	Ala Ala	Ala	Ala	Lys Gly	Thr	Ser	Val	Leu	Val 		20			25				30		 Arg	Pro Leu	Val Ser Ala Asp		Thr	Ser	Ala Phe	Lys	Thr	Ala	Ile	Gln 	35			40				45			 Thr	Leu Gly Ala Asn		Val Ser	Ala	Asp	Gly Asp	Asn	Trp	Val	Val	Glu 	50		55				60				 Gly Leu Gly Gln Ala			Pro His	Leu Asp		Ala Asp	Ile	Trp	Cys	Glu	Asp 65			70			75					80 Ala	Gly Thr Val Ala		Arg Phe	Leu	Pro	Pro Phe	Val	Ala	Ala	Gly Gln	 		85				90				95	 Gly	Lys Phe	Thr Val	Asp Gly	Ser	Glu	Gln Leu	Arg	Arg	Arg	Pro	Leu 		100			105				110		 Arg	Pro Leu	Val Asp	Gly Ile	Arg	His	Leu Gly	Ala	Arg	Val	Ser	Ser 	115			120				125			 Glu	Gln Leu	Pro Leu	Thr Ile	Glu	Ala	Ser Gly	Leu	Ala	Gly	Gly Glu	 	130		135				140				 Tyr	Glu Ile	Glu Ala	His Gln	Ser	Ser	Gln Phe	Ala	Ser	Gly	Leu	Ile 145			150			155					160 Met	Ala Ala	Pro Tyr Ala Arg		Gln Gly		Leu Arg	Val	Arg	Ile	Pro	Asn 		165				170				175	 Pro	Val Ser	Gln Pro	Tyr Leu	Thr	Met	Thr Leu	Arg	Met	Met	Arg Asp	 		180			185				190		 Phe	Gly Leu	Glu Thr	Ser Thr	Asp	Gly	Ala Thr	Val	Ser	Val	Pro	Pro 	195			200				205			 Gly	Arg Tyr Thr Ala Arg Arg			Tyr	Glu	Ile Glu	Pro	Asp	Ala	Ser	Thr 	210		215				220				 Ala	Ser Tyr	Phe Ala	Ala Ala	Ser	Ala	Val Ser	Gly	Arg	Ser	Phe	Glu 225			230			235					240 Phe	Gln Gly Leu Gly Thr Asp			Ser	Ile	Gln Gly	Asp	Thr	Ser	Phe	Phe 		245				250				255	 	Val Leu	Gly Arg	Leu Gly	Ala	Glu	Val His	Trp	Ala	Pro	Asn	Ser 		260			265				270		 tfal	Thr Ile	Thr Gly Pro Glu		Arg	Leu	Asn Gly	Asp	Ile	Glu	Val	Asp 	275			280				285			 Ylet	Gly Glu	Ile Ser Asp Thr		Phe	Met	Thr Leu	Ala	Ala	Ile	Ala	Pro 	290		295				300				 jeu Ala Asp		Gly Pro	Ile Thr	Ile	Thr	Asn Ile	Gly	His	Ala	Arg Leu	 05			310			315					320 jys	Glu Ser Asp Arg		Ile Ser	Ala	Met	Glu Thr	Asn	Leu	Arg	Thr	Leu 32S				330				335</span>IV) Sequence: SEQ ID NO. 15 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Leu Wing Wing Wing Wing Lys Gly Thr As Val Leu Val Wing 20 25 30 Arg Pro Leu Val Ser Wing Asp Thr Be Wing Phe Lys Thr Wing Ile Gln 35 40 45 Thr Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing His Pro Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Be Glu Glu Leu Arg Arg Pro Leu 100 105 110 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Wing Wing Ser Be Wing Val Ser Gly Arg Ser Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255 Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Wing Pro Asn Ser 260 265 270 tfal Thr Ile Thr Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Ylet Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Wing Ile Wing Pro Pro 290 295 300 jeu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Arg Wing Leu 05 310 315 320 jys Glu Be Asp Arg Ile Be Met Glu Thr Wing Asu Leu Arg Thr Leu 32S 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>Met Wing Phe Ser Ile Leu Gly Leu Arg Val Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>Asp Pro Gln Cys Val Gly Lys Thr Phe Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 16</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 I.a) Sequence identifier number: SEQ ID No: 16</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242 Il.b) tipo: DNA</span>II.a) Size: 1242 Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace2) III.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (ace2) III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 16</span>IV) Sequence: SEQ ID NO. 16</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15	10	15</span>atg gaa act gat cgc ctt gtg until cca gga tcg aaa acts till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac ctc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac ctc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gea gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140     tac gaa atY gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Gly Gly Glu 130 135 140 tac gaa atY gaa gcc cat cag age age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu Ile Glu Wing His Gln Being Gln Phe Wing Being Gly Leu Ile 145 150 155 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc ctt gag acc age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc ctt gag acc ac acc gac gga gcc acc gtc ac gtc cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata cgg gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Arg Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata cgg gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Arg Gly Pro Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">jac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 sp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>jac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Atp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 17</span>gga cgc ct ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag 1242 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No: 17</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace2)</span>III.c) Other information: grg23 (ace2)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ivL.	Seqncia			: SEQ		ID i	NO.	17							 Met	Glu	Thr	Asp	Arg	Leu	Val	Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1				5					10					15	 Arg	Ala	Leu	Leu	Leu	Ala	Ala	Ala	Ala	Lys	Gly	Thr	Ser	Val	Leu	Val 			20					25					30		 Arg	Pro	Leu	Val	Ser	Ala	Asp	Thr	Ser	Ala	Phe	Lys	Thr	Ala	Ile	Gln 		35					40					45			 Ala	Leu	Gly	Ala	Asn	Val	Ser	Ala Asp		Gly	Asp	Asn	Trp	Val	Val	Glu 	50					55					60				 Gly	Leu	Gly	Gln	Ala	Pro	His	Leu Asp		Ala	Asp	Ile	Trp	Cys	Glu	Asp 65					70					75					80 Ala	Gly	Thr	Val	Ala	Arg	Phe	Leu	Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 				85					90					95	 Gly	Lys	Phe	Thr	Val	Asp	Gly	Ser	Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 			100					105					110		 Arg	Pro	Leu	Val	Asp	Gly	Ile	Arg	His	Leu	Gly	Ala	Arg	Val	Ser	Ser 		115					120					125			 Glu	Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala	Gly	Gly	Glu 	130					135					140				 Tyr	Glu	Ile	Glu	Ala	His	Gln	Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145					150					155					160 Met	Ala	Ala	Pro	Tyr	Ala	Arg	Gln Gly		Leu	Arg	Val	Arg	Ile	Pro	Asn 				165					170					175	 Pro	Val	Ser	Gln	Pro	Tyr	Leu	Thr	Met	Thr	Leu	Arg	Met	Met	Arg	Asp 			180					185					190		 Phe	Gly	Leu	Glu	Thr	Ser	Thr	Asp Gly		Ala	Thr	Val	Ser	Val	Pro	Pro 		195					200					205			 Gly	Arg	Tyr	Thr	Ala	Arg	Arg	Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 	210					215					220				 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225					230					235					240 Phe	Gln	Gly	Leu	Gly	Thr	Asp	Ser	Ile	Gln	Gly	Asp	Thr	Ser	Phe	Phe 				245					250					255	 Asn	Val	Leu	Gly	Arg	Leu	Gly	Ala	Glu	Val	His	Trp	Ala	Pro	Asn	Ser 			260					265					270		 Val	Thr	Ile	Arg	Gly	Pro	Glu	Arg	Leu	Asn	Gly	Asp	Ile	Glu	Val	Asp 		275					280					285			 Met	Gly	Glu	Ile	Ser	Asp	Thr	Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 	290					295					300				 Leu	Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305					310					315					320 Lys	Glu	Ser	Asp	Arg	Ile	Ser	Ala	Met	Glu	Thr	Asn	Leu	Arg	Thr	Leu 				325					330					335	 Gly	Val	Gln	Thr	Asp	Val	Gly	His	Asp	Trp	Met	Arg	Ile	Tyr	Pro	Ser 	345					350		 Thr	Pro	Hls	Gly Gly Arg Val				Asn Cys His Arg Asp His Arg							Ile	Ala</span>ivL. Sequence: SEQ ID i NO. 17 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Leu Wing Wing Wing Wing Lys Gly Thr As Val Leu Val Wing 20 25 30 Arg Pro Leu Val Ser Wing Asp Thr Be Wing Phe Lys Thr Wing Ile Gln 35 40 45 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Be Glu Glu Leu Arg Arg Pro Leu 100 105 110 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln Pro T yr Leu Thr Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Wing Wing Wing Be Wing Val Be Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Pro Wing Asn Ser 260 265 270 Val Thr Ile Arg Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Wing Ala Ile Ala Pro 290 295 300 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Be Wing Met Glu Thr Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 345 350 Thr Pro Hls Gly Gly Arg Val Asn Cys His Ar g Asp His Arg Ile Wing</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">355	360	365</span>355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met Ala Phe Ser Xle	Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp</span>Met Wing Phe Ser Xle Leu Gly Leu Arg Val Val Asp Gly Ile Thr Leu Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">370	375	380</span>370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Asp Pro Gln Cys Val	Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu</span>Asp Pro Gln Cys Val Gly Pys Thr Phe Gly Phe Phe Asp Tyr Leu</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">385	390	395	400</span>385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro	Glu Lys Ala Leu Thr Leu Pro Gly 405 410     I.a)	Nmero identificador da seqncia: SEQ ID No: 18</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 I.a) Sequence identifier number: SEQ ID No: 18</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242 II.b)    tipo: DNA</span>II.a) Size: 1242 II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg51.4 III.a) Nome/Legenda: CDS</span>III.c) Other information: grg51.4 III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 18</span>IV) Sequence: SEQ ID NO. 18</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cga cta gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1        5	10	15</span>atg gaa act gat cga cta gtg up to cca gga tcg aaa acts up to acc aac 48 Met Glu Thr Asp Arg Read Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea att cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea att cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcg gac ggt gat gat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asp Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcg gac ggt gat gat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggc cag gea ccc aac ctc gac gcc gac ate tgg tgc gag gat 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggc cag gea ccc aac ctc gac gcc gac up to tgg tgc gag gat 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ggt acc gtg gcc cgg ttc ctc cct cca ttc gtc gcc gea gga cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gcc ggt acc gtg gcc cgg ttc ctc cct cca ttc gtc gcc gea gga cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga age gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga age gag cag ctg cgg cgg cgg ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Glu Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc gtg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc gtg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc cta acg att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc cta acg att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggt ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile     145 TSO	155	160</span>tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggt ctg until 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 TSO 155 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg cga caa ggc ctg cgt gtt cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Xle Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg cga caa ggc ctg cgt gtt cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Xle Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg age cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg age cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc att gag acc age acc gac gga gcg acc gtc age gtt cct ccc 624 Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc att gag ac acc gac gga gcg acc gtc age gtt cct ccc 624 Phe Gly Ile Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcg cgg cgg tat gag att gaa ccg gac gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Xle Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcg cgg cgg tat gag att gaa ccg gac gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Xle Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc cgg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225	230	235	240</span>gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc cgg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225 230 235 240 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc cag ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttc cag ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggc gea gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260	265	270</span>aat gta ctt ggg cgg ctc ggc gea gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata cgc gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata cgc gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag ata tcg gac acc ttc atg aca ctg gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag ata tcg gac acc ttc atg aca ctg gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cta gcc gat gga ccc ate acg ata aca aac att ggc cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>cta gcc gat gga ccc till acg ata acac aac att ggc cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tcg gcg atg gaa age aac ctt cga acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc until tcg gcg atg gaa age aac ctt cga acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg cga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg cga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg ate gcc 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggc aga gtc aat tgc cac cgg gac cac agg until gcc 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg cga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg cga gtg gac ggg att acc ctc gac 1152 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgt gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgt gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccg gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct ttc ccg gaa aag gcg ctt acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No:</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b) tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg51.4</span>III.c) Other information: grg51.4</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ				ID	NO.	19							 Met	Glu	Thr	Asp Arg Leu		Val	Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1				5				10					15	 Arg	Ala	Leu	Leu 20	Leu Ala	Ala	Ala	Ala 25	Lys	Gly	Thr	Ser	Val 30	Leu	Val Arg	Pro	Leu 35	Val	Ser Ala	Asp	Thr 40	Ser	Ala	Phe	Lys	Thr 45	Ala	Ile	Gln Ala	Leu	Gly Ala Asn Val			Ser	Ala	Asp	Gly	Asp	Asp	Trp	Val	Val	Glu 	50				55					60				 Gly	Leu	Gly Gln Ala Pro			Asn	Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu	Asp 55				70					75					80 Ala	Gly	Thr	Val	Ala Arg 85	Phe	Leu	Pro	Pro 90	Phe	Val	Ala	Ala	Gly 95	Gln Gly Lys		Phe	Thr	Val Asp	Gly	Ser	Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 			100				105					110		 Arg	Pro	Val 115	Val	Asp Gly	Ile	Arg 120	His	Leu	Gly	Ala	Arg 125	Val	Ser	Ser Glu	Gln	Leu	Pro	Leu Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala Gly Gly			Glu 	130				135					140				 Tyr	Glu	Ile	Glu	Ala His	Gln	Ser	Ser	Gln	Phe	Ala	Ser Gly		Leu	Ile 145				150					155					160 Met	Ala	Ala	Pro	Tyr Ala	Arg	Gln Gly		Leu	Arg	Val	Arg	Ile	Pro	Asn 				165				170					175	 Pro	Val	Ser	Gln 180	Pro Tyr	Leu	Thr	Met 185	Thr	Leu	Arg	Met	Met 190	Arg	Asp Phe	Gly	Xle 195	Glu	Thr Ser	Thr	Asp 200	Gly	Ala	Thr	Val	Ser 205	Val	Pro	Pro Gly Arg		Tyr	Thr	Ala Arg	Arg	Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 	210				215					220				 Ala	Ser	Tyr	Phe	Ala Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg Arg		Phe	Glu 225				230					235					240 Phe	Gln	Gly Leu		Gly Thr	Asp	Ser	Ile	Gln	Gly	Asp	Thr	Ser	Phe	Phe 				245				250					255	 Asn	Val	Leu Gly Arg Leu			Gly	Ala	Glu	Val	His	Trp	Ala	Ser	Asn	Ser 			260				265					270		 Val	Thr	Ile Arg Gly Pro			Glu	Arg	Leu	Thr	Gly	Asp	Ile	Glu	Val	Asp 		275				280					285			 Met	Gly 290	Glu	Ile	Ser Asp	Thr 295	Phe	Met	Thr	Leu	Ala 300	Ala	Ile	Ala	Pro Leu	Ala	Asp	Gly	Pro Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305				310					315					320 Lys	Glu	Ser Asp		Arg Ile	Ser	Ala	Met	Glu	Ser	Asn	Leu Arg		Thr	Leu 				325				330					335	 Gly Val		Gln Thr Asp Val			Gly	His	Asp	Trp	Met	Arg	Ile	Tyr	Pro	Ser 			340				345					350		 Thr	Pro	His	Gly	Gly Arg	Val	Asn	Cys	His	Arg	Asp	His	Arg	Ile	Ala 				360					365			 Met	Ala	Phe	Ser	Ile Leu	Gly	Leu Arg		Val	Asp	Gly	Ile	Thr Leu Asp		 	370				375					380				 Asp Pro Gln Cys Val Gly					Lys	Thr	Phe	Pro	Gly	Phe	Phe	Asp	Tyr	Leu 385				390					395					400 Gly Arg		Leu	Phe	Pro Glu	Lys	Ala	Leu	Thr	Leu	Pro Gly				 				405				410     I.a)	Nmero identificador da seqncia: SEQ ID No: 20</span>IV) Sequence: SEQ ID NO. 19 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Read Le 20 Wing Ala Wing Wing 25 Lys Gly Thr Ser Val 30 Leu Val Arg Pro Leu 35 Val Ser Asp Thr 40 Ser Wing Phe Lys Thr 45 Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro Asn Leu Asp Wing Asp Ile Trp Cys Glu Asp 55 70 75 80 Wing Gly Thr Val Wing Arg 85 Phe Leu Pro Pro 90 Phe Val Wing Ala Gly 95 Gln Gly Lys Phe Thr Val Val Asp Gly Be Glu Leu Arg Arg Arg Pro Leu 100 105 110 Arg Pro Val 115 Val Asp Gly Ile Arg 120 His Leu Gly Ala Arg 125 Val Ser Be Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Be Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln 180 Pro Tyr Leu Thr Met 185 Thr Leu Arg Met Met 190 Arg A sp Phe Gly Xle 195 Glu Thr Be Thr Asp 200 Gly Wing Thr Val Ser 205 Val Pro Pro Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Thr Thr 210 215 220 Wing Be Tyr Phe Wing Wing Be Wing Val Ser Gly Arg Arg Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Wing Be Asn Ser 260 265 270 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285 Met Gly 290 Glu Ile Be Asp Thr 295 Phe Met Thr Leu Wing 300 Wing Ile Pro Pro Read Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Be Ala Met Glu Be Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Be 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 360 365 Met Wing Phe Ser Ile Read Gly Read Arg Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 Ia) Sequence identifier number : SEQ ID No: 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242</span>II.a) Size: 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Il.b) tipo: DNA</span>Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace3)</span>III.c) Other information: grg23 (ace3)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a) Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 20</span>IV) Sequence: SEQ ID NO. 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5	10	15</span>atg gaa act gat cgc ctt gtg till cca gga tcg aaa age till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcc gac ggt gac gat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asp Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcc gac ggt gac gat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc aac ctc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc aac ctc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">85	90	95</span>85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc gtg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc gtg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160     atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Xle Pro Asn 165 .	170	175</span>tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu Ile Glu Ala His Gln Ser Be Gln Phe Ala Ser Gly Leu Ile 145 150 155 160 atg gcc gcc aga caa ggc ctg ctg cgg ata cca aat 528 Met Pro Wing Ward Tyr Wing Arg Gln Gly Leu Arg Val Arg Xle Pro Asn 165. 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc att gag acc age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc att gag ac acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Ile Glu Thr Be Thr Asp Gly Wing Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225	230	235	240</span>gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225 230 235 240 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata cgt gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata cgt gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa age aac ctg cgc acg ctc 10 OE Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc until tca gcg atg gaa age aac ctg cgc acg ctc 10 OE Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 12 OC Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 12 OC Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tc ccc gaa aag gcg ctc acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">" Sly Xrg Ku IPhett 1Pro" SliT' Lys Ala Leu Thr Leu Pro Gly *</span>"Sly Xrg Ku IPhett 1Pro" SliT 'Lys Wing Read Thr Read Read Gly *</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 21</span>405 410 I.a) Sequence identifier number: SEQ ID No: 21</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace3)												 IV) Seqnci.			a: SEQ	ID	NO.	21							 Met Glu	Thr	Asp	Arg Leu	vai	He	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1			5				10					15	 Arg Ala	Leu	Leu	Leu Ala	Ala	Ala	Ala	Lys	Gly	Thr	Ser	Val	Leu	Val 		20				25					30		 Arg Pro	Leu	Val	Ser Ala	Asp	Thr	Ser	Ala	Phe	Lys	Thr	Ala	Ile	Gln 	35				40					45			 Ala Leu	Gly Ala		Asn Val	Ser	Ala	Asp	Gly	Asp	Asp	Trp	Val	Val	Glu 50				55					60				 Gly Leu Gly Gln			Ala Pro	Asn	Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu	Asp 65			70					75					80 Ala Gly	Thr	Val	Ala Arg	Phe	Leu	Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 			85				90					95	 Gly Lys	Phe	Thr	Val Asp	Gly	Ser	Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 		100				105					110		 Arg Pro	Val	Val	Asp Gly	Ile	Arg	His	Leu	Gly	Ala	Arg	Val	Ser	Ser 	115				120					125			 Glu Gln	Leu	Pro	Leu Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala	Gly	Gly	Glu 130				135					14 0				 Tyr Glu	Ile	Glu	Ala His	Gln	Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145			150					155					160 Met Ala	Ala	Pro	Tyr Ala	Arg	Gln	Gly	Leu	Arg	Val	Arg	Ile	Pro	Asn 			165				170					175	 Pro Val	Ser	Gln	Pro Tyr	Leu	Thr	Met	Thr	Leu	Arg	Met	Met	Arg	Asp 		180				185					190		 Phe Gly	Ile	Glu	Thr Ser	Thr	Asp	Gly	Ala	Thr	Val	Ser	Val	Pro	Pro 	195				200					205			 Gly Arg	Tyr	Thr	Ala Arg	Arg	Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 210				215					220				 Ala Ser	Tyr	Phe	Ala Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg	Arg	Phe	Glu 225			230					235					240 Phe Gln	Gly Leu		Gly Thr	Asp	Ser	Ile	Gln	Gly	Asp	Thr	Ser	Phe	Phe 			245				250					255	 Asn Val	Leu	Gly	Arg Leu	Gly	Ala	Glu	Val	His	Trp	Ala	Ser	Asn	Ser 		260				265					270		 Val Thr	Ile	Arg	Gly Pro	Glu	Arg	Leu	Thr	Gly	Asp	Ile	Glu	Val	Asp 	275				280					285			 Met Gly	Glu	Ile	Ser Asp	Thr	Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 290				295					300				 Leu Ala	Asp	Gly	Pro Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305			310					315					320 Lys Glu	Ser	Asp	Arg Ile	Ser	Ala	Met	Glu	Ser	Asn	Leu	Arg	Thr	Leu 			325				330					335	 Gly Val	Gln	Thr	Asp Val	Gly	His	Asp	Trp	Met	Arg	Ile	Tyr	Pro	Ser 		340				345					350		 Thr Pro	His	Gly	Gly Arg	Val	Asn	Cys	His	Arg	Asp	His	Arg	Ile	Ala 	355				360					365			 Met Ala	Phe	Ser	Ile Leu	Gly	Leu	Arg	Val	Asp	Gly	Ile	Thr	Leu	Asp 370		        375						380				 Asp Pro	Gln	Cys	Val Gly Lys		Thr	Phe	Pro	Gly	Phe	Phe	Asp	Tyr	Leu 385			390					395					400 Gly Arg	Leu	Phe	Pro Glu	Lys	Ala	Leu	Thr	Leu	Pro	Gly			 			405				410     I.a) Nmero identificador da seqncia: SEQ ID No: 22</span>III.c) Other information: grg23 (ace3) IV) Sequence. a: SEQ ID NO. 21 Met Glu Thr Asp Arg Leu Go He Pro Gly Be Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Read Wing Wing Wing Wing Lys Gly Thr Be Val Leu Val 20 25 30 Arg Pro Leu Val Be Wing Asp Thr Be Wing Phe Lys Thr Wing Ile Gln 35 40 45 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro Asn Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Gln Leu Arg Arg Arg Pro Leu 100 105 110 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 14 0 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Ala Wing Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 Phe Gly Ile Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Wing Wing Wing Wing Be Val Wing Gly Arg Arg Phe Glu 225 230 235 240 Phe Wing Glly Gly Leu Gly Thr Asp Ile Gln Gly Asp Thr Wing Phe Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Wing Wing As Asn Ser 260 265 270 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Read Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Being Wing Met Glu Be Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg 365 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Ghe Phe Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly 405 410 Ia) Sequence identifier number: SEQ ID No: 22</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 1242 Il.b) tipo: DNA</span>II.a) Size: 1242 Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c) Outras informaes: grg23(L5P2.J2) III.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (L5P2.J2) III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1) ... (1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 22</span>IV) Sequence: SEQ ID NO. 22</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15	10	15</span>atg gaa act gat cgc ctt gtg until cca gga tcg aaa acts till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thsr Ssir Va.1 Leu. Va.1 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Ala Leu Leu Wing Ala Wing Ala Lys Gly Thsr Ssir Va.1 Leu. Va.1 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Thr Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>acc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Thr Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac ctc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac ctc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">85	90	95</span>85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc ttc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Phe Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc ttc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Phe Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg agt ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc ctt aca att gaa gcg agt ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 4 80 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg until 4 80 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn     165     170      175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc ctt gag acc age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc ctt gag acc ac acc gac gga gcc acc gtc ac gtc cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca tcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ser Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca tcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Be Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg age ttc gaa 72 0 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc tcc gcc tcc gcc tet ggc agg age ttc gaa 72 0 Wing Ser Tyr Phe Wing Wing Ser Wing Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata act gga ccg gaa agg ctg aac ggc aac att gaa gtg gat 864 Val Thr Ile Thr Gly Pro Glu Arg Leu Asn Gly Asn Ile Glu Val Asp 275	280	285</span>gtc acc ata act gga ccg gaa agg ctg aac ggc aac att gaa gtg gat 864 Val Ile Thr Gly Pro Glu Arg Leu Asn Gly Asn Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 100 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc  100 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tc ccc gaa aag gcg ctc acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No:</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b) tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L5P2.J2)</span>III.c) Other information: grg23 (L5P2.J2)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ					ID	NO.	23						 Met	Glu	Thr	Asp	Arg	Leu	Val	Ile	Pro	Gly	Ser	Lys Ser	Ile	Thr	Asn 1				5					10				15	 Arg	Ala	Leu	Leu 20	Leu	Ala	Ala	Ala	Ala 25	Lys	Gly	Thr Ser	Val 30	Leu	Val Arg	Pro	Leu 35	Val	Ser	Ala	Asp	Thr 40	Ser	Ala	Phe	Lys Thr 45	Ala	Ile	Gln Thr	Leu	Gly	Ala	Asn	Val	Ser	Ala Asp		Gly	Asp	Asn Trp	Val	Val	Glu 	50					55					60			 Gly	Leu	Gly	Gln	Ala	Pro	His	Leu Asp		Ala	Asp	Ile Trp	Cys	Glu	Asp 65					70					75				80 Ala Gly		Thr	Val	Ala	Arg	Phe	Leu	Pro	Pro	Phe	Val Ala	Ala	Gly	Gln 				85					90				95	 Gly Lys		Phe	Thr	Phe	Asp	Gly	Ser	Glu	Gln	Leu	Arg Arg	Arg	Pro	Leu 			100					105				110		 Arg	Pro	Leu 115	Val	Asp	Gly	Ile	Arg 120	His	Leu	Gly	Ala Arg 12 5	Val	Ser	Ser Glu	Gln 130	Leu	Pro	Leu	Thr	Ile 135	Glu	Ala	Ser	Gly	Leu Ala 140	Gly	Gly	Glu Tyr	Glu	Xle	Glu	Ala	His	Gln	Ser	Ser	Gln	Phe	Ala Ser	Gly	Leu	Ile 145					150					155				160 Met	Ala	Ala	Pro	Tyr	Ala	Arg	Gln Gly		Leu	Arg	Val Arg	Ile	Pro	Asn 				165					170				175	 Pro	Val	Ser	Gln 180	Pro	Tyr	Leu	Thr	Met 185	Thr	Leu	Arg Met	Met 190	Arg	Asp Phe Gly		Leu	Glu	Thr	Ser	Thr	Asp	Gly	Ala	Thr	Val Ser	Val	Pro	Pro 		195					200				205			 Gly Arg		Tyr	Thr	Ser	Arg	Arg	Tyr	Glu	Ile	Glu	Pro Asp	Ala	Ser	Thr 	210					215					220			 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser	Gly Arg	Ser	Phe	Glu 225					230					235				240 Phe	Gln	Gly	Leu	Gly 245	Thr	Asp	Ser	Ile	Gln 250	Gly	Asp Thr	Ser	Phe 255	Phe Asn	Val	Leu	Gly Arg		Leu	Gly	Ala	Glu	Val	His	Trp Ala	Pro	Asn	Ser 			260					265				270		 Val	Thr	Ile	Thr Gly		Pro	Glu	Arg	Leu	Asn	Gly	Asn Ile	Glu	Val	Asp 		275					280				285			 Met	Gly 290	Glu	Ile	Ser	Asp	Thr 295	Phe	Met	Thr	Leu	Ala Ala 300	Ile	Ala	Pro Leu	Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr	Asn	Ile	Gly His	Ala	Arg	Leu 305					310					315				320 Lys	Glu	Ser	Asp	Arg 325	Ile	Ser	Ala	Met	Glu 330	Thr	Asn Leu	Arg	Thr 335	Leu Gly Val		Gln	Thr	Asp	Val	Gly	His	Asp	Trp	Met	Arg Ile	Tyr	Pro	Ser 			340					345				350		 Thr	Pro	His	Gly Gly		Arg	Val	Asn	Cys	His	Arg	Asp His	Arg	Ile	Ala 		355					360				365			 Met	Ala	Phe	Ser	Ile	Leu	Gly	Leu Arg		Val	Asp	Gly Ile	Thr	Leu	Asp 	370					375					380			 Asp	Pro	Gln	Cys	Val	Gly	Lys	Thr	Phe	Pro	Gly	Phe Phe	Asp	Tyr	Leu ir	Ur uV	IhpP Ilteff' ..'' ""U				a-				395				400 Gly Arg		Leu	Phe	Pro	Glu	Lys	Ala	Leu	Thr	Leu Pro Gly				 				405					410     I.a)	Nmero identificador da seqncia: SEQ ID No: 24</span>IV) Sequence: SEQ ID NO. 23 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu 20 Leu Wing Wing Wing Wing 25 Lys Gly Thr Ser Val 30 Leu Val Arg Pro Leu 35 Val Ser Wing Asp Thr 40 Ser Ala Phe Lys Thr 45 Alle Ile Gln Thr Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80 Ala Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr Phe Asp Gly Gln Leu Arg Arg Arg Pro Leu 100 105 110 Arg Pro Leu 115 Val Asp Gly Ile Arg 120 His Leu Gly Ala Arg 12 5 Val Ser Ser Glu Gln 130 Leu Pro Leu Thr Ile 135 Glu Wing Ser Gly Leu Wing 140 Gly Gly Glu Tyr Glu Xle Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Ala Wing Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln 180 Pro Tyr Leu Thr Met 185 Thr Read Le Arg Met Met 190 Arg Asp Ph and Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Be Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Wing Wing Be Wing Val Ser Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly 245 Thr Asp Ser Ile Gln 250 Gly Asp Thr Be Phe 255 Phe Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Pro Wing Asn Ser 260 265 270 Val Thr Ile Thr Gly Pro Glu Arg Leu Asn Gly Asn Ile Glu Val Asp 275 280 285 Met Gly 290 Glu Ile Ser Asp Thr 295 Phe Met Thr Leu Wing Ala 300 Ile Pro Wing Leu Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305 310 315 320 Lys Glu Be Asp Arg 325 Ile Be Ala Met Glu 330 Thr Asn Leu Arg Thr 335 Leu Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Be 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr L i Asp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu ir Ur uV IhpP Ilteff '.. ' '"" U-395 400 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly 405 410 Ia) Sequence identifier number: SEQ ID No: 24</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 1242</span>II.a) Size: 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: DNA</span>II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace4)</span>III.c) Other information: grg23 (ace4)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a) Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 24</span>IV) Sequence: SEQ ID NO. 24</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15	10	15</span>atg gaa act gat cgc ctt gtg until cca gga tcg aaa acts till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcc gac ggt gac gat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asp Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcc gac ggt gac gat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc aac ctc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc aac ctc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro Asn Leu Asp Ala Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly. Gln</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly. Gln</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">85	90	95</span>85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc ttc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Phe Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc ttc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Phe Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc gtg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 3 84 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc gtg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 3 84 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat age cag age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175     ccc gtg Tca cag ccc tac etc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>atg gcc gcc ccg tac ggg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Pro Wing Ala Pro Tyr Arg Wing Gln Gly Leu Arg Val Ile Pro Asn 165 170 175 ccc gtg Tca cag ccc tac atg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Read Thr Met Thr Read Met Arg Met Met Arg Asp 180 185 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc att gag aec age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Ile Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ttc ggc att gag aec ac gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Ile Glu Thr Be Thr Asp Gly Wing Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225	230	235	240</span>gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg cgc ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Arg Phe Glu 225 230 235 240 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg etc ggt gcg gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260	265	270</span>aat gta ctt ggg cgg etc ggt gcg gag gtc cac tgg gea tcc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata cgg gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata cgg gga ccg gaa agg ctg acc ggc gac att gaa gtg gat 864 Val Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa age aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Ser Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc until tca gcg atg gaa age aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Be Ala Met Glu Ser Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gae ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gae ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410</span>gga cgc ct ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405 410</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1242     I.a) Nmero identificador da seqncia: SEQ ID No: 25</span>1242 I.a) Sequence identifier number: SEQ ID No: 25</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(ace4)</span>III.c) Other information: grg23 (ace4)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 25</span>IV) Sequence: SEQ ID NO. 25</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Glu	Thr	Asp	Arg	Leu	Val	Ile	Pro	Gly	Ser Lys	Ser	Ile	Thr	Asn 1				5					10				15	 Arg	Ala	Leu	Leu	Leu	Ala	Ala	Ala	Ala	Lys	Gly Thr	Ser	Val	Leu	Val 			20					25				30		 Arg	Pro	Leu	Val	Ser	Ala Asp Thr			Ser	Ala	Phe Lys	Thr	Ala	Ile	Gln 		35					40				45			 Ala	Leu	Gly Ala		Asn	Val	Ser	Ala	Asp	Gly	Asp Asp	Trp	Val	Val	Glu 	50					55				60				 Gly Leu		Gly Gln		Ala	Pro	Asn	Leu	Asp	Ala	Asp Ile	Trp	Cys	Glu	Asp 65					70					75				80 Ala	Gly	Thr	Val	Ala	Arg	Phe	Leu	Pro	Pro	Phe Val	Ala	Ala	Gly	Gln 				85					90				95	 Gly	Lys	Phe	Thr	Phe	Asp Gly		Ser	Glu	Gln	Leu Arg	Arg	Arg	Pro	Leu 			100					105				110		 Arg	Pro	Val	Val	Asp	Gly	Ile	Arg	His	Leu	Gly Ala	Arg	Val	Ser	Ser 		115					120				125			 Glu	Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala	Ser	Gly Leu	Ala	Gly	Gly	Glu 	130					135				140				 Tyr	Glu	Ile	Glu	Ala	His	Gln	Ser	Ser	Gln	Phe Ala	Ser	Gly	Leu	Ile 145					150					155				160 Met	Ala	Ala	Pro	Tyr	Ala	Arg	Gln	Gly	Leu	Arg Val	Arg	Ile	Pro	Asn 				165					170				175	 Pro	Val	Ser	Gln	Pro	Tyr	Leu	Thr	Met	Thr	Leu Arg	Met	Met	Arg	Asp 			180					185				190		 Phe	Gly	Ile	Glu	Thr	Ser	Thr	Asp	Gly	Ala	Thr Val	Ser	Val	Pro	Pro 		195					200				205			 Gly Arg		Tyr Thr		Ala	Arg Arg		Tyr	Glu	Ile	Glu Pro	Asp	Ala	Ser	Thr 	210					215				220				 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser Gly	Arg	Arg	Phe	Glu 225					230					235				240 Phe	Gln	Gly Leu		Gly	Thr	Asp	Ser	Ile	Gln	Gly Asp	Thr	Ser	Phe	Phe 				245					250				255	 Asn	Val	Leu Gly		Arg	Leu Gly Ala			Glu	Val	His Trp	Ala	Ser	Asn	Ser 			260					265				270		 Val	Thr	Ile	Arg	Gly	Pro Glu Arg			Leu	Thr	Gly Asp	Ile	Glu	Val	Asp 		275					280				285			 Met	Gly	Glu	Ile	Ser	Asp	Thr	Phe	Met	Thr	Leu Ala	Ala	Ile	Ala	Pro 	290					2 95				300				 Leu	Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr	Asn	Ile Gly	His	Ala	Arg	Leu 305					310					315				320 Lys	Glu	Ser	Asp	Arg	Ile	Ser	Ala	Met	Glu	Ser Asn	Leu	Arg	Thr	Leu 				325					330				335	 Gly Val		Gln	Thr	Asp	Val	Gly His		Asp	Trp	Met Arg	Ile	Tyr	Pro	Ser 			340					345				350		 Thr	Pro	His	Gly	Gly	Arg	Val	Asn	Cys	His	Arg Asp	His	Arg	Ile	Ala 		355					360				365			 Met	Ala	Phe	Ser	Ile	Leu	Gly	Leu	Arg	Val	Asp Gly	Ile	Thr	Leu	Asp 	370					375				380				 Asp	Pro	Gln	Cys	Val	Gly Lys		Thr	Phe	Pro	Gly Phe	Phe	Asp	Tyr	Leu 385					390					395				400 Gly Arg		Leu	Phe	Pro	Glu	Lys	Ala	Leu	Thr	Leu Pro	Gly     I.a) Nmero identificador da seqncia: SEQ ID No: 26</span>Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Leu Wing Wing Wing Lys Gly Thr As Val Leu Val 20 25 30 Arg Pro Leu Val Ser Asp Thr Wing Al Phe Lys Thr Wing Ile Gln 35 40 45 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asp Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro Asn Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95 Gly Lys Phe Thr Phe Asp Gly Be Glu Gln Leu Arg Arg Pro Leu 100 105 110 Arg Pro Val Val Asp Gly Ile Arg His Leu Gly Wing Val Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Leu Arg Met Met Arg Asp 180 185 190 Phe Gly Ile Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Ala Wing Ala Wing Ala Val Ser Gly Arg Arg Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Ile Gln Gly Asp Thr Be Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Ser Asn Ser 260 265 270 Val Thr Ile Arg Gly Pro Glu Arg Leu Thr Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Being Asp Thr Phe Met Thr Leu Wing Ile Wing Pro 290 2 95 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Being Asp Arg Ile Being Wing Met Glu Being Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His rg Ile Wing 355 360 365 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Leys Thr Phe Pro Gly Phe Ashe Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly Ia) Sequence identifier number: SEQ ID No: 26</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 1244</span>II.a) Size: 1244</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Il.b) tipo: DNA</span>Il.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.B20) I II.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (L3P1.B20) I II.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (I)... (1242)</span>III.b) Location: (I) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 26</span>IV) Sequence: SEQ ID NO. 26</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1   5	10	15</span>atg gaa act gat cgc ctt gtg till cca gga tcg aaa age till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc etc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>gcc etc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac etc gac gcc gac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala Asp Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac etc gac gcc gac up to tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 2 88 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 2 88 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ttg cgg cgg cgc ccg ctt 3 36 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ttg cgg cgg cgc ccg ctt 3 36 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtt gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc ctg gtt gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat age cag age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp     180         185          190</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc ctt gag acc age acc gac gga gcc acc gtc age ate cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Ile Pro Pro 195	200	205</span>ttc ggc ctt gag acc ac acc gac gga gcc acc gtc ac until cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Val Val Ile Pro Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230 	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 10 08 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc until tca gcg atg gaa acc aac ctg cgc acg ctc 10 08 Lys Glu Ser Asp Arg Ile Ser Asa Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tc ccc gaa aag gcg ctc acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No:</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b) tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.B20)</span>III.c) Other information: grg23 (L3P1.B20)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia	: SEQ		ID	NO.	27 							 Met	Glu	Thr	Asp	Arg	Leu	Val	Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1				5					10					15	 Arg	Ala	Leu	Leu	Leu	Ala	Ala	Ala	Ala	Lys	Gly	Thr	Ser	Val	Leu	Val 			20					25					30		 Arg	Pro	Leu	Val	Ser	Ala	Asp	Thr	Ser	Ala	Phe	Lys	Thr	Ala	Ile	Gln 		35					40					45			 Ala	Leu	Gly	Ala	Asn	Val	Ser	Ala	Asp	Gly	Asp	Asn	Trp	Val	Val	Glu 	50					55					60				 Gly	Leu	Gly	Gln	Ala	Pro	His	Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu	Asp 65					70					75					80 Ala	Gly	Thr	Val	Ala	Arg	Phe	Leu	Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 				85					90					95	 Gly	Lys	Phe	Thr	Val	Asp	Gly	Ser	Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 			100					105					110		 Arg	Pro	Leu	Val	Asp	Gly	Ile	Arg	His	Leu	Gly	Ala	Arg	Val	Ser	Ser 		115					120					125			 Glu	Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala	Gly	Gly	Glu 	130					135					140				 Tyr	Glu	Ile	Glu	Ala	Hls	Gln	Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145					150					155					160 Met	Ala	Ala	Pro	Tyr	Ala	Arg	Gln	Gly	Leu	Arg	Val	Arg	Ile	Pro	Asn 				165					170					175	 Pro	Val	Ser	Gln	Pro	Tyr	Leu	Thr	Met	Thr	Leu	Arg	Met	Met	Arg	Asp 			180					185					190		 Phe	Gly	Leu	Glu	Thr	Ser	Thr	Asp	Gly	Ala	Thr	Val	Ser	Ile	Pro	Pro 		195					200					205			 Gly	Arg	Tyr	Thr	Ala	Arg	Arg	Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 	210					215					220				 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225					230					235					240 Phe	Gln	Gly	Leu	Gly	Thr	Asp	Ser	Ile	Gln	Gly	Asp	Thr	Ser	Phe	Phe 				245					250					255	 Asn	Val	Leu	Gly	Arg	Leu	Gly	Ala	Glu	Val	His	Trp	Ala	Pro	Asn	Ser 			260					265					270		 Val	Thr	Ile	Ser	Gly	Pro	Glu	Arg	Leu	Asn	Gly	Asp	Ile	Glu	Val	Asp 		275					280					285			 Met	Gly	Glu	Ile	Ser	Asp	Thr	Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 	290					295					300				 Leu	Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305					310					315					320 Lys	Glu	Ser	Asp	Arg	Ile	Ser	Ala	Met	Glu	Thr	Asn	Leu	Arg	Thr	Leu 				325					330					335	 Gly	Val	Gln	Thr	Asp	Val	Gly	His	Asp	Trp	Met	Arg	Ile	Tyr	Pro	Ser 			340					345					350		 Thr	Pro	His	Gly	Gly	Arg	Val	Asn	Cys	His	Arg	Asp	His	Arg	Ile	Ala 		355					360					365			 Met	Ala	Phe	Ser	Ile	Leu	Gly	Leu	Arg	Val	Asp	Gly	Ile	Thr	Leu	Asp 	370					375					380				 Asp	Pro	Gln	Cys	Val	Gly	Lys	Thr	Phe	Pro	Gly	Phe	Phe	Asp	Tyr	Leu 385					390					395					400 Gly	Arg	Leu	Phe	Pro	Glu	Lys	Ala	Leu	Thr	Leu	Pro	Gly			 				405					410     I.a) Nmero identificador da seqncia: SEQ ID No: 28</span>IV) Sequence: SEQ ID NO. 27 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Be Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Read Wing Ala Wing Wing Lys Gly Thr Be Val Leu Val 20 25 30 Arg Pro Leu Val Ser Wing Asp Thr Be Ala Phe Lys Thr Wing Ile Gln 35 40 45 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Be Glu Glu Leu Arg Arg Pro Leu 100 105 110 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing Hls Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Read Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val Ser Ile Pro Pro 195 200 205 Gly Arg Tyr Thr Ala Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210 215 220 Wing Be Tyr Phe Wing Wing Wing Be Wing Val Be Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly Arg Read Le Gly Ala Glu Val His Trp Wing Pro Asn Ser 260 265 270 Val Thr Ile Be Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Be Asp Thr Phe Met Thr Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Be Met Wing Glu Thr Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350 Thr His Gly Gly Arg Val Asn Cys Hi s Arg Asp His Arg Ile Wing 355 360 365 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 Ia) Sequence identifier number: SEQ ID No: 28</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 12 4 4 II.b) tipo: DNA</span>II.a) Size: 12 4 4 II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.B3) III.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (L3P1.B3) III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1) ... (1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 28</span>IV) Sequence: SEQ ID NO. 28</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15	10	15</span>atg gaa act gat cgc ctt gtg until cca gga tcg aaa acts till acc aac 48 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 15 10 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg gct ttg Ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Ala Leu Leu Leu Ala Ala Ala Ala Lys Gly Thr Ser Val Leu Val 20	25	30</span>cgg gct ttg Ctt ttg gct gcc gea gcg aag ggc acg tcg gtc ctg gtg 96 Arg Wing Leu Wing Leu Wing Wing Wing Wing Lys Gly Thr Ser Val Leu Val 20 25 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea ate cag 144 Arg Pro Leu Val Ser Ala Asp Thr Ser Ala Phe Lys Thr Ala Ile Gln 35	40	45</span>aga cca ttg gtc age gcc gat acc tca gea ttc aaa act gea till cag 144 Arg Pro Read Val Ser Wing Asp Thr Ser Wing Phe Lys Thr Wing Ile Gln 35 40 45</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Ala Leu Gly Ala Asn Val Ser Ala Asp Gly Asp Asn Trp Val Val Glu 50	55	60</span>gcc ctc ggt gcc aac gtc tca gcc gac ggt gac aat tgg gtc gtt gaa 192 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggc ctg ggt cag gea ccc cac ctc gac gcc cac ate tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala His Ile Trp Cys Glu Asp 65	70	75	80</span>ggc ctg ggt cag gea ccc cac ctc gac gcc cac up tgg tgc gag gac 240 Gly Leu Gly Gln Ala Pro His Leu Asp Ala His Ile Trp Cys Glu Asp 65 70 75 80</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gcc gea ggt cag 288 Ala Gly Thr Val Ala Arg Phe Leu Pro Pro Phe Val Ala Ala Gly Gln 85	90	95</span>gea ggt act gtg gcc cgg ttc ctc cct cca ttc gta gea gea ggt cag 288 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100	105	110</span>ggg aag ttc acc gtc gac gga tca gag cag ctg cgg cgg cgc ccg ctt 336 Gly Lys Phe Thr Val Asp Gly Ser Glu Gln Leu Arg Arg Arg Pro Leu 100 105 110</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">cgg ccc ctg gtc gac ggc ate cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115	120	125</span>cgg ccc ctg gtc gac ggc up to cgc cac ctg ggc gcc cgc gtc tcc tcc 384 Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gag cag ctg ccc ctt aca att gaa gcg age ggg ctg gea ggc ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Ala Ser Gly Leu Ala Gly Gly Glu 130	135	140</span>gag cag ctg ccc act att gaa gcg age ggg ctg gea ggg ggg gag 432 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tac gaa att gaa gcc cat cag age age cag ttc gcc tcc ggc ctg ate 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Ala Ser Gly Leu Ile 145	150	155	160</span>tac gaa att gaa gcc cat age cag age cag ttc gcc tcc ggc ctg up to 480 Tyr Glu Ile Glu Ala His Gln Ser Ser Gln Phe Al Ser Ser Gly Leu Ile 145 150 155 160 160</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Ala Ala Pro Tyr Ala Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165	170	175</span>atg gcc gcc ccg tac gcg aga caa ggc ctg cgt gtg cgg ata cca aat 528 Met Wing Pro Wing Tyr Arg Wing Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190     ttc 'ggC "ctt "gag "acc age acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro 195	200	205</span>ccc gtg tca cag ccc tac ctc acg atg aca ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190 ttc 'ggC "ctt" gag "acc acc acc gac gga gcc acc gtc age gtc cct cca 624 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Ser Val Pro 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat aaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Lys Xle Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat aaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Lys Xle Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc tet ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc acc ata tet gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga until tac ccc tet 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cga gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cga gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt ' 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt '1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242</span>gga cgc ct tc ccc gaa aag gcg ctc acg ctc ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410     I.a)	Nmero identificador da seqncia: SEQ ID No: 2</span>Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410 I.a) Sequence identifier number: SEQ ID No: 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413 II.b) tipo: PRT</span>II.a) Size: 413 II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.B3)</span>III.c) Other information: grg23 (L3P1.B3)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia:			SEQ ID NO.		29							 Met Glu	Thr	Asp Arg		Leu Val Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn Z			5			10					15	 Arg Ala	Leu	Leu 20	Leu	Ala Ala Ala	Ala 25	Lys	Gly	Thr	Ser	Val 30	Leu	Val Arg Pro	Leu 35	Val	Ser	Ala Asp Thr 40	Ser	Ala	Phe	Lys	Thr 45	Ala	Ile	Gln Ala Leu Gly		Ala	Asn	Val Ser Ala	Asp	Gly Asp		Asn	Trp	Val	Val	Glu 50				55				60				 Gly Leu Gly		Gln	Ala	Pro His Leu	Asp	Ala	His	Ile	Trp	Cys	Glu	Asp 65				70			75					80 Ala Gly Thr		Val	Ala	Arg Phe Leu	Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 			85			90					95	 Gly Lys	Phe	Thr 100	Val	Asp Gly Ser	Glu 105	Gln	Leu	Arg	Arg	Arg 110	Pro	Leu Arg Pro	Leu	Val	Asp	Gly Ile Arg	His	Leu Gly		Ala	Arg	Val	Ser	Ser 	115			120					125			 Glu Gln	Leu	Pro	Leu	Thr Ile Glu	Ala	Ser Gly		Leu	Ala	Gly	Gly	Glu 130				135				14 0				 Tyr Glu	Ile	Glu	Ala	His Gln Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145				150			155					160 Met Ala	Ala	Pro	Tyr 165	Ala Arg Gln	Gly	Leu 170	Arg	Val	Arg	Ile	Pro 175	Asn Pro Val	Ser	Gln 180	Pro	Tyr Leu Thr	Met 185	Thr	Leu	Arg	Met	Met 190	Arg	Asp Phe Gly	Leu 195	Glu	Thr	Ser Thr Asp 200	Gly	Ala	Thr	Val	Ser 205	Val	Pro	Pro Gly Arg Tyr		Thr	Ala	Arg Arg Tyr	Lys	Ile	Glu	Pro	Asp	Ala	Ser	Thr 210				215				220				 Ala Ser	Tyr	Phe	Ala	Ala Ala Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225				230			235					240 Phe Gln	Gly	Leu Gly		Thr Asp Ser	Ile	Gln Gly		Asp	Thr	Ser	Phe	Phe 			245			250					255	 Asn Val	Leu	Gly Arg		Leu Gly Ala	Glu	Val	His	Trp	Ala	Pro	Asn	Ser 		260			265					270		 Val Thr	Xle	Ser Gly		Pro Glu Arg	Leu	Asn	Gly	Asp	Ile	Glu	Val	Asp 	275			280					285			 Met Gly Glu		Ile	Ser	Asp Thr Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 290				295				300				 Leu Ala Asp		Gly	Pro	Ile Thr Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305				310			315					320 Lys Glu	Ser	Asp Arg		Ile Ser Ala	Met	Glu	Thr	Asn	Leu	Arg	Thr	Leu 			325			330					335	 Gly Val	Gln	Thr Asp		Val Gly His	Asp	Trp	Met	Arg	Ile	Tyr	Pro	Ser 		340			345					350		 Thr Pro	His	Gly Gly		Arg Val Asn	Cys	His	Arg	Asp	His	Arg	Ile	Ala 	355			360					365			 Met Ala	Phe	Ser	Ile	Leu Gly Leu	Arg	Val	Asp	Gly	Ile	Thr	Leu	Asp 370				375				380				 Asp Pro	Gln	Cys	Val	Gly Lys Thr	Phe	Pro Gly		Phe	Phe	Asp	Tyr	Leu 385				390			395					400 Gly Arg	Leu	Phe	Pro 405	Glu Lys Ala	Leu	Thr 410	Leu	Pro	Gly     I.a)	Nmero identificador da seqncia: SEQ ID No: 30</span>IV) Sequence: SEQ ID NO. 29 Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn Z 5 10 15 Arg Wing Leu Read Le 20 Wing Ala Wing Wing 25 Lys Gly Thr Ser Val 30 Leu Val Arg Pro Leu 35 Val Ser Asp Thr 40 Ser Wing Phe Lys Thr 45 Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing His Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Ala Gly Gln 85 90 95 Gly Lys Phe Thr 100 Val Asp Gly Ser Glu 105 Gln Leu Arg Arg Arg 110 Pro Leu Arg Pro Leu Val Asp Gly Ile Arg His Leu Gly Ala Arg Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 14 0 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Ala Wing Pro Tyr 165 Wing Arg Gln Gly Leu 170 Arg Val Arg Ile Pro 175 Asn Pro Val Ser Gln 180 Pro Tyr Leu Thr Met 185 Thr Leu Arg Met Met 190 Arg Asp Phe Gly Leu 1 95 Glu Thr Be Thr Asp 200 Gly Wing Thr Val Ser 205 Val Pro Pro Gly Arg Tyr Thr Wing Arg Arg Tyr Lys Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Wing Wing Be Wing Val Be Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Be Phe Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Wing Glu Val His Trp Pro Wing Asn Ser 260 265 270 Val Thr Xle Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Being Asp Thr Phe Met Thr Leu Wing Wing Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Wing Ile Thr Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Be Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Be 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu A sp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro 405 Glu Lys Wing Leu Thr 410 Leu Pro Gly Ia) Sequence identifier number: SEQ ID No: 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho:1244 II.b) tipo: DNA</span>II.a) Size: 1244 II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23 (L3P1.F18) III.a) Nome/Legenda: CDS</span>III.c) Other information: grg23 (L3P1.F18) III.a) Name / Legend: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1)...(1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV)	Seqncia: SEQ ID NO. 30</span>IV) Sequence: SEQ ID NO. 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gaa act gat cgc ctt gtg ate cca gga tcg aaa age ate ace aac 48</span>atg gaa act gat cgc ctt gtg till cca gga tcg aaa act till ace aac 48</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met 1	Glu	Thr	Asp	Arg 5	Leu	Val	Ile	Pro Gly 10		Ser	Lys	Ser	Ile	Thr 15	Asn	 cgg Arg	gct Ala	ttg Leu	ctt Leu 20	ttg Leu	gct Ala	gcc Ala	gca Ala	gcg Ala 25	aag Lys	ggc acg Gly Thr		tcg Ser	gtc Val 30	ctg Leu	gtg Val	96 aga Arg	cca Pro	ttg Leu 35	gtc Val	age Ser	gcc Ala	gat Asp	acc Thr 40	tca Ser	gca Ala	ttc Phe	aaa Lys	act Thr 45	gca Ala	ate Ile	cag Gln	144 gce Ala	ctc Leu 50	ggt Gly	gcc Ala	aac Asn	gtc Val	tca Ser 55	gcc Ala	gac ggt Asp Gly		gac Asp	aat Asn 60	tgg gtc Trp Val		gtt Val	gaa Glu	192 ggc Gly 65	ctg ggt Leu Gly		cag Gln	gca Ala	ccc Pro 70	cac His	ctc Leu	gac Asp	gcc Ala	gac Asp 75	ate Ile	tgg Trp	tgc Cys	gag Glu	gac Asp 80	240 gca Ala	ggt act Gly Thr		gtg Val	gcc Ala 85	cgg Arg	ttc Phe	ctc Leu	cct Pro	cca Pro 90	ttc Phe	gta Val	gcc Ala	gca Ala	ggt  Gly 95	cag Gln	288 ggg  Gly	aag. Lys	ttc Phe	acc Thr 100	gtc Val	gac Asp	gga Gly	tca Ser	gag Glu 105	cag Gln	ctg cgg Leu Arg		cgg cgc Arg Arg 110		ccg Pro	ctt Leu	336 cgg Arg	ccc Pro	ctg Leu 115	gtc Val	gac Asp	ggc Gly	ate Ile	cgc Arg 120	cac His	ctg Leu	ggc gcc Gly Ala		cgc Arg 125	gtc Val	tcc Ser	tcc Ser	384 gag Glu	cag Gln 130	ctg Leu	ccc Pro	ctt Leu	aca Thr	att Ile 135	gaa Glu	gcg  Ala	age Ser	ggg ctg Gly Leu 140		gca ggc Ala Gly		ggg  Gly	gag Glu	432 tac Tyr 145	gaa Glu	att Ile	gaa Glu	gcc Ala	cat His 150	cag Gln	age Ser	age Ser	cag Gln	ttc Phe 155	gcc Ala	tcc ggc Ser Gly		ctg Leu	ate Ile 160	480 atg Met	gcc Ala	gcc Ala	ccg Pro	tac Tyr 165	gcg Ala	aga Arg	caa Gln	ggc ctg Gly Leu 170		cgt Arg	gtg Val	cgg Arg	ata Ile	cca Pro 175	aat Asn	528</span>Met 1 Glu Thr Asp Arg 5 Leu Val Ile Pro Gly 10 Ser Lys Ser Ile Thr 15 Asn cgg Arg gct Ala ttg Leu ctt Leu 20 ttg Leu gct Ala gcc Ala gcg Ala 25 aag Lys ggc acg Gly Thr Tcg Ser gtc Val 30 ctg Leu gtg Val 96 aga Arg cca Pro ttg Leu 35 gtc Val age Ser gcc Ala gat Asp acc Thr 40 tca Ser gca Ala ttc Phe aaa Lys act Thr 45 gca Ala until Ile cag Gln 144 gce Ala ctc Leu 50 ggt Gly gcc Ala aac Asn gtc Val tca Ser 55 gcc Ala gac ggt Asp Gly gac Asp aat Asn 60 tgg gtc Trp Val gtt Val gaa Glu 192 ggc Gly 65 ctg ggt Leu Gly cag Gln gca Ala ccc Pro 70 cac His ctc Leu gac Asp gcc Ala gac Asp 75 up to Ile tgg Trp tgc Cys gag Glu gac Asp 80 240 gca Wing ggt act Gly Thr Val gcc Wing 85 cgg Arg ttc Phe ctc Leu cct Pro cca Pro 90 ttc Phe gta Val gcc Wing ggt Gly 95 cag Gln 288 ggg Gly aag. Lys ttc Phe acc Thr 100 gtc Val gac Asp gga Gly tca Being gag Glu 105 cag Gln ctg cgg Leu Arg cgg cgc Arg Arg 110 ccg Pro ctt Leu 336 cgg Arg ccc Pro ctg Leu 115 gtc Val gac Asp ggc Gly to Ile cgc Arg 120 cac His ctg Leu ggc gcc Gly Ala cgc Arg 125 gtc Val tcc Ser tcc Ser 384 gag Glu cag Gln 130 ctg Leu ccc Pro ctt Leu aca Thr att Ile 135 gaa Glu gcg Ala Age Ser ggg ctg Gly Leu 140 gca ggc Ala Gly ggg Gly gag Glu 432 tac Tyr 145 gaa Glu att Ile gaa Glu gcc Wing cat His 150 cag Gln age Ser age Ser cag Gln ttc Phe 155 gcc Wing tcc ggc Ser Gly ctg Leu until Ile 160 480 atg Met gcc Wing gcc Ala ccg Pro tac Tyr 165 gcg Wing aga Arg caa Gln ggc ctg Gly Leu 170 cgt Arg gtg Val cgg Arg ata Ile cca Pro 175 aat Asn 528</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ccc gtg tca cag ccc tac ctc acg atg aca Ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyx Leu Thr Met Thr Leu Arg Met Met Arg Asp 180	185	190</span>ccc gtg tca cag ccc tac ctc acg atg aca Ctg cgg atg atg agg gac 576 Pro Val Ser Gln Pro Tyx Leu Thr Met Thr Leu Arg Met Met Arg Asp 180 185 190</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttc ggc ctt gag acc age acc gac gga gce acc gtc age gtc cct cca Phe Gly Leu Glu Thr Ser Thr Asp Gly Ala Thr Val Ser Val Pro Pro</span>ttc ggc ctt gag acc acc gac gga gce acc gtc age gtc cct cca Phe Gly Leu Glu Thr Be Thr Asp Gly Ala Thr Val Ser Val Pro Pro</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">624     195               200             205</span>624 195 200 205</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg cgc tac aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tct ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc ttc ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttc ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260	265	270</span>at gta ctt ggg cgg ctc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro 260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc ate ata tct gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Ile Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275	280	285</span>gtc till till tct gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Ile Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac gtc gga cac gac tgg atg aga ate tac ccc tct 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac gtc gga cac gac tgg atg aga till tac ccc tct 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc cte gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc cte gac 1152 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag	1242 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410</span>gga cgc ct ttc ccc gaa aag gcg ctt acg ctc ccc ggc tag 1242 Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405 410</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gg                                                               1244     I.a)	Nmero identificador da seqncia: SEQ ID No: 31</span>gg 1244 I.a) Sequence identifier number: SEQ ID No: 31</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.F18)</span>III.c) Other information: grg23 (L3P1.F18)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 31</span>IV) Sequence: SEQ ID NO. 31</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Met	Glu	Thr	Asp Arg		Leu	Val	Ile Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1				5				10					15	 Arg	Ala	Leu	Leu	Leu	Ala	Ala	Ala Ala	Lys	Gly	Thr	Ser	Val	Leu	Val 			20				25					30		 Arg	Pro	Leu	Val	Ser	Ala	Asp	Thr Ser	Ala	Phe	Lys	Thr	Ala	Ile	Gln 		35					40				45			 Ala	Leu	Gly	Ala	Asn	Val	Ser	Ala Asp	Gly Asp		Asn	Trp	Val	Val	Glu 	50					55				60				 Gly	Leu	Gly	Gln	Ala	Pro	His	Leu Asp	Ala Asp		Ile	Trp	Cys	Glu	Asp 65					70				75					80 Ala	Gly	Thr	Val	Ala	Arg	Phe	Leu Pro	Pro	Phe	Val	Ala	Ala	Gly	Gln 				85				90					95	 Gly Lys		Phe	Thr	Val	Asp	Gly	Ser Glu	Gln	Leu	Arg	Arg	Arg	Pro	Leu 			100				105					110		 Arg	Pro	Leu	Val	Asp	Gly	Ile	Arg His	Leu	Gly	Ala	Arg	Val	Ser	Ser 		115					120				125			 Glu	Gln	Leu	Pro	Leu	Thr	Ile	Glu Ala	Ser	Gly	Leu	Ala	Gly	Gly	Glu 	130					135				140				 Tyr	Glu	Ile	Glu	Ala	His	Gln	Ser Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145					150				155					160 Met	Ala	Ala	Pro	Tyr	Ala	Arg	Gln Gly	Leu	Arg	Val	Arg	Ile	Pro	Asn 				165				170					175	 Pro	Val	Ser	Gln	Pro	Tyr	Leu	Thr Met	Thr	Leu	Arg	Met	Met	Arg	Asp 			180				185					190		 Phe	Gly	Leu	Glu	Thr	Ser	Thr	Asp Gly	Ala	Thr	Val	Ser	Val	Pro	Pro 		195					200				205			 Gly Arg		Tyr	Thr	Ala	Arg	Arg	Tyr Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 	210					215				220				 Ala	Ser	Tyr	Phe	Ala	Ala	Ala	Ser Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225					230				235					240 Phe	Gln	Gly	Leu	Gly	Thr	Asp	Ser Ile	Gln Gly		Asp	Thr	Ser	Phe	Phe 				245				250					255	 Asn	Val	Leu	Gly Arg		Leu	Gly	Ala Glu	Val	His	Trp	Ala	Pro	Asn	Ser 			260				265					270		 Val	Ile	Ile	Ser Gly		Pro	Glu	Arg Leu	Asn	Gly	Asp	Ile	Glu	Val	Asp 		275					280				285			 Met	Gly	Glu	Ile	Ser	Asp	Thr	Phe Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 	290					295				300				 Leu	Ala	Asp	Gly	Pro	Ile	Thr	Ile Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305					310				315					320 Lys	Glu	Ser	Asp	Arg	Ile	Ser	Ala Met	Glu	Thr	Asn	Leu	Arg	Thr	Leu 				325				330					335	 Gly Val		Gln	Thr	Asp	Val	Gly	His Asp	Trp Met		Arg	Ile	Tyr	Pro	Ser 			340				345					350		 Thr	Pro	His	Gly Gly		Arg	Val	Asn Cys	His	Arg	Asp	His	Arg	Ile	Ala 		355					360				365			 Met	Ala	Phe	Ser	Ile	Leu	Gly	Leu Arg	Val	Asp	Gly	Ile	Thr	Leu	Asp 	370					375				380				 Asp	Pro	Gln	Cys	Val	Gly	Lys	Thr Phe	Pro Gly		Phe	Phe	Asp	Tyr	Leu 385					390				395					400 Gly Arg		Leu	Phe	Pro	Glu	Lys	Ala Leu	Thr	Leu	Pro	Gly			 				405				410     I.a) Nmero identificador da seqncia: SEQ ID No:</span>Met Glu Thr Asp Arg Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu Leu Wing Wing Wing Lys Gly Thr As Val Leu Val 20 25 30 Arg Pro Leu Val Ser Asp Thr Wing Al Phe Lys Thr Wing Ile Gln 35 40 45 Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Asn Trp Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing Arg Phe Leu Pro Pro Phe Val Wing Wing Gly Gln 85 90 95 Gly Lys Phe Thr Val Asp Gly Be Glu Glu Leu Arg Arg Pro Leu 100 105 110 Arg Pro Read Val Asp Gly Ile Arg His Leu Gly Wing Val Val Ser Ser 115 120 125 Glu Gln Leu Pro Leu Thr Ile Glu Wing Ser Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Ser Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Ala Pro Tyr Wing Arg Gln Gly Leu Arg Val Arg Ile Pro Asn 165 170 175 Pro Val Ser Gln Pro Tyr Leu Thr Met Thr L I Arg Met Met Arg Asp 180 185 190 Phe Gly Leu Glu Thr Be Thr Asp Gly Wing Thr Val Be Val Pro Pro 195 200 205 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Be Thr 210 215 220 Wing Be Tyr Phe Ala Wing Ala Wing Be Val Val Gly Arg Be Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly Thr Asp Be Ile Gln Gly Asp Thr Be Phe 245 250 255 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser 260 265 270 Val Ile Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Read Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg Ile Being Wing Met Glu Thr Asn Leu Arg Thr Leu 325 330 335 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340 345 350 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365 Met Wing Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Leys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly 405 410 Ia) Sequence identifier number: SEQ ID No:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II) Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a) tamanho: 1244</span>II.a) Size: 1244</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: DNA</span>II.b) Type: DNA</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c) organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III) Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c) Outras, informaes: grg23(L3P1.023)</span>III.c) Other information: grg23 (L3P1.023)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.a) Nome/Legenda: CDS</span>III.a) Name / Caption: CDS</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.b) Localizao: (1) ... (1242)</span>III.b) Location: (1) ... (1242)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia: SEQ ID NO. 32</span>IV) Sequence: SEQ ID NO. 32</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggg~cgc~tc' aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Ala Arg Arg Tyr Glu Ile Glu Pro Asp Ala Ser Thr 210	215	220</span>ggg ~ cgc ~ t 'aca gcc cgg cgg tat gaa ata gaa ccg gat gcg tca act 672 Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Ser Thr 210 215 220</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gcg tcg tac ttc gcc gcc gct tcc gcc gtc tct ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225	230	235	240</span>gcg tcg tac tcc gcc gcc gcc tcc gcc gcc ttc ggc agg age ttc gaa 720 Ala Ser Tyr Phe Ala Ala Ser Ala Val Ser Gly Arg Ser Phe Glu 225 230 235 240</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttt caa ggc ctt ggc aca gac age ate caa ggc gac acg tca ttt ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245	250	255</span>ttt caa ggc ctt ggc aca gac age till caa ggc gac acg tca ttt ttc 768 Phe Gln Gly Leu Gly Thr Asp Ser Ile Gln Gly Asp Thr Ser Phe Phe 245 250 255</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aat gta ctt ggg cgg etc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser</span>aat gta ctt ggg cgg etc ggt gcg gag gtc cac tgg gea ccc aac tcg 816 Asn Val Leu Gly Arg Leu Gly Ala Glu Val His Trp Ala Pro Asn Ser</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">260	265	270</span>260 265 270</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gtc acc ata tct gga ccg gaa agg ctg aac ggc gac att	gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>gtc acc ata tct gga ccg gaa agg ctg aac ggc gac att gaa gtg gat 864 Val Thr Ile Ser Gly Pro Glu Arg Leu Asn Gly Asp Ile Glu Val Asp 275 280 285</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ala Ile Ala Pro 290	295	300</span>atg ggc gag att tcg gac acc ttc atg aca ctc gcg gcg att gcc cct 912 Met Gly Glu Ile Ser Asp Thr Phe Met Thr Leu Ala Ile Ala Pro 290 295 300</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ttg gcc gat gga ccc ate acg ata acc aac att ggt cat gea cgg ttg 960 Leu Ala Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Ala Arg Leu 305	310	315	320</span>ttg gcc gat gga ccc till acg ata acc aac att ggt cat gea cgg ttg 960 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asn Ile Gly His Wing Arg Leu 305 310 315 320</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">aag gaa tcc gac cgc ate tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325	330	335</span>aag gaa tcc gac cgc up to tca gcg atg gaa acc aac ctg cgc acg ctc 1008 Lys Glu Ser Asp Arg Ile Ser Ala Met Glu Thr Asn Leu Arg Thr Leu 325 330 335</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ggt gta caa acc gac' gtc gga cac gac tgg atg aga ate tac ccc tct 1056 Gly Val Gln Thr Asp Val Gly His Asp Trp Met Arg Ile Tyr Pro Ser 340	345	350</span>ggt gta caa acc gac 'gtc gga cac gac tgg atg aga until tac ccc tct 1056 Gly Val Gln Thr Asp</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg ate gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Ala 355	360	365</span>acc ccg cac ggc ggt aga gtg aat tgc cac cgg gac cac agg till gct 1104 Thr Pro His Gly Gly Arg Val Asn Cys His Arg Asp His Arg Ile Wing 355 360 365</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">atg gcg ttt tca ate ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370	375	380</span>atg gcg ttt tca to ctg gga ctg aga gtg gac ggg att acc ctc gac 1152 Met Phe Ser Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385	390	395	400</span>gac cct caa tgc gtc ggg aag acc ttt cct ggc ttc ttc gac tac ctt 1200 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Asp Tyr Leu 385 390 395 400</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gga cgc ctt ttc ccc gaa aag gcg ctt acg ctt ccc ggc tag	1242</span>gga cgc ct ttc ccc gaa aag gcg ctt acg ct ccc ggc tag 1242</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gly Arg Leu Phe Pro Glu Lys Ala Leu Thr Leu Pro Gly * 405	410</span>Gly Arg Read Le Phe Pro Glu Lys Wing Leu Thr Leu Pro Gly * 405 410</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">gg	1244     I.a)	Nmero identificador da seqncia: SEQ ID No: 33</span>gg 1244 I.a) Sequence identifier number: SEQ ID No: 33</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II)	Caractersticas da seqncia:</span>II) Sequence Characteristics:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.a)	tamanho: 413</span>II.a) Size: 413</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.b) tipo: PRT</span>II.b) Type: PRT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II.c)	organismo: Seqncia artificial</span>II.c) organism: Artificial sequence</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III)	Caracterstica:</span>III) Characteristic:</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">III.c)	Outras informaes: grg23(L3P1.023)</span>III.c) Other information: grg23 (L3P1.023)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IV) Seqncia:	SEQ ID NO.33 				 Met Glu	Thr	Asp	His	Leu	Val	Ile	Pro	Gly	Ser	Lys	Ser	Ile	Thr	Asn 1			5					10					15	 Arg Ala	Leu	Leu 20	Leu	Ala	Ala	Ala	Ala 25	Lys	Gly	Thr	Ser	Val 30	Leu	Val Arg Pro	Leu 35	Val	Ser	Ala	Asp	Thr 40	Ser	Ala	Phe	Lys	Thr 45	Ala	Ile	Gln Ala Leu	Gly	Ala	Asn	Val	Ser	Ala	Asp	Gly	Asp	Asn	Trp	Val	Val	Glu 50					55					60				 Gly Leu	Gly	Gln	Ala	Pro	His	Leu	Asp	Ala	Asp	Ile	Trp	Cys	Glu	Asp 65				70					75					80 Ala Gly	Thr	Val	Ala 85	Arg	Phe	Leu	Pro	Pro 90	Phe	Val	Ala	Ala	Gly 95	Gln Gly Lys	Phe	Thr 100	Val	Asp	Gly	Ser	Glu 105	Gln	Leu	Arg	Arg	Arg 110	Pro	Leu Arg Pro	Leu 115	Val	Asp	Gly	Ile	Arg 120	His	Leu	Gly	Ala	Arg 125	Val	Ser	Ser Glu Gln	Leu	Pro	Leu	Thr	Ile	Glu	Ala	Ser	Gly	Leu	Ala	Gly	Gly	Glu 130					135					140				 Tyr Glu	Ile	Glu	Ala	His	Gln	Ser	Ser	Gln	Phe	Ala	Ser	Gly	Leu	Ile 145				150					155					160 Met Ala	Ala	Pro	Tyr 165	Ala	Arg	Gln	Gly	Leu 170	Arg	Val	Arg	Ile	Pro 175	Asn Pro Val	Ser	Gln 180	Pro	Tyr	Leu	Thr	Met 185	Thr	Leu	Arg	Met	Met 190	Arg	Asp Phe Gly	Leu 195	Glu	Thr	Ser	Thr	Asp 200	Gly	Ala	Thr	Val	Ser 205	Val	Pro	Pro Gly Arg	Tyr	Thr	Ala	Arg	Arg	Tyr	Glu	Ile	Glu	Pro	Asp	Ala	Ser	Thr 210					215					220				 Ala Ser	Tyr	Phe	Ala	Ala	Ala	Ser	Ala	Val	Ser	Gly	Arg	Ser	Phe	Glu 225				230					235					240 Phe Gln	Gly	Leu	Gly 245	Thr	Asp	Ser	Ile	Gln 250	Gly	Asp	Thr	Ser	Phe 255	Phe Asn Val	Leu	Gly 260	Arg	Leu	Gly	Ala	Glu 265	Val	His	Trp	Ala	Pro 270	Asn	Ser Val Thr	Xle 275	Ser	Gly	Pro	Glu	Arg 280	Leu	Asn	Gly	Asp	Ile 285	Glu	Val	Asp Met Gly	Glu	Ile	Ser	Asp	Thr	Phe	Met	Thr	Leu	Ala	Ala	Ile	Ala	Pro 290					295					300				 Leu Ala	Asp	Gly	Pro	Ile	Thr	Ile	Thr	Asn	Ile	Gly	His	Ala	Arg	Leu 305				310					315					320 Lys Glu	Ser	Asp	Arg 325	Ile	Ser	Ala	Met	Glu 330	Thr	Asn	Leu	Arg	Thr 335	Leu Gly Val	Gln	Thr 340	Asp	Val	Gly	His	Asp 345	Trp	Met	Arg	Ile	Tyr 350	Pro	Ser Thr Pro	His 355	Gly	Gly	Arg	Val	Asn 360	Cys	His	Arg	Asp	His 365	Arg	Ile	Ala Met Ala	Phe	Ser	Ile	Leu	Gly	Leu	Arg	Val	Asp	Gly	Ile	Thr	Leu	Asp 370					375					380				 Asp Pro	Gln	Cys	Val	Gly	Lys	Thr	Phe	Pro	Gly	Phe	Phe	Asp	Tyr	Leu 385				390					395					400 Gly Arg	Leu	Phe	Pro 405	Glu	Lys	Ala	Leu	Thr 410	Leu	Pro	Gly</span>IV) Sequence: SEQ ID NO.33 Met Glu Thr Asp His Leu Val Ile Pro Gly Ser Lys Ser Ile Thr Asn 1 5 10 15 Arg Wing Leu Leu 20 Leu Wing Wing Wing 25 Lys Gly Thr Ser Val 30 Leu Val Arg Pro Leu 35 Val Ser Wing Asp Thr 40 Ser Wing Phe Lys Thr 45 Wing Ile Gln Wing Leu Gly Wing Asn Val Ser Wing Asp Gly Asp Trn Val Val Glu 50 55 60 Gly Leu Gly Gln Wing Pro His Leu Asp Wing Asp Ile Trp Cys Glu Asp 65 70 75 80 Wing Gly Thr Val Wing 85 Arg Phe Leu Pro Pro 90 Phe Val Wing Gly 95 Wing Gln Gly Lys Phe Thr 100 Val Asp Gly Ser Glu 105 Gln Leu Arg Arg 110 Pro Leu Arg Pro Leu 115 Val Asp Gly Ile Arg 120 His Leu Gly Wing Arg 125 Val Be Ser Glu Gln Leu Pro Leu Thr Ile Glu Wing Be Gly Leu Wing Gly Gly Glu 130 135 140 Tyr Glu Ile Glu Wing His Gln Be Ser Gln Phe Wing Ser Gly Leu Ile 145 150 155 160 Met Wing Pro Wing Tyr 165 Wing Arg Gln Gly Leu 170 Arg Val Arg Ile Pro 175 Asn Pro Val Ser Gln 180 Pro Tyr Leu Thr Met 185 Thr Leu Arg Met Met 190 Arg Asp Phe Gl and Leu 195 Glu Thr Be Thr Asp 200 Gly Wing Thr Val Ser 205 Val Pro Pro Gly Arg Tyr Thr Wing Arg Arg Tyr Glu Ile Glu Pro Asp Wing Thr Thr 210 215 220 Wing Be Tyr Phe Wing Wing Be Wing Val Ser Gly Arg Ser Phe Glu 225 230 235 240 Phe Gln Gly Leu Gly 245 Thr Asp Ser Ile Gln 250 Gly Asp Thr Ser Phe 255 Phe Asn Val Leu Gly 260 Arg Leu Gly Wing Ala 265 Val His Trp Pro Wing 270 Asn Ser Val Thr Xle 275 Ser Gly Pro Glu Arg 280 Leu Asn Gly Asp Ile 285 Glu Val Asp Met Gly Glu Ile Ser Asp Thr Phe Met Thr Wing Ala Ile Wing Pro 290 295 300 Leu Wing Asp Gly Pro Ile Thr Ile Thr Asle Ile Gly His Wing Arg Leu 305 310 315 320 Lys Glu Be Asp Arg 325 Ile Be Ala Met Glu 330 Thr Asn Leu Arg Thr 335 Leu Gly Val Gln Thr 340 Asp Val Gly His Asp 345 Trp Met Arg Ile Tyr 350 Pro Ser Thr Pro His 355 Gly Gly Arg Val Asn 360 Cys His Arg Asp His 365 Arg Ile Ala Met Ala Phe Ser Ile Leu Gly Leu Arg Val Asp Gly Ile Thr Leu Asp 370 375 380 Asp Pro Gln Cys Val Gly Lys Thr Phe Pro Gly Phe Phe Asp Tyr Leu 385 390 395 400 Gly Arg Leu Phe Pro 405 Glu Lys Wing Leu Thr 410 Leu Pro Gly</span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(24)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Portuguese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM88613238" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1. Molcula de cido nuclico isolada, caracterizada pelo fato de que  selecionada do grupo consistindo de:  a) molcula de cido nuclico compreendendo a seqncia de nucleotideos de SEQ ID NO: 1, 3, ou -5, ou um complemento dessas;  b) molcula de cido nuclico compreendendo a seqncia de nucleotideos tendo ao menos 80% de identidade de seqncia  seqncia de nucleotideos de SEQ ID NO: 1, 3, ou 5, ou um complemento dessas;  c)	seqncia de nucleotideos de resistncia a herbicidas da insero de DNA do plasmidio depositado com o No. De Acesso NRRL B-30888 ou B- -30949, ou um complemento dessas;  d)	molcula de cido nuclico que codifica o polipeptideo compreendendo a seqncia de aminocidos de SEQ ID N0:2, 4, ou 6; e,  e) molcula de cido nuclico compreendendo a seqncia de nucleotideos codificando	um polipeptideo tendo ao menos 80% de identidade de seqncia de aminocidos  seqncia	de aminocidos de SEQ ID NO:2, 4, ou 6.</span>An isolated nucleic acid molecule, characterized in that it is selected from the group consisting of: (a) a nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO: 1, 3, or -5, or a complement thereof; b) nucleic acid molecule comprising the nucleotide sequence having at least 80% sequence identity to the nucleotide sequence of SEQ ID NO: 1, 3, or 5, or a complement thereof; c) herbicide resistance nucleotide sequence of the plasmid DNA insert deposited with Accession No. NRRL B-30888 or B-30949, or a complement thereof; d) nucleic acid molecule encoding the polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, or 6; and e) a nucleic acid molecule comprising the nucleotide sequence encoding a polypeptide having at least 80% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 2, 4, or 6.</span>
    </claim-text>
  </claim>
  <claim num="2" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2. Molcula de cido nuclico isolada de acordo com a reivindicao 1, caracterizada pelo fato de que dita seqncia de nucleotideos  uma seqncia sinttica que foi projetada para expresso em uma planta.</span>An isolated nucleic acid molecule according to claim 1, characterized in that said nucleotide sequence is a synthetic sequence that has been designed for expression in a plant.</span>
    </claim-text>
  </claim>
  <claim num="3" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3. Vetor, caracterizado pelo fato de que compreende a molcula de cido nuclico como definida na reivindicao 1.</span>Vector, characterized in that it comprises the nucleic acid molecule as defined in claim 1.</span>
    </claim-text>
  </claim>
  <claim num="4" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4. Vetor de acordo com a reivindicao 3, caracterizado pelo fato de que compreende ainda uma molcula de cido nuclico codificando um polipeptideo heterlogo.</span>A vector according to claim 3, further comprising a nucleic acid molecule encoding a heterologous polypeptide.</span>
    </claim-text>
  </claim>
  <claim num="5" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5. Clula hospedeira, caracterizada pelo fato de que contm o vetor como definido na reivindicao 3.</span>Host cell, characterized in that it contains the vector as defined in claim 3.</span>
    </claim-text>
  </claim>
  <claim num="6" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">6. Clula hospedeira de acordo com a reivindicao 5, caracterizada pelo fato de que  uma clula hospedeira bacteriana.</span>Host cell according to claim 5, characterized in that it is a bacterial host cell.</span>
    </claim-text>
  </claim>
  <claim num="7" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">7. Clula hospedeira de acordo com a reivindicao 5, caracterizada pelo fato de que  uma clula vegetal.</span>Host cell according to claim 5, characterized in that it is a plant cell.</span>
    </claim-text>
  </claim>
  <claim num="8" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">8. Planta transgnica, caracterizada pelo fato de que compreende a clula hospedeira como definida na reivindicao 7.</span>Transgenic plant, characterized in that it comprises the host cell as defined in claim 7.</span>
    </claim-text>
  </claim>
  <claim num="9" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">9.	Planta de acordo com a reivindicao 8, caracterizada pelo fato de que dita planta  selecionada do grupo consistindo de milho, sorgo, trigo, girassol, tomate, cruciferas, pimentas, batata, algodo, arroz, soja, beterraba, cana-de-acar, tabaco, cevada, e couve.</span>Plant according to claim 8, characterized in that said plant is selected from the group consisting of corn, sorghum, wheat, sunflower, tomato, crucifer, pepper, potato, cotton, rice, soybean, sugarcane, cane -sugar, tobacco, barley, and kale.</span>
    </claim-text>
  </claim>
  <claim num="10" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">10.	Semente, caracterizada pelo fato de que  a semente transformada da planta como definida na reivindicao 8.</span>Seed, characterized in that it is the transformed seed of the plant as defined in claim 8.</span>
    </claim-text>
  </claim>
  <claim num="11" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">11. Polipeptideo isolado, caracterizado pelo fato de que  selecionado do grupo consistindo de:  a)	polipeptideo compreendendo a seqncia de aminocidos de SEQ ID NO:2, 4, ou 6;  b)	polipeptideo codificado pela seqncia de nucleotideos de SEQ ID N0:1, 3, ou 5;  c)	polipeptideo compreendendo a seqncia de  aminocidos tendo pelo menos 80% de identidade de seqncia  seqncia de aminocidos de SEQ ID N0:2, 4, ou 6, em que dito polipeptideo possui atividade de resistncia a herbicidas;  d) polipeptideo que  codificado pela seqncia	de nucleotideos que  ao menos 80% idntica	  seqncia de nucleotideos de SEQ ID N0:1, 3,	ou -5, em que dito polipeptideo possui atividade	de resistncia a herbicidas; e,    e) polipeptideo que codificado pela seqncia de nucleotideos de resistncia a herbicidas da insero de DNA do plasmdio depositado com o No. De Acesso NRRL B-30888 ou B-30949.</span>An isolated polypeptide, characterized in that it is selected from the group consisting of: a) polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, or 6; b) polypeptide encoded by the nucleotide sequence of SEQ ID NO: 1, 3, or 5; c) polypeptide comprising the amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 2, 4, or 6, wherein said polypeptide has herbicide resistance activity; d) polypeptide which is encoded by the nucleotide sequence which is at least 80% identical to the nucleotide sequence of SEQ ID NO: 1, 3, or -5, wherein said polypeptide has herbicide resistance activity; and, e) polypeptide which is encoded by the herbicide resistance nucleotide sequence of the plasmid DNA insert deposited with Accession No. NRRL B-30888 or B-30949.</span>
    </claim-text>
  </claim>
  <claim num="12" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12. Polipeptideo de acordo com a reivindicao 11, caracterizado pelo fato de que compreende ainda uma seqncia de aminocidos heterloga.</span>Polypeptide according to claim 11, characterized in that it further comprises a heterologous amino acid sequence.</span>
    </claim-text>
  </claim>
  <claim num="13" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">13. Mtodo para produzir um polipeptideo com atividade de resistncia a herbicidas, caracterizado pelo fato de que compreende cultivar a clula hospedeira como definida na reivindicao 5 sob condies nas quais uma molcula de cido nuclico codificando o polipeptideo  expressada, dito polipeptideo sendo selecionado do grupo consistindo de:  a) polipeptideo compreendendo a seqncia de aminocidos de SEQ ID NO:2, 4, ou 6;  b) polipeptideo codificado pela seqncia de cidos nuclicos de SEQ ID NO:l, 3, ou 5;  c) polipeptideo compreendendo a seqncia de aminocidos tendo ao menos 80% de identidade de seqncia a um polipeptideo com a seqncia de aminocidos de SEQ ID NO:2, 4, ou 6, em que dito    polipeptdeo possui atividade de resistncia a herbicidas;  d)	polipeptdeo codificado pela molcula de cido nuclico compreendendo uma seqncia de nucleotdeos tendo ao menos 80% de identidade de seqncia  seqncia de cidos nuclicos de SEQ ID NO:l, 3, ou 5, em que dito polipeptdeo possui atividade de resistncia a herbicidas; e,  e)	polipeptdeo que codificado pela seqncia de nucleotdeos de resistncia a herbicidas da insero de DNA insert do plasmdio depositado com o No. De Acesso NRRL B-30888 ou B-30949.</span>A method for producing a herbicide resistance activity polypeptide, characterized in that it comprises culturing the host cell as defined in claim 5 under conditions in which a nucleic acid molecule encoding the polypeptide is expressed, said polypeptide being selected from the group. consisting of: a) polypeptide comprising the amino acid sequence of SEQ ID NO: 2, 4, or 6; b) polypeptide encoded by the nucleic acid sequence of SEQ ID NO: 1, 3, or 5; c) polypeptide comprising the amino acid sequence having at least 80% sequence identity to a polypeptide having the amino acid sequence of SEQ ID NO: 2, 4, or 6, wherein said polypeptide has herbicide resistance activity; d) polypeptide encoded by the nucleic acid molecule comprising a nucleotide sequence having at least 80% sequence identity to the nucleic acid sequence of SEQ ID NO: 1, 3, or 5, wherein said polypeptide has herbicide resistance activity ; and, e) polypeptide encoded by the herbicide resistance nucleotide sequence of the plasmid DNA insert deposited with Accession No. NRRL B-30888 or B-30949.</span>
    </claim-text>
  </claim>
  <claim num="14" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">14. Mtodo para conferir resistncia a um herbicida para uma planta, caracterizado pelo fato de que compreende transformar dita planta com um constructo de DNA, dito constructo compreendendo um promotor que dirige a expresso em uma clula vegetal operacionalmente ligada com uma seqncia de nucleotdeos pelo menos 80% idntica  seqncia de nucleotdeos de SEQ ID NO: 1, 3, ou 5, e regenerar uma planta transformada.</span>A method for conferring herbicide resistance to a plant, characterized in that it comprises transforming said plant with a DNA construct, said construct comprising a promoter that directs expression in a plant cell operably linked with at least one nucleotide sequence. 80% identical to the nucleotide sequence of SEQ ID NO: 1, 3, or 5, and regenerate a transformed plant.</span>
    </claim-text>
  </claim>
  <claim num="15" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15. Mtodo de acordo com a reivindicao 14, caracterizado pelo fato de que dito herbicida  glifosato.</span>A method according to claim 14, characterized in that said herbicide is glyphosate.</span>
    </claim-text>
  </claim>
  <claim num="16" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">16. Planta, caracterizada pelo fato de que tem estavelmente incorporado em seu genoma um constructo de DNA    compreendendo uma seqncia de nucleotdeos que codifica uma protena tendo atividade de resistncia a herbicidas, em que dita seqncia de nucleotdeos  selecionada do grupo consistindo de:  a) seqncia de nucleotdeos de SEQ ID NO: 1, 3, ou 5;  b) seqncia de nucleotdeos tendo ao menos 80% de identidade de seqncia a uma seqncia de  nucleotdeos de SEQ ID NO: 1, 3, ou 5, em que dita seqncia de nucleotdeos codifica um polipeptdeo tendo atividade de resistncia a herbicidas;  c) seqncia de nucleotdeos codificando o polipeptdeo compreendendo uma seqncia de aminocidos de SEQ ID NO: 2, 4, ou 6;  d) seqncia de nucleotdeos codificando o polipeptdeo tendo ao menos 80% de identidade de seqncia de aminocidos  seqncia de aminocidos de SEQ ID NO: 2, 4, ou 6, em que dito polipeptdeo possui atividade de resistncia a herbicidas; e,  e) seqncia de nucleotdeos de resistncia a herbicidas da insero de DNA do plasmdio depositado com o No. de acesso NRRL B-30888 ou B-    -3094 9; em que dita seqncia de nucleotideos  operacionalmente ligada a um promotor que dirige</span>16. Plant, characterized in that it has stably incorporated into its genome a DNA construct comprising a nucleotide sequence encoding a protein having herbicide resistance activity, wherein said nucleotide sequence is selected from the group consisting of: a) nucleotide sequence of SEQ ID NO: 1, 3, or 5; b) nucleotide sequence having at least 80% sequence identity to a nucleotide sequence of SEQ ID NO: 1, 3, or 5, wherein said nucleotide sequence encodes a polypeptide having herbicide resistance activity; c) nucleotide sequence encoding the polypeptide comprising an amino acid sequence of SEQ ID NO: 2, 4, or 6; d) nucleotide sequence encoding the polypeptide having at least 80% amino acid sequence identity to the amino acid sequence of SEQ ID NO: 2, 4, or 6, wherein said polypeptide has herbicide resistance activity; and, e) herbicide resistance nucleotide sequence of the plasmid DNA insert deposited with accession number NRRL B-30888 or B-30949; wherein said nucleotide sequence is operably linked to a promoter that directs</span>
    </claim-text>
  </claim>
  <claim num="17" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">17. Planta de acordo com a reivindicao 16, caracterizada pelo fato de que dita planta  uma clula vegetal.</span>Plant according to claim 16, characterized in that said plant is a plant cell.</span>
    </claim-text>
  </claim>
  <claim num="18" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">18.	Molcula de cido nuclico isolada, caracterizada pelo fato de que codifica a enzima EPSPS resistente ao glifosato, em que dita enzima EPSPS resistente a glifosato possui uma Km para fosfoenolpiruvato (PEP) entre cerca de 1 e cerca de 150uM e uma Kj (glifosato)/ Km (PEP) entre cerca de 500 e cerca de 1000.</span>18. Isolated nucleic acid molecule, characterized in that it encodes the glyphosate-resistant EPSPS enzyme, wherein said glyphosate-resistant EPSPS enzyme has a Km for phosphoenolpyruvate (PEP) between about 1 and about 150uM and a Kj (glyphosate). ) / Km (PEP) between about 500 and about 1000.</span>
    </claim-text>
  </claim>
  <claim num="19" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">19.	Planta, caracterizada pelo fato de que tem estavelmente incorporado em seu genoma o constructo de DNA compreendendo uma seqncia de nucleotideos que codifica um polipeptideo EPSPS, dito polipeptideo EPSPS tendo uma Km para PEP entre cerca de 1 e cerca de 150uM e uma Kj (glifosato) / Km (PEP) entre cerca de 500 e cerca de 1000, dita planta exibindo tolerncia a herbicida glifosato.</span>19. Plant, characterized in that it has stably incorporated into its genome the DNA construct comprising a nucleotide sequence encoding an EPSPS polypeptide, said EPSPS polypeptide having a Km to PEP of from about 1 to about 150uM and a Kj ( glyphosate) / Km (PEP) between about 500 and about 1000, said plant exhibiting tolerance to glyphosate herbicide.</span>
    </claim-text>
  </claim>
  <claim num="20" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">20.	Planta de acordo com a reivindicao 19, caracterizada pelo fato de que dita planta  uma planta de soja.</span>Plant according to claim 19, characterized in that said plant is a soybean plant.</span>
    </claim-text>
  </claim>
  <claim num="21" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">21.	Planta de acordo com a reivindicao 19, caracterizada pelo fato de que dita planta  uma planta de milho.</span>Plant according to claim 19, characterized in that said plant is a corn plant.</span>
    </claim-text>
  </claim>
  <claim num="22" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">22. Planta de acordo com a reivindicao 19, caracterizada pelo fato de que dita planta  selecionada do grupo consistindo de milho, sorgo, trigo, girassol, tomate, cruciferas, pimentas, batata, algodo, arroz, soja, beterraba, cana-de-acar, tabaco, cevada, e couve.</span>Plant according to claim 19, characterized in that said plant is selected from the group consisting of corn, sorghum, wheat, sunflower, tomato, crucifer, pepper, potato, cotton, rice, soybean, beet, cane -sugar, tobacco, barley, and kale.</span>
    </claim-text>
  </claim>
  <claim num="23" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">23. Mtodo para medir a liberao de fosfato por uma enzima, caracterizado pelo fato de que compreende incubar dita enzima na presena de um substrato da enzima e um ou mais componentes de reao selecionados do grupo consistindo de:  a) xantina oxidase a uma concentrao de pelo menos -1 U/ml;  b) purina nucleosideo fosforilase a uma concentrao maior do que 0,1 U/ml; e,  c) N-acetil-3,7-dihidroxifenoxacina	a	uma concentrao maior do que 100 ; por onde a liberao de fosfato  associada com a formao do composto fluorescente resorufina.</span>23. Method for measuring phosphate release by an enzyme, characterized in that it comprises incubating said enzyme in the presence of an enzyme substrate and one or more reaction components selected from the group consisting of: a) xanthine oxidase at a concentration of at least -1 U / ml; b) purine nucleoside phosphorylase at a concentration greater than 0.1 U / ml; and, (c) N-acetyl-3,7-dihydroxyphenoxacin at a concentration greater than 100 ; whereby phosphate release is associated with the formation of the resorufin fluorescent compound.</span>
    </claim-text>
  </claim>
  <claim num="24" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">24. Mtodo de acordo com a reivindicao 23, caracterizado pelo fato de que dita enzima  EPSPS.</span>A method according to claim 23, characterized in that said enzyme is EPSPS.</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (15)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4196265A/en"><a id="link" href="#" class="style-scope state-modifier">US4196265A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1977-06-15</span>
                    <span class="td style-scope patent-result">1980-04-01</span>
                    <span class="td style-scope patent-result">The Wistar Institute</span>
                    <span class="td style-scope patent-result">Method of producing antibodies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US4535060A/en"><a id="link" href="#" class="style-scope state-modifier">US4535060A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-01-05</span>
                    <span class="td style-scope patent-result">1985-08-13</span>
                    <span class="td style-scope patent-result">Calgene, Inc.</span>
                    <span class="td style-scope patent-result">Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5094945A/en"><a id="link" href="#" class="style-scope state-modifier">US5094945A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1983-01-05</span>
                    <span class="td style-scope patent-result">1992-03-10</span>
                    <span class="td style-scope patent-result">Calgene, Inc.</span>
                    <span class="td style-scope patent-result">Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthase, production and use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5380831A/en"><a id="link" href="#" class="style-scope state-modifier">US5380831A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1986-04-04</span>
                    <span class="td style-scope patent-result">1995-01-10</span>
                    <span class="td style-scope patent-result">Mycogen Plant Science, Inc.</span>
                    <span class="td style-scope patent-result">Synthetic insecticidal crystal protein gene 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE85360T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE85360T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-07</span>
                    <span class="td style-scope patent-result">1993-02-15</span>
                    <span class="td style-scope patent-result">Monsanto Co</span>
                    <span class="td style-scope patent-result">
  GLYPHOSATE RESISTANT PLANTS.
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5240842A/en"><a id="link" href="#" class="style-scope state-modifier">US5240842A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-07-11</span>
                    <span class="td style-scope patent-result">1993-08-31</span>
                    <span class="td style-scope patent-result">Biotechnology Research And Development Corporation</span>
                    <span class="td style-scope patent-result">Aerosol beam microinjector 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20010003849A1/en"><a id="link" href="#" class="style-scope state-modifier">US20010003849A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1989-08-07</span>
                    <span class="td style-scope patent-result">2001-06-14</span>
                    <span class="td style-scope patent-result">Kenneth A. Barton</span>
                    <span class="td style-scope patent-result">Expression of genes in plants 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5633435A/en"><a id="link" href="#" class="style-scope state-modifier">US5633435A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1990-08-31</span>
                    <span class="td style-scope patent-result">1997-05-27</span>
                    <span class="td style-scope patent-result">Monsanto Company</span>
                    <span class="td style-scope patent-result">Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/UA48104C2/en"><a id="link" href="#" class="style-scope state-modifier">UA48104C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-10-04</span>
                    <span class="td style-scope patent-result">2002-08-15</span>
                    <span class="td style-scope patent-result"> </span>
                    <span class="td style-scope patent-result">Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW261517B/en"><a id="link" href="#" class="style-scope state-modifier">TW261517B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1991-11-29</span>
                    <span class="td style-scope patent-result">1995-11-01</span>
                    <span class="td style-scope patent-result">Mitsubishi Shozi Kk</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5605793A/en"><a id="link" href="#" class="style-scope state-modifier">US5605793A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-02-17</span>
                    <span class="td style-scope patent-result">1997-02-25</span>
                    <span class="td style-scope patent-result">Affymax Technologies N.V.</span>
                    <span class="td style-scope patent-result">Methods for in vitro recombination 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5837458A/en"><a id="link" href="#" class="style-scope state-modifier">US5837458A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-02-17</span>
                    <span class="td style-scope patent-result">1998-11-17</span>
                    <span class="td style-scope patent-result">Maxygen, Inc.</span>
                    <span class="td style-scope patent-result">Methods and compositions for cellular and metabolic engineering 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/ATE538205T1/en"><a id="link" href="#" class="style-scope state-modifier">ATE538205T1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-29</span>
                    <span class="td style-scope patent-result">2012-01-15</span>
                    <span class="td style-scope patent-result">Midwest Oilseeds Inc</span>
                    <span class="td style-scope patent-result">
  METHOD, MEDIA AND DEVICE FOR INTRODUCING MOLECULES INTO PLANT CELLS AND BACTERIA USING AEROSOL JETS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003085114A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2003085114A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-04-01</span>
                    <span class="td style-scope patent-result">2003-10-16</span>
                    <span class="td style-scope patent-result">Walter Reed Army Institute Of Research</span>
                    <span class="td style-scope patent-result">Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004074443A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2004074443A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-02-18</span>
                    <span class="td style-scope patent-result">2004-09-02</span>
                    <span class="td style-scope patent-result">Monsanto Technology Llc</span>
                    <span class="td style-scope patent-result">Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps) 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (27)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2007223364B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2007223364B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-03-02</span>
                    <span class="td style-scope patent-result">2014-02-13</span>
                    <span class="td style-scope patent-result">Athenix Corporation</span>
                    <span class="td style-scope patent-result">Methods and compositions for improved enzyme activity in transgenic plant 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9045765B2/en"><a id="link" href="#" class="style-scope state-modifier">US9045765B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-06-09</span>
                    <span class="td style-scope patent-result">2015-06-02</span>
                    <span class="td style-scope patent-result">Athenix Corporation</span>
                    <span class="td style-scope patent-result">EPSP synthase genes conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2087124B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2087124B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006-11-29</span>
                    <span class="td style-scope patent-result">2011-05-11</span>
                    <span class="td style-scope patent-result">Athenix Corporation</span>
                    <span class="td style-scope patent-result">Improved grg23 epsp synthases: compositions and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN101429499B/en"><a id="link" href="#" class="style-scope state-modifier">CN101429499B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-11-09</span>
                    <span class="td style-scope patent-result">2010-08-11</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Glyphosate highly-tolerant EPSP synthase and coded sequence thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2009210450A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2009210450A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2008-02-01</span>
                    <span class="td style-scope patent-result">2009-08-13</span>
                    <span class="td style-scope patent-result">Athenix Corporation</span>
                    <span class="td style-scope patent-result">Directed evolution of GRG31 and GRG36 EPSP synthase enzymes 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2011000498A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2011000498A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-07-01</span>
                    <span class="td style-scope patent-result">2011-01-06</span>
                    <span class="td style-scope patent-result">Bayer Bioscience N.V.</span>
                    <span class="td style-scope patent-result">Methods and means for obtaining plants with enhanced glyphosate tolerance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2525658B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2525658B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-01-22</span>
                    <span class="td style-scope patent-result">2017-03-01</span>
                    <span class="td style-scope patent-result">Bayer Intellectual Property GmbH</span>
                    <span class="td style-scope patent-result">Acaricides and/or insecticidal agent combinations 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9593317B2/en"><a id="link" href="#" class="style-scope state-modifier">US9593317B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-06-09</span>
                    <span class="td style-scope patent-result">2017-03-14</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Nv</span>
                    <span class="td style-scope patent-result">Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN109504700A/en"><a id="link" href="#" class="style-scope state-modifier">CN109504700A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-06-09</span>
                    <span class="td style-scope patent-result">2019-03-22</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Plant Genome transformation in commonly on nucleotide sequence modified plant genome Method and kit for 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX2013005258A/en"><a id="link" href="#" class="style-scope state-modifier">MX2013005258A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-11-15</span>
                    <span class="td style-scope patent-result">2013-07-05</span>
                    <span class="td style-scope patent-result">Bayer Ip Gmbh</span>
                    <span class="td style-scope patent-result">N-aryl pyrazole(thio)carboxamides. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013014241A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013014241A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-07-28</span>
                    <span class="td style-scope patent-result">2013-01-31</span>
                    <span class="td style-scope patent-result">Genective</span>
                    <span class="td style-scope patent-result">Glyphosate tolerant corn event vco-1981-5 and kit and method for detecting the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112014002855A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112014002855A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-08-10</span>
                    <span class="td style-scope patent-result">2017-02-21</span>
                    <span class="td style-scope patent-result">Bayer Ip Gmbh</span>
                    <span class="td style-scope patent-result">
  active compound combinations including specific tetramic acid derivatives
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MX346439B/en"><a id="link" href="#" class="style-scope state-modifier">MX346439B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-08-22</span>
                    <span class="td style-scope patent-result">2017-03-17</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Nv</span>
                    <span class="td style-scope patent-result">Methods and means to modify a plant genome. 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP6018477B2/en"><a id="link" href="#" class="style-scope state-modifier">JP6018477B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-11-11</span>
                    <span class="td style-scope patent-result">2016-11-02</span>
                    <span class="td style-scope patent-result">Hoya</span>
                    <span class="td style-scope patent-result">
  Artificial bone-cartilage complex and method for producing the same
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2720973C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2720973C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-02-01</span>
                    <span class="td style-scope patent-result">2020-05-15</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">Synthetic transit peptides of chloroplasts 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN104245940A/en"><a id="link" href="#" class="style-scope state-modifier">CN104245940A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-23</span>
                    <span class="td style-scope patent-result">2014-12-24</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Targeted genome engineering in plants 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112015014307A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112015014307A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-19</span>
                    <span class="td style-scope patent-result">2017-07-11</span>
                    <span class="td style-scope patent-result">Bayer Cropscience Ag</span>
                    <span class="td style-scope patent-result">
  difluoromethyl nicotinic tetrahydronaphthyl carboxamides
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN105008541A/en"><a id="link" href="#" class="style-scope state-modifier">CN105008541A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-12-21</span>
                    <span class="td style-scope patent-result">2015-10-28</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Compositions and methods for auxin-analog conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20140289906A1/en"><a id="link" href="#" class="style-scope state-modifier">US20140289906A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-14</span>
                    <span class="td style-scope patent-result">2014-09-25</span>
                    <span class="td style-scope patent-result">Pioneer Hi-Bred International, Inc.</span>
                    <span class="td style-scope patent-result">Compositions Having Dicamba Decarboxylase Activity and Methods of Use 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160040149A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160040149A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-03-14</span>
                    <span class="td style-scope patent-result">2016-02-11</span>
                    <span class="td style-scope patent-result">Pioneer Hi-Bred International Inc.</span>
                    <span class="td style-scope patent-result">Compositions Having Dicamba Decarboxylase Activity and Methods of Use 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BR112016008489A2/en"><a id="link" href="#" class="style-scope state-modifier">BR112016008489A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-10-18</span>
                    <span class="td style-scope patent-result">2017-10-03</span>
                    <span class="td style-scope patent-result">Pioneer Hi Bred Int</span>
                    <span class="td style-scope patent-result">
  GLYPHOSATE-N-ACETYLTRANSFERASE (GLYAT) SEQUENCES AND METHODS OF USE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9877486B2/en"><a id="link" href="#" class="style-scope state-modifier">US9877486B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-01-31</span>
                    <span class="td style-scope patent-result">2018-01-30</span>
                    <span class="td style-scope patent-result">AgBiome, Inc.</span>
                    <span class="td style-scope patent-result">Methods of growing plants using modified biological control agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR102566936B1/en"><a id="link" href="#" class="style-scope state-modifier">KR102566936B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-01-31</span>
                    <span class="td style-scope patent-result">2023-08-14</span>
                    <span class="td style-scope patent-result">, .</span>
                    <span class="td style-scope patent-result">Modified biological control agents and their uses 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10053702B2/en"><a id="link" href="#" class="style-scope state-modifier">US10053702B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-04-22</span>
                    <span class="td style-scope patent-result">2018-08-21</span>
                    <span class="td style-scope patent-result">E I Du Pont De Nemours And Company</span>
                    <span class="td style-scope patent-result">Plastidic carbonic anhydrase genes for oil augmentation in seeds with increased DGAT expression 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN104611307B/en"><a id="link" href="#" class="style-scope state-modifier">CN104611307B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-13</span>
                    <span class="td style-scope patent-result">2018-04-27</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">Herbicide resistance protein, its encoding gene and purposes 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN107531676A/en"><a id="link" href="#" class="style-scope state-modifier">CN107531676A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-04-13</span>
                    <span class="td style-scope patent-result">2018-01-02</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">N cycloalkyl N (double heterocyclic radical ethylidene) (thio) carboxamide derivative 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2020232103A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2020232103A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-05-13</span>
                    <span class="td style-scope patent-result">2020-11-19</span>
                    <span class="td style-scope patent-result">AgBiome, Inc.</span>
                    <span class="td style-scope patent-result">Dried biological control agents and their uses 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0619092A2/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0619092A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-09-13</span>
                    <span class="td style-scope patent-result">
  isolated nucleic acid molecule, isolated polypeptide, vector, host cell, transgenic plant, seed, method for producing polypeptide with herbicide resistance activity, method for conferring herbicide resistance to plant, method for measuring enzyme phosphate release
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP4879969B2/en"><a id="link" href="#" class="style-scope state-modifier">JP4879969B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-02-22</span>
                    <span class="td style-scope patent-result">
  Identification of a new class of EPSP synthase
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2671203C/en"><a id="link" href="#" class="style-scope state-modifier">CA2671203C</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-02-10</span>
                    <span class="td style-scope patent-result">Improved grg23 epsp synthases: compositions and methods of use 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7538262B2/en"><a id="link" href="#" class="style-scope state-modifier">US7538262B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-05-26</span>
                    <span class="td style-scope patent-result">GDC-2 genes conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7960615B2/en"><a id="link" href="#" class="style-scope state-modifier">US7960615B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-06-14</span>
                    <span class="td style-scope patent-result">GRG36: novel EPSP synthase gene conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8003854B2/en"><a id="link" href="#" class="style-scope state-modifier">US8003854B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-08-23</span>
                    <span class="td style-scope patent-result">GRG32: a novel EPSP synthase gene conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9045765B2/en"><a id="link" href="#" class="style-scope state-modifier">US9045765B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-06-02</span>
                    <span class="td style-scope patent-result">EPSP synthase genes conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2005330520B2/en"><a id="link" href="#" class="style-scope state-modifier">AU2005330520B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-02-23</span>
                    <span class="td style-scope patent-result">Genes conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0711953A2/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0711953A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-17</span>
                    <span class="td style-scope patent-result">
  isolated polynucleotide and polypeptide conferring resistance to glutamine synthetase and methods for producing transgenic plants and plant cells having improved nitrogen production and utilization
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2637054A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2637054A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-07-19</span>
                    <span class="td style-scope patent-result">Epsp synthase enzyme domains conferring glyphosate resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0712991A2/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0712991A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-04-17</span>
                    <span class="td style-scope patent-result">
  isolated polynucleotide, method of producing a transformed plant showing glyphosate tolerance, glyphosate tolerant plant cell and plant, transformed seed, method for selectively controlling weeds, isolated nucleic acid molecules and plant
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2009210450A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2009210450A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-08-13</span>
                    <span class="td style-scope patent-result">Directed evolution of GRG31 and GRG36 EPSP synthase enzymes 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2336306A2/en"><a id="link" href="#" class="style-scope state-modifier">EP2336306A2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-06-22</span>
                    <span class="td style-scope patent-result">Novel EPSP synthase genes conferring herbicide resistance 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/BRPI0719672B1/en"><a id="link" href="#" class="style-scope state-modifier">BRPI0719672B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-09-05</span>
                    <span class="td style-scope patent-result">
  ISOLATED POLYOPEPTIDE ISOLATED, METHOD FOR PRODUCING A POLYMPEPTIDE WITH RESISTANCE ACTIVITY FOR HERBICIDES, METHOD FOR CONFERING RESISTANCE TO A HERBICIDE IN PLANT
 
     </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (5)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US74116605P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2005-12-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/741,166<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2005-12-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US81779906P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2006-06-30</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US60/817,799<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2006-06-30</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2007064828A2/en"><a id="link" href="#" class="style-scope state-modifier">PCT/US2006/045908</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2006-12-01</span>
                    <span class="td style-scope patent-result">Grg23 and grg51 genes conferring herbicide resistance 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-06-26</span>
                    <span class="td nowrap style-scope patent-result">B08F</span>
                    <span class="td nowrap style-scope patent-result">Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: REFERENTE A 4A ANUIDADE(S).</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2012-09-25</span>
                    <span class="td nowrap style-scope patent-result">B08H</span>
                    <span class="td nowrap style-scope patent-result">Application fees: decision cancelled [chapter 8.8 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: REFERENTE AO DESPACHO 8.6 NA RPI 2164  NA DATA 26/06/2012.</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-01-31</span>
                    <span class="td nowrap style-scope patent-result">B25G</span>
                    <span class="td nowrap style-scope patent-result">Requested change of headquarter approved</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: ATHENIX CORPORATION (US)</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-04-04</span>
                    <span class="td nowrap style-scope patent-result">B06F</span>
                    <span class="td nowrap style-scope patent-result">Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-06-27</span>
                    <span class="td nowrap style-scope patent-result">B06A</span>
                    <span class="td nowrap style-scope patent-result">Patent application procedure suspended [chapter 6.1 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2017-11-14</span>
                    <span class="td nowrap style-scope patent-result">B09B</span>
                    <span class="td nowrap style-scope patent-result">Patent application refused [chapter 9.2 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2018-02-27</span>
                    <span class="td nowrap style-scope patent-result">B09B</span>
                    <span class="td nowrap style-scope patent-result">Patent application refused [chapter 9.2 patent gazette]</span>
                    <span class="td style-scope patent-result">
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4217134345" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.4217134345" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=741353738" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>